{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 68
    },
    "colab_type": "code",
    "id": "n5R1APadwANc",
    "outputId": "3553d1b6-cb0c-4adf-efac-333da6e7f547",
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Using TensorFlow backend.\n",
      "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
      "[nltk_data]   Unzipping corpora/stopwords.zip.\n"
     ]
    }
   ],
   "source": [
    "# import libraries\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")\n",
    "from nltk import FreqDist\n",
    "import seaborn as sns\n",
    "%matplotlib inline\n",
    "import re\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import nltk\n",
    "from nltk.tokenize import word_tokenize\n",
    "import requests\n",
    "from nltk.tokenize import word_tokenize\n",
    "import matplotlib.pyplot as plt\n",
    "#from gensim.models import KeyedVectors\n",
    "\n",
    "from keras.preprocessing.text import Tokenizer\n",
    "from keras.utils import to_categorical\n",
    "from keras.preprocessing.sequence import pad_sequences\n",
    "from keras.utils.vis_utils import plot_model\n",
    "from keras.layers import Embedding\n",
    "import os\n",
    "from nltk import TreebankWordTokenizer\n",
    "from nltk.stem.porter import PorterStemmer\n",
    "from nltk.corpus import stopwords\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "from gensim.models import Word2Vec\n",
    "nltk.download('stopwords')\n",
    "stemmer = PorterStemmer()\n",
    "tw = TreebankWordTokenizer()\n",
    "import json\n",
    "from collections import Counter\n",
    "import itertools\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#nltk.download('stopwords')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('max_colwidth', 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "mt = []\n",
    "tt = []\n",
    "abst = []\n",
    "lt = []\n",
    "fl = []\n",
    "pdi = []\n",
    "rds = 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'/mnt/disks/user/project'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#os.getcwd()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#stemmer = PorterStemmer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "#tw = TreebankWordTokenizer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "#import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "def input_df(pth):\n",
    "    mt = []\n",
    "    tt = []\n",
    "    abst = []\n",
    "    lt = []\n",
    "    fl = []\n",
    "    pdi = []\n",
    "    rds = 0\n",
    "    #import json\n",
    "    #i = 2\n",
    "    chec = 0\n",
    "    path = pth\n",
    "    #path = '/mnt/disks/user/project/Corona_Kaggle_project/biorxiv_medrxiv/biorxiv_medrxiv/pdf_json/'\n",
    "    files = os.listdir(path)\n",
    "    #print(files)\n",
    "    #keyword = 'your_keyword'\n",
    "    for file in files:\n",
    "        #print(file)\n",
    "        #print(os.path.isfile(os.path.join(path,file)))\n",
    "        if os.path.isfile(os.path.join(path,file)):\n",
    "            with open(os.path.join(path,file)) as f:\n",
    "                data = json.load(f)\n",
    "        if chec == 0:\n",
    "            print(data.keys())\n",
    "            chec = 1\n",
    "        fl.append(file)\n",
    "        title = data['metadata']\n",
    "        title = title['title']\n",
    "        title = re.sub(r\"\\s+\", \" \", title)\n",
    "        title = re.sub(r\"(\\s+\\.)\", \".\", title)\n",
    "        tt.append(title)\n",
    "        abtr = data['abstract']\n",
    "        #print(abtr)\n",
    "        if abtr != []:\n",
    "            abtr = abtr[0]\n",
    "            abtr = abtr['text']\n",
    "            abtr = re.sub(r\"\\s+\", \" \", abtr)\n",
    "            abtr = re.sub(r\"(\\s+\\.)\", \".\", abtr)\n",
    "        else:\n",
    "            abtr = title\n",
    "        abst.append(abtr)\n",
    "        bd = data['body_text']\n",
    "        pdi.append(data['paper_id'])\n",
    "        for i in range(len(bd)):\n",
    "            fd = bd[i]\n",
    "            str1 = fd['text']\n",
    "            str1 = re.sub(r\"\\b(\\d\\s\\d\\s\\d)\\b\", \"\", str1)\n",
    "            str1 = re.sub(r\"\\s+\", \" \", str1)\n",
    "            str1 = re.sub(r\"(\\s+\\.)\", \".\", str1)\n",
    "            if rds == 0:\n",
    "                rds = 1\n",
    "            lt.append(str1)\n",
    "        lt = \" \".join(lt)\n",
    "        f.close()\n",
    "        mt.append(lt)\n",
    "        lt = []\n",
    "    return(pdi, mt, tt, abst)\n",
    "\n",
    "        \n",
    "            \n",
    "            \n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'title': 'Two novel bocaparvovirus species identified in wild Himalayan marmots',\n",
       " 'authors': [{'first': 'Yuanyun',\n",
       "   'middle': [],\n",
       "   'last': 'Ao',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Viral Diseases Control and Prevention',\n",
       "    'location': {'postCode': '100052',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'â€ ',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'Xiaoyue',\n",
       "   'middle': [],\n",
       "   'last': 'Li',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': 'Laboratory Department',\n",
       "    'institution': \"the First People's Hospital of Anqing\",\n",
       "    'location': {'postCode': '246000',\n",
       "     'settlement': 'Anqing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Lili',\n",
       "   'middle': [],\n",
       "   'last': 'Li',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Viral Diseases Control and Prevention',\n",
       "    'location': {'postCode': '100052',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Xiaolu',\n",
       "   'middle': [],\n",
       "   'last': 'Xie',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'Peking Union Medical College Hospital',\n",
       "    'location': {'postCode': '100730',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Dong',\n",
       "   'middle': [],\n",
       "   'last': 'Jin',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Communicable Disease Control and Prevention',\n",
       "    'location': {'postCode': '102206',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Jiemei',\n",
       "   'middle': [],\n",
       "   'last': 'Yu',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Viral Diseases Control and Prevention',\n",
       "    'location': {'postCode': '100052',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Shan',\n",
       "   'middle': [],\n",
       "   'last': 'Lu',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Communicable Disease Control and Prevention',\n",
       "    'location': {'postCode': '102206',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Zhaojun',\n",
       "   'middle': [],\n",
       "   'last': 'Duan',\n",
       "   'suffix': '',\n",
       "   'affiliation': {'laboratory': '',\n",
       "    'institution': 'National Institute for Viral Diseases Control and Prevention',\n",
       "    'location': {'postCode': '100052',\n",
       "     'settlement': 'Beijing',\n",
       "     'country': 'China'}},\n",
       "   'email': ''},\n",
       "  {'first': 'Y',\n",
       "   'middle': [],\n",
       "   'last': 'Ao',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'X',\n",
       "   'middle': [],\n",
       "   'last': 'Li',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'L',\n",
       "   'middle': [],\n",
       "   'last': 'Li',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'X',\n",
       "   'middle': [],\n",
       "   'last': 'Xie',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'Jin',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'D',\n",
       "   'middle': [],\n",
       "   'last': 'Lu',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'S',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'Yu',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'J',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'Duan',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''},\n",
       "  {'first': 'Z',\n",
       "   'middle': [],\n",
       "   'last': '',\n",
       "   'suffix': '',\n",
       "   'affiliation': {},\n",
       "   'email': ''}]}"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Trial code\n",
    "#data['metadata']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [],
   "source": [
    "#dr = data['metadata']\n",
    "#dr = dr['title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Two novel bocaparvovirus species identified in wild Himalayan marmots'"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#dr"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It can be seen that \"Abstract\" from the respective files is a better source for search of the answers as the full body\n",
    "text section consists of detailed explaination as well as analysis of various experiments that would not be required \n",
    "for short and crisp answers for the questions\"\n",
    "Therefore, will consider \"Abstract\" section only for answer generation. However, will consider mentioning the full \"body text\" within the dataframe for reference."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1b9fed2824e97db8cb35912549dd2e9cde7b6c18\n"
     ]
    }
   ],
   "source": [
    "#print(data['paper_id'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1342\n"
     ]
    }
   ],
   "source": [
    "print(len(pdi))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1342\n"
     ]
    }
   ],
   "source": [
    "print(len(mt))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1889"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#len(mt[0].split())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "pdi, mt, tt, abst = input_df('/mnt/disks/user/project/Corona_Kaggle_project/biorxiv_medrxiv/biorxiv_medrxiv/pdf_json/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "pid = pd.DataFrame(data = {'sha':pdi, 'Body_text':mt, 'fl_title':tt, 'fl_abstract':abst})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>518b635f78bdc65dc6666380eafc3b7a283b3af7</td>\n",
       "      <td>To quantify the effects of the most informative risk factors, partial dependences were Table). A...</td>\n",
       "      <td>Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2</td>\n",
       "      <td>Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4bc43084ccdb8d3bb704ca577473169cd1a64f9c</td>\n",
       "      <td>belong to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae...</td>\n",
       "      <td>Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) ...</td>\n",
       "      <td>Background: In December 2019, an outbreak of novel coronavirus disease emerged in Wuhan, China a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>e4e5e67fd4f75548dffab7f75484bc14fa15c0c2</td>\n",
       "      <td>new genes involved in phi6 host range expansion, expanding our knowledge of this important model...</td>\n",
       "      <td>Existing host range mutations constrain further emergence of RNA viruses</td>\n",
       "      <td>RNA viruses are capable of rapid host shifting, typically due to a point mutation that confers e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>5f7e6772c35ba7d67891202d43e0a43917f90971</td>\n",
       "      <td>Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...</td>\n",
       "      <td>EARLY ESTIMATION OF REPRODUCTION NUMBER OF COVID-19 IN VIETNAM</td>\n",
       "      <td>Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a625e5d6fc8956c231c500a40e887e248a69de61</td>\n",
       "      <td>The bulk of death cases had comorbidity (76.8%). Respiratory failure remained the leading cause ...</td>\n",
       "      <td>Clinical characteristics of 82 death cases with COVID-19</td>\n",
       "      <td>A recently developing pneumonia caused by SARS-CoV-2 was originated in Wuhan, China, and has qui...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  518b635f78bdc65dc6666380eafc3b7a283b3af7   \n",
       "1  4bc43084ccdb8d3bb704ca577473169cd1a64f9c   \n",
       "2  e4e5e67fd4f75548dffab7f75484bc14fa15c0c2   \n",
       "3  5f7e6772c35ba7d67891202d43e0a43917f90971   \n",
       "4  a625e5d6fc8956c231c500a40e887e248a69de61   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  To quantify the effects of the most informative risk factors, partial dependences were Table). A...   \n",
       "1  belong to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae...   \n",
       "2  new genes involved in phi6 host range expansion, expanding our knowledge of this important model...   \n",
       "3  Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...   \n",
       "4  The bulk of death cases had comorbidity (76.8%). Respiratory failure remained the leading cause ...   \n",
       "\n",
       "                                                                                              fl_title  \\\n",
       "0                     Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2   \n",
       "1  Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) ...   \n",
       "2                             Existing host range mutations constrain further emergence of RNA viruses   \n",
       "3                                       EARLY ESTIMATION OF REPRODUCTION NUMBER OF COVID-19 IN VIETNAM   \n",
       "4                                             Clinical characteristics of 82 death cases with COVID-19   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0                     Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2  \n",
       "1  Background: In December 2019, an outbreak of novel coronavirus disease emerged in Wuhan, China a...  \n",
       "2  RNA viruses are capable of rapid host shifting, typically due to a point mutation that confers e...  \n",
       "3  Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...  \n",
       "4  A recently developing pneumonia caused by SARS-CoV-2 was originated in Wuhan, China, and has qui...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1342"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 185,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. 2019 Novel Coronavirus (2019-nCoV) is a coronavirus identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV has been transmitted from civet cats to humans and MERS-CoV from camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Early on, many of the patients in the outbreak in Wuhan, China reportedly have some link to a large seafood and animal market, suggesting animal-toperson spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. The 2019-nCoV is spreading from person to person in China and limited spread among close contacts has been detected in some countries outside China. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. There is currently no vaccine to protect against 2019-nCoV. According to Lu et al, 2020 [1] , genome sequence of 2019-nCoV is closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21 and genetically distinct from SARS-CoV. Two complete virus genomes (HKU-SZ-002a and HKU-SZ-005b) are sequenced from 2019-nCoV infected patients [2]. HKU-SZ-002a and HKU-SZ-005b differ from each other by only two bases. One of them is a non-synonymous mutation at amino acid position 336 of non-structural protein 4 (Ser336 for HKU-SZ-002a; Leu336 for HKU-SZ-005b). The amino acid sequence of the N-terminal domain of Spike subunit 1 of this novel coronavirus is around 66% identical to those of the SARS-related coronaviruses, and the core domain of the receptor binding domain of this novel coronavirus has about 68% amino acid identity with those of the SARS-related coronavirus. But the protein sequence of the external subdomain region of receptor binding domain of Spike subunit 1 has only 39% identity, which might affect the choice of human receptor and therefore the biological activity of this virus. Coronaviruses encode large replicase polyproteins which are proteolytically processed by viral proteases to generate mature nonstructural proteins (nsps) that form the viral replication complex. Positive-strand RNA viruses, such as coronaviruses, can induce cellular membrane rearrangements during replication to form replication organelles which allows efficient viral RNA synthesis. Nonstructural Protein 4 alone induces membrane pairing in infectious bronchitis virus [3]. Infection with coronavirus causes rearrangement in the host cell membrane to accumulate a replication and transcription complex in which replication of the viral genome and transcription of viral mRNA can occur. For coronaviruses, a major pathogenicity factor has now been identified with non-structural protein 1 in a murine model of coronavirus infection [4]. Sakai et al in 2017 [5] highlighted the role of nsp4 of SARS coronavirus in viral replication. It has been discovered that only a change in two amino acids in nsp4 protein sequence can abolish viral replication completely. So, to prevent coronavirus infection by designing vaccine, nonstructural protein 4 of beta coronavirus can be selected as target protein in this study. Prevention of viral diseases by vaccination purposes for controlled induction of protective immune responses against viral pathogens such as small pox, hepatitis etc. Attenuated viral vaccines can be produced by targeting essential pathogenicity factors. This study has implicated for the rational design of live attenuated coronavirus vaccines aiming to prevent coronavirus-induced diseases of human as well as animal origin, including the lethal severe acute respiratory syndrome. In this study nonstructural protein 4 has been analyzed in order to predict informative epitopes which will help for future vaccine designing. The knowledge of peptide vaccine is used to identify B-cell and T-cell epitopes which can induce specific immune responses [6] , [7]. These designed epitopes will offer cost effective, high quality therapeutics against corona virus. By using online algorithms in immunoinformatics, potentially active immunogenic T and B cell epitopes for this viral protein has been identified and modelled to design possible peptide vaccine for coronavirus infection. The protein family information of Coronavirus nonstructural protein NS4 containing 78 protein is retrieved from InterPro database (https://www.ebi.ac.uk/interpro/entry/InterPro/IPR005603/). To find conserved region, retrieved sequences were aligned using Muscle tool 3.8.31 [8] where k-mer clustering is used. In the next step a phylogenetic tree is constructed by the method known as progressive alignment. The evolutionary divergence analysis for all 78 virus proteins are completed by forming a phylogenetic tree using Phy ML 3.1/3.0 aLRT software [9]. Here the phylogenetic tree was reconstructed using the maximum likelihood method. The default substitution model was selected assuming an estimated proportional of invariant sites (of 0.008) and 4 gammadistributed rate categorized to account for rate heterogenicity across sites. The gamma shape parameter was estimated directly from the data (gamma = 1.788). Reliability for internal branch was assessed using the aLRT test (SH-like). Among these proteins non-structural protein NS4, with accession number A0A0A7UXD8, known as Beta coronavirus HKU24 (due to its Chinese origin) with length 136 is selected in FASTA format. Antigenicity of this protein is predicted by VaxiJen v 2.0, an online prediction server [10]. B cell epitopes are part of allergen which come in interaction with B lymphocytes to induce immune response. Among two types of B cell epitopes, linear type of B cell epitopes is predicted. Various physico-chemical properties e.g. hydrophilicity, flexibility, accessibility, turns, exposed surface, polarity and antigenic propensity of peptides chains have been estimated to identify the locations of linear epitopes of an antigenic protein [11]. Thus, different tools from IEDB (www.iedb.org), including the classical propensity scale methods such as Kolaskar and Tongaonkar antigenicity scale [12] , E mini surface accessibility prediction [13] , Parker hydrophilicity prediction [14] , Karplus and Schulz flexibilty prediction [15] , Bepipred linear epitope prediction [16] and Chou and Fashman beta turn prediction tool [17] are used to predict linear or continous B cell epitopes of nonstructural protein NS4 protein in coronavirus. With the help of graphical findings and prediction scores the most probable B cell epitope of that antigenic protein has been identified. BepiPred prediction method is a combination of Hidden Markov model and propensity scale method to predict score and identification of B cell epitopes of antigenic protein [16]. Linear T-cell epitopes for MHC-I binding for nonstructural protein NS4 protein in coronavirus are recognized by consensus methods using various methods such as Artificial neural network (ANN) [18] , Stabilized matrix method (SMM) [19] and Scoring Matrices Derived from Combinatorial Peptide Libraries (Comblib) from tools for MHC -I binding prediction methods of Immune Epitope Database (IEDB) (www.iedb.org) [20]. This serverbased method forecasts the MHC class I binding predication to 26 MHC supertypes as percentile rank. SMM algorithm of MHC-1 binding, transporter of antigenic peptides (TAP) transport efficiency and proteasomal cleavage efficiency are also considered to determine the IC 50 values for processing prediction of epitopes by MHC-I molecules [21]. On the basis of low IC 50 values, 5 best epitopes bind with specific MHC-1 molecules are elected for further evaluation. CD4+ T-cell receptor responses against concerned nonstructural protein NS4 protein are done by using Peptide binding to MHC class II molecules software using MHC II binding prediction tool in IEDB analysis resource, including a consensus approach which combines NNalign, SMM-align [21] and Combinatorial library methods. For this prediction we chose thirty HLA class II alleles from the reference set. For the predicted T-cell epitopes with low percentile rank are identified and their IC50 values for respective alleles are determined by SMM-align method [22]. Population coverage for identified T cell epitopes is assessed for world, as well as China and Indian population with the help of IEDB population coverage calculation tool [23]. This tool calculates the fraction of individuals predicted to reply to a specified set of epitopes with recognized MHC restrictions. This calculation is finished considering the HLA genotypic frequencies assuming non-linkage disequilibrium between HLA loci. For docking studies, the T cell epitope PTDTYTSVY (MHC I restricted) and PTDTYTSVYLGKFRG (MHC II restricted) are selected and subjected to PEP-FOLD server [24] , [25] for 3D structure formation. To identify the molecular interactions with specific HLA protein for respective epitopes, docking studies are performed with ClusPro 2.2 web server [26]. Cluster scores for lowest binding energy prediction are calculated using the formula-E = 0.40E_{rep} + -0.40E_{att} + 600E_{elec} + 1.00E_{DARS}. Here, repulsive, attractive, electrostatic as well as interactions extracted from the decoys as the reference state, are considered for structure-based pairwise potential calculation in epitope-MHC molecule docking [27]. Modified PDB ID 4NQX for HLA-A*01:01 is used as allelic protein for docking study of T cell epitope with MHC I restricted. Similarly, 3D structure (PDB ID 1FV1) for HLA-DRB5*01:01 MHC molecule is used as receptor molecule for T cell epitope docking analysis with MHC II restriction. From InterPro database, 78 homologous protein sequences are recovered for nonstructural protein NS4 protein for coronavirus as shown in Table 1. A phylogenetic tree illustrating the evolutionary relationship among the 78 homologous non-structural protein 4 of coronavirus is depicted in Figure 1a and the relevant enlarged version is shown in Figure 1b. author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.27.967422 doi: bioRxiv preprint Phylogenetic tree shows that Non-structural protein NS4 of Beta coronavirus HKU24 (AOAO7UXD8_9BETC), rat coronavirus (NS4_CVRSD), murine coronavirus (NS4_CVMJH, NS$_CVMS and NSA_CVMA5) and ORF4 protein of murine hepatitis virus (Q9J3EC) are very similar in their structures (identity vary 42.3% to 38.3%). All these five protein sequences are author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.27.967422 doi: bioRxiv preprint aligned to identify conserved sequences with varying length using Muscle tool 3.8.31 [8] is shown in Figure 2. Conserved regions are highlighted. Potential T-cell epitope prediction Among the five peptide sequences, 76 PTDTYTSVY 84 peptide sequence (MHC I restricted) and 76 PTDTYTSVYLGKFRG 90 (MHC II restricted) are selected as most probable T cell epitope for the antigenic protein present in non-structural protein NS4 of beta coronavirus HKU24 on the basis of its interactions with highest number of alleles (Table 2 and 3 ). The IC 50 author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.27.967422 doi: bioRxiv preprint values of these peptides are least for the MHCI HLA-A*01:01and MHC II allele HLA-DRB5*01:01 respectively. IEDB population coverage tool [23] is used to calculate the population coverage of the predicted epitopes. The result for class I MHC restriction for the China, whole world and Indian population with the selected MHC I alleles is shown in Table 4. Predicted T-cell epitopes Interacting MHC-I alleles RTPPTSVVTSGDDGRV 71 reveals that these short stretches of antigenic protein can act as linear B cell epitopes. The T cell epitope 76 PTDTYTSVYLGKFRG 90 (MHC II restricted) is selected on the basis of its interactions with large number of alleles and lowest IC50 value with HLA-DRB5*01:01 MHC II allele. Similarly, 76 PTDTYTSVY 84 , restricted with MHC I allelic protein HLA-A*01:01 is designated as most probable T cell epitope which is also present in conserved region of non-structural protein NS4 of coronavirus. Docking studies are performed with these two epitopes with human HLA-DRB5*01:01MHC II molecule and MHC I allelic protein HLA-A*01:01 respectively. Docking study of PTDTYTSVYLGKFRG epitope with HLA-DRB5*01:01, shows lowest binding energy -786.0 Kcal/mole, shown in Figure 4. Docking structure is stabilized by H bonds, are shown in Table 6. Interaction between T cell epitope PTDTYTSVY MHC I allelic protein HLA-A*01:01 with binding energy -725.0 Kcal/mole is shown in Figure 5.  At present in China and whole world, considering the emergency situation due to corona virus infection, rapid development in vaccine design is the most argent step to prevent pandemics. Because by using vaccine the mortality rate due to coronavirus can be controlled. This technique is applied successfully for smallpox virus, polio virus etc. Though for some other common viruses such as dengue virus, hepatitis C virus, human immunodeficiency virus and coronavirus, vaccine has not been invented till now. Due to lack of definite information about growth, replication and pathogenesis of these viruses. Therefore, computational techniques are used for epitope mapping, which is the preliminary step for vaccine design to prevent coronavirus infection. This study integrates several immunoinformatics and molecular docking methods to recognize potential epitopes of non-structural protein NS4 in coronavirus. At first, all seventy-nine non-structural protein 4 from different coronaviruses are retrieved from InterPro database and aligned to detect conserved sequences present in them. A phylogenetic investigation reveals a closed evolutionary relationship among these homologous author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.27.967422 doi: bioRxiv preprint proteins. Non-structural protein 4 is considered as our protein of interest for vaccine design assuming its role in viral replication during coronavirus infection and considering its antigenic nature in human. Not only that, this selected protein has structural similarity with non-structural protein 4 present in rat, murine coronavirus containing various strains. Therefore, the proposed peptide-based vaccine might be effective to prevent coronavirus infection not only in human, but also in rat, murine etc. Here, computational method for vaccine design is totally safe, rapid and cost effective at this emergency situation, caused due to coronavirus infection. Five potent T cell epitope having potentiality for binding with MHC molecules are predicted. For MHC I and MHC II molecules both 9 mer and 15 mer peptide structures are projected from IEDB recommended prediction method and modeled by peptide modeling algorithm. The percentile rank and IC 50 values with SMM/ANN method covering all MHC class I supertypes are also analyzed. The five most effective epitopes are presented in Table 2 along with their IC 50 values. For MHC I binding prediction scores, the peptide with the lowest percentile rank and IC 50 value, is selected for their highest affinity for that interacting MHC I allele. The T cell epitope 76 PTDTYTSVY 84 is considered on the basis of its interaction with large number of alleles and lowest IC 50 value with HLA-A*01:01 MHC I allele. For this epitope, MHC I processing score with that specific allele comprises proteasome score 1.25, TAP score 1.02, MHC IC 50 value is 6.7 nm. This means that this specific epitope has high affinity to MHC I molecule during antigen presentation. Moreover that, this epitope when interacting with selective MHC I allele shows the highest population coverage not only for Chinese population, but also has higher population coverage compared to other epitopes, for Indian and whole world population. Henceforth, this epitope is considered as epitope of choice for CD8 + T cells. Likewise, presence of wider peptide binding groove in MHC II molecule than that of MHC I, 15 mer epitopes are investigated by smm/nn/sturnilo method along with their IC 50 values and are listed in Table 3. For MHC II binding prediction method, a 15 mer T cell epitope sequence 76 PTDTYTSVYLGKFRG 90 of non-structural protein 4, displays a percentile rank 22.0 with IC 50 value 22.0 at the time of interaction with HLA-DRB5*01:01MHC II allele. This result approves that this peptide can be selected as T cell epitope with MHC II restriction for our protein of interest. Moreover, this T cell epitope sequence is well conserved among the nonstructural protein 4 present in different corona viruses. B cell epitope identification method, the prediction scores for Emini surface accessibility, Parker hydrophilicity, Chou and Fashman beta turn and Karplus and Schulz flexibility for each residue of peptides IRNTTNPSAR, starting from sequence 38 position and ending at 47 position of that viral antigenic protein, predicts that this is the most potent B cell epitope present in it. Additionally, Kolarskar and Tangaonkar antigenicity prediction values, confirm our estimation. The predicted T cell epitopes are validated by using molecular docking study. These two epitopes are preferably fitted in the epitope binding grooves of the two MHC protein molecules with highly negative binding energies and stabilized by H-bonds. author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.27.967422 doi: bioRxiv preprint An important factor in vaccine design is the distribution of selected HLA allelic protein. This distribution varies among the human population according to the population in different geographic regions of the world. Our predicted T cell epitope, 76 PTDTYTSVY 84 , bound with MHC I HLA-A*01:01 allele, which is present among 58.87% and 45.77% of Chinese and Indian populations respectively and 50.16% of world populations. So, it may be concluded that the predicted T cell epitope must be specifically restricted with the predominant MHC molecule, which is present in target population in India and China, as well as in whole world against coronavirus. Though in general most peptide-based vaccines are developed considering B cell epitopes, in our present study both B cell and T cell epitopes, present in non-structural protein 4, are considered for vaccine design against coronavirus. These two T cell epitopes can stimulate immunogenic response after administration inside the human body. This immunological reaction can prevent coronavirus infection in human as well as rat and murine, when they come in contact with this virus in future. Since these epitopes are well restricted with MHC molecules and at the same time, they are almost conserved among other homologous proteins. These proteins include non-structural protein 4, obtained from novel-coronavirus infected patient in China. Thus, these epitopes can be proceeded for further experimental verification during vaccine designing against coronavirus infection. This work is not supported by any funding.\n"
     ]
    }
   ],
   "source": [
    "print(mt[-1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1b9fed2824e97db8cb35912549dd2e9cde7b6c18\n"
     ]
    }
   ],
   "source": [
    "print(pdi[-1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'list'>\n",
      "1\n",
      "<class 'dict'>\n",
      "The cutting-edge technology vaccinomics is the combination of two topics immunogenetics and immunogenomics with the knowledge of systems biology and immune profiling for designing vaccine against infectious disease. In our present study, an epitope-based peptide vaccine against nonstructural protein 4 of beta coronavirus, using a combination of B cell and T cell epitope predictions, followed by molecular docking methods are performed. Here, protein sequences of homologous nonstructural protein 4 of beta coronavirus are collected and conserved regions present in them are investigated via phylogenetic study to determine the most immunogenic part of protein. From the identified region of the target protein, the peptide sequence IRNTTNPSAR from the region ranging from 38-47 and the sequence PTDTYTSVYLGKFRG from the positions of 76-90 are considered as the most potential B cell and T cell epitopes respectively. Furthermore, this predicted T cell epitopes PTDTYTSVY and PTDTYTSVYLGKFRG interacted with MHC allelic proteins HLA-A*01:01 and HLA-DRB5*01:01 respectively with the low IC 50 values. These epitopes are perfectly fitted into the epitope binding grooves of alpha helix of MHC I molecule and MHC II molecule with binding energy scores -725.0 Kcal/mole and -786.0 Kcal/mole respectively, showing stability in MHC molecules binding. This MHC restricted epitope PTDTYTSVY also showed a good conservancy of 50.16% in world population coverage. This MHC I HLA-A*01:01 allele is present among 58.87% of Chinese population also. Therefore, the epitopes IRNTTNPSAR and PTDTYTSVYLGKFRG may be considered as potential peptides for peptide-based vaccine for coronavirus after further experimental study.\n"
     ]
    }
   ],
   "source": [
    "# Trial code\n",
    "#fc = data['abstract']\n",
    "#print(type(fc))\n",
    "#print(len(fc))\n",
    "#jc = fc[0]\n",
    "#print(type(jc))\n",
    "#print(jc['text'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Loading body text from other folders"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "#Practice code\n",
    "#mt = []\n",
    "#tt = []\n",
    "#abst = []\n",
    "#lt = []\n",
    "#fl = []\n",
    "#pdi = []\n",
    "#rds = 0\n",
    "#import json\n",
    "#i = 2\n",
    "#chec = 0\n",
    "#path = '/mnt/disks/user/project/Corona_Kaggle_project/comm_use_subset/comm_use_subset/pdf_json/'\n",
    "#files = os.listdir(path)\n",
    "#print(files)\n",
    "#keyword = 'your_keyword'\n",
    "#for file in files:\n",
    "    #print(file)\n",
    "    #print(os.path.isfile(os.path.join(path,file)))\n",
    "    #if os.path.isfile(os.path.join(path,file)):\n",
    "        #print(i)\n",
    "        #with open(os.path.join(path,file)) as f:\n",
    "          #data = json.load(f)\n",
    "    #if chec == 0:\n",
    "        #print(data.keys())\n",
    "        #chec = 1\n",
    "    #print(data)\n",
    "    #fl.append(file)\n",
    "    #title = data['metadata']\n",
    "    #title = title['title']\n",
    "    #title = re.sub(r\"\\s+\", \" \", title)\n",
    "    #title = re.sub(r\"(\\s+\\.)\", \".\", title)\n",
    "    #tt.append(title)\n",
    "    #print(data['abstract'])\n",
    "    #abtr = data['abstract']\n",
    "    #print(abtr)\n",
    "    #if abtr != []:\n",
    "        #abtr = abtr[0]\n",
    "        #abtr = abtr['text']\n",
    "        #abtr = re.sub(r\"\\s+\", \" \", abtr)\n",
    "        #abtr = re.sub(r\"(\\s+\\.)\", \".\", abtr)\n",
    "    #else:\n",
    "        #abtr = title\n",
    "    #abst.append(abtr)\n",
    "    #bd = data['body_text']\n",
    "    #pdi.append(data['paper_id'])\n",
    "    #print(bd)\n",
    "    #for i in range(len(bd)):\n",
    "        #print(i)\n",
    "        #print(bd[i])\n",
    "        #fd = bd[i]\n",
    "        #print(fd)\n",
    "        #str1 = fd['text']\n",
    "        #str1 = re.sub(r\"\\b(\\d\\s\\d\\s\\d)\\b\", \"\", str1)\n",
    "        #str1 = re.sub(r\"\\s+\", \" \", str1)\n",
    "        #str1 = re.sub(r\"(\\s+\\.)\", \".\", str1)\n",
    "        #if rds == 0:\n",
    "            #print(str1)\n",
    "            #rds = 1\n",
    "        #lt.append(str1)\n",
    "    #lt = \" \".join(lt)\n",
    "    #f.close()\n",
    "    #mt.append(lt)\n",
    "    #print(mt)\n",
    "    #lt = []\n",
    "\n",
    "        \n",
    "            \n",
    "            \n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "pdi, mt, tt, abst = input_df('/mnt/disks/user/project/Corona_Kaggle_project/comm_use_subset/comm_use_subset/pdf_json/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "pid2 = pd.DataFrame(data = {'sha':pdi, 'Body_text':mt, 'fl_title':tt, 'fl_abstract':abst})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>fc151568de57c0456578757131c3b49b86286b3c</td>\n",
       "      <td>To convert a closed double-stranded DNA or RNA helix into two open single strands, so that other...</td>\n",
       "      <td>Inhibition of RNA Helicases of ssRNA + Virus Belonging to Flaviviridae, Coronaviridae and Picorn...</td>\n",
       "      <td>Many viral pathogens encode the motor proteins named RNA helicases which display various functio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>15dd9abbe4084c12712f094415c5ca9980aaacda</td>\n",
       "      <td>Pathogens are considered to be one of the driving forces of evolution. The major histocompatibil...</td>\n",
       "      <td>The major histocompatibility complex in Old World camelids and low polymorphism of its class II ...</td>\n",
       "      <td>Background: The Major Histocompatibility Complex (MHC) is a genomic region containing genes with...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>eabfb15b60476742917f92c6fb60a7bc6ec203aa</td>\n",
       "      <td>Porcine hemagglutinating encephalomyelitis virus (PHEV) belongs to the order Nidovirales, family...</td>\n",
       "      <td>miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis...</td>\n",
       "      <td>miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>e3785336f334b853b3d269a8301dfc564f5fae74</td>\n",
       "      <td>Streptococcus pyogenes (Group A streptococcus) is a common pathogen responsible for a number of ...</td>\n",
       "      <td>BMC Microbiology Association of the shuffling of Streptococcus pyogenes clones and the fluctuati...</td>\n",
       "      <td>The number of scarlet fever occurrences reported between 2000 and 2006 fluctuated considerably i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9663f9f18256ca7161c2af2ce451911c90f629da</td>\n",
       "      <td>Supplementary Figure 1. The setting up of the dot blot immunoassays for human and mouse samples....</td>\n",
       "      <td>Supplementary Material Decreased levels of foldase and chaperone proteins are associated with an...</td>\n",
       "      <td>Supplementary Material Decreased levels of foldase and chaperone proteins are associated with an...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  fc151568de57c0456578757131c3b49b86286b3c   \n",
       "1  15dd9abbe4084c12712f094415c5ca9980aaacda   \n",
       "2  eabfb15b60476742917f92c6fb60a7bc6ec203aa   \n",
       "3  e3785336f334b853b3d269a8301dfc564f5fae74   \n",
       "4  9663f9f18256ca7161c2af2ce451911c90f629da   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  To convert a closed double-stranded DNA or RNA helix into two open single strands, so that other...   \n",
       "1  Pathogens are considered to be one of the driving forces of evolution. The major histocompatibil...   \n",
       "2  Porcine hemagglutinating encephalomyelitis virus (PHEV) belongs to the order Nidovirales, family...   \n",
       "3  Streptococcus pyogenes (Group A streptococcus) is a common pathogen responsible for a number of ...   \n",
       "4  Supplementary Figure 1. The setting up of the dot blot immunoassays for human and mouse samples....   \n",
       "\n",
       "                                                                                              fl_title  \\\n",
       "0  Inhibition of RNA Helicases of ssRNA + Virus Belonging to Flaviviridae, Coronaviridae and Picorn...   \n",
       "1  The major histocompatibility complex in Old World camelids and low polymorphism of its class II ...   \n",
       "2  miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis...   \n",
       "3  BMC Microbiology Association of the shuffling of Streptococcus pyogenes clones and the fluctuati...   \n",
       "4  Supplementary Material Decreased levels of foldase and chaperone proteins are associated with an...   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0  Many viral pathogens encode the motor proteins named RNA helicases which display various functio...  \n",
       "1  Background: The Major Histocompatibility Complex (MHC) is a genomic region containing genes with...  \n",
       "2  miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis...  \n",
       "3  The number of scarlet fever occurrences reported between 2000 and 2006 fluctuated considerably i...  \n",
       "4  Supplementary Material Decreased levels of foldase and chaperone proteins are associated with an...  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid2.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n",
      "individuals at a higher risk of transmitting WFB communicable diseases as they may have come from areas where the population is living in a high-density, poor, social environment.\n"
     ]
    }
   ],
   "source": [
    "# Practice code\n",
    "#mt = []\n",
    "#tt = []\n",
    "#abst = []\n",
    "#lt = []\n",
    "#fl = []\n",
    "#pdi = []\n",
    "#rds = 0\n",
    "#import json\n",
    "#i = 2\n",
    "#chec = 0\n",
    "#path = '/mnt/disks/user/project/Corona_Kaggle_project/noncomm_use_subset/noncomm_use_subset/pdf_json/'\n",
    "#files = os.listdir(path)\n",
    "#print(files)\n",
    "#keyword = 'your_keyword'\n",
    "#for file in files:\n",
    "    #print(file)\n",
    "    #print(os.path.isfile(os.path.join(path,file)))\n",
    "    #if os.path.isfile(os.path.join(path,file)):\n",
    "        #print(i)\n",
    "        #with open(os.path.join(path,file)) as f:\n",
    "          #data = json.load(f)\n",
    "    #if chec == 0:\n",
    "        #print(data.keys())\n",
    "        #chec = 1\n",
    "    #print(data)\n",
    "    #fl.append(file)\n",
    "    #title = data['metadata']\n",
    "    #title = title['title']\n",
    "    #title = re.sub(r\"\\s+\", \" \", title)\n",
    "    #title = re.sub(r\"(\\s+\\.)\", \".\", title)\n",
    "    #tt.append(title)\n",
    "    #print(data['abstract'])\n",
    "    #abtr = data['abstract']\n",
    "    #print(abtr)\n",
    "    #if abtr != []:\n",
    "        #abtr = abtr[0]\n",
    "        #abtr = abtr['text']\n",
    "        #abtr = re.sub(r\"\\s+\", \" \", abtr)\n",
    "        #abtr = re.sub(r\"(\\s+\\.)\", \".\", abtr)\n",
    "    #else:\n",
    "        #abtr = title\n",
    "    #abst.append(abtr)\n",
    "    #bd = data['body_text']\n",
    "    #pdi.append(data['paper_id'])\n",
    "    #print(bd)\n",
    "    #for i in range(len(bd)):\n",
    "        #print(i)\n",
    "        #print(bd[i])\n",
    "        #fd = bd[i]\n",
    "        #print(fd)\n",
    "        #str1 = fd['text']\n",
    "        #str1 = re.sub(r\"\\b(\\d\\s\\d\\s\\d)\\b\", \"\", str1)\n",
    "        #str1 = re.sub(r\"\\s+\", \" \", str1)\n",
    "        #str1 = re.sub(r\"(\\s+\\.)\", \".\", str1)\n",
    "        #if rds == 0:\n",
    "            #print(str1)\n",
    "            #rds = 1\n",
    "        #lt.append(str1)\n",
    "    #lt = \" \".join(lt)\n",
    "    #f.close()\n",
    "    #mt.append(lt)\n",
    "    #print(mt)\n",
    "    #lt = []\n",
    "\n",
    "        \n",
    "            \n",
    "            \n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "pdi, mt, tt, abst = input_df('/mnt/disks/user/project/Corona_Kaggle_project/noncomm_use_subset/noncomm_use_subset/pdf_json/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "pid3 = pd.DataFrame(data = {'sha':pdi, 'Body_text':mt, 'fl_title':tt, 'fl_abstract':abst})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>e35295b96d9cee71829be853fe2a43accd1dff37</td>\n",
       "      <td>individuals at a higher risk of transmitting WFB communicable diseases as they may have come fro...</td>\n",
       "      <td>Enemy at the Gate Osong Public Health and Research Perspectives</td>\n",
       "      <td>Enemy at the Gate Osong Public Health and Research Perspectives</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>75251cc3d312b0d2c63117458c68dba563715155</td>\n",
       "      <td>Nosocomial transmission of respiratory viruses (RVs) can lead to unanticipated complications for...</td>\n",
       "      <td>Prevention of respiratory outbreaks in the rehabilitation setting</td>\n",
       "      <td>Background Respiratory viral (RV) outbreaks in rehabilitation facilities can jeopardise patient ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>041adbe00a7ca71fcbc38ff4406297ce86e93a6a</td>\n",
       "      <td>Influenza or flu is an acute disease of the respiratory system and is present worldwide. The ant...</td>\n",
       "      <td>A DESCRIPTIVE STUDY OF PANDEMIC INFLUENZA A(H1N1)PDM09</td>\n",
       "      <td>Influenza A viruses undergo frequent antigenic mutations and may thus cause seasonal epidemics a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>a60e292d31e4bb27e20f3ace17fc295ad60990c8</td>\n",
       "      <td>I n 2014, 1.1 billion travelers crossed international borders. 1 A 2012 report outlined that 18%...</td>\n",
       "      <td>Pre-Travel Medical Preparation of Business and Occupational Travelers</td>\n",
       "      <td>were analyzed. Results: Of 23,534 travelers, 61% were non-occupational and 39% occupational. Bus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1dc5516776928be0a80cf9c69d19d7ee641dafeb</td>\n",
       "      <td>Korea has designated notifying infectious diseases and controlled infectious diseases since 1954...</td>\n",
       "      <td>Epidemic Intelligence Service Officers and Field Epidemiology Training Program in Korea</td>\n",
       "      <td>Korea has adopted Epidemic Intelligence Service (EIS) officers through the Field Epidemiology Tr...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  e35295b96d9cee71829be853fe2a43accd1dff37   \n",
       "1  75251cc3d312b0d2c63117458c68dba563715155   \n",
       "2  041adbe00a7ca71fcbc38ff4406297ce86e93a6a   \n",
       "3  a60e292d31e4bb27e20f3ace17fc295ad60990c8   \n",
       "4  1dc5516776928be0a80cf9c69d19d7ee641dafeb   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  individuals at a higher risk of transmitting WFB communicable diseases as they may have come fro...   \n",
       "1  Nosocomial transmission of respiratory viruses (RVs) can lead to unanticipated complications for...   \n",
       "2  Influenza or flu is an acute disease of the respiratory system and is present worldwide. The ant...   \n",
       "3  I n 2014, 1.1 billion travelers crossed international borders. 1 A 2012 report outlined that 18%...   \n",
       "4  Korea has designated notifying infectious diseases and controlled infectious diseases since 1954...   \n",
       "\n",
       "                                                                                  fl_title  \\\n",
       "0                          Enemy at the Gate Osong Public Health and Research Perspectives   \n",
       "1                        Prevention of respiratory outbreaks in the rehabilitation setting   \n",
       "2                                   A DESCRIPTIVE STUDY OF PANDEMIC INFLUENZA A(H1N1)PDM09   \n",
       "3                    Pre-Travel Medical Preparation of Business and Occupational Travelers   \n",
       "4  Epidemic Intelligence Service Officers and Field Epidemiology Training Program in Korea   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0                                      Enemy at the Gate Osong Public Health and Research Perspectives  \n",
       "1  Background Respiratory viral (RV) outbreaks in rehabilitation facilities can jeopardise patient ...  \n",
       "2  Influenza A viruses undergo frequent antigenic mutations and may thus cause seasonal epidemics a...  \n",
       "3  were analyzed. Results: Of 23,534 travelers, 61% were non-occupational and 39% occupational. Bus...  \n",
       "4  Korea has adopted Epidemic Intelligence Service (EIS) officers through the Field Epidemiology Tr...  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid3.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "# Practice code\n",
    "#mt = []\n",
    "#tt = []\n",
    "#abst = []\n",
    "#lt = []\n",
    "#fl = []\n",
    "#pdi = []\n",
    "#rds = 0\n",
    "#import json\n",
    "#i = 2\n",
    "#chec = 0\n",
    "#path = '/mnt/disks/user/project/Corona_Kaggle_project/custom_license/custom_license/pdf_json/'\n",
    "#files = os.listdir(path)\n",
    "#print(files)\n",
    "#keyword = 'your_keyword'\n",
    "#for file in files:\n",
    "    #print(file)\n",
    "    #print(os.path.isfile(os.path.join(path,file)))\n",
    "    #if os.path.isfile(os.path.join(path,file)):\n",
    "        #print(i)\n",
    "        #with open(os.path.join(path,file)) as f:\n",
    "          #data = json.load(f)\n",
    "    #if chec == 0:\n",
    "        #print(data.keys())\n",
    "        #chec = 1\n",
    "    #print(data)\n",
    "    #fl.append(file)\n",
    "    #title = data['metadata']\n",
    "    #title = title['title']\n",
    "    #title = re.sub(r\"\\s+\", \" \", title)\n",
    "    #title = re.sub(r\"(\\s+\\.)\", \".\", title)\n",
    "    #tt.append(title)\n",
    "    #print(data['abstract'])\n",
    "    #abtr = data['abstract']\n",
    "    #print(abtr)\n",
    "    #if abtr != []:\n",
    "        #abtr = abtr[0]\n",
    "        #abtr = abtr['text']\n",
    "        #abtr = re.sub(r\"\\s+\", \" \", abtr)\n",
    "        #abtr = re.sub(r\"(\\s+\\.)\", \".\", abtr)\n",
    "    #else:\n",
    "        #abtr = title\n",
    "    #abst.append(abtr)\n",
    "    #bd = data['body_text']\n",
    "    #pdi.append(data['paper_id'])\n",
    "    #print(bd)\n",
    "    #for i in range(len(bd)):\n",
    "        #print(i)\n",
    "        #print(bd[i])\n",
    "        #fd = bd[i]\n",
    "        #print(fd)\n",
    "        #str1 = fd['text']\n",
    "        #str1 = re.sub(r\"\\b(\\d\\s\\d\\s\\d)\\b\", \"\", str1)\n",
    "        #str1 = re.sub(r\"\\s+\", \" \", str1)\n",
    "        #str1 = re.sub(r\"(\\s+\\.)\", \".\", str1)\n",
    "        #if rds == 0:\n",
    "            #print(str1)\n",
    "            #rds = 1\n",
    "        #lt.append(str1)\n",
    "    #lt = \" \".join(lt)\n",
    "    #f.close()\n",
    "    #mt.append(lt)\n",
    "    #print(mt)\n",
    "    #lt = []\n",
    "\n",
    "        \n",
    "            \n",
    "            \n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['paper_id', 'metadata', 'abstract', 'body_text', 'bib_entries', 'ref_entries', 'back_matter'])\n"
     ]
    }
   ],
   "source": [
    "pdi, mt, tt, abst = input_df('/mnt/disks/user/project/Corona_Kaggle_project/custom_license/custom_license/pdf_json/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "pid4 = pd.DataFrame(data = {'sha':pdi, 'Body_text':mt, 'fl_title':tt, 'fl_abstract':abst})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>c646e655066d0982c151b516ebdf0334d037ffcf</td>\n",
       "      <td>Coronaviruses (CoV) are able to infect humans, birds and many animal species [68]. In humans, co...</td>\n",
       "      <td>Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations</td>\n",
       "      <td>In 2012, a novel human coronavirus emerged and was tentatively named ''Middle East respiratory s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4d77c1be3e298496537c5d106afeb77655b9ca13</td>\n",
       "      <td>The vast majority of infectious diseases in all species are initiated by colonization of, or ent...</td>\n",
       "      <td>Challenges in mucosal vaccination of cattle</td>\n",
       "      <td>Challenges in mucosal vaccination of cattle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>586cc97876444b5ebac56140971f4ce8ed3007d5</td>\n",
       "      <td>This is a PDF file of an article that has undergone enhancements after acceptance, such as the a...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>8b43b0a17be0dd0140d0b4145591c9e8f080f92e</td>\n",
       "      <td>Pseudoknots are known to be involved in protein expression and especially in the modulation of t...</td>\n",
       "      <td>Pseudoknot and translational control in the expression of the S15 ribosomal protein S15 I pseudo...</td>\n",
       "      <td>Translational autocontrol of the expression of the ribosomal protein S15 proceeds through the tr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>f5a95ba3b592c46903d5f4a4c00bd15a2cbb74f9</td>\n",
       "      <td>Influenza causes seasonal infections worldwide that can lead to complications and deaths in ever...</td>\n",
       "      <td>Influenza vaccines and vaccinations in Poland -past, present and future</td>\n",
       "      <td>Influenza vaccines and vaccinations in Poland -past, present and future</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  c646e655066d0982c151b516ebdf0334d037ffcf   \n",
       "1  4d77c1be3e298496537c5d106afeb77655b9ca13   \n",
       "2  586cc97876444b5ebac56140971f4ce8ed3007d5   \n",
       "3  8b43b0a17be0dd0140d0b4145591c9e8f080f92e   \n",
       "4  f5a95ba3b592c46903d5f4a4c00bd15a2cbb74f9   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  Coronaviruses (CoV) are able to infect humans, birds and many animal species [68]. In humans, co...   \n",
       "1  The vast majority of infectious diseases in all species are initiated by colonization of, or ent...   \n",
       "2  This is a PDF file of an article that has undergone enhancements after acceptance, such as the a...   \n",
       "3  Pseudoknots are known to be involved in protein expression and especially in the modulation of t...   \n",
       "4  Influenza causes seasonal infections worldwide that can lead to complications and deaths in ever...   \n",
       "\n",
       "                                                                                              fl_title  \\\n",
       "0                   Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations   \n",
       "1                                                          Challenges in mucosal vaccination of cattle   \n",
       "2                                                                                                        \n",
       "3  Pseudoknot and translational control in the expression of the S15 ribosomal protein S15 I pseudo...   \n",
       "4                              Influenza vaccines and vaccinations in Poland -past, present and future   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0  In 2012, a novel human coronavirus emerged and was tentatively named ''Middle East respiratory s...  \n",
       "1                                                          Challenges in mucosal vaccination of cattle  \n",
       "2                                                                                                       \n",
       "3  Translational autocontrol of the expression of the ribosomal protein S15 proceeds through the tr...  \n",
       "4                              Influenza vaccines and vaccinations in Poland -past, present and future  "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid4.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "pid =  pd.concat([pid, pid2, pid3, pid4], ignore_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>518b635f78bdc65dc6666380eafc3b7a283b3af7</td>\n",
       "      <td>To quantify the effects of the most informative risk factors, partial dependences were Table). A...</td>\n",
       "      <td>Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2</td>\n",
       "      <td>Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4bc43084ccdb8d3bb704ca577473169cd1a64f9c</td>\n",
       "      <td>belong to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae...</td>\n",
       "      <td>Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) ...</td>\n",
       "      <td>Background: In December 2019, an outbreak of novel coronavirus disease emerged in Wuhan, China a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>e4e5e67fd4f75548dffab7f75484bc14fa15c0c2</td>\n",
       "      <td>new genes involved in phi6 host range expansion, expanding our knowledge of this important model...</td>\n",
       "      <td>Existing host range mutations constrain further emergence of RNA viruses</td>\n",
       "      <td>RNA viruses are capable of rapid host shifting, typically due to a point mutation that confers e...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>5f7e6772c35ba7d67891202d43e0a43917f90971</td>\n",
       "      <td>Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...</td>\n",
       "      <td>EARLY ESTIMATION OF REPRODUCTION NUMBER OF COVID-19 IN VIETNAM</td>\n",
       "      <td>Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a625e5d6fc8956c231c500a40e887e248a69de61</td>\n",
       "      <td>The bulk of death cases had comorbidity (76.8%). Respiratory failure remained the leading cause ...</td>\n",
       "      <td>Clinical characteristics of 82 death cases with COVID-19</td>\n",
       "      <td>A recently developing pneumonia caused by SARS-CoV-2 was originated in Wuhan, China, and has qui...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  518b635f78bdc65dc6666380eafc3b7a283b3af7   \n",
       "1  4bc43084ccdb8d3bb704ca577473169cd1a64f9c   \n",
       "2  e4e5e67fd4f75548dffab7f75484bc14fa15c0c2   \n",
       "3  5f7e6772c35ba7d67891202d43e0a43917f90971   \n",
       "4  a625e5d6fc8956c231c500a40e887e248a69de61   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  To quantify the effects of the most informative risk factors, partial dependences were Table). A...   \n",
       "1  belong to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae...   \n",
       "2  new genes involved in phi6 host range expansion, expanding our knowledge of this important model...   \n",
       "3  Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...   \n",
       "4  The bulk of death cases had comorbidity (76.8%). Respiratory failure remained the leading cause ...   \n",
       "\n",
       "                                                                                              fl_title  \\\n",
       "0                     Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2   \n",
       "1  Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) ...   \n",
       "2                             Existing host range mutations constrain further emergence of RNA viruses   \n",
       "3                                       EARLY ESTIMATION OF REPRODUCTION NUMBER OF COVID-19 IN VIETNAM   \n",
       "4                                             Clinical characteristics of 82 death cases with COVID-19   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0                     Tissue Tropism and Transmission Ecology Predict Virulence of Human RNA Viruses 2  \n",
       "1  Background: In December 2019, an outbreak of novel coronavirus disease emerged in Wuhan, China a...  \n",
       "2  RNA viruses are capable of rapid host shifting, typically due to a point mutation that confers e...  \n",
       "3  Reproduction number is an epidemiologic indicator that reflects the contagiousness and transmiss...  \n",
       "4  A recently developing pneumonia caused by SARS-CoV-2 was originated in Wuhan, China, and has qui...  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>36231</th>\n",
       "      <td>cc50f83beb4dae7f0a60291c3e1d4868d0884c5a</td>\n",
       "      <td>LAMP will be useful not only for the detection of infected plants but also quarantine. The react...</td>\n",
       "      <td>The Plant Pathology Journal Development of a Rapid Detection Method for Potato virus X by Revers...</td>\n",
       "      <td>The primary step for efficient control of viral diseases is the development of simple, rapid, an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36232</th>\n",
       "      <td>6217c77be15bba46ecbc3568159ff0dabf484043</td>\n",
       "      <td>Coronaviruses (CoVs) are enveloped, single-stranded, positive sense RNA viruses that can be divi...</td>\n",
       "      <td>Susceptibility of porcine IPI-2I intestinal epithelial cells to infection with swine enteric cor...</td>\n",
       "      <td>Swine enteric coronavirus (CoV) is an important group of pathogens causing diarrhea in piglets. ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36233</th>\n",
       "      <td>f50072cb0c2b1dfd3fa5b8badcf53fa41ece25b8</td>\n",
       "      <td>Microbial molecular markers and epidemiological surveillance in the era of high throughput seque...</td>\n",
       "      <td></td>\n",
       "      <td>publicly funded repositories, such as the WHO COVID database with rights for unrestricted resear...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36234</th>\n",
       "      <td>e7fa9d575a7d7acaa850e2062f17ef30b3293704</td>\n",
       "      <td>geographical framework, has the analytical power to help answer these questions. When the diseas...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36235</th>\n",
       "      <td>4b802901270fa1f6865899ec8b02066f37c176c8</td>\n",
       "      <td>Recently, many severe, emerging infectious diseases have occurred in humans after the respective...</td>\n",
       "      <td>Two novel bocaparvovirus species identified in wild Himalayan marmots</td>\n",
       "      <td>Bocaparvovirus (BOV) is a genetically diverse group of DNA viruses and a possible cause of respi...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            sha  \\\n",
       "36231  cc50f83beb4dae7f0a60291c3e1d4868d0884c5a   \n",
       "36232  6217c77be15bba46ecbc3568159ff0dabf484043   \n",
       "36233  f50072cb0c2b1dfd3fa5b8badcf53fa41ece25b8   \n",
       "36234  e7fa9d575a7d7acaa850e2062f17ef30b3293704   \n",
       "36235  4b802901270fa1f6865899ec8b02066f37c176c8   \n",
       "\n",
       "                                                                                                 Body_text  \\\n",
       "36231  LAMP will be useful not only for the detection of infected plants but also quarantine. The react...   \n",
       "36232  Coronaviruses (CoVs) are enveloped, single-stranded, positive sense RNA viruses that can be divi...   \n",
       "36233  Microbial molecular markers and epidemiological surveillance in the era of high throughput seque...   \n",
       "36234  geographical framework, has the analytical power to help answer these questions. When the diseas...   \n",
       "36235  Recently, many severe, emerging infectious diseases have occurred in humans after the respective...   \n",
       "\n",
       "                                                                                                  fl_title  \\\n",
       "36231  The Plant Pathology Journal Development of a Rapid Detection Method for Potato virus X by Revers...   \n",
       "36232  Susceptibility of porcine IPI-2I intestinal epithelial cells to infection with swine enteric cor...   \n",
       "36233                                                                                                        \n",
       "36234                                                                                                        \n",
       "36235                                Two novel bocaparvovirus species identified in wild Himalayan marmots   \n",
       "\n",
       "                                                                                               fl_abstract  \n",
       "36231  The primary step for efficient control of viral diseases is the development of simple, rapid, an...  \n",
       "36232  Swine enteric coronavirus (CoV) is an important group of pathogens causing diarrhea in piglets. ...  \n",
       "36233  publicly funded repositories, such as the WHO COVID database with rights for unrestricted resear...  \n",
       "36234                                                                                                       \n",
       "36235  Bocaparvovirus (BOV) is a genetically diverse group of DNA viruses and a possible cause of respi...  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36236"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36236"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid[\"sha\"].unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid['fl_abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pid['fl_title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36236"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid['fl_abstract'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We can see that there are no null 'abstract' values extracted straight from\n",
    "# the pdf files. Therefore, will consider 'abstract' from this source and\n",
    "# merge it within the working dataframe "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Loading the metadata csv file into a dataframe. This will be the master dataframe consisting of key parameters such as 'Abstract', 'body_text', 'title', 'paper_id', etc being considered for this project "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "path2 = '/mnt/disks/user/project/Corona_Kaggle_project'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdat = pd.read_csv(path2 + '/' + 'metadata.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cord_uid</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_pdf_parse</th>\n",
       "      <th>has_pmc_xml_parse</th>\n",
       "      <th>full_text_file</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>8q5ondtn</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Intrauterine virus infections and congenital heart disease</td>\n",
       "      <td>10.1016/0002-8703(72)90077-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4361535.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract The etiologic basis for the vast majority of cases of congenital heart disease remains ...</td>\n",
       "      <td>1972-12-31</td>\n",
       "      <td>Overall, James C.</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-8703(72)90077-4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>pzfd0e50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Coronaviruses in Balkan nephritis</td>\n",
       "      <td>10.1016/0002-8703(80)90355-5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6243850.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1980-03-31</td>\n",
       "      <td>Georgescu, Leonida; Diosi, Peter; BuÅ£iu, Ioan; PlavoÅŸin, Livia; Herzog, Georgeta</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-8703(80)90355-5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>22bka3gi</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Cigarette smoking and coronary heart disease: new evidence and old reactions</td>\n",
       "      <td>10.1016/0002-8703(80)90356-7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7355701.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1980-03-31</td>\n",
       "      <td>Friedman, Gary D</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-8703(80)90356-7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>zp9k1k3z</td>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>10.1016/0002-9343(73)90176-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4579077.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>1973-08-31</td>\n",
       "      <td>Brunner, Carolyn M.; Horwitz, David A.; Shann, Mary K.; Sturgill, Benjamin A.; Davis, John S.</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-9343(73)90176-9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cjuzul89</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Epidemiology of community-acquired respiratory tract infections in adults Incidence, etiology, a...</td>\n",
       "      <td>10.1016/0002-9343(85)90361-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4014285.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Upper respiratory tract infections are the most common types of infectious diseases amo...</td>\n",
       "      <td>1985-06-28</td>\n",
       "      <td>Garibaldi, Richard A.</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-9343(85)90361-4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   cord_uid                                       sha  source_x  \\\n",
       "0  8q5ondtn                                       NaN  Elsevier   \n",
       "1  pzfd0e50                                       NaN  Elsevier   \n",
       "2  22bka3gi                                       NaN  Elsevier   \n",
       "3  zp9k1k3z  aecbc613ebdab36753235197ffb4f35734b5ca63  Elsevier   \n",
       "4  cjuzul89                                       NaN  Elsevier   \n",
       "\n",
       "                                                                                                 title  \\\n",
       "0                                           Intrauterine virus infections and congenital heart disease   \n",
       "1                                                                    Coronaviruses in Balkan nephritis   \n",
       "2                         Cigarette smoking and coronary heart disease: new evidence and old reactions   \n",
       "3      Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "4  Epidemiology of community-acquired respiratory tract infections in adults Incidence, etiology, a...   \n",
       "\n",
       "                            doi pmcid  pubmed_id    license  \\\n",
       "0  10.1016/0002-8703(72)90077-4   NaN  4361535.0  els-covid   \n",
       "1  10.1016/0002-8703(80)90355-5   NaN  6243850.0  els-covid   \n",
       "2  10.1016/0002-8703(80)90356-7   NaN  7355701.0  els-covid   \n",
       "3  10.1016/0002-9343(73)90176-9   NaN  4579077.0  els-covid   \n",
       "4  10.1016/0002-9343(85)90361-4   NaN  4014285.0  els-covid   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract The etiologic basis for the vast majority of cases of congenital heart disease remains ...   \n",
       "1                                                                                                  NaN   \n",
       "2                                                                                                  NaN   \n",
       "3  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "4  Abstract Upper respiratory tract infections are the most common types of infectious diseases amo...   \n",
       "\n",
       "  publish_time  \\\n",
       "0   1972-12-31   \n",
       "1   1980-03-31   \n",
       "2   1980-03-31   \n",
       "3   1973-08-31   \n",
       "4   1985-06-28   \n",
       "\n",
       "                                                                                         authors  \\\n",
       "0                                                                              Overall, James C.   \n",
       "1               Georgescu, Leonida; Diosi, Peter; BuÅ£iu, Ioan; PlavoÅŸin, Livia; Herzog, Georgeta   \n",
       "2                                                                               Friedman, Gary D   \n",
       "3  Brunner, Carolyn M.; Horwitz, David A.; Shann, Mary K.; Sturgill, Benjamin A.; Davis, John S.   \n",
       "4                                                                          Garibaldi, Richard A.   \n",
       "\n",
       "                            journal  Microsoft Academic Paper ID  \\\n",
       "0            American Heart Journal                          NaN   \n",
       "1            American Heart Journal                          NaN   \n",
       "2            American Heart Journal                          NaN   \n",
       "3  The American Journal of Medicine                          NaN   \n",
       "4  The American Journal of Medicine                          NaN   \n",
       "\n",
       "  WHO #Covidence  has_pdf_parse  has_pmc_xml_parse  full_text_file  \\\n",
       "0            NaN          False              False  custom_license   \n",
       "1            NaN          False              False  custom_license   \n",
       "2            NaN          False              False  custom_license   \n",
       "3            NaN           True              False  custom_license   \n",
       "4            NaN          False              False  custom_license   \n",
       "\n",
       "                                            url  \n",
       "0  https://doi.org/10.1016/0002-8703(72)90077-4  \n",
       "1  https://doi.org/10.1016/0002-8703(80)90355-5  \n",
       "2  https://doi.org/10.1016/0002-8703(80)90356-7  \n",
       "3  https://doi.org/10.1016/0002-9343(73)90176-9  \n",
       "4  https://doi.org/10.1016/0002-9343(85)90361-4  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdat = metdat.loc[metdat[\"has_pdf_parse\"] == True, :]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "34283"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdat)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "custom_license        21979\n",
       "comm_use_subset        8917\n",
       "noncomm_use_subset     2045\n",
       "biorxiv_medrxiv        1342\n",
       "Name: full_text_file, dtype: int64"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat[\"full_text_file\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "9365"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2377"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "23152"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pid4)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Seems there are few research papers missing in the meta data file. I will focus on the papers \n",
    "mentioned in the meta file only as it still consists of information on sizeable number of\n",
    "number of documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Considering files only in folder \"biorxiv_medrxiv\"\n",
    "#metdat = metdat.loc[metdat[\"full_text_file\"] == \"biorxiv_medrxiv\", :]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cord_uid</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_pdf_parse</th>\n",
       "      <th>has_pmc_xml_parse</th>\n",
       "      <th>full_text_file</th>\n",
       "      <th>url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>zp9k1k3z</td>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>10.1016/0002-9343(73)90176-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4579077.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>1973-08-31</td>\n",
       "      <td>Brunner, Carolyn M.; Horwitz, David A.; Shann, Mary K.; Sturgill, Benjamin A.; Davis, John S.</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-9343(73)90176-9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>wwf90zxt</td>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>10.1016/0002-9343(85)90367-5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2861742.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "      <td>1985-06-28</td>\n",
       "      <td>Cantey, J.Robert</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-9343(85)90367-5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>dlh93ax6</td>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>10.1016/0002-9343(88)90356-7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3052052.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "      <td>1988-10-14</td>\n",
       "      <td>Zvaifler, Nathan J.</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/0002-9343(88)90356-7</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   cord_uid                                       sha  source_x  \\\n",
       "3  zp9k1k3z  aecbc613ebdab36753235197ffb4f35734b5ca63  Elsevier   \n",
       "5  wwf90zxt  212e990b378e8d267042753d5f9d4a64ea5e9869  Elsevier   \n",
       "6  dlh93ax6  bf5d344243153d58be692ceb26f52c08e2bd2d2f  Elsevier   \n",
       "\n",
       "                                                                                             title  \\\n",
       "3  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "5                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "6                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "\n",
       "                            doi pmcid  pubmed_id    license  \\\n",
       "3  10.1016/0002-9343(73)90176-9   NaN  4579077.0  els-covid   \n",
       "5  10.1016/0002-9343(85)90367-5   NaN  2861742.0  els-covid   \n",
       "6  10.1016/0002-9343(88)90356-7   NaN  3052052.0  els-covid   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "3  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "5  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...   \n",
       "6  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...   \n",
       "\n",
       "  publish_time  \\\n",
       "3   1973-08-31   \n",
       "5   1985-06-28   \n",
       "6   1988-10-14   \n",
       "\n",
       "                                                                                         authors  \\\n",
       "3  Brunner, Carolyn M.; Horwitz, David A.; Shann, Mary K.; Sturgill, Benjamin A.; Davis, John S.   \n",
       "5                                                                               Cantey, J.Robert   \n",
       "6                                                                            Zvaifler, Nathan J.   \n",
       "\n",
       "                            journal  Microsoft Academic Paper ID  \\\n",
       "3  The American Journal of Medicine                          NaN   \n",
       "5  The American Journal of Medicine                          NaN   \n",
       "6  The American Journal of Medicine                          NaN   \n",
       "\n",
       "  WHO #Covidence  has_pdf_parse  has_pmc_xml_parse  full_text_file  \\\n",
       "3            NaN           True              False  custom_license   \n",
       "5            NaN           True              False  custom_license   \n",
       "6            NaN           True              False  custom_license   \n",
       "\n",
       "                                            url  \n",
       "3  https://doi.org/10.1016/0002-9343(73)90176-9  \n",
       "5  https://doi.org/10.1016/0002-9343(85)90367-5  \n",
       "6  https://doi.org/10.1016/0002-9343(88)90356-7  "
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "34283"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdat)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4126"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat['abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat['sha'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat['title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "custom_license        3729\n",
       "comm_use_subset        241\n",
       "noncomm_use_subset     155\n",
       "biorxiv_medrxiv          1\n",
       "Name: full_text_file, dtype: int64"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdat.loc[metdat['abstract'].isnull() == True, 'full_text_file'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can see that there are number of 'abstracts' and even 'title' values are missing in the\n",
    "main meta file. Will get these values from the files but will restrict to the files \n",
    "that are mentioned in meta data file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extracting only the dataframe fields that are of importance\n",
    "metdatfn = metdat[['sha','title','abstract']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "3  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "\n",
       "                                                                                             title  \\\n",
       "3  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "\n",
       "                                                                                              abstract  \n",
       "3  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...  "
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn.index = pd.RangeIndex(0, len(metdatfn.index))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "\n",
       "                                                                                              abstract  \n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...  \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...  \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...  "
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "34283\n"
     ]
    }
   ],
   "source": [
    "print(len(metdatfn))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "36236\n"
     ]
    }
   ],
   "source": [
    "print(len(pid))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Merging the Dataframes, metdatfn and pid to get the final dataframe \n",
    "# with features required for model learning\n",
    "metdatfn = pd.merge(metdatfn, pid, how = 'inner', on = 'sha')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>The patient (Fo, ) was a 58 year old mentally retarded white woman, born in a rural area of sout...</td>\n",
       "      <td>Clinical and Immunologic Studies in Identical Twins Discordant for Systemic Lupus Erythematosus</td>\n",
       "      <td>Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE), were eva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "      <td>Pathogenesis and Risk Factors J. ROBERT CANTEY, M.D. Charleston, South Carolina Our understandin...</td>\n",
       "      <td>Infectious Diarrhea Pathogenesis and Risk Factors</td>\n",
       "      <td>Infectious Diarrhea Pathogenesis and Risk Factors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "      <td>In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with an incitin...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...   \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  The patient (Fo, ) was a 58 year old mentally retarded white woman, born in a rural area of sout...   \n",
       "1  Pathogenesis and Risk Factors J. ROBERT CANTEY, M.D. Charleston, South Carolina Our understandin...   \n",
       "2  In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with an incitin...   \n",
       "\n",
       "                                                                                          fl_title  \\\n",
       "0  Clinical and Immunologic Studies in Identical Twins Discordant for Systemic Lupus Erythematosus   \n",
       "1                                                Infectious Diarrhea Pathogenesis and Risk Factors   \n",
       "2                                                                                                    \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0  Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE), were eva...  \n",
       "1                                                    Infectious Diarrhea Pathogenesis and Risk Factors  \n",
       "2                                                                                                       "
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "32425\n"
     ]
    }
   ],
   "source": [
    "print(len(metdatfn))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4040"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "36"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['fl_title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['fl_abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>32420</th>\n",
       "      <td>014ce88b18095a1eaa877ab5aae818df6ec214f6</td>\n",
       "      <td>Viral load of SARS-CoV-2 in clinical samples</td>\n",
       "      <td>NaN</td>\n",
       "      <td>, days 4-7 (RÂ²=0Â·93, p&lt;0Â·001) , and days 7-14 (RÂ²=0Â·95, p=0Â·028). From 17 confirmed cases of SAR...</td>\n",
       "      <td>Correspondence</td>\n",
       "      <td>Correspondence</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32421</th>\n",
       "      <td>df42da6659fa90742caa430143fa8fae6fe7da3e</td>\n",
       "      <td>Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...</td>\n",
       "      <td>Abstract This paper combines two advances to detect MERS-CoV, the causative agent of Middle East...</td>\n",
       "      <td>The coronavirus that causes Middle East respiratory syndrome (MERS-CoV) is highly contagious, ca...</td>\n",
       "      <td>Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...</td>\n",
       "      <td>This paper combines two advances to detect MERS-CoV, the causative agent of Middle East Respirat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32422</th>\n",
       "      <td>f186e5f78bd1203264270110fd788805756715a5</td>\n",
       "      <td>The psychiatric impact of the novel coronavirus outbreak</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Letter to the Editor Patients with confirmed or suspected 2019-nCoV (new coronavirus disease) ma...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32423</th>\n",
       "      <td>0a603b52939b7dab816c56ffc774c1ddda67a484</td>\n",
       "      <td>Advising the traveller</td>\n",
       "      <td>Abstract Global travel continues to increase, particularly to tropical destinations that have di...</td>\n",
       "      <td>International travel continues to increase, with &gt;1 billion travellers worldwide now crossing in...</td>\n",
       "      <td>Advising the traveller</td>\n",
       "      <td>Global travel continues to increase, particularly to tropical destinations that have different h...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32424</th>\n",
       "      <td>a92e70c0a129a56173ef38bf186c1cd7ecfe6d9f</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Abstract Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of c...</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of cats and d...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            sha  \\\n",
       "32420  014ce88b18095a1eaa877ab5aae818df6ec214f6   \n",
       "32421  df42da6659fa90742caa430143fa8fae6fe7da3e   \n",
       "32422  f186e5f78bd1203264270110fd788805756715a5   \n",
       "32423  0a603b52939b7dab816c56ffc774c1ddda67a484   \n",
       "32424  a92e70c0a129a56173ef38bf186c1cd7ecfe6d9f   \n",
       "\n",
       "                                                                                                     title  \\\n",
       "32420                                                         Viral load of SARS-CoV-2 in clinical samples   \n",
       "32421  Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...   \n",
       "32422                                             The psychiatric impact of the novel coronavirus outbreak   \n",
       "32423                                                                               Advising the traveller   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                                  abstract  \\\n",
       "32420                                                                                                  NaN   \n",
       "32421  Abstract This paper combines two advances to detect MERS-CoV, the causative agent of Middle East...   \n",
       "32422                                                                                                  NaN   \n",
       "32423  Abstract Global travel continues to increase, particularly to tropical destinations that have di...   \n",
       "32424  Abstract Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of c...   \n",
       "\n",
       "                                                                                                 Body_text  \\\n",
       "32420  , days 4-7 (RÂ²=0Â·93, p<0Â·001) , and days 7-14 (RÂ²=0Â·95, p=0Â·028). From 17 confirmed cases of SAR...   \n",
       "32421  The coronavirus that causes Middle East respiratory syndrome (MERS-CoV) is highly contagious, ca...   \n",
       "32422  Letter to the Editor Patients with confirmed or suspected 2019-nCoV (new coronavirus disease) ma...   \n",
       "32423  International travel continues to increase, with >1 billion travellers worldwide now crossing in...   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                                  fl_title  \\\n",
       "32420                                                                                       Correspondence   \n",
       "32421  Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...   \n",
       "32422                                                                                                        \n",
       "32423                                                                               Advising the traveller   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                               fl_abstract  \n",
       "32420                                                                                       Correspondence  \n",
       "32421  This paper combines two advances to detect MERS-CoV, the causative agent of Middle East Respirat...  \n",
       "32422                                                                                                       \n",
       "32423  Global travel continues to increase, particularly to tropical destinations that have different h...  \n",
       "32424  Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of cats and d...  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We can see that few 'title' values from meta file are missing as well\n",
    "# abstract values from meta file are missing.\n",
    "# Will copy the missing values from respective 'fl_title' and 'fl_abstract'\n",
    "# values extracted from files\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn.loc[metdatfn['abstract'].isnull() == True, 'abstract'] = metdatfn.loc[metdatfn['abstract'].isnull() == True, 'fl_abstract'] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "24        \n",
       "25        \n",
       "34        \n",
       "43        \n",
       "56        \n",
       "        ..\n",
       "32309     \n",
       "32324     \n",
       "32351     \n",
       "32365     \n",
       "32422     \n",
       "Name: abstract, Length: 1446, dtype: object"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'] == '', 'abstract']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "''"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[32351, 'abstract']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1446"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'] == '', 'abstract'].count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "# There still seems to be missing values for 'abstract' values even after\n",
    "# copying from the 'fl_abstract'. Will now see if we can consider 'title'\n",
    "# values for the same\n",
    "metdatfn.loc[metdatfn['abstract'] == '', 'abstract'] = metdatfn.loc[metdatfn['abstract'] == '', 'title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'] == '', 'abstract'].count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'].isnull() == True, 'abstract'].count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# There are no null or '' values of abstract now"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn.loc[metdatfn['title'].isnull() == True, 'title'] = metdatfn.loc[metdatfn['title'].isnull() == True, 'fl_title'] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "30"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['title'] == '', 'title'].count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['sha'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We now can have a dataframe of files with no null or missing 'abstract'\n",
    "# values. There are few files with missing 'title' values but since answers\n",
    "# are to be extracted from 'abstract', we can still consider such files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'list'>\n",
      "['ABSTRACTThe cutting-edge technology vaccinomics is the combination of two topics immunogenetics and immunogenomics with the knowledge of systems biology and immune profiling for designing vaccine against infectious disease. In our present study, an epitope-based peptide vaccine against nonstructural protein 4 of beta coronavirus, using a combination of B cell and T cell epitope predictions, followed by molecular docking methods are performed. Here, protein sequences of homologous nonstructural protein 4 of beta coronavirus are collected and conserved regions present in them are investigated via phylogenetic study to determine the most immunogenic part of protein. From the identified region of the target protein, the peptide sequence IRNTTNPSAR from the region ranging from 38-47 and the sequence PTDTYTSVYLGKFRG from the positions of 76-90 are considered as the most potential B cell and T cell epitopes respectively. Furthermore, this predicted T cell epitopes PTDTYTSVY and PTDTYTSVYLGKFRG interacted with MHC allelic proteins HLA-A*01:01 and HLA-DRB5*01:01 respectively with the low IC50 values. These epitopes are perfectly fitted into the epitope binding grooves of alpha helix of MHC I molecule and MHC II molecule with binding energy scores âˆ’725.0 Kcal/mole and âˆ’786.0 Kcal/mole respectively, showing stability in MHC molecules binding. This MHC restricted epitope PTDTYTSVY also showed a good conservancy of 50.16% in world population coverage. This MHC I HLA-A*01:01 allele is present among 58.87% of Chinese population also. Therefore, the epitopes IRNTTNPSAR and PTDTYTSVYLGKFRG may be considered as potential peptides for peptide-based vaccine for coronavirus after further experimental study.']\n"
     ]
    }
   ],
   "source": [
    "# Trial code\n",
    "#tr = list(metdat.loc[metdat['sha']== '1b9fed2824e97db8cb35912549dd2e9cde7b6c18', 'abstract'])\n",
    "#print(type(tr))\n",
    "#print(tr)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>The patient (Fo, ) was a 58 year old mentally retarded white woman, born in a rural area of sout...</td>\n",
       "      <td>Clinical and Immunologic Studies in Identical Twins Discordant for Systemic Lupus Erythematosus</td>\n",
       "      <td>Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE), were eva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "      <td>Pathogenesis and Risk Factors J. ROBERT CANTEY, M.D. Charleston, South Carolina Our understandin...</td>\n",
       "      <td>Infectious Diarrhea Pathogenesis and Risk Factors</td>\n",
       "      <td>Infectious Diarrhea Pathogenesis and Risk Factors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "      <td>In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with an incitin...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ddd2ecf42ec86ad66072962081e1ce4594431f9c</td>\n",
       "      <td>Management of acute and chronic respiratory tract infections</td>\n",
       "      <td>Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...</td>\n",
       "      <td>Respiratory Tract Infections JERROLD J. ELLNER, M.D. Cleveland, CM Pharyngitis, bronchitis, and ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a55cb4e724091ced46b5e55b982a14525eea1c7e</td>\n",
       "      <td>Acute bronchitis: Results of U.S. and European trials of antibiotic therapy</td>\n",
       "      <td>Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...</td>\n",
       "      <td>A cute bronchitis, an illness frequently encountered by primary-care physicians [1] , is an infl...</td>\n",
       "      <td>Acute Bronchitis: Results of U.S. and European Trials of Antibiotic Therapy</td>\n",
       "      <td>Acute bronchitis, an illness frequently encountered by primary-care physicians, is an inflammati...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "3  ddd2ecf42ec86ad66072962081e1ce4594431f9c   \n",
       "4  a55cb4e724091ced46b5e55b982a14525eea1c7e   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "3                                     Management of acute and chronic respiratory tract infections   \n",
       "4                      Acute bronchitis: Results of U.S. and European trials of antibiotic therapy   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...   \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...   \n",
       "3  Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...   \n",
       "4  Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...   \n",
       "\n",
       "                                                                                             Body_text  \\\n",
       "0  The patient (Fo, ) was a 58 year old mentally retarded white woman, born in a rural area of sout...   \n",
       "1  Pathogenesis and Risk Factors J. ROBERT CANTEY, M.D. Charleston, South Carolina Our understandin...   \n",
       "2  In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with an incitin...   \n",
       "3  Respiratory Tract Infections JERROLD J. ELLNER, M.D. Cleveland, CM Pharyngitis, bronchitis, and ...   \n",
       "4  A cute bronchitis, an illness frequently encountered by primary-care physicians [1] , is an infl...   \n",
       "\n",
       "                                                                                          fl_title  \\\n",
       "0  Clinical and Immunologic Studies in Identical Twins Discordant for Systemic Lupus Erythematosus   \n",
       "1                                                Infectious Diarrhea Pathogenesis and Risk Factors   \n",
       "2                                                                                                    \n",
       "3                                                                                                    \n",
       "4                      Acute Bronchitis: Results of U.S. and European Trials of Antibiotic Therapy   \n",
       "\n",
       "                                                                                           fl_abstract  \n",
       "0  Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE), were eva...  \n",
       "1                                                    Infectious Diarrhea Pathogenesis and Risk Factors  \n",
       "2                                                                                                       \n",
       "3                                                                                                       \n",
       "4  Acute bronchitis, an illness frequently encountered by primary-care physicians, is an inflammati...  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32425"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>Body_text</th>\n",
       "      <th>fl_title</th>\n",
       "      <th>fl_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>32420</th>\n",
       "      <td>014ce88b18095a1eaa877ab5aae818df6ec214f6</td>\n",
       "      <td>Viral load of SARS-CoV-2 in clinical samples</td>\n",
       "      <td>Correspondence</td>\n",
       "      <td>, days 4-7 (RÂ²=0Â·93, p&lt;0Â·001) , and days 7-14 (RÂ²=0Â·95, p=0Â·028). From 17 confirmed cases of SAR...</td>\n",
       "      <td>Correspondence</td>\n",
       "      <td>Correspondence</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32421</th>\n",
       "      <td>df42da6659fa90742caa430143fa8fae6fe7da3e</td>\n",
       "      <td>Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...</td>\n",
       "      <td>Abstract This paper combines two advances to detect MERS-CoV, the causative agent of Middle East...</td>\n",
       "      <td>The coronavirus that causes Middle East respiratory syndrome (MERS-CoV) is highly contagious, ca...</td>\n",
       "      <td>Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...</td>\n",
       "      <td>This paper combines two advances to detect MERS-CoV, the causative agent of Middle East Respirat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32422</th>\n",
       "      <td>f186e5f78bd1203264270110fd788805756715a5</td>\n",
       "      <td>The psychiatric impact of the novel coronavirus outbreak</td>\n",
       "      <td>The psychiatric impact of the novel coronavirus outbreak</td>\n",
       "      <td>Letter to the Editor Patients with confirmed or suspected 2019-nCoV (new coronavirus disease) ma...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32423</th>\n",
       "      <td>0a603b52939b7dab816c56ffc774c1ddda67a484</td>\n",
       "      <td>Advising the traveller</td>\n",
       "      <td>Abstract Global travel continues to increase, particularly to tropical destinations that have di...</td>\n",
       "      <td>International travel continues to increase, with &gt;1 billion travellers worldwide now crossing in...</td>\n",
       "      <td>Advising the traveller</td>\n",
       "      <td>Global travel continues to increase, particularly to tropical destinations that have different h...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32424</th>\n",
       "      <td>a92e70c0a129a56173ef38bf186c1cd7ecfe6d9f</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Abstract Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of c...</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...</td>\n",
       "      <td>Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of cats and d...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            sha  \\\n",
       "32420  014ce88b18095a1eaa877ab5aae818df6ec214f6   \n",
       "32421  df42da6659fa90742caa430143fa8fae6fe7da3e   \n",
       "32422  f186e5f78bd1203264270110fd788805756715a5   \n",
       "32423  0a603b52939b7dab816c56ffc774c1ddda67a484   \n",
       "32424  a92e70c0a129a56173ef38bf186c1cd7ecfe6d9f   \n",
       "\n",
       "                                                                                                     title  \\\n",
       "32420                                                         Viral load of SARS-CoV-2 in clinical samples   \n",
       "32421  Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...   \n",
       "32422                                             The psychiatric impact of the novel coronavirus outbreak   \n",
       "32423                                                                               Advising the traveller   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                                  abstract  \\\n",
       "32420                                                                                       Correspondence   \n",
       "32421  Abstract This paper combines two advances to detect MERS-CoV, the causative agent of Middle East...   \n",
       "32422                                             The psychiatric impact of the novel coronavirus outbreak   \n",
       "32423  Abstract Global travel continues to increase, particularly to tropical destinations that have di...   \n",
       "32424  Abstract Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of c...   \n",
       "\n",
       "                                                                                                 Body_text  \\\n",
       "32420  , days 4-7 (RÂ²=0Â·93, p<0Â·001) , and days 7-14 (RÂ²=0Â·95, p=0Â·028). From 17 confirmed cases of SAR...   \n",
       "32421  The coronavirus that causes Middle East respiratory syndrome (MERS-CoV) is highly contagious, ca...   \n",
       "32422  Letter to the Editor Patients with confirmed or suspected 2019-nCoV (new coronavirus disease) ma...   \n",
       "32423  International travel continues to increase, with >1 billion travellers worldwide now crossing in...   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                                  fl_title  \\\n",
       "32420                                                                                       Correspondence   \n",
       "32421  Standard and AEGIS nicking molecular beacons detect amplicons from the Middle East respiratory s...   \n",
       "32422                                                                                                        \n",
       "32423                                                                               Advising the traveller   \n",
       "32424  Infection of cats with atypical feline coronaviruses harbouring a truncated form of the canine t...   \n",
       "\n",
       "                                                                                               fl_abstract  \n",
       "32420                                                                                       Correspondence  \n",
       "32421  This paper combines two advances to detect MERS-CoV, the causative agent of Middle East Respirat...  \n",
       "32422                                                                                                       \n",
       "32423  Global travel continues to increase, particularly to tropical destinations that have different h...  \n",
       "32424  Feline and canine coronaviruses (FCoV and CCoV, respectively) are common pathogens of cats and d...  "
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn = metdatfn[['sha','title', 'abstract']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ddd2ecf42ec86ad66072962081e1ce4594431f9c</td>\n",
       "      <td>Management of acute and chronic respiratory tract infections</td>\n",
       "      <td>Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a55cb4e724091ced46b5e55b982a14525eea1c7e</td>\n",
       "      <td>Acute bronchitis: Results of U.S. and European trials of antibiotic therapy</td>\n",
       "      <td>Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "3  ddd2ecf42ec86ad66072962081e1ce4594431f9c   \n",
       "4  a55cb4e724091ced46b5e55b982a14525eea1c7e   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "3                                     Management of acute and chronic respiratory tract infections   \n",
       "4                      Acute bronchitis: Results of U.S. and European trials of antibiotic therapy   \n",
       "\n",
       "                                                                                              abstract  \n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...  \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...  \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...  \n",
       "3  Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...  \n",
       "4  Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...  "
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7128     \n",
       "12686    \n",
       "Name: title, dtype: object"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'].isnull() == True, 'title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "''"
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[7128, 'title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "''"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[12686, 'title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['title'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abstract'] == '', 'abstract'].count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Two 'abstract' rows still exist with '' values. Will remove these rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn = metdatfn[~pd.isnull(metdatfn['abstract'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['abstract'].isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "metdatfn.index = pd.RangeIndex(0, len(metdatfn.index))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ddd2ecf42ec86ad66072962081e1ce4594431f9c</td>\n",
       "      <td>Management of acute and chronic respiratory tract infections</td>\n",
       "      <td>Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a55cb4e724091ced46b5e55b982a14525eea1c7e</td>\n",
       "      <td>Acute bronchitis: Results of U.S. and European trials of antibiotic therapy</td>\n",
       "      <td>Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "3  ddd2ecf42ec86ad66072962081e1ce4594431f9c   \n",
       "4  a55cb4e724091ced46b5e55b982a14525eea1c7e   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "3                                     Management of acute and chronic respiratory tract infections   \n",
       "4                      Acute bronchitis: Results of U.S. and European trials of antibiotic therapy   \n",
       "\n",
       "                                                                                              abstract  \n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...  \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...  \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...  \n",
       "3  Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...  \n",
       "4  Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32423"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(metdatfn)):\n",
    "    metdatfn.loc[i, \"abs_length\"] = int(len(metdatfn.loc[i, \"abstract\"]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.0       100\n",
       "302.0      71\n",
       "27.0       50\n",
       "39.0       50\n",
       "37.0       49\n",
       "         ... \n",
       "5329.0      1\n",
       "3064.0      1\n",
       "3914.0      1\n",
       "2644.0      1\n",
       "3286.0      1\n",
       "Name: abs_length, Length: 3003, dtype: int64"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn['abs_length'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.0      100\n",
       "302.0     71\n",
       "27.0      50\n",
       "39.0      50\n",
       "37.0      49\n",
       "        ... \n",
       "2.0        1\n",
       "172.0      1\n",
       "216.0      1\n",
       "168.0      1\n",
       "483.0      1\n",
       "Name: abs_length, Length: 488, dtype: int64"
      ]
     },
     "execution_count": 94,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.loc[metdatfn['abs_length'] < 500, 'abs_length'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4978"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdatfn[metdatfn['abs_length'] < 500])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "27440"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdatfn[metdatfn['abs_length'] > 500])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extracting total words (except stop words and irrelevant characters such as paranthesis)\n",
    "comb_abs = (\".\").join(metdatfn[\"abstract\"])\n",
    "abs_words = conv_word(comb_abs)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to plot the frequency of words\n",
    "def plot_word_frequency(words, xlab, ylab, top_n=10):\n",
    "    plt.figure(figsize=(12,10))\n",
    "    word_freq = FreqDist(words)\n",
    "    labels = [element[0] for element in word_freq.most_common(top_n)]\n",
    "    counts = [element[1] for element in word_freq.most_common(top_n)]\n",
    "    plot = sns.barplot(counts, labels)\n",
    "    plt.xlabel(xlab)\n",
    "    plt.ylabel(ylab)\n",
    "    plt.legend(loc = 'Best')\n",
    "    return plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 20:52:11.760568 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fe5b9a68e80>"
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_word_frequency(abs_words, 'Frequency', 'Words', 15)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The top 15 words mentioned in the complete abstract dataset are shown above along with their frequencies.\n",
    "The word 'virus' was most common used word while other more commonly used words included words like 'viral', 'respiratory', 'infection', 'disease', etc "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "WARNING: Logging before flag parsing goes to stderr.\n",
      "W1122 20:12:33.395789 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,8))\n",
    "plt.bar(np.arange(1), len(metdatfn[\"sha\"].index), color = 'blue')\n",
    "plt.xticks(np.arange(1), \"Records\")\n",
    "plt.xlabel('Total number of files')\n",
    "plt.ylabel('Count')\n",
    "plt.legend(loc = 'Best')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 21:22:14.752402 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,8))\n",
    "ticks = ['Abstracts of length <= 500', 'Abstracts of length > 500']\n",
    "plt.bar(np.arange(2), [len(metdatfn[metdatfn['abs_length'] <= 500].index), len(metdatfn[metdatfn['abs_length'] > 500].index)], color = ['blue', 'green'])\n",
    "plt.xticks(np.arange(2), ticks)\n",
    "plt.xlabel('Abstract length')\n",
    "plt.ylabel('Count')\n",
    "plt.legend(loc = 'Best')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It can be seen that majority of abstracts are of length greater than 500 words. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "174"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "abs_words.index('animal')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['virulence', 'genes', 'additional', 'host-specific', 'animal']"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "abs_words[170:175]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_freq = FreqDist(abs_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2605"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word_freq['animal']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The word 'animal' does occur in the abstracts based context being considered for answering the questions. This means that "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Loading tasks, Questions and respective reference ansewrs into a dataframe\n",
    "qa_dt = pd.read_csv(path2 + '/' + 'Q_A_Sheet.csv', encoding='cp1252')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "\n",
       "                                                                                     Reference Answers  \n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...  "
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extracting total words in questions (except stop words and irrelevant characters such as paranthesis)\n",
    "comb_qt = (\".\").join(qa_dt[\"Questions\"])\n",
    "qt_words = conv_word(comb_qt)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 20:54:19.982895 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fe5b9a5a278>"
      ]
     },
     "execution_count": 142,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_word_frequency(qt_words, 'Frequency', 'Words', 15)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 20:33:31.038264 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,8))\n",
    "plt.bar(np.arange(1), len(qa_dt[\"Questions\"].index), color = 'green')\n",
    "plt.xticks(np.arange(1), \"Questions\")\n",
    "plt.xlabel('Total number of Questions')\n",
    "plt.ylabel('Count')\n",
    "plt.legend(loc = 'Best')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Some of the most common used words in questions (except stop words and irrelevant characters such as paranthesis) include 'how', 'what', 'covid 19', 'affect', 'virus', 'patients' and 'health'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Practice cells to derive correct regular expression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#trp = \"ft-rg@ https://ftrt//trail\\. http://gtdp love Debi when will u meet. 4.34 https://doi.org/10.1101/2020.03.30.016485\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pattern1 = \"[^(\\w.)]|(^https.+\\w$)|(https.+\\w$)|(^http.+\\w$)|(http.+\\w$)\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#pattern = \"[^\\w\\-\\d+.\\d+]|https://[\\w.]+(([/\\w.]+)+)|http://[\\w.]+(([/\\w.]+)+)\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#tgh = re.sub(pattern, \" \", trp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#tgh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#trp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#trp = [word for word in trp if word not in stopwords.words(\"english\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#trp = \" \".join(trp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#trp"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 1. Preprocess data for the TM-IDF stage"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Text tokenization, stemming Function"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "# define a function to clean text data\n",
    "def clean_document(document, char_filter = r\"[^\\w\\-\\d+.\\d+]|https://[\\w.]+(([/\\w.]+)+)|http://[\\w.]+(([/\\w.]+)+)\"):\n",
    "    '''\n",
    "    input:\n",
    "    document          :  string\n",
    "    char_filter       :  regex pattern - removes those characters from the text that match the pattern\n",
    "\n",
    "    output: clean document\n",
    "    '''\n",
    "    \n",
    "    # convert words to lower case\n",
    "    document = document.lower()\n",
    "    \n",
    "    # remove unwanted characters\n",
    "    document = re.sub(char_filter, \" \", document)\n",
    "\n",
    "    # replace multiple whitespaces with single whitespace\n",
    "    document = re.sub(r\"\\s+\", \" \", document)\n",
    "\n",
    "    # tokenise words\n",
    "    words = tw.tokenize(document)\n",
    "   \n",
    "   # remove stop words\n",
    "    words = [word for word in words if word not in stopwords.words(\"english\")]\n",
    "    \n",
    "    # stem\n",
    "    words = [stemmer.stem(word) for word in words]\n",
    "    \n",
    "    # strip whitespace from all words\n",
    "    words = [word.strip() for word in words]\n",
    "\n",
    "    # join back words to get document\n",
    "    document = \" \".join(words)\n",
    "\n",
    "    # strip whitespace from document\n",
    "    document = document.strip()\n",
    "\n",
    "    return document\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "# define a function to data processing for word2vec model \n",
    "def conv_word(document, char_filter = r\"[^\\w\\-\\d+.\\d+]|https://[\\w.]+(([/\\w.]+)+)|http://[\\w.]+(([/\\w.]+)+)\"):\n",
    "    '''\n",
    "    input:\n",
    "    document          :  string\n",
    "    char_filter       :  regex pattern - removes those characters from the text that match the pattern\n",
    "\n",
    "    output: clean document\n",
    "    '''\n",
    "    \n",
    "    # convert words to lower case\n",
    "    document = document.lower()\n",
    "    \n",
    "    # remove unwanted characters\n",
    "    document = re.sub(char_filter, \" \", document)\n",
    "\n",
    "    # replace multiple whitespaces with single whitespace\n",
    "    document = re.sub(r\"\\s+\", \" \", document)\n",
    "\n",
    "    # tokenise words\n",
    "    words = tw.tokenize(document)\n",
    "   \n",
    "   # remove stop words\n",
    "    words = [word for word in words if word not in stopwords.words(\"english\")]\n",
    "    \n",
    "    # strip whitespace from all words\n",
    "    words = [word.strip() for word in words]\n",
    "\n",
    "    return words\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "# define a function to clean text data\n",
    "def abs_proc(document, char_filter = r\"[^\\w\\-\\d+.\\d+]|https://[\\w.]+(([/\\w.]+)+)|http://[\\w.]+(([/\\w.]+)+)\"):\n",
    "    '''\n",
    "    input:\n",
    "    document          :  string\n",
    "    char_filter       :  regex pattern - removes those characters from the text that match the pattern\n",
    "\n",
    "    output: clean document\n",
    "    '''\n",
    "    \n",
    "    # convert words to lower case\n",
    "    document = document.lower()\n",
    "    \n",
    "    # remove unwanted characters\n",
    "    document = re.sub(char_filter, \" \", document)\n",
    "\n",
    "    # replace multiple whitespaces with single whitespace\n",
    "    document = re.sub(r\"\\s+\", \" \", document)\n",
    "\n",
    "    # tokenise words\n",
    "    words = tw.tokenize(document)\n",
    "   \n",
    "   # remove stop words\n",
    "    words = [word for word in words if word not in stopwords.words(\"english\")]\n",
    "    \n",
    "    # strip whitespace from all words\n",
    "    words = [word.strip() for word in words]\n",
    "\n",
    "    # join back words to get document\n",
    "    document = \"\".join(words)\n",
    "\n",
    "    # strip whitespace from document\n",
    "    document = document.strip()\n",
    "\n",
    "    return document\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [],
   "source": [
    "for j in range(len(metdatfn)):\n",
    "    metdatfn.loc[j, \"prp_abstract\"] = clean_document(metdatfn.loc[j, \"abstract\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>abs_length</th>\n",
       "      <th>prp_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>882.0</td>\n",
       "      <td>abstract middle-ag femal ident twin one system lupu erythematosu sle evalu immunolog reactiv pre...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "\n",
       "   abs_length  \\\n",
       "0       882.0   \n",
       "\n",
       "                                                                                          prp_abstract  \n",
       "0  abstract middle-ag femal ident twin one system lupu erythematosu sle evalu immunolog reactiv pre...  "
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metdatfn.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32423"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  (0, 59453)\t0.06178815103603215\n",
      "  (0, 72506)\t0.0456444753708397\n",
      "  (0, 49029)\t0.038176873316604985\n",
      "  (0, 75223)\t0.06684242331476671\n",
      "  (0, 34416)\t0.05443754863907482\n",
      "  (0, 18473)\t0.05492178230452705\n",
      "  (0, 26109)\t0.10494184236646456\n",
      "  (0, 56229)\t0.04735615250893744\n",
      "  (0, 40770)\t0.10364533089264773\n",
      "  (0, 25211)\t0.03604460174348514\n",
      "  (0, 39634)\t0.10995544093820316\n",
      "  (0, 24503)\t0.07594684283246646\n",
      "  (0, 33570)\t0.058356695975782906\n",
      "  (0, 17235)\t0.11137560857562122\n",
      "  (0, 79530)\t0.14067163819034598\n",
      "  (0, 74943)\t0.15933841050014022\n",
      "  (0, 74946)\t0.15933841050014022\n",
      "  (0, 20759)\t0.051184569467835304\n",
      "  (0, 10577)\t0.1429685576508497\n",
      "  (0, 38801)\t0.04061434882658179\n",
      "  (0, 78421)\t0.10657640913013258\n",
      "  (0, 82771)\t0.035003032075520545\n",
      "  (0, 72613)\t0.10373250380698869\n",
      "  (0, 83805)\t0.04386013825314429\n",
      "  (0, 67734)\t0.04031538374009984\n",
      "  :\t:\n",
      "  (32422, 21168)\t0.0329194507150667\n",
      "  (32422, 41733)\t0.02883655517983825\n",
      "  (32422, 74859)\t0.16928104318643494\n",
      "  (32422, 67594)\t0.028251639121313055\n",
      "  (32422, 22132)\t0.02624054303804158\n",
      "  (32422, 40427)\t0.1457896501355984\n",
      "  (32422, 63509)\t0.03167648247976827\n",
      "  (32422, 62738)\t0.02978312714096657\n",
      "  (32422, 31274)\t0.0260681297512165\n",
      "  (32422, 40134)\t0.022479779676215075\n",
      "  (32422, 75052)\t0.016306626479954442\n",
      "  (32422, 59449)\t0.023992533519273745\n",
      "  (32422, 38754)\t0.02602819265508779\n",
      "  (32422, 34367)\t0.12744037213709902\n",
      "  (32422, 41738)\t0.03562299081508126\n",
      "  (32422, 24958)\t0.028682885295802464\n",
      "  (32422, 32574)\t0.042006688667500514\n",
      "  (32422, 41718)\t0.024489499342723802\n",
      "  (32422, 34416)\t0.03079773859981594\n",
      "  (32422, 20759)\t0.028957383831993623\n",
      "  (32422, 46998)\t0.037209825592910376\n",
      "  (32422, 80251)\t0.022684597630714776\n",
      "  (32422, 30481)\t0.02700773001301336\n",
      "  (32422, 56865)\t0.0475461138096851\n",
      "  (32422, 7680)\t0.01906819002924851\n"
     ]
    }
   ],
   "source": [
    "vectorizer = TfidfVectorizer()\n",
    "tfidf_model = vectorizer.fit_transform(metdatfn[\"prp_abstract\"])\n",
    "print(tfidf_model)  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(32423, 85873)"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tfidf_model.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Functions for Preprocessing queries and then using TD-IDF to score documents \n",
    "#relevance with respect to queries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age dispariti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: H...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "1  What is known about transmission, incubation, and environmental stability?   \n",
       "2  What is known about transmission, incubation, and environmental stability?   \n",
       "3  What is known about transmission, incubation, and environmental stability?   \n",
       "4  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "1                                          How long is the incubation period for the virus in humans?   \n",
       "2                    How does the incubation period in humans vary across age and health conditions?    \n",
       "3                      Can the virus be transmitted asymptomatically or during the incubation period?   \n",
       "4                           How does weather, heat, and humidity affect the transmission of COVID 19?   \n",
       "\n",
       "                                                                                     Reference Answers  \n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...  \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start....  \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age dispariti...  \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appe...  \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: H...  "
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [],
   "source": [
    "for j in range(len(qa_dt)):\n",
    "    qa_dt.loc[j, \"prp_qa\"] = clean_document(qa_dt.loc[j, \"Questions\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start....</td>\n",
       "      <td>long incub period viru human</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age dispariti...</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appe...</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: H...</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "1  What is known about transmission, incubation, and environmental stability?   \n",
       "2  What is known about transmission, incubation, and environmental stability?   \n",
       "3  What is known about transmission, incubation, and environmental stability?   \n",
       "4  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "1                                          How long is the incubation period for the virus in humans?   \n",
       "2                    How does the incubation period in humans vary across age and health conditions?    \n",
       "3                      Can the virus be transmitted asymptomatically or during the incubation period?   \n",
       "4                           How does weather, heat, and humidity affect the transmission of COVID 19?   \n",
       "\n",
       "                                                                                     Reference Answers  \\\n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet ...   \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start....   \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age dispariti...   \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appe...   \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: H...   \n",
       "\n",
       "                                                                       prp_qa  \n",
       "0  covid viru transmit aerosol droplet food close contact faecal matter water  \n",
       "1                                                long incub period viru human  \n",
       "2                            incub period human vari across age health condit  \n",
       "3                                       viru transmit asymptomat incub period  \n",
       "4                                weather heat humid affect transmiss covid 19  "
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [],
   "source": [
    "def doc_ranker(query, context_TDIDF, vectorizer, metdatfn):\n",
    "    tfd_qr = vectorizer.transform([query])\n",
    "    cos_sim = cosine_similarity(context_TDIDF,tfd_qr)\n",
    "    metdatfn[\"TD_IDF_sim_score\"] = cos_sim\n",
    "    return(metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "covid viru transmit aerosol droplet food close contact faecal matter water\n"
     ]
    }
   ],
   "source": [
    "# Test code\n",
    "print(qa_dt.loc[0, \"prp_qa\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to ...</td>\n",
       "      <td>anim transmit covid 19</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                            Task  \\\n",
       "18  What do we know about virus genetics, origin, and evolution?   \n",
       "\n",
       "                         Questions  \\\n",
       "18  Can animals transmit COVID 19?   \n",
       "\n",
       "                                                                                      Reference Answers  \\\n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to ...   \n",
       "\n",
       "                    prp_qa  \n",
       "18  anim transmit covid 19  "
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt.loc[qa_dt[\"Questions\"]== \"Can animals transmit COVID 19?\", :]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# Practice code\n",
    "#metdatfn = doc_ranker(qa_dt.loc[0, \"prp_qa\"], tfidf_model, vectorizer, metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#print(cos_sim.flatten())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#len(cos_sim)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#cos_sim.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32418    0.000000\n",
       "32419    0.003022\n",
       "32420    0.000000\n",
       "32421    0.025699\n",
       "32422    0.047249\n",
       "Name: TD_IDF_sim_score, dtype: float64"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Practice code\n",
    "#metdatfn[\"TD_IDF_sim_score\"].tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>prp_abstract</th>\n",
       "      <th>TD_IDF_sim_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus</td>\n",
       "      <td>Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...</td>\n",
       "      <td>abstract middle-ag femal ident twin one system lupu erythematosu sle evalu immunolog reactiv pre...</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>212e990b378e8d267042753d5f9d4a64ea5e9869</td>\n",
       "      <td>Infectious diarrhea: Pathogenesis and risk factors</td>\n",
       "      <td>Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...</td>\n",
       "      <td>abstract understand pathogenesi infecti especi bacteri diarrhea increas dramatically. new etiolo...</td>\n",
       "      <td>0.015729</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>bf5d344243153d58be692ceb26f52c08e2bd2d2f</td>\n",
       "      <td>New perspectives on the pathogenesis of rheumatoid arthritis</td>\n",
       "      <td>Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...</td>\n",
       "      <td>abstract pathogenesi rheumatoid arthriti local produc antibodi complex incit antigen yet identif...</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ddd2ecf42ec86ad66072962081e1ce4594431f9c</td>\n",
       "      <td>Management of acute and chronic respiratory tract infections</td>\n",
       "      <td>Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...</td>\n",
       "      <td>abstract pharyng bronchiti pneumonia repres common respiratori tract infections. view establish ...</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>a55cb4e724091ced46b5e55b982a14525eea1c7e</td>\n",
       "      <td>Acute bronchitis: Results of U.S. and European trials of antibiotic therapy</td>\n",
       "      <td>Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...</td>\n",
       "      <td>abstract acut bronchiti ill frequent encount primary-car physician inflamm tracheobronchi tree r...</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  aecbc613ebdab36753235197ffb4f35734b5ca63   \n",
       "1  212e990b378e8d267042753d5f9d4a64ea5e9869   \n",
       "2  bf5d344243153d58be692ceb26f52c08e2bd2d2f   \n",
       "3  ddd2ecf42ec86ad66072962081e1ce4594431f9c   \n",
       "4  a55cb4e724091ced46b5e55b982a14525eea1c7e   \n",
       "\n",
       "                                                                                             title  \\\n",
       "0  Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus   \n",
       "1                                               Infectious diarrhea: Pathogenesis and risk factors   \n",
       "2                                     New perspectives on the pathogenesis of rheumatoid arthritis   \n",
       "3                                     Management of acute and chronic respiratory tract infections   \n",
       "4                      Acute bronchitis: Results of U.S. and European trials of antibiotic therapy   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Middle-aged female identical twins, one of whom had systemic lupus erythematosus (SLE),...   \n",
       "1  Abstract Our understanding of the pathogenesis of infectious, especially bacterial, diarrhea has...   \n",
       "2  Abstract In the pathogenesis of rheumatoid arthritis, locally produced antibodies complex with a...   \n",
       "3  Abstract Pharyngitis, bronchitis, and pneumonia represent the most common respiratory tract infe...   \n",
       "4  Abstract Acute bronchitis, an illness frequently encountered by primary-care physicians, is an i...   \n",
       "\n",
       "                                                                                          prp_abstract  \\\n",
       "0  abstract middle-ag femal ident twin one system lupu erythematosu sle evalu immunolog reactiv pre...   \n",
       "1  abstract understand pathogenesi infecti especi bacteri diarrhea increas dramatically. new etiolo...   \n",
       "2  abstract pathogenesi rheumatoid arthriti local produc antibodi complex incit antigen yet identif...   \n",
       "3  abstract pharyng bronchiti pneumonia repres common respiratori tract infections. view establish ...   \n",
       "4  abstract acut bronchiti ill frequent encount primary-car physician inflamm tracheobronchi tree r...   \n",
       "\n",
       "   TD_IDF_sim_score  \n",
       "0          0.000000  \n",
       "1          0.015729  \n",
       "2          0.000000  \n",
       "3          0.000000  \n",
       "4          0.000000  "
      ]
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Practice code\n",
    "#metdatfn.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to generate dataframe with top 10 abstracts from documents relative to given query\n",
    "# Calculated similarity score between the processed query and abstract by taking cosine product\n",
    "# between respective TD-IDF vectors  \n",
    "# Sorting and then considering info of top 10 documents only\n",
    "def td_idf_cos(qadt, tfidf_model, vectorizer, metdatfn):\n",
    "    metdatfn = doc_ranker(qadt, tfidf_model, vectorizer, metdatfn)\n",
    "    metdatfn_srt = metdatfn.sort_values(by = 'TD_IDF_sim_score', ascending = False)\n",
    "    mtdatfntop = metdatfn_srt.head(10)\n",
    "    mtdatfntop.index = pd.RangeIndex(0, len(mtdatfntop.index))\n",
    "    return(mtdatfntop)\n",
    "#metdatfn_srt.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [],
   "source": [
    "def wrd2vec_cos(word2vec_md, qa_dt_v2):\n",
    "    vs_set = []\n",
    "    for i in range(len(qa_dt_v2)):\n",
    "        sent1 = abs_proc(qa_dt_v2.loc[i, \"Model_Sum_Answer\"])\n",
    "        sent2 = abs_proc(qa_dt_v2.loc[i, \"Sum_Reference_answers\"])\n",
    "        for answer in [sent1, sent2]:\n",
    "            vs = np.zeros(300)\n",
    "            for word in answer:\n",
    "                vs = np.add(vs, word2vec_md.wv[word]) \n",
    "            vs_set.append(vs)\n",
    "            #print(len(vs_set))\n",
    "        cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))[0][0]\n",
    "        #print(cost)\n",
    "        qa_dt_v2.loc[i, \"similarity_score\"] = cost\n",
    "        vs_set = []\n",
    "    return qa_dt_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [],
   "source": [
    "#metdatfntop_tr = td_idf_cos(qa_dt.loc[18, \"prp_qa\"], tfidf_model, vectorizer, metdatfn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>prp_abstract</th>\n",
       "      <th>TD_IDF_sim_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>045bff414afcee22d7f2f6667cae10b10ba99571</td>\n",
       "      <td>Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection</td>\n",
       "      <td>COVID-19) infection</td>\n",
       "      <td>covid-19 infect</td>\n",
       "      <td>0.646951</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>17de15d04f7a7643550666d2f0da773f5b7dc95c</td>\n",
       "      <td>COVID-19 Therapeutic and Prevention</td>\n",
       "      <td>COVID-19 Therapeutic and Prevention</td>\n",
       "      <td>covid-19 therapeut prevent</td>\n",
       "      <td>0.512276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>6fcf4019b0be24071210f97eda4baba53a6a79de</td>\n",
       "      <td>Clinical and pathological characteristics of 2019 novel coronavirus disease (COVID-19): a system...</td>\n",
       "      <td>Importance: In 2002-2003, a severe pulmonary infectious disease occurred in Guangdong, China. Th...</td>\n",
       "      <td>import 2002-2003 sever pulmonari infecti diseas occur guangdong china. diseas caus sars-cov 17 y...</td>\n",
       "      <td>0.487696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>f17c6ac4986aecba2dc22f67b32f2d16b369117b</td>\n",
       "      <td>Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronaviru...</td>\n",
       "      <td>Objectives: Latest epidemic data of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)...</td>\n",
       "      <td>object latest epidem data sever acut respiratori syndrom coronaviru 2 sars-cov-2 infect pneumoni...</td>\n",
       "      <td>0.460194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0eee9760aee0ca2fdf8d1d215c3689d5f8d84df5</td>\n",
       "      <td>Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clini...</td>\n",
       "      <td>Background With the spread of COVID-19 from Wuhan, Hubei Province to other areas of the country,...</td>\n",
       "      <td>background spread covid-19 wuhan hubei provinc area countri medic staff fever clinic face challe...</td>\n",
       "      <td>0.451951</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>a282fc6ac1a87980e363dfb9a09793d519cacbd5</td>\n",
       "      <td>Parenting in a time of COVID-19</td>\n",
       "      <td>Parenting in a time of COVID-19</td>\n",
       "      <td>parent time covid-19</td>\n",
       "      <td>0.451002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ca9be3e297299069e973493982e0c93fa9e4e2ee</td>\n",
       "      <td>COVID-19: what is next for public health?</td>\n",
       "      <td>COVID-19: what is next for public health?</td>\n",
       "      <td>covid-19 next public health</td>\n",
       "      <td>0.440614</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>ff54e074416d584681566019cdec2d3683ac2fc5</td>\n",
       "      <td>Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient</td>\n",
       "      <td>Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute res...</td>\n",
       "      <td>coronaviru diseas 2019 covid-19 highli infect diseas caus sever acut respiratori syndrom coronav...</td>\n",
       "      <td>0.427497</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>0e154f30a23e2d11bc5674354f3f7c74fb6a0008</td>\n",
       "      <td>On the assessment of more reliable COVID-19 infected number: the italian case.</td>\n",
       "      <td>COVID-19 (SARS-CoV-2) is the most recent pandemic disease the world is currently managing. It st...</td>\n",
       "      <td>covid-19 sars-cov-2 recent pandem diseas world current managing. start china end 2019 diffus thr...</td>\n",
       "      <td>0.420030</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>6f07f5dc2599b774baffd5a80e0b0a59662b7f35</td>\n",
       "      <td>Initiation of a new infection control system for the COVID-19 outbreak</td>\n",
       "      <td>Initiation of a new infection control system for the COVID-19 outbreak</td>\n",
       "      <td>initi new infect control system covid-19 outbreak</td>\n",
       "      <td>0.417856</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  045bff414afcee22d7f2f6667cae10b10ba99571   \n",
       "1  17de15d04f7a7643550666d2f0da773f5b7dc95c   \n",
       "2  6fcf4019b0be24071210f97eda4baba53a6a79de   \n",
       "3  f17c6ac4986aecba2dc22f67b32f2d16b369117b   \n",
       "4  0eee9760aee0ca2fdf8d1d215c3689d5f8d84df5   \n",
       "5  a282fc6ac1a87980e363dfb9a09793d519cacbd5   \n",
       "6  ca9be3e297299069e973493982e0c93fa9e4e2ee   \n",
       "7  ff54e074416d584681566019cdec2d3683ac2fc5   \n",
       "8  0e154f30a23e2d11bc5674354f3f7c74fb6a0008   \n",
       "9  6f07f5dc2599b774baffd5a80e0b0a59662b7f35   \n",
       "\n",
       "                                                                                                 title  \\\n",
       "0               Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection   \n",
       "1                                                                  COVID-19 Therapeutic and Prevention   \n",
       "2  Clinical and pathological characteristics of 2019 novel coronavirus disease (COVID-19): a system...   \n",
       "3  Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronaviru...   \n",
       "4  Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clini...   \n",
       "5                                                                      Parenting in a time of COVID-19   \n",
       "6                                                            COVID-19: what is next for public health?   \n",
       "7                              Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient   \n",
       "8                       On the assessment of more reliable COVID-19 infected number: the italian case.   \n",
       "9                               Initiation of a new infection control system for the COVID-19 outbreak   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0                                                                                  COVID-19) infection   \n",
       "1                                                                  COVID-19 Therapeutic and Prevention   \n",
       "2  Importance: In 2002-2003, a severe pulmonary infectious disease occurred in Guangdong, China. Th...   \n",
       "3  Objectives: Latest epidemic data of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)...   \n",
       "4  Background With the spread of COVID-19 from Wuhan, Hubei Province to other areas of the country,...   \n",
       "5                                                                      Parenting in a time of COVID-19   \n",
       "6                                                            COVID-19: what is next for public health?   \n",
       "7  Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute res...   \n",
       "8  COVID-19 (SARS-CoV-2) is the most recent pandemic disease the world is currently managing. It st...   \n",
       "9                               Initiation of a new infection control system for the COVID-19 outbreak   \n",
       "\n",
       "                                                                                          prp_abstract  \\\n",
       "0                                                                                      covid-19 infect   \n",
       "1                                                                           covid-19 therapeut prevent   \n",
       "2  import 2002-2003 sever pulmonari infecti diseas occur guangdong china. diseas caus sars-cov 17 y...   \n",
       "3  object latest epidem data sever acut respiratori syndrom coronaviru 2 sars-cov-2 infect pneumoni...   \n",
       "4  background spread covid-19 wuhan hubei provinc area countri medic staff fever clinic face challe...   \n",
       "5                                                                                 parent time covid-19   \n",
       "6                                                                          covid-19 next public health   \n",
       "7  coronaviru diseas 2019 covid-19 highli infect diseas caus sever acut respiratori syndrom coronav...   \n",
       "8  covid-19 sars-cov-2 recent pandem diseas world current managing. start china end 2019 diffus thr...   \n",
       "9                                                    initi new infect control system covid-19 outbreak   \n",
       "\n",
       "   TD_IDF_sim_score  \n",
       "0          0.646951  \n",
       "1          0.512276  \n",
       "2          0.487696  \n",
       "3          0.460194  \n",
       "4          0.451951  \n",
       "5          0.451002  \n",
       "6          0.440614  \n",
       "7          0.427497  \n",
       "8          0.420030  \n",
       "9          0.417856  "
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#metdatfntop_tr"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [],
   "source": [
    "#metdatfntop_tr.to_excel(\"test.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 176,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?\n"
     ]
    }
   ],
   "source": [
    "#print(qa_dt.loc[0, \"Questions\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 278,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>prp_abstract</th>\n",
       "      <th>TD_IDF_sim_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>30fb77bb67dd41ee831fc9ed1cffc80e5c41761b</td>\n",
       "      <td>Chapter 9 Safety of Water Used in Food Production</td>\n",
       "      <td>Abstract Water has a major and fundamental role in safety of food production. It is a critical r...</td>\n",
       "      <td>abstract water major fundament role safeti food production. critic resourc food industri wide us...</td>\n",
       "      <td>0.375564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>da4fb62d8f1829d3957949dfb18dc0b6d1d223ff</td>\n",
       "      <td>Factors involved in the aerosol transmission of infection and control of ventilation in healthca...</td>\n",
       "      <td>Summary The epidemics of severe acute respiratory syndrome (SARS) in 2003 highlighted both short...</td>\n",
       "      <td>summari epidem sever acut respiratori syndrom sar 2003 highlight short- long-rang transmiss rout...</td>\n",
       "      <td>0.346695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0</td>\n",
       "      <td>Severe Acute Respiratory Syndrome (SARS) and the GDP. Part II: Implications for GDPs</td>\n",
       "      <td>The transmission modes of SARS-coronavirus appear to be through droplet spread, close contact an...</td>\n",
       "      <td>transmiss mode sars-coronaviru appear droplet spread close contact fomit although air born trans...</td>\n",
       "      <td>0.320411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>11ad2acc16067afbf2ce40d422647c3d899ecbd4</td>\n",
       "      <td>Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectio...</td>\n",
       "      <td>BACKGROUND: The Influenza A H1N1 virus can be transmitted via direct, indirect, and airborne rou...</td>\n",
       "      <td>background influenza h1n1 viru transmit via direct indirect airborn rout non-infect subject infe...</td>\n",
       "      <td>0.310106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>04e8b80ed7a2ffd701f7fa9079698fe01c94f278</td>\n",
       "      <td>Documentary Research of Human Respiratory Droplet Characteristics</td>\n",
       "      <td>Abstract Respiratory droplet characteristics are key to determine the droplet-borne pathogen tra...</td>\n",
       "      <td>abstract respiratori droplet characterist key determin droplet-born pathogen transmiss provid sc...</td>\n",
       "      <td>0.299934</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>709e51c08788944db48106970f38cebe2b5bd596</td>\n",
       "      <td>Role of viral bioaerosols in nosocomial infections and measures for prevention and control</td>\n",
       "      <td>Abstract The presence of patients with diverse pathologies in hospitals results in an environmen...</td>\n",
       "      <td>abstract presenc patient divers patholog hospit result environ rich variou microorgan includ res...</td>\n",
       "      <td>0.293366</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>dc845f9fdcd05760f704f4250fae42c9f29773b0</td>\n",
       "      <td>Chapter 4 Viral Diseases Transmissible by Kissing</td>\n",
       "      <td>Abstract Viral infections can be transmitted by various routes. At one extreme, airborne or drop...</td>\n",
       "      <td>abstract viral infect transmit variou routes. one extrem airborn droplet viral infect e.g. varic...</td>\n",
       "      <td>0.285603</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>c3cb6dbc8f9856954962672e54253ab8fe627446</td>\n",
       "      <td>Possible SARS Coronavirus Transmission during Cardiopulmonary Resuscitation</td>\n",
       "      <td>Infection of healthcare workers with the severe acute respiratory syndromeâ€“associated coronaviru...</td>\n",
       "      <td>infect healthcar worker sever acut respiratori syndrom associ coronaviru sars-cov thought occur ...</td>\n",
       "      <td>0.280251</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>327bc5f754f40be82f7abcd9b95b3ff62a620394</td>\n",
       "      <td>Exceptional matters</td>\n",
       "      <td>Exceptional matters</td>\n",
       "      <td>except matter</td>\n",
       "      <td>0.271126</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>6f192000b0e87fe2c55632441655de31c61596c4</td>\n",
       "      <td>Bacterial survival in evaporating deposited droplets on a teflon-coated surface</td>\n",
       "      <td>Understanding of bacterial survival in aerosols is crucial for controlling infection transmissio...</td>\n",
       "      <td>understand bacteri surviv aerosol crucial control infect transmiss via airborn aerosol larg drop...</td>\n",
       "      <td>0.265386</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  30fb77bb67dd41ee831fc9ed1cffc80e5c41761b   \n",
       "1  da4fb62d8f1829d3957949dfb18dc0b6d1d223ff   \n",
       "2  f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0   \n",
       "3  11ad2acc16067afbf2ce40d422647c3d899ecbd4   \n",
       "4  04e8b80ed7a2ffd701f7fa9079698fe01c94f278   \n",
       "5  709e51c08788944db48106970f38cebe2b5bd596   \n",
       "6  dc845f9fdcd05760f704f4250fae42c9f29773b0   \n",
       "7  c3cb6dbc8f9856954962672e54253ab8fe627446   \n",
       "8  327bc5f754f40be82f7abcd9b95b3ff62a620394   \n",
       "9  6f192000b0e87fe2c55632441655de31c61596c4   \n",
       "\n",
       "                                                                                                 title  \\\n",
       "0                                                    Chapter 9 Safety of Water Used in Food Production   \n",
       "1  Factors involved in the aerosol transmission of infection and control of ventilation in healthca...   \n",
       "2                 Severe Acute Respiratory Syndrome (SARS) and the GDP. Part II: Implications for GDPs   \n",
       "3  Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectio...   \n",
       "4                                    Documentary Research of Human Respiratory Droplet Characteristics   \n",
       "5           Role of viral bioaerosols in nosocomial infections and measures for prevention and control   \n",
       "6                                                    Chapter 4 Viral Diseases Transmissible by Kissing   \n",
       "7                          Possible SARS Coronavirus Transmission during Cardiopulmonary Resuscitation   \n",
       "8                                                                                  Exceptional matters   \n",
       "9                      Bacterial survival in evaporating deposited droplets on a teflon-coated surface   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Water has a major and fundamental role in safety of food production. It is a critical r...   \n",
       "1  Summary The epidemics of severe acute respiratory syndrome (SARS) in 2003 highlighted both short...   \n",
       "2  The transmission modes of SARS-coronavirus appear to be through droplet spread, close contact an...   \n",
       "3  BACKGROUND: The Influenza A H1N1 virus can be transmitted via direct, indirect, and airborne rou...   \n",
       "4  Abstract Respiratory droplet characteristics are key to determine the droplet-borne pathogen tra...   \n",
       "5  Abstract The presence of patients with diverse pathologies in hospitals results in an environmen...   \n",
       "6  Abstract Viral infections can be transmitted by various routes. At one extreme, airborne or drop...   \n",
       "7  Infection of healthcare workers with the severe acute respiratory syndromeâ€“associated coronaviru...   \n",
       "8                                                                                  Exceptional matters   \n",
       "9  Understanding of bacterial survival in aerosols is crucial for controlling infection transmissio...   \n",
       "\n",
       "                                                                                          prp_abstract  \\\n",
       "0  abstract water major fundament role safeti food production. critic resourc food industri wide us...   \n",
       "1  summari epidem sever acut respiratori syndrom sar 2003 highlight short- long-rang transmiss rout...   \n",
       "2  transmiss mode sars-coronaviru appear droplet spread close contact fomit although air born trans...   \n",
       "3  background influenza h1n1 viru transmit via direct indirect airborn rout non-infect subject infe...   \n",
       "4  abstract respiratori droplet characterist key determin droplet-born pathogen transmiss provid sc...   \n",
       "5  abstract presenc patient divers patholog hospit result environ rich variou microorgan includ res...   \n",
       "6  abstract viral infect transmit variou routes. one extrem airborn droplet viral infect e.g. varic...   \n",
       "7  infect healthcar worker sever acut respiratori syndrom associ coronaviru sars-cov thought occur ...   \n",
       "8                                                                                        except matter   \n",
       "9  understand bacteri surviv aerosol crucial control infect transmiss via airborn aerosol larg drop...   \n",
       "\n",
       "   TD_IDF_sim_score  \n",
       "0          0.375564  \n",
       "1          0.346695  \n",
       "2          0.320411  \n",
       "3          0.310106  \n",
       "4          0.299934  \n",
       "5          0.293366  \n",
       "6          0.285603  \n",
       "7          0.280251  \n",
       "8          0.271126  \n",
       "9          0.265386  "
      ]
     },
     "execution_count": 278,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#metdatfntop_tr"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Practice code\n",
    "#metdatfntop = metdatfn_srt.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10"
      ]
     },
     "execution_count": 120,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Practice code\n",
    "#len(metdatfntop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Practice code\n",
    "#metdatfntop.index = pd.RangeIndex(0, len(metdatfntop.index))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>prp_abstract</th>\n",
       "      <th>TD_IDF_sim_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>30fb77bb67dd41ee831fc9ed1cffc80e5c41761b</td>\n",
       "      <td>Chapter 9 Safety of Water Used in Food Production</td>\n",
       "      <td>Abstract Water has a major and fundamental role in safety of food production. It is a critical r...</td>\n",
       "      <td>abstract water major fundament role safeti food production. critic resourc food industri wide us...</td>\n",
       "      <td>0.375564</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>da4fb62d8f1829d3957949dfb18dc0b6d1d223ff</td>\n",
       "      <td>Factors involved in the aerosol transmission of infection and control of ventilation in healthca...</td>\n",
       "      <td>Summary The epidemics of severe acute respiratory syndrome (SARS) in 2003 highlighted both short...</td>\n",
       "      <td>summari epidem sever acut respiratori syndrom sar 2003 highlight short- long-rang transmiss rout...</td>\n",
       "      <td>0.346695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0</td>\n",
       "      <td>Severe Acute Respiratory Syndrome (SARS) and the GDP. Part II: Implications for GDPs</td>\n",
       "      <td>The transmission modes of SARS-coronavirus appear to be through droplet spread, close contact an...</td>\n",
       "      <td>transmiss mode sars-coronaviru appear droplet spread close contact fomit although air born trans...</td>\n",
       "      <td>0.320411</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  \\\n",
       "0  30fb77bb67dd41ee831fc9ed1cffc80e5c41761b   \n",
       "1  da4fb62d8f1829d3957949dfb18dc0b6d1d223ff   \n",
       "2  f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0   \n",
       "\n",
       "                                                                                                 title  \\\n",
       "0                                                    Chapter 9 Safety of Water Used in Food Production   \n",
       "1  Factors involved in the aerosol transmission of infection and control of ventilation in healthca...   \n",
       "2                 Severe Acute Respiratory Syndrome (SARS) and the GDP. Part II: Implications for GDPs   \n",
       "\n",
       "                                                                                              abstract  \\\n",
       "0  Abstract Water has a major and fundamental role in safety of food production. It is a critical r...   \n",
       "1  Summary The epidemics of severe acute respiratory syndrome (SARS) in 2003 highlighted both short...   \n",
       "2  The transmission modes of SARS-coronavirus appear to be through droplet spread, close contact an...   \n",
       "\n",
       "                                                                                          prp_abstract  \\\n",
       "0  abstract water major fundament role safeti food production. critic resourc food industri wide us...   \n",
       "1  summari epidem sever acut respiratori syndrom sar 2003 highlight short- long-rang transmiss rout...   \n",
       "2  transmiss mode sars-coronaviru appear droplet spread close contact fomit although air born trans...   \n",
       "\n",
       "   TD_IDF_sim_score  \n",
       "0          0.375564  \n",
       "1          0.346695  \n",
       "2          0.320411  "
      ]
     },
     "execution_count": 122,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Practice code\n",
    "#metdatfntop.head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Download of BERT and dependencies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting transformers==3.3.1\n",
      "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/19/22/aff234f4a841f8999e68a7a94bdd4b60b4cebcfeca5d67d61cd08c9179de/transformers-3.3.1-py3-none-any.whl (1.1MB)\n",
      "\u001b[K    100% |â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 1.1MB 8.4MB/s ta 0:00:011\n",
      "\u001b[?25hCollecting sentencepiece!=0.1.92 (from transformers==3.3.1)\n",
      "  Using cached https://files.pythonhosted.org/packages/72/e0/57edbab017a204e9f39448c1717292437a45b5f7cf3a9dbf4a9c026b03c5/sentencepiece-0.1.94.tar.gz\n",
      "Requirement already satisfied: packaging in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (19.0)\n",
      "Requirement already satisfied: requests in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (2.21.0)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (2020.10.23)\n",
      "Collecting tokenizers==0.8.1.rc2 (from transformers==3.3.1)\n",
      "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/75/26/c02ba92ecb8b780bdae4a862d351433c2912fe49469dac7f87a5c85ccca6/tokenizers-0.8.1rc2-cp37-cp37m-manylinux1_x86_64.whl (3.0MB)\n",
      "\u001b[K    100% |â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 3.0MB 8.4MB/s eta 0:00:01\n",
      "\u001b[?25hRequirement already satisfied: filelock in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (3.0.10)\n",
      "Requirement already satisfied: tqdm>=4.27 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (4.31.0)\n",
      "Requirement already satisfied: numpy in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from transformers==3.3.1) (1.16.1)\n",
      "Collecting sacremoses (from transformers==3.3.1)\n",
      "Requirement already satisfied: six in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from packaging->transformers==3.3.1) (1.12.0)\n",
      "Requirement already satisfied: pyparsing>=2.0.2 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from packaging->transformers==3.3.1) (2.3.1)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from requests->transformers==3.3.1) (2019.3.9)\n",
      "Requirement already satisfied: idna<2.9,>=2.5 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from requests->transformers==3.3.1) (2.8)\n",
      "Requirement already satisfied: chardet<3.1.0,>=3.0.2 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from requests->transformers==3.3.1) (3.0.4)\n",
      "Requirement already satisfied: urllib3<1.25,>=1.21.1 in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from requests->transformers==3.3.1) (1.24.1)\n",
      "Requirement already satisfied: click in /mnt/disks/user/anaconda3/lib/python3.7/site-packages (from sacremoses->transformers==3.3.1) (7.0)\n",
      "Collecting joblib (from sacremoses->transformers==3.3.1)\n",
      "  Using cached https://files.pythonhosted.org/packages/fc/c9/f58220ac44a1592f79a343caba12f6837f9e0c04c196176a3d66338e1ea8/joblib-0.17.0-py3-none-any.whl\n",
      "Building wheels for collected packages: sentencepiece\n",
      "  Building wheel for sentencepiece (setup.py) ... \u001b[?25lerror\n",
      "  Complete output from command /mnt/disks/user/anaconda3/bin/python -u -c \"import setuptools, tokenize;__file__='/tmp/pip-install-h16zuvy9/sentencepiece/setup.py';f=getattr(tokenize, 'open', open)(__file__);code=f.read().replace('\\r\\n', '\\n');f.close();exec(compile(code, __file__, 'exec'))\" bdist_wheel -d /tmp/pip-wheel-0n2dqqm2 --python-tag cp37:\n",
      "  running bdist_wheel\n",
      "  running build\n",
      "  running build_py\n",
      "  creating build\n",
      "  creating build/lib.linux-x86_64-3.7\n",
      "  creating build/lib.linux-x86_64-3.7/sentencepiece\n",
      "  copying src/sentencepiece/__init__.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "  copying src/sentencepiece/sentencepiece_model_pb2.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "  copying src/sentencepiece/sentencepiece_pb2.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "  running build_ext\n",
      "  Package sentencepiece was not found in the pkg-config search path.\n",
      "  Perhaps you should add the directory containing `sentencepiece.pc'\n",
      "  to the PKG_CONFIG_PATH environment variable\n",
      "  No package 'sentencepiece' found\n",
      "  Cloning into 'sentencepiece'...\n",
      "  Note: checking out '8336bbd0c1cfba02a879afe625bf1ddaf7cd93c5'.\n",
      "  \n",
      "  You are in 'detached HEAD' state. You can look around, make experimental\n",
      "  changes and commit them, and you can discard any commits you make in this\n",
      "  state without impacting any branches by performing another checkout.\n",
      "  \n",
      "  If you want to create a new branch to retain commits you create, you may\n",
      "  do so (now or later) by using -b with the checkout command again. Example:\n",
      "  \n",
      "    git checkout -b <new-branch-name>\n",
      "  \n",
      "  ./build_bundled.sh: 15: ./build_bundled.sh: cmake: not found\n",
      "  make: *** No targets specified and no makefile found.  Stop.\n",
      "  make: *** No rule to make target 'install'.  Stop.\n",
      "  Package sentencepiece was not found in the pkg-config search path.\n",
      "  Perhaps you should add the directory containing `sentencepiece.pc'\n",
      "  to the PKG_CONFIG_PATH environment variable\n",
      "  No package 'sentencepiece' found\n",
      "  Failed to find sentencepiece pkg-config\n",
      "  \n",
      "  ----------------------------------------\n",
      "\u001b[31m  Failed building wheel for sentencepiece\u001b[0m\n",
      "\u001b[?25h  Running setup.py clean for sentencepiece\n",
      "Failed to build sentencepiece\n",
      "Installing collected packages: sentencepiece, tokenizers, joblib, sacremoses, transformers\n",
      "  Running setup.py install for sentencepiece ... \u001b[?25lerror\n",
      "    Complete output from command /mnt/disks/user/anaconda3/bin/python -u -c \"import setuptools, tokenize;__file__='/tmp/pip-install-h16zuvy9/sentencepiece/setup.py';f=getattr(tokenize, 'open', open)(__file__);code=f.read().replace('\\r\\n', '\\n');f.close();exec(compile(code, __file__, 'exec'))\" install --record /tmp/pip-record-v7kdbf3k/install-record.txt --single-version-externally-managed --compile:\n",
      "    running install\n",
      "    running build\n",
      "    running build_py\n",
      "    creating build\n",
      "    creating build/lib.linux-x86_64-3.7\n",
      "    creating build/lib.linux-x86_64-3.7/sentencepiece\n",
      "    copying src/sentencepiece/__init__.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "    copying src/sentencepiece/sentencepiece_model_pb2.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "    copying src/sentencepiece/sentencepiece_pb2.py -> build/lib.linux-x86_64-3.7/sentencepiece\n",
      "    running build_ext\n",
      "    Package sentencepiece was not found in the pkg-config search path.\n",
      "    Perhaps you should add the directory containing `sentencepiece.pc'\n",
      "    to the PKG_CONFIG_PATH environment variable\n",
      "    No package 'sentencepiece' found\n",
      "    mkdir: cannot create directory â€˜bundledâ€™: File exists\n",
      "    fatal: destination path 'sentencepiece' already exists and is not an empty directory.\n",
      "    fatal: destination path 'sentencepiece' already exists and is not an empty directory.\n",
      "    mkdir: cannot create directory â€˜buildâ€™: File exists\n",
      "    ./build_bundled.sh: 15: ./build_bundled.sh: cmake: not found\n",
      "    make: *** No targets specified and no makefile found.  Stop.\n",
      "    make: *** No rule to make target 'install'.  Stop.\n",
      "    Package sentencepiece was not found in the pkg-config search path.\n",
      "    Perhaps you should add the directory containing `sentencepiece.pc'\n",
      "    to the PKG_CONFIG_PATH environment variable\n",
      "    No package 'sentencepiece' found\n",
      "    Failed to find sentencepiece pkg-config\n",
      "    \n",
      "    ----------------------------------------\n",
      "\u001b[?25h\u001b[31mCommand \"/mnt/disks/user/anaconda3/bin/python -u -c \"import setuptools, tokenize;__file__='/tmp/pip-install-h16zuvy9/sentencepiece/setup.py';f=getattr(tokenize, 'open', open)(__file__);code=f.read().replace('\\r\\n', '\\n');f.close();exec(compile(code, __file__, 'exec'))\" install --record /tmp/pip-record-v7kdbf3k/install-record.txt --single-version-externally-managed --compile\" failed with error code 1 in /tmp/pip-install-h16zuvy9/sentencepiece/\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "#!pip install transformers==3.3.1\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:14:31.162966 140212937652032 filelock.py:274] Lock 140210150718040 acquired on /root/.cache/torch/transformers/00bf8b18639562831ff9d22825e646f00f34a6976c6ed0ed1c4b35d334bb7a51.b772b6b6a8558acff388e409ffb931bf7aa1c06b8bf788f0e0b64a548908ae4f.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "99a0532d687643f2bf84e54cd2a6113e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=443, style=ProgressStyle(description_width=â€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:14:31.957112 140212937652032 filelock.py:318] Lock 140210150718040 released on /root/.cache/torch/transformers/00bf8b18639562831ff9d22825e646f00f34a6976c6ed0ed1c4b35d334bb7a51.b772b6b6a8558acff388e409ffb931bf7aa1c06b8bf788f0e0b64a548908ae4f.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:14:32.311906 140212937652032 filelock.py:274] Lock 140210148756784 acquired on /root/.cache/torch/transformers/951442347f8499682d264a4ca7b8ef1169963526e761ec58de8328f4f57f5249.2db7ae79c41a184c87600faabafa1369db2b16457723fd154ca3b436c4172807.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0a6d924c8ad0435999245e89623536bb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=1340675298, style=ProgressStyle(descriptionâ€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:14:55.694745 140212937652032 filelock.py:318] Lock 140210148756784 released on /root/.cache/torch/transformers/951442347f8499682d264a4ca7b8ef1169963526e761ec58de8328f4f57f5249.2db7ae79c41a184c87600faabafa1369db2b16457723fd154ca3b436c4172807.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:15:10.893942 140212937652032 filelock.py:274] Lock 140210153325176 acquired on /root/.cache/torch/transformers/425869b134694b14f3fd06adbee0d84e62abc76097792a5c6f94524239e0e8b4.542ce4285a40d23a559526243235df47c5f75c197f04f37d1a0c124c32c9a084.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "594e8b7142ff4119b61e696764951dd0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=231508, style=ProgressStyle(description_widâ€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:15:12.234672 140212937652032 filelock.py:318] Lock 140210153325176 released on /root/.cache/torch/transformers/425869b134694b14f3fd06adbee0d84e62abc76097792a5c6f94524239e0e8b4.542ce4285a40d23a559526243235df47c5f75c197f04f37d1a0c124c32c9a084.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import torch\n",
    "from transformers import BertTokenizer\n",
    "from transformers import BertForQuestionAnswering\n",
    "\n",
    "torch_device = 'cuda' if torch.cuda.is_available() else 'cpu'\n",
    "\n",
    "BERT_SQUAD = 'bert-large-uncased-whole-word-masking-finetuned-squad'\n",
    "\n",
    "model = BertForQuestionAnswering.from_pretrained(BERT_SQUAD)\n",
    "tokenizer = BertTokenizer.from_pretrained(BERT_SQUAD)\n",
    "\n",
    "model = model.to(torch_device)\n",
    "model.eval()\n",
    "\n",
    "print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "BartForConditionalGeneration(\n",
       "  (model): BartModel(\n",
       "    (shared): Embedding(50264, 1024, padding_idx=1)\n",
       "    (encoder): BartEncoder(\n",
       "      (embed_tokens): Embedding(50264, 1024, padding_idx=1)\n",
       "      (embed_positions): LearnedPositionalEmbedding(1026, 1024, padding_idx=1)\n",
       "      (layers): ModuleList(\n",
       "        (0): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (1): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (2): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (3): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (4): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (5): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (6): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (7): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (8): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (9): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (10): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (11): EncoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "      )\n",
       "      (layernorm_embedding): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "    )\n",
       "    (decoder): BartDecoder(\n",
       "      (embed_tokens): Embedding(50264, 1024, padding_idx=1)\n",
       "      (embed_positions): LearnedPositionalEmbedding(1026, 1024, padding_idx=1)\n",
       "      (layers): ModuleList(\n",
       "        (0): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (1): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (2): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (3): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (4): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (5): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (6): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (7): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (8): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (9): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (10): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "        (11): DecoderLayer(\n",
       "          (self_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (self_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (encoder_attn): Attention(\n",
       "            (k_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (v_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (q_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "            (out_proj): Linear(in_features=1024, out_features=1024, bias=True)\n",
       "          )\n",
       "          (encoder_attn_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "          (fc1): Linear(in_features=1024, out_features=4096, bias=True)\n",
       "          (fc2): Linear(in_features=4096, out_features=1024, bias=True)\n",
       "          (final_layer_norm): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "        )\n",
       "      )\n",
       "      (layernorm_embedding): LayerNorm(torch.Size([1024]), eps=1e-05, elementwise_affine=True)\n",
       "    )\n",
       "  )\n",
       ")"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Summary generator model initiation\n",
    "#from transformers import BartTokenizer, BartForConditionalGeneration, BartConfig\n",
    "#bart_model = 'facebook/bart-large-cnn'\n",
    "#sum_tokenizer = BartTokenizer.from_pretrained(bart_model)\n",
    "#sum_model = BartForConditionalGeneration.from_pretrained(bart_model)\n",
    "#sum_model.to(torch_device)\n",
    "#sum_model.eval()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:15:45.646034 140212937652032 filelock.py:274] Lock 140209794959792 acquired on /root/.cache/torch/transformers/6dfaed860471b03ab5b9acb6153bea82b6632fb9bbe514d3fff050fe1319ee6d.788fed32bb8481a9b15ce726d41c53d5d5066b04c667e34ce3a7a3826d1573d8.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8c9e24dfee54421ea4633006d240ea34",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=434, style=ProgressStyle(description_width=â€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:15:46.476850 140212937652032 filelock.py:318] Lock 140209794959792 released on /root/.cache/torch/transformers/6dfaed860471b03ab5b9acb6153bea82b6632fb9bbe514d3fff050fe1319ee6d.788fed32bb8481a9b15ce726d41c53d5d5066b04c667e34ce3a7a3826d1573d8.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:15:46.762005 140212937652032 filelock.py:274] Lock 140209794969216 acquired on /root/.cache/torch/transformers/73e65a4648c1a5eab31ecea94e04a92a7168cd7089d588b68e5bc057aff40421.4d5343a4b979c4beeaadef17a0453d1bb183dd9b084f58b84c7cc781df343ae6.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3a413133b8ce445eb928260292130884",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=1344997306, style=ProgressStyle(descriptionâ€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:17:55.242703 140212937652032 filelock.py:318] Lock 140209794969216 released on /root/.cache/torch/transformers/73e65a4648c1a5eab31ecea94e04a92a7168cd7089d588b68e5bc057aff40421.4d5343a4b979c4beeaadef17a0453d1bb183dd9b084f58b84c7cc781df343ae6.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:18:07.261841 140212937652032 filelock.py:274] Lock 140210153356256 acquired on /root/.cache/torch/transformers/9b3c03a36e83b13d5ba95ac965c9f9074a99e14340c523ab405703179e79fc46.542ce4285a40d23a559526243235df47c5f75c197f04f37d1a0c124c32c9a084.lock\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "98a44cc7ea484989a3f9ffe529fa9393",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "HBox(children=(IntProgress(value=0, description='Downloading', max=231508, style=ProgressStyle(description_widâ€¦"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:18:08.586525 140212937652032 filelock.py:318] Lock 140210153356256 released on /root/.cache/torch/transformers/9b3c03a36e83b13d5ba95ac965c9f9074a99e14340c523ab405703179e79fc46.542ce4285a40d23a559526243235df47c5f75c197f04f37d1a0c124c32c9a084.lock\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "from summarizer import Summarizer\n",
    "sum_model = Summarizer()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Reconstructing or cleaning token answers received from BERTSQUAD pretrained model by removing \n",
    "# '##' and extra whitespaces \n",
    "def cleanText(tokens, start=0, stop=-1):\n",
    "    tokens = tokens[start: stop]\n",
    "    if '[SEP]' in tokens:\n",
    "        sepind = tokens.index('[SEP]')\n",
    "        tokens = tokens[sepind+1:]\n",
    "    txt = ' '.join(tokens)\n",
    "    txt = txt.replace(' ##', '')\n",
    "    txt = txt.replace('##', '')\n",
    "    txt = txt.strip()\n",
    "    txt = \" \".join(txt.split())\n",
    "    txt = txt.replace(' .', '.')\n",
    "    txt = txt.replace('( ', '(')\n",
    "    txt = txt.replace(' )', ')')\n",
    "    txt = txt.replace(' - ', '-')\n",
    "    txt_list = txt.split(' , ')\n",
    "    txt = ''\n",
    "    nTxtL = len(txt_list)\n",
    "    if nTxtL == 1:\n",
    "        return txt_list[0]\n",
    "    newList =[]\n",
    "    for i,t in enumerate(txt_list):\n",
    "        if i < nTxtL -1:\n",
    "            if t[-1].isdigit() and txt_list[i+1][0].isdigit():\n",
    "                newList += [t,',']\n",
    "            else:\n",
    "                newList += [t, ', ']\n",
    "        else:\n",
    "            newList += [t]\n",
    "    return ''.join(newList)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # First iteration and thats why commented out\n",
    "# def BERTSQUADPred(context, question):\n",
    "#     ## the following code chuncks the \"abstract\" into multiple smaller word segments with\n",
    "#     ## word overlaps on either end so that model can better understand and check longer abstracts\n",
    "#     nWords = len(context.split())\n",
    "#     input_ids_all = tokenizer.encode(question, context)\n",
    "#     tokens_all = tokenizer.convert_ids_to_tokens(input_ids_all)\n",
    "#     #print(nWords)\n",
    "#     #print(len(input_ids_all))\n",
    "#     overlapFac = 1.1 # factor that determines number of 'overlap' words considered\n",
    "#     if len(input_ids_all)*overlapFac > 2048:\n",
    "#         nSearchWords = int(np.ceil(nWords/5))\n",
    "#         quarter = int(np.ceil(nWords/4))\n",
    "#         contsplit = context.split()\n",
    "#         contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "#                      ' '.join(contsplit[quarter-int(nSearchWords*overlapFac/2):quarter+int(quarter*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[quarter*2-int(nSearchWords*overlapFac/2):quarter*2+int(quarter*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[quarter*3-int(nSearchWords*overlapFac/2):quarter*3+int(quarter*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "#         input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "#         #len(input_ids)\n",
    "        \n",
    "#     elif len(input_ids_all)*overlapFac > 1536:\n",
    "#         nSearchWords = int(np.ceil(nWords/4))\n",
    "#         third = int(np.ceil(nWords/3))\n",
    "#         contsplit = context.split()\n",
    "#         contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "#                      ' '.join(contsplit[third-int(nSearchWords*overlapFac/2):third+int(nSearchWords*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[third*2-int(nSearchWords*overlapFac/2):third*2+int(nSearchWords*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "#         input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "#         #len(input_ids)\n",
    "        \n",
    "#     elif len(input_ids_all)*overlapFac > 1024:\n",
    "#         nSearchWords = int(np.ceil(nWords/3))\n",
    "#         middle = int(np.ceil(nWords/2))\n",
    "#         contsplit = context.split()\n",
    "#         contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "#                      ' '.join(contsplit[middle-int(nSearchWords*overlapFac/2):middle+int(nSearchWords*overlapFac/2)]),\n",
    "#                      ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "#         input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "#         #len(input_ids)\n",
    "#     elif len(input_ids_all)*overlapFac > 512:\n",
    "#         nSearchWords = int(np.ceil(nWords/2))\n",
    "#         contsplit = context.split()\n",
    "#         contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "#         input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "#         #print(len(input_ids))\n",
    "#     else:\n",
    "#         input_ids = [input_ids_all]\n",
    "#         #print(len(input_ids))\n",
    "#     absTooLong = False    \n",
    "#     #print(input_ids)\n",
    "#     answers = []\n",
    "#     cons = []\n",
    "#     for iptIds in input_ids:\n",
    "#         tokens = tokenizer.convert_ids_to_tokens(iptIds)\n",
    "#         sep_index = iptIds.index(tokenizer.sep_token_id)\n",
    "#         num_seg_a = sep_index + 1\n",
    "#         num_seg_b = len(iptIds) - num_seg_a\n",
    "#         segment_ids = [0]*num_seg_a + [1]*num_seg_b\n",
    "#         #print(segment_ids)\n",
    "#         assert len(segment_ids) == len(iptIds)\n",
    "#         n_ids = len(segment_ids)\n",
    "        \n",
    "#         #print(n_ids)\n",
    "#         if n_ids < 512:\n",
    "#             start_scores, end_scores = model(torch.tensor([iptIds]).to(torch_device), \n",
    "#                                      token_type_ids=torch.tensor([segment_ids]).to(torch_device))\n",
    "#         else:\n",
    "#             #this cuts off the text if its more than 512 words so it fits in model space\n",
    "#             #need run multiple inferences for longer text. add to the todo\n",
    "#             print('****** warning only considering first 512 tokens, document is '+str(nWords)+' words long.  There are '+str(n_ids)+ ' tokens')\n",
    "#             absTooLong = True\n",
    "#             start_scores, end_scores = model(torch.tensor([iptIds[:512]]).to(torch_device), \n",
    "#                                      token_type_ids=torch.tensor([segment_ids[:512]]).to(torch_device))\n",
    "#         start_scores = start_scores[:,1:-1]\n",
    "#         end_scores = end_scores[:,1:-1]\n",
    "#         answer_start = torch.argmax(start_scores)\n",
    "#         answer_end = torch.argmax(end_scores)\n",
    "#         #print(answer_start, answer_end)\n",
    "#         answer = cleanText(tokens, answer_start, answer_end+2)\n",
    "    \n",
    "#         if answer.startswith('. ') or answer.startswith(', '):\n",
    "#             answer = answer[2:]\n",
    "            \n",
    "#         c = start_scores[0,answer_start].item()+end_scores[0,answer_end].item()\n",
    "#         answers.append(answer)\n",
    "#         cons.append(c)\n",
    "#     #print(answers)\n",
    "#     #print(cons)\n",
    "#     # Considering the 'confidence' and respective answer for 'max confidence'\n",
    "#     # value\n",
    "#     maxC = max(cons)\n",
    "#     iMaxC = [i for i, j in enumerate(cons) if j == maxC][0]\n",
    "#     confidence = cons[iMaxC]\n",
    "#     answer = answers[iMaxC]\n",
    "#     #print(answer)\n",
    "#     #print(confidence)\n",
    "#     sep_index = tokens_all.index('[SEP]')\n",
    "#     full_txt_tokens = tokens_all[sep_index+1:]\n",
    "    \n",
    "#     abs_returned = cleanText(full_txt_tokens)\n",
    "\n",
    "#     ans={}\n",
    "#     ans['answer'] = answer\n",
    "#     if answer.startswith('[CLS]') or answer_end.item() < sep_index or answer.endswith('[SEP]'):\n",
    "#         ans['confidence'] = -1000000\n",
    "#     else:\n",
    "#         ans['confidence'] = confidence\n",
    "#         ans['abstract_bert'] = abs_returned\n",
    "#         ans['abs_too_long'] = absTooLong\n",
    "#     return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # First iteration and thats why commented out\n",
    "# #brtmp_ans = []\n",
    "# #brt_ans = []\n",
    "# #brt_conf = []\n",
    "# #brt_abst = []\n",
    "# #brt_qt = []\n",
    "# def answergen(metdatfn, qa_dt, tfidf_model, vectorizer):\n",
    "#     brtmp_ans = []\n",
    "#     brt_ans = []\n",
    "#     brt_conf = []\n",
    "#     brt_abst = []\n",
    "#     brt_qt = []\n",
    "#     brt_sha = []\n",
    "#     #t = 0\n",
    "#     for j in range(len(qa_dt)):\n",
    "#         #print('i')\n",
    "#         metdatfntop = td_idf_cos(qa_dt.loc[j, \"prp_qa\"], tfidf_model, vectorizer, metdatfn)\n",
    "#         #print(len(metdatfntop))\n",
    "#         #answ = BERTSQUADPred(metdatfntop.loc[, \"abstract\"], qa_dt.loc[0, \"Questions\"])\n",
    "#         #print(len(answ))\n",
    "#         for i in range(len(metdatfntop)):\n",
    "#             #print(i)\n",
    "#             #print(len(metdatfntop))\n",
    "#             #print(qa_dt.loc[j, \"Questions\"])\n",
    "#             answ = BERTSQUADPred(metdatfntop.loc[i, \"abstract\"], qa_dt.loc[j, \"Questions\"])\n",
    "#             #print(qa_dt.loc[j, \"Questions\"])\n",
    "#             if answ['answer'] != '' and answ['confidence'] > 0:\n",
    "#                 #print('i')\n",
    "#                 brtmp_ans.append(answ['answer'])\n",
    "#                 brt_conf.append(answ['confidence'])\n",
    "#                 brt_abst.append(answ['abstract_bert'])\n",
    "#                 brt_qt.append(qa_dt.loc[j,\"Questions\"])\n",
    "#                 brt_sha.append(metdatfntop.loc[i, \"sha\"])\n",
    "#             #df_ans = pd.DataFrame(data = {'brt_ans':brt_ans, 'brt_conf':brt_conf, 'brt_abst':brt_abst, 'brt_question':brt_qt})\n",
    "#         #print(len(brtmp_ans))\n",
    "#         brt_ans = brt_ans + brtmp_ans\n",
    "#         bart_answ = \" \".join(brtmp_ans)\n",
    "#             #bart_answ = \" \".join(df_ans['brt_ans'])\n",
    "#         bart_answ = bart_answ.replace('\\s+',' ')\n",
    "#         sum_answ = sum_model(bart_answ, ratio = 0.4)\n",
    "#         qa_dt.loc[j, \"Model_Sum_Answer\"] = sum_answ\n",
    "#         #brt_ans.append(brtmp_ans)\n",
    "#         brtmp_ans = []\n",
    "#         sum_answ = ''\n",
    "#         answ = {}\n",
    "#         #t = t+ 1\n",
    "#     #print(len(brt_ans))\n",
    "#     #print(len(brt_conf))\n",
    "#     #print(len(brt_abst))\n",
    "#     #print(len(brt_qt))\n",
    "#     df_ans = pd.DataFrame(data = {'brt_sha':brt_sha,'brt_ans':brt_ans, 'brt_conf':brt_conf, 'brt_abst':brt_abst, 'brt_question':brt_qt})\n",
    "#     #print(t)\n",
    "#     return(df_ans, qa_dt)\n",
    "            \n",
    "\n",
    "            \n",
    "# #df_ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_colwidth', -1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Token indices sequence length is longer than the specified maximum sequence length for this model (591 > 512). Running this sequence through the model will result in indexing errors\n"
     ]
    }
   ],
   "source": [
    "#df_ans, qa_dt = answergen(metdatfn, qa_dt, tfidf_model, vectorizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 112 entries, 0 to 111\n",
      "Data columns (total 5 columns):\n",
      "brt_sha         112 non-null object\n",
      "brt_ans         112 non-null object\n",
      "brt_conf        112 non-null float64\n",
      "brt_abst        112 non-null object\n",
      "brt_question    112 non-null object\n",
      "dtypes: float64(1), object(4)\n",
      "memory usage: 4.5+ KB\n"
     ]
    }
   ],
   "source": [
    "#df_ans.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 23 entries, 0 to 22\n",
      "Data columns (total 5 columns):\n",
      "Task                 23 non-null object\n",
      "Questions            23 non-null object\n",
      "Reference Answers    23 non-null object\n",
      "prp_qa               23 non-null object\n",
      "Model_Sum_Answer     23 non-null object\n",
      "dtypes: object(5)\n",
      "memory usage: 1.0+ KB\n"
     ]
    }
   ],
   "source": [
    "#qa_dt.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The above function,'answergen', generates two dataframes- df_ans and qa_dt. The df_ans dataframe consists of queries, respective answers from abstracts as generated by 'BERTSQUADPred' function, abstracts themselves, the respective confidence scores, the file ids.\n",
    "The qa_dt dataframe consists of the 'Task', respective questions, the 'Reference answers', the processed queries 'prp_qa' and the answers generated by model-'Model_Sum_Answer'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brt_sha</th>\n",
       "      <th>brt_ans</th>\n",
       "      <th>brt_conf</th>\n",
       "      <th>brt_abst</th>\n",
       "      <th>brt_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites</td>\n",
       "      <td>5.082181</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites although air borne transmission has not been ruled out. this clearly places dental personnel at risks as they work in close proximity to their patients employing droplet and aerosol generating procedures. although the principle of universal precautions is widely advocated and followed throughout the dental community, additional precautionary measures â€” termed standard precaution may be necessary to help control the spread of this highly contagious disease. patient assessment should include questions on recent travel to sars infected areas and, contacts of patients, fever and symptoms of respiratory infections. special management protocols and modified measures that regulate droplet and aerosol contamination in a dental setting have to be introduced and may include the reduction or avoidance of droplet / aerosol generation, the disinfection of the treatment field, application of rubber dam, pre-procedural antiseptic mouthrinse and the dilution and efficient removal of contaminated ambient air. the gag, cough or vomiting reflexes that lead to the generation of aerosols should also be prevented.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>709e51c08788944db48106970f38cebe2b5bd596</td>\n",
       "      <td>through direct or indirect physical contact, droplets or aerosols</td>\n",
       "      <td>7.419631</td>\n",
       "      <td>abstract the presence of patients with diverse pathologies in hospitals results in an environment that can be rich in various microorganisms including respiratory and enteric viruses, leading to outbreaks in hospitals or spillover infections to the community. all hospital patients are at risk of nosocomial viral infections, but vulnerable groups such as older adults, children and immuno-compromised /-suppressed patients are at particular risk of severe outcomes including prolonged hospitalization or death. these pathogens could transmit through direct or indirect physical contact, droplets or aerosols, with increasing evidence suggesting the importance of aerosol transmission in nosocomial infections of respiratory and enteric viruses. factors affecting the propensity to transmit and the severity of disease transmitted via the aerosol route include the biological characteristics affecting infectivity of the viruses and susceptibility of the host, the physical properties of aerosol particles, and the environmental stresses that alter these properties such as temperature and humidity. non-specific systematic and individual-based interventions designed to mitigate the aerosol route are available although empirical evidence of their effectiveness in controlling transmission of respiratory and enteric viruses in healthcare settings are sparse. the relative importance of aerosol transmission in healthcare setting is still an on-going debate, with particular challenge being the recovery of infectious viral bioaerosols from real-life settings and the difficulty in delineating transmission events that may also be a result of other modes of transmission. for the prevention and control of nosocomial infections via the aerosol route, more research is needed on identifying settings, medical procedures or equipment that may be associated with an increased risk of aerosol transmission, including defining which procedures are aerosol-generating ; and on the effectiveness of systematic interventions on aerosol transmission of respiratory and enteric viruses in healthcare settings.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>dc845f9fdcd05760f704f4250fae42c9f29773b0</td>\n",
       "      <td>when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.</td>\n",
       "      <td>2.446246</td>\n",
       "      <td>abstract viral infections can be transmitted by various routes. at one extreme, airborne or droplet viral infections (e. g., varicella zoster, ebola) are highly contagious. most viruses can be spread by touching surfaces contaminated by the virus and then touching the mouth or eyes. mass gatherings, clinical, and chronic care facilities may be hotspots for virus spread when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>c3cb6dbc8f9856954962672e54253ab8fe627446</td>\n",
       "      <td>either contact or large respiratory droplet transmission</td>\n",
       "      <td>2.585962</td>\n",
       "      <td>infection of healthcare workers with the severe acute respiratory syndrome â€“ associated coronavirus (sars-cov) is thought to occur primarily by either contact or large respiratory droplet transmission. however, infrequent healthcare worker infections occurred despite the use of contact and droplet precautions, particularly during certain aerosol-generating medical procedures. we investigated a possible cluster of sars-cov infections in healthcare workers who used contact and droplet precautions during attempted cardiopulmonary resuscitation of a sars patient. unlike previously reported instances of transmission during aerosol-generating procedures, the index case-patient was unresponsive, and the intubation procedure was performed quickly and without difficulty. however, before intubation, the patient was ventilated with a bag-valve-mask that may have contributed to aerosolization of sars-cov. on the basis of the results of this investigation and previous reports of sars transmission during aerosol-generating procedures, a systematic approach to the problem is outlined, including the use of the following : 1) administrative controls, 2) environmental engineering controls, 3) personal protective equipment, and 4) quality control.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>6f192000b0e87fe2c55632441655de31c61596c4</td>\n",
       "      <td>via airborne aerosols and / or large droplets routes</td>\n",
       "      <td>3.018323</td>\n",
       "      <td>understanding of bacterial survival in aerosols is crucial for controlling infection transmission via airborne aerosols and / or large droplets routes. the cell viability changes of four bacteria species (escherichia coli k12 jm109 ; acinetobacter sp. 5a5 ; pseudomonas oleovorans x5 ; and staphylococcus aureus x8), three gram-negative and one gram-positive, in a large evaporating droplet of size 1,800 Î¼m in diameter on teflon-coated slides were measured using the live / dead baclight solution and a microscope. droplets of three levels of salinity (0,0. 9, and 36 % w / v) were tested. all four species survived well during the droplet evaporation process, but died mostly at the time when droplets were dried out at 40 â€“ 45 min. the final bacteria survival rate after droplets were completely dried was dependent on bacteria species and the salinity of the suspension solution. droplet evaporation over the first 35 â€“ 40 min had no adverse effect on bacterial survival for the droplets tested. the lethal effect of desiccation was found to be the most important death mechanism.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>6.145387</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>fd96fc1859201e13e35526c188e022fa6e335327</td>\n",
       "      <td>was 4. 9 days</td>\n",
       "      <td>6.049369</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days (2. 5th to 97. 5th percentile). the observed mean and standard deviation (sd) of serial interval was 4. 1Â±3. 3 days, with the 2. 5th and 97. 5th percentiles at-1 and 13 days. the infectious curve showed that in 73. 0 % of the secondary cases, their date of getting infected was before symptom onset of the first-generation cases, particularly in the last three days of the incubation period. conclusions : the results indicated the transmission of covid-9 occurs among close contacts during the incubation period, which may lead to a quarantine loophole. strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the incubation period in populations at high risk.</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>ce8609a60724d457d5b5916d57a31dea0ffb831b</td>\n",
       "      <td>be 5. 1 days</td>\n",
       "      <td>4.711199</td>\n",
       "      <td>background : a novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (sars-cov-2), was identified in china in december 2019. there is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [ covid-19 ]), which has important implications for surveillance and control activities. objective : to estimate the length of the incubation period of covid-19 and describe its public health implications. design : pooled analysis of confirmed covid-19 cases reported between 4 january 2020 and 24 february 2020. setting : news reports and press releases from 50 provinces, regions, and countries outside wuhan, hubei province, china. participants : persons with confirmed sars-cov-2 infection outside hubei province, china. measurements : patient demographic characteristics and dates and times of possible exposure, symptom onset, fever onset, and hospitalization. results : there were 181 confirmed cases with identifiable exposure and symptom onset windows to estimate the incubation period of covid-19. the median incubation period was estimated to be 5. 1 days (95 % ci, 4. 5 to 5. 8 days), and 97. 5 % of those who develop symptoms will do so within 11. 5 days (ci, 8. 2 to 15. 6 days) of infection. these estimates imply that, under conservative assumptions, 101 out of every 10 000 cases (99th percentile, 482) will develop symptoms after 14 days of active monitoring or quarantine. limitation : publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases. conclusion : this work provides additional evidence for a median incubation period for covid-19 of approximately 5 days, similar to sars. our results support current proposals for the length of quarantine or active monitoring of persons potentially exposed to sars-cov-2, although longer monitoring periods might be justified in extreme cases. primary funding source : u. s. centers for disease control and prevention, national institute of allergy and infectious diseases, national institute of general medical sciences, and alexander von humboldt foundation.</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>c1ae608c7ffb926a0f50a6a34c0780983274ea74</td>\n",
       "      <td>the former group had a longer incubation period and a larger variance than the latter</td>\n",
       "      <td>3.663782</td>\n",
       "      <td>motivation : wuhan pneumonia is an acute infectious disease caused by the 2019 novel coronavirus (covid-19). it is being treated as a class a infectious disease though it was classified as class b according to the infectious disease prevention act of china. accurate estimation of the incubation period of the coronavirus is essential to the prevention and control. however, it remains unclear about its exact incubation period though it is believed that symptoms of covid-19 can appear in as few as 2 days or as long as 14 or even more after exposure. the accurate incubation period calculation requires original chain-of-infection data that may not be fully available in the wuhan regions. in this study, we aim to accurately calculate the incubation period of covid-19 by taking advantage of the chain-of-infection data, which is well-documented and epidemiologically informative, outside the wuhan regions. methods : we acquired and collected officially reported covid-19 data from 10 regions in china except for hubei province. to achieve the accurate calculation of the incubation period, we only involved the officially confirmed cases with a clear history of exposure and time of onset. we excluded those without relevant epidemiological descriptions, working or living in wuhan for a long time, or hard to determine the possible exposure time. we proposed a monte caro simulation approach to estimate the incubation of covid-19 as well as employed nonparametric ways. we also employed manifold learning and related statistical analysis to decipher the incubation relationships between different age / gender groups. result : the incubation period of covid-19 did not follow general incubation distributions such as lognormal, weibull, and gamma distributions. we estimated that the mean and median of its incubation were 5. 84 and 5. 0 days via bootstrap and proposed monte carlo simulations. we found that the incubation periods of the groups with age &gt; = 40 years and age &lt; 40 years demonstrated a statistically significant difference. the former group had a longer incubation period and a larger variance than the latter. it further suggested that different quarantine time should be applied to the groups for their different incubation periods. our machine learning analysis also showed that the two groups were linearly separable. incubation of covid-19 along with previous statistical analysis. our results further indicated that the incubation difference between males and females did not demonstrate a statistical significance.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>154c8e9d755975afaee2877623277747ddaa47d2</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter</td>\n",
       "      <td>1.778185</td>\n",
       "      <td>background : few previous studies have investigated the association between the severity of an infectious disease and the length of incubation period. methods : we estimated the association between the length of the incubation period and the severity of infection with the severe acute respiratory syndrome (sars) coronavirus, using data from the epidemic in 2003 in hong kong. results : we estimated the incubation period of sars based on a subset of patients with available data on exposure periods and a separate subset of patients in a putative common source outbreak, and we found significant associations between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter incubation period proceeded to have more severe disease. further studies are needed to investigate potential biological mechanisms for this association.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>the incubation period is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>7.114547</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>fd96fc1859201e13e35526c188e022fa6e335327</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days</td>\n",
       "      <td>2.443212</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days (2. 5th to 97. 5th percentile). the observed mean and standard deviation (sd) of serial interval was 4. 1Â±3. 3 days, with the 2. 5th and 97. 5th percentiles at-1 and 13 days. the infectious curve showed that in 73. 0 % of the secondary cases, their date of getting infected was before symptom onset of the first-generation cases, particularly in the last three days of the incubation period. conclusions : the results indicated the transmission of covid-9 occurs among close contacts during the incubation period, which may lead to a quarantine loophole. strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the incubation period in populations at high risk.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>fd96fc1859201e13e35526c188e022fa6e335327</td>\n",
       "      <td>igate asymptomatic</td>\n",
       "      <td>11.980872</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days (2. 5th to 97. 5th percentile). the observed mean and standard deviation (sd) of serial interval was 4. 1Â±3. 3 days, with the 2. 5th and 97. 5th percentiles at-1 and 13 days. the infectious curve showed that in 73. 0 % of the secondary cases, their date of getting infected was before symptom onset of the first-generation cases, particularly in the last three days of the incubation period. conclusions : the results indicated the transmission of covid-9 occurs among close contacts during the incubation period, which may lead to a quarantine loophole. strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the incubation period in populations at high risk.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>6d3b3f4ab80a61c45f82c61c6c756cfc6ddf4bf2</td>\n",
       "      <td>those asymptomatic</td>\n",
       "      <td>9.338732</td>\n",
       "      <td>background : the current outbreak of coronavirus disease 2019 (covid-19) has quickly spread across countries and become a global crisis. however, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. different estimates of the incubation period of covid-19 were reported in recent published studies, but all have their own limitations. in this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. methods : we have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from wuhan and then following them until their symptoms developed. the renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. findings : the estimated distribution of forward time fits the observations in the collected data well. the estimated median of incubation period is 8. 13 days (95 % confidence interval [ ci ] : 7. 37-8. 91), the mean is 8. 62 days (95 % ci : 8. 02-9. 28), the 90th percentile is 14. 65 days (95 % ci : 14. 00-15. 26), and the 99th percentile is 20. 59 days (95 % ci : 19. 47,21. 62). compared with results in other studies, the incubation period estimated in this study is longer. interpretation : based on the estimated incubation distribution in this study, about 10 % of patients with covid-19 would not develop symptoms until 14 days after infection. further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>81c38d0128aa0df674b72dde14fdc50282a709cb</td>\n",
       "      <td>do asymptomatic</td>\n",
       "      <td>11.688661</td>\n",
       "      <td>do asymptomatic respiratory viral infections occur ?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>the incubation period</td>\n",
       "      <td>1.267918</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>ae7e5e5093d61a99b23cbca955555f7884011ec2</td>\n",
       "      <td>of asymptomatic</td>\n",
       "      <td>3.401018</td>\n",
       "      <td>abstract background the middle east respiratory syndrome coronavirus (mers-cov) emerged in 2012 and attracted an international attention as the virus caused multiple healthcare associated outbreaks. there are reports of the role of asymptomatic individuals in the transmission of mers-cov, however, the exact role is not known. method the medline / pubmed and scopus databases were searched for relevant papers published till august 2018 describing asymptomatic mers-cov infection. results a total of 10 papers were retrieved and included in the final analysis and review. the extent of asymptomatic mers infection had increased with change in the policy of testing asymptomatic contacts. in early cases in april 2012 â€“ october 2013,12. 5 % were asymptomatic among 144 pcr laboratory-confirmed mers-cov cases while in 2014 the proportion rose to 25. 1 % among 255 confirmed cases. the proportion of asymptomatic cases reported among pediatric confirmed mers-cov cases were higher (41. 9 % â€“ 81. 8 %). overall, the detection rate of mers infection among asymptomatic contacts was 1-3. 9 % in studies included in this review. asymptomatic individuals were less likely to have underlying condition compared to fatal cases. of particular interest is that most of the identified pediatric cases were asymptomatic with no clear explanation. conclusions the proportion of asymptomatic mers cases were detected with increasing frequency as the disease progressed overtime. those patients were less likely to have comorbid disease and may contribute to the transmission of the virus.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>a204aafa38365dbcc0a26af3ca2c6d3313d7fab2</td>\n",
       "      <td>of asymptomatic</td>\n",
       "      <td>4.279393</td>\n",
       "      <td>background : the respiratory syncytial virus (rsv) is recognized as an important cause of respiratory tract infections. immunocompromised patients, healthcare workers (hcws) and children contacts are at increased risk of acquiring the infection. however, the impact of asymptomatic infection in transmission has not been well studied. objectives : this study evaluated the frequency and viral load (vl) of rsv in nasal swab samples of individuals with different risk factors for acquiring infection in a university hospital in sao paulo, brazil. methods : we included 196 symptomatic children and their 192 asymptomatic caregivers, 70 symptomatic and 95 asymptomatic hcws, 43 samples from symptomatic hiv â€ positive outpatients, and 100 samples of asymptomatic hiv patients in the period of 2009 â€ 2013. results : rsv infection was detected in 10. 1 % (70 / 696) of samples, 4. 4 % (17 / 387) of asymptomatic patients, and 17. 1 % (53 / 309) from symptomatic patients. (p &lt;. 0001). the vl of symptomatic patients (4. 7 log copies / ml) was significantly higher compared to asymptomatic patients (2. 3 log copies / ml). rsv detection among asymptomatic caregivers (6. 8 % ; 13 / 192) was significantly higher compared to other asymptomatic adults, hiv and hcws (2. 0 % ; 4 / 195 ; p =. 0252). a close contact with an infected child at home was an important risk to rsv acquisition [ or 22. 6 (95 % ci 4. 8 â€ 106. 7) ]. children who possibly transmitted the virus to their asymptomatic contacts had significantly higher viral load than children who probably did not transmit (p &lt;. 0001). conclusions : according to our results, it is important to know if people circulating inside the hospital have close contact with acute respiratory infected children.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>61559322c523ddef97e84fceb71a629c56ed2605</td>\n",
       "      <td>of asymptomatic</td>\n",
       "      <td>5.454861</td>\n",
       "      <td>we propose a compartmental disease transmission model with an asymptomatic (or subclinical) infective class to study the role of asymptomatic infection in the transmission dynamics of infectious diseases with asymptomatic infectives, e. g., influenza. analytical results are obtained using the respective ratios of susceptible, exposed (incubating), and asymptomatic classes to the clinical symptomatic infective class. conditions are given for bistability of equilibria to occur, where trajectories with distinct initial values could result in either a major outbreak where the disease spreads to the whole population or a lesser outbreak where some members of the population remain uninfected. this dynamic behavior did not arise in a sars model without asymptomatic infective class studied by hsu and hsieh (siam j. appl. math. 66 (2), 627 â€“ 647,2006). hence, this illustrates that depending on the initial states, control of a disease outbreak with asymptomatic infections may involve more than simply reducing the reproduction number. moreover, the presence of asymptomatic infections could result in either a positive or negative impact on the outbreak, depending on different sets of conditions on the parameters, as illustrated with numerical simulations. biological interpretations of the analytical and numerical results are also given.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>90b5ecf991032f3918ad43b252e17d1171b4ea63</td>\n",
       "      <td>) will not necessarily lead to declines in covid-19 case counts</td>\n",
       "      <td>7.980705</td>\n",
       "      <td>a novel coronavirus (covid-19) was identified in wuhan, hubei province, china, in december 2019 and has caused over 40,000 cases worldwide to date. previous studies have supported an epidemiological hypothesis that cold and dry (low absolute humidity) environments facilitate the survival and spread of droplet-mediated viral diseases, and warm and humid (high absolute humidity) environments see attenuated viral transmission (i. e., influenza). however, the role of absolute humidity in transmission of covid-19 has not yet been established. here, we examine province-level variability of the basic reproductive numbers of covid-19 across china and find that changes in weather alone (i. e., increase of temperature and humidity as spring and summer months arrive in the north hemisphere) will not necessarily lead to declines in covid-19 case counts without the implementation of extensive public health interventions.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>bbd9d63dc2c733c763770f62205ef9adeceb0127</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality</td>\n",
       "      <td>3.377445</td>\n",
       "      <td>object meteorological parameters are the important factors influencing the infectious diseases like severe acute respiratory syndrome (sars). this study aims to explore the association between coronavirus disease (covid-19) death and weather parameters. methods in this study, we collected the daily death number of covid-19, meteorological and air pollutant data from 20 january, 2020 to 29 february, 2020 in wuhan, china. then, the generalized additive model was applied to explore the impact of temperature, humidity and diurnal temperature range on daily mortality of covid-19. results there were in total 2299 covid-19 mortality counts in wuhan. a positive association with covid-19 mortality was observed for diurnal temperature range (r = 0. 44), but negative association for relative humidity (r = âˆ’0. 32). in addition, each 1 unit increase in diurnal temperature range was only associated with a 2. 92 % (95 % ci : 0. 61 %, 5. 28 %) increase in covid-19 mortality at lag 3. however, both per 1 unit increase of temperature and absolute humidity were related to the decreased covid-19 mortality at lag 3 and lag 5, respectively. conclusion in summary, this study suggests the temperature variation and humidity may be important factors affecting the covid-19 mortality.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>045bff414afcee22d7f2f6667cae10b10ba99571</td>\n",
       "      <td>) infection</td>\n",
       "      <td>1.961383</td>\n",
       "      <td>covid-19) infection</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>b83e73208243975983aec9ea7caeaa0f6f4df2ec</td>\n",
       "      <td>19 mortality</td>\n",
       "      <td>4.779947</td>\n",
       "      <td>abstract meteorological parameters are the important factors influencing the infectious diseases such as severe acute respiratory syndrome (sars) and influenza. this study aims to explore the association between corona virus disease 2019 (covid-19) deaths and weather parameters. in this study, we collected the daily death numbers of covid-19, meteorological parameters and air pollutant data from 20 january 2020 to 29 february 2020 in wuhan, china. generalized additive model was applied to explore the effect of temperature, humidity and diurnal temperature range on the daily death counts of covid-19. there were 2299 covid-19 death counts in wuhan during the study period. a positive association with covid-19 daily death counts was observed for diurnal temperature range (r = 0. 44), but negative association for relative humidity (r = âˆ’0. 32). in addition, one unit increase in diurnal temperature range was only associated with a 2. 92 % (95 % ci : 0. 61 %, 5. 28 %) increase in covid-19 deaths in lag 3. however, both 1 unit increase of temperature and absolute humidity were related to the decreased covid-19 death in lag 3 and lag 5, with the greatest decrease both in lag 3 [ âˆ’7. 50 % (95 % ci : âˆ’10. 99 %, âˆ’3. 88 %) and âˆ’11. 41 % (95 % ci : âˆ’19. 68 %, âˆ’2. 29 %) ]. in summary, this study suggests the temperature variation and humidity may also be important factors affecting the covid-19 mortality.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>7d7255ec9a213b7fe04cb8c08b326e0aacd2fd9b</td>\n",
       "      <td>ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld</td>\n",
       "      <td>4.479241</td>\n",
       "      <td>using the nationwide inpatient sample and us weather data, we estimated the probability of community-acquired pneumonia (cap) being diagnosed as legionnaires â€™ disease (ld). ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. when the mean temperature was 60Â° â€“ 80Â°f with high humidity (&gt; 80. 0 %), the odds for cap being diagnosed with ld were 3. 1 times higher than with lower levels of humidity (&lt; 50. 0 %). thus, in some regions (e. g., the southwest), ld is rarely the cause of hospitalizations. in other regions and seasons (e. g., the mid-atlantic in summer), ld is much more common. thus, suspicion for ld should increase when weather is warm and humid. however, when weather is cold, dry, or extremely hot, empirically treating all cap patients for ld might contribute to excessive antimicrobial drug use at a population level.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>e9e27abe482c8949d0edbd0bbd9702c1ce355dd8</td>\n",
       "      <td>there were appreciable associations between weather and covid-19 incidence during the epidemic in china. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19</td>\n",
       "      <td>2.352647</td>\n",
       "      <td>background : the outbreak of covid-19 in china in early 2020 provides a rich data source for exploring the ecological determinants of this new infection, which may be of relevance elsewhere. objectives : assessing the spread of the covid-19 across china, in relation to associations between cases and ecological factors including population density, temperature, solar radiation and precipitation. methods : open-access covid-19 case data include 18,069 geo-located cases in china during january and february 2020, which were mapped onto a 0. 25Â° latitude / longitude grid together with population and weather data (temperature, solar radiation and precipitation). of 15,539 grid cells, 559 (3. 6 %) contained at least one case, and these were used to construct a poisson regression model of cell-weeks. weather parameters were taken for the preceding week given the established 5-7 day incubation period for covid-19. the dependent variable in the poisson model was incident cases per cell-week and exposure was cell population, allowing for clustering of cells over weeks, to give incidence rate ratios. results : the overall covid-19 incidence rate in cells with confirmed cases was 0. 12 per 1,000. there was a single case in 113 / 559 (20. 2 %) of cells, while two grid cells recorded over 1,000 cases. weekly means of maximum daily temperature varied from-28. 0 to 30. 1 Â°c, minimum daily temperature from-42. 4 to 23. 0 Â°c, maximum solar radiation from 0. 04 to 2. 74 mjm-2 and total precipitation from 0 to 72. 6 mm. adjusted incidence rate ratios suggested brighter, warmer and drier conditions were associated with lower incidence. conclusion : though not demonstrating cause and effect, there were appreciable associations between weather and covid-19 incidence during the epidemic in china. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>2ae710bf5f60c23c489e4c61245a35a4f85178cb</td>\n",
       "      <td>heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission</td>\n",
       "      <td>2.218985</td>\n",
       "      <td>the detection of serum antibodies to the severe acute respiratory syndrome coronavirus 2 (sars-cov-2) is emerging as a new tool for the coronavirus disease-2019 (covid-19) diagnosis. since many coronaviruses are sensitive to heat, heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission, but the effect of heating on the measurement of sars-cov-2 antibodies is still unclear. by comparing the levels of sars-cov-2 antibodies before and after heat inactivation of serum at 56 [UNK] for 30 minutes using a quantitative fluorescence immunochromatographic assay, we shown that heat inactivation significantly interferes with the levels of antibodies to sars-cov-2. the igm levels of all the 34 serum samples (100 %) from covid-19 patients decreased by an average level of 53. 56 %. the igg levels were decreased in 22 of 34 samples (64. 71 %) by an average level of 49. 54 %. similar changes can also be observed in the non-covid-19 diseases group (n = 9). of note, 44. 12 % of the detected igm levels were dropped below the cut-off value after heating, suggesting heat inactivation can lead to false-negative results of these samples. our results indicate that heat inactivation of serum at 56 [UNK] for 30 minutes interferes with the immunoanalysis of antibodies to sars-cov-2. heat inactivation prior to immunoanalysis is not recommended and the possibility of false-negative results should be considered if the sample was pre-inactivated by heating.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>d87523b89f762c34133a495ccd495489e7d061da</td>\n",
       "      <td>patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>4.097483</td>\n",
       "      <td>patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>598d3eb737dfa7701ce8c29c86bc9f6589d8a581</td>\n",
       "      <td>for long periods</td>\n",
       "      <td>5.343609</td>\n",
       "      <td>the rapid spread of coronavirus disease 2019 (covid-19) raises concern about a global pandemic. knowledge about the duration of viral shedding remains important for patient management and infection control. we report the duration of viral detection in throat and rectum of a covid-19 patient treated at the hospital for tropical diseases in ho chi minh city, vietnam. despite clinical recovery, sars-cov-2 rna remained detectable by real time rt-pcr in throat and rectal swabs until day 11 and 18 of hospitalization, respectively. because live sars-cov-2 has been successfully isolated from a stool sample from a covid-19 patient in china, the results demonstrate that covid-19 patients may remain infectious for long periods, and fecal-oral transmission may be possible. therefore, our finding has important implications for infection control.</td>\n",
       "      <td>How long can the COVID 19 virus remain viable on common surfaces?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>8c7de742ccdab73cf04032fc703ad83aa65b685e</td>\n",
       "      <td>a crucial means of preventing influenza pandemics</td>\n",
       "      <td>6.709593</td>\n",
       "      <td>background personal protective equipment (ppe) is known to be a crucial means of preventing influenza pandemics ; however, the amount of ppe that should be stored in hospital settings has been unclear. objectives the purpose of this paper is to propose a ppe calculation system to help hospitals to decide their ppe stockpile. methods we searched influenza guidelines from a number of countries and research papers on protective devices and infectious diseases. the ppe calculation system included factors such as the influenza pandemic period, risk classification by health care workers (hcw) type, and the type and number of ppe for a hcw per day. results we concluded that 4 sets of ppe (n95 respirators, double gloves, gowns, and goggles) per day should be prepared for hcws in a high-risk group. similarly, 2 sets of appropriate ppe, depending on the risk level, are required for medium-and low-risk groups. in addition, 2 surgical masks are required for every worker and inpatient and 1 for each outpatient. the ppe stockpile should be prepared to cover at least an 8-week pandemic. conclusion purchasing a ppe stockpile requires a sizable budget. the ppe calculation system in this paper will hopefully support hospitals in deciding their ppe stockpile.</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>fd51530ed73c17ccd16690c0bfa046be2f360f7f</td>\n",
       "      <td>a primary strategy to protect health care personnel (hcp) from infectious diseases</td>\n",
       "      <td>2.922970</td>\n",
       "      <td>background personal protective equipment (ppe) is a primary strategy to protect health care personnel (hcp) from infectious diseases. when transmission-based ppe ensembles are not appropriate, hcp must recognize the transmission pathway of the disease and anticipate the exposures to select ppe. because guidance for this process is extremely limited, we proposed a systematic, risk-based approach to the selection and evaluation of ppe ensembles to protect hcp against infectious diseases. methods the approach used in this study included the following 4 steps : (1) job hazard analysis, (2) infectious disease hazard analysis, (3) selection of ppe, and (4) evaluation of selected ppe. selected ppe should protect hcp from exposure, be usable by hcp, and fit for purpose. results the approach was demonstrated for the activity of intubation of a patient with methicillin-resistant staphylococcus aureus or severe acute respiratory syndrome coronavirus. as expected, the approach led to the selection of different ensembles of ppe for these 2 pathogens. discussion a systematic risk-based approach to the selection of ppe will help health care facilities and hcp select ppe when transmission-based precautions are not appropriate. owing to the complexity of ppe ensemble selection and evaluation, a team with expertise in infectious diseases, occupational health, the health care activity, and related disciplines, such as human factors, should be engaged. conclusions participation, documentation, and transparency are necessary to ensure the decisions can be communicated, critiqued, and understood by hcp.</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>045bff414afcee22d7f2f6667cae10b10ba99571</td>\n",
       "      <td>) infection</td>\n",
       "      <td>2.193988</td>\n",
       "      <td>covid-19) infection</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>f17c6ac4986aecba2dc22f67b32f2d16b369117b</td>\n",
       "      <td>is lower than that of 2003-sars</td>\n",
       "      <td>8.632621</td>\n",
       "      <td>objectives : latest epidemic data of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infected pneumonia (covid-19) was collected and a detailed statistical analysis was carried out to make comparison with 2003-sars in order to provide scientific reference for the prevention and control of covid-19. methods : the information of covid-19 and 2003-sars from websites of nhcprc and the world health organization was collected, and then the transmission dynamics of the two kinds of infectious diseases were analyzed. the information of 853 confirmed covid-19 patients obtained from the website of health committees of 18 provinces. a descriptive epidemiological analysis method was employed to carefully analyze the epidemic characteristics. subsequently, the covid-19 epidemic data in wuhan and other inland regions of china was analyzed separately and compared. a multivariate function model was constructed based on the confirmed covid-19 case data. results : the growth rate of new cases and deaths of covid-19 were significantly faster than those of 2003-sars. the number of confirmed cases in wuhan and other inland areas both showed increasing trends. 853 confirmed covid-19 cases aged 1 months to 94 years and the average age was (45. 05 Â± 17. 22) years. the gender ratio (m : f) was 1. 12 : 1. conclusions : the fatality rate of covid-19 is lower than that of 2003-sars and the cure rate is higher. the age of covid-19 patients is mainly concentrated in the 30-50 years old (60. 61 %). the harm of the first-generation covid-19 patients is higher than that of secondary cases.</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>6fcf4019b0be24071210f97eda4baba53a6a79de</td>\n",
       "      <td>were 2. 5 %</td>\n",
       "      <td>17.745360</td>\n",
       "      <td>importance : in 2002-2003, a severe pulmonary infectious disease occurred in guangdong, china. the disease was caused by sars-cov, 17 years apart, also happen in china, and sars-cov-2, this epidemic has posed a significant hazard to people health both china and the whole world. objective : summarized the latest epidemiological changes, clinical manifestations, auxiliary examination and pathological characteristics of covid-19. evidence review : pubmed database were searched from 2019 to 2020 using the index terms novel coronavirus or covid-19 or 2019-ncov or sars-cov-2 and synonyms. articles that reported clinical characteristics, laboratory results, imageological diagnosis and pathologic condition were included and were retrospectively reviewed for these cases. this paper adopts the method of descriptive statistics. results : 34 covid-19-related articles were eligible for this systematic review ; four of the articles were related to pathology. we found that fever (86. 0 %), cough (63. 9 %) and malaise / fatigue (34. 7 %) were the most common symptoms in covid-19. but in general, the clinical symptoms and signs of covid-19 were not obvious. compared with sars, covid-19 was transmitted in a more diverse way. the mortality rates of covid-19 were 2. 5 %, and the overall infection rate of healthcare worker of covid-19 was 3. 9 %. we also found that the pathological features of covid-19 have greatly similar with sars, which manifested as ards. but the latest pathological examination of covid-19 revealed the obvious mucinous secretions in the lungs. interpretation : the clinical and pathological characteristics of sars and covid-19 in china are very similar, but also difference. the latest finds of pathological examination on covid-19 may upend existing treatment schemes, so the early recognition of disease by healthcare worker is very important.</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>982689f92bf67e90a43fc142c605da9a5045f756</td>\n",
       "      <td>was 3. 4 %</td>\n",
       "      <td>7.065405</td>\n",
       "      <td>background the outbreak of coronavirus disease 2019 (covid-19) initially appeared and has most rapidly spread in wuhan, china. the case fatality rate is the most direct indicator to assess the hazards of an infectious disease. we aimed to estimate the instant fatality rate and cure rate of covid-19 in wuhan city and its affiliated hubei province. methods we collected the daily case notification data of covid-19 from dec 8,2019 to mar 10,2020 in wuhan city and hubei province officially announced by the chinese authority. the numbers of daily confirmed / deaths / cured cases and the numbers of daily cumulative confirmed / deaths / cured cases were obtained. the death time and cure time of covid-19 patients were calculated based on the dates of diagnosis, death and discharge of individual cases. then the estimated diagnosis dates of deaths and cured cases were obtained on the basis of the median death or medium cure time, respectively. finally, the instant fatality rate of covid-19 was calculated according to the numbers of deaths and cured cases on the same estimated diagnosis dates. results from jan 1,2020 to feb 22,2020 in wuhan city, the instant case fatality rate of covid-19 was 3. 4 % ï½ž19. 5 % and the instant cured rate was 80. 0 % ï½ž96. 6 %. the average fatality rate reached 11. 4 % while the average cure rate was 88. 6 %. during the same period in hubei province, the instant case fatality rate was 3. 8 % ï½ž16. 6 % and the instant cured rate was 83. 4 % ï½ž96. 6 %. the average fatality rate and the average cure rate were 9. 2 % and 91. 8 %, respectively. conclusions the fatality rate and cure rate of covid-19 in wuhan city and hubei province were underestimated. wuhan showed higher fatality rate and cure rate than the whole hubei province did.</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>e5f19b6daf956e815c779228cc0cad1293d65bbb</td>\n",
       "      <td>= 1062</td>\n",
       "      <td>8.144536</td>\n",
       "      <td>after the outbreak of the middle east respiratory syndrome (mers) worldwide in 2012. currently, a novel human coronavirus has caused a major disease outbreak, and named corona virus disease 2019 (covid-19). the emergency of mres-cov and covid-19 has caused global panic and threatened health security. unfortunately, the similarities and differences between the two coronavirus diseases remain to be unknown. the aim of this study, therefore, is to perform a systematic review to compare epidemiological, clinical and laboratory features of covid-19 and mers-cov population. we searched pubmed, embase and cochrane register of controlled trials database to identify potential studies reported covid-19 or mers-cov. epidemiological, clinical and laboratory outcomes, the admission rate of intensive cure unit (icu), discharge rate and fatality rate were evaluated using graphpad prism software. thirty-two studies involving 3770 patients (covid-19 = 1062, mers-cov = 2708) were included in this study. the present study revealed that compared with covid-19 population, mers-cov population had a higher rate of icu admission, discharge and fatality and longer incubation time. it pointed out that fever, cough and generalised weakness and myalgia were main clinical manifestations of both covid-19 and mers-cov, whereas ards was main complication. the most effective drug for mers-cov is ribavirin and interferon.</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>17de15d04f7a7643550666d2f0da773f5b7dc95c</td>\n",
       "      <td>19 therapeutic and prevention</td>\n",
       "      <td>10.176889</td>\n",
       "      <td>covid-19 therapeutic and prevention</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>ed4831fb9499b8c666ebcf39b3775c534d251c84</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers</td>\n",
       "      <td>8.746075</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (covid-19)</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>779049336b1de2f878e213f502f0792bda55cbff</td>\n",
       "      <td>public health</td>\n",
       "      <td>1.527089</td>\n",
       "      <td>public health</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>7044a0c756ba23b2d38769fa409ed1fea89aa350</td>\n",
       "      <td>public health</td>\n",
       "      <td>1.527089</td>\n",
       "      <td>public health</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>6f07f5dc2599b774baffd5a80e0b0a59662b7f35</td>\n",
       "      <td>a new infection control system</td>\n",
       "      <td>5.490075</td>\n",
       "      <td>initiation of a new infection control system for the covid-19 outbreak</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>59ebacae3048d5db81d51968371b6350658e8b94</td>\n",
       "      <td>create targeted measures</td>\n",
       "      <td>6.119755</td>\n",
       "      <td>background : since the new coronavirus epidemic in china in december 2019, information and discussions about covid-19 have spread rapidly on the internet and have quickly become the focus of worldwide attention, especially on social media. objective : this study aims to investigate and analyze the public ' s attention to covid-19-related events in china at the beginning of the covid-19 epidemic in china (december 31,2019, to february 20,2020) through the sina microblog hot search list. methods : we collected topics related to the covid-19 epidemic on the sina microblog hot search list from december 31,2019, to february 20,2020 and described the trend of public attention on covid-19 epidemic-related topics. rost cm6. 0 (rost content mining system version 6. 0) was used to analyze the collected text for word segmentation, word frequency, and sentiment analysis. we further described the hot topic keywords and sentiment trends of public attention. we used vosviewer to implement a visual cluster analysis of hot keywords and build a social network of public opinion content. results : the study has four main findings. first, we analyzed the changing trend of the public ' s attention to the covid-19 epidemic, which can be divided into three stages. second, the hot topic keywords of public attention at each stage are slightly different. in addition, the emotional tendency of the public toward the covid-19 epidemic-related hot topics has changed from negative to neutral, with negative emotions weakening and positive emotions increasing as a whole. finally, we divided the covid-19 topics with the most public concern into five categories : (1) new covid-19 epidemics and their impact ; (2) frontline reporting of the epidemic and prevention and control measures ; (3) expert interpretation and discussion on the source of infection ; (4) medical services on the frontline of the epidemic ; and (5) focus on the global epidemic and the search for suspected cases. conclusions : this is the first study of public attention on the covid-19 epidemic using a chinese social media platform (i. e., sina microblog). our study found that social media (e. g., sina microblog) can be used to measure public attention to public health emergencies. during the epidemic of the novel coronavirus, a large amount of information about the covid-19 epidemic was disseminated on sina microblog and received widespread public attention. we have learned about the hotspots of public concern regarding the covid-19 epidemic. these findings can help the government and health departments better communicate with the public on health and translate public health needs into practice to create targeted measures to prevent and control the spread of covid-19. keywords : covid-19 ; sina microblog ; public attention ; social media ; china ; public health emergency</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>045bff414afcee22d7f2f6667cae10b10ba99571</td>\n",
       "      <td>) infection</td>\n",
       "      <td>0.654951</td>\n",
       "      <td>covid-19) infection</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>6fcf4019b0be24071210f97eda4baba53a6a79de</td>\n",
       "      <td>covid-19 was transmitted in a more diverse way</td>\n",
       "      <td>6.311663</td>\n",
       "      <td>importance : in 2002-2003, a severe pulmonary infectious disease occurred in guangdong, china. the disease was caused by sars-cov, 17 years apart, also happen in china, and sars-cov-2, this epidemic has posed a significant hazard to people health both china and the whole world. objective : summarized the latest epidemiological changes, clinical manifestations, auxiliary examination and pathological characteristics of covid-19. evidence review : pubmed database were searched from 2019 to 2020 using the index terms novel coronavirus or covid-19 or 2019-ncov or sars-cov-2 and synonyms. articles that reported clinical characteristics, laboratory results, imageological diagnosis and pathologic condition were included and were retrospectively reviewed for these cases. this paper adopts the method of descriptive statistics. results : 34 covid-19-related articles were eligible for this systematic review ; four of the articles were related to pathology. we found that fever (86. 0 %), cough (63. 9 %) and malaise / fatigue (34. 7 %) were the most common symptoms in covid-19. but in general, the clinical symptoms and signs of covid-19 were not obvious. compared with sars, covid-19 was transmitted in a more diverse way. the mortality rates of covid-19 were 2. 5 %, and the overall infection rate of healthcare worker of covid-19 was 3. 9 %. we also found that the pathological features of covid-19 have greatly similar with sars, which manifested as ards. but the latest pathological examination of covid-19 revealed the obvious mucinous secretions in the lungs. interpretation : the clinical and pathological characteristics of sars and covid-19 in china are very similar, but also difference. the latest finds of pathological examination on covid-19 may upend existing treatment schemes, so the early recognition of disease by healthcare worker is very important.</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>a282fc6ac1a87980e363dfb9a09793d519cacbd5</td>\n",
       "      <td>parenting</td>\n",
       "      <td>0.201567</td>\n",
       "      <td>parenting in a time of covid-19</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>6f07f5dc2599b774baffd5a80e0b0a59662b7f35</td>\n",
       "      <td>initiation of a new infection control system</td>\n",
       "      <td>0.942579</td>\n",
       "      <td>initiation of a new infection control system for the covid-19 outbreak</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>a282fc6ac1a87980e363dfb9a09793d519cacbd5</td>\n",
       "      <td>of covid</td>\n",
       "      <td>2.213914</td>\n",
       "      <td>parenting in a time of covid-19</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>29ec2cb55404207c68a64bf13c58cd70dc57c37b</td>\n",
       "      <td>country china</td>\n",
       "      <td>3.327373</td>\n",
       "      <td>we here predicted some trajectories of covid-19 in the coming days (until april 30,2020) using the most advanced auto-regressive integrated moving average model (arima). our analysis predicted very frightening outcomes, which defines to worsen the conditions in iran, entire europe, especially italy, spain, and france. while south korea, after the initial blast, has come to stability, the same goes for the covid-19 origin country china with more positive recovery cases and confirm to remain stable. the united states of america (usa) will come as a surprise and going to become the epicenter for new cases during the mid-april 2020. based on our predictions, public health officials should tailor aggressive interventions to grasp the power exponential growth, and rapid infection control measures at hospital levels are urgently needed to curtail the covid-19 pandemic.</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>0e154f30a23e2d11bc5674354f3f7c74fb6a0008</td>\n",
       "      <td>in china</td>\n",
       "      <td>1.128572</td>\n",
       "      <td>covid-19 (sars-cov-2) is the most recent pandemic disease the world is currently managing. it started in china at the end of 2019, and it is diffusing throughout italy, one of the most affected countries, and it is currently spreading through european countries and usa. patients affected by covid-19 are identified employing medical swabs applied mainly to (i) citizens with covid-19 symptoms such as flu or high temperature, or (ii) citizens that had contacts with covid-19 patients. a percentage of covid-19 affected patients needs hospitalisation, whereas a portion needs to be treated in intensive care units (icus). nevertheless, it is a matter of current intuition that covid-19 infected citizens are more than those detected, and sometime the infection is detected too late. thus there are many efforts in both tracking people activities as well as diffusing low cost reliable covid-19 tests for early detection. starting from mortality rates of diseases caused by viruses in the same family (e. g. mers, sars, h1n1), we study the relations between the number of covid-19 infections and the number of deaths, through italian regions. we thus assess several infections being higher than the ones currently measured. we thus focus on the characterisation of the pandemic diffusion by estimating the infected number of patients versus the number of death. we use such an estimated number of infections, to foresee the effects of restriction actions adopted by governments to constrain virus diffusion. we finally think that our model can support the healthcare system to react when covid-19 is increasing.</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>d75af019ef5ffd2aeba20f07de567d9c827a7142</td>\n",
       "      <td>to clinical laboratory diagnostics</td>\n",
       "      <td>1.169152</td>\n",
       "      <td>advances in real-time pcr : application to clinical laboratory diagnostics</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>90a31cc826fade05b0a3670af7a5d47d6f972b07</td>\n",
       "      <td>using social media</td>\n",
       "      <td>0.818193</td>\n",
       "      <td>trending now : using social media to predict and track disease outbreaks</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>623fb8ad6037966919e2feccfaf25068892779bb</td>\n",
       "      <td>â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "      <td>2.934915</td>\n",
       "      <td>our research is motivated by the rapidly-evolving outbreaks of rare and fatal infectious diseases, for example, the severe acute respiratory syndrome (sars) and the middle east respiratory syndrome. in many of these outbreaks, main transmission routes were healthcare facility-associated and through person-to-person contact. while a majority of existing work on modelling of the spread of infectious diseases focuses on transmission processes at a community level, we propose a new methodology to model the outbreaks of healthcare-associated infections (hais), which must be considered at an individual level. our work also contributes to a novel aspect of integrating real-time positioning technologies into the tracking and modelling framework for effective hai outbreak control and prompt responses. our proposed solution methodology is developed based on three key components â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation â€“ and aims to identify the hidden health state of each patient and worker within the healthcare facility. we conduct experiments with a four-month human tracking data set collected in a hospital, which bore a big nosocomial outbreak of the 2003 sars in hong kong. the evaluation results demonstrate that our framework outperforms existing epidemic models for characterizing macro-level phenomena such as the number of infected people and epidemic threshold.</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>88bdd99c41f943dd769a81f74a53434f3eb4f371</td>\n",
       "      <td>seasonal</td>\n",
       "      <td>1.409262</td>\n",
       "      <td>seasonal variation in covid-19 incidence could impact the trajectory of the pandemic. using global line-list data on covid-19 cases reported until 29th february 2020 and global gridded temperature data, and after adjusting for surveillance capacity and time since first imported case, higher average temperature was strongly associated with lower covid-19 incidence for temperatures of 1Â°c and higher. however, temperature explained a relatively modest amount of the total variation in covid-19 incidence. these preliminary findings support stringent containment efforts in europe and elsewhere.</td>\n",
       "      <td>What geographic variations are there in the genome of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>a1f9e6d1c2717f4555275f25d6169063b7f8bb23</td>\n",
       "      <td>to cases isolation and contact tracing measures</td>\n",
       "      <td>5.070963</td>\n",
       "      <td>what further should be done to control covid-19 outbreaks in addition to cases isolation and contact tracing measures ?</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>4634bbdcdabf5d53fb7b2f81f1625a815540aae5</td>\n",
       "      <td>efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials</td>\n",
       "      <td>5.882801</td>\n",
       "      <td>summary the causative agent of severe acute respiratory syndrome (sars), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002 â€“ 2003 outbreak, is a coronavirus that was unknown before the outbreak. although many different treatments were used during the outbreak, none were implemented in a controlled fashion. thus, the optimal treatment for sars is unknown. since the outbreak, much work has been done testing new agents against sars using in-vitro methods and animal models. in addition, global research efforts have focused on the development of vaccines against sars. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials, should another sars outbreak occur.</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>b39171b7e9363a54727c33c8d7d197d2acfbc1ce</td>\n",
       "      <td>infectious diseases and regional security</td>\n",
       "      <td>1.128130</td>\n",
       "      <td>infectious diseases and regional security in east asia</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>d535e9201c038010f5cdad2faab7418d7fe520eb</td>\n",
       "      <td>we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures</td>\n",
       "      <td>3.939699</td>\n",
       "      <td>abstract objective mers-cov infection is uncommonly identified among patients visiting healthcare facilities &amp; we were vigilant in screening all patients entering our hospital to prevent cross infection among patients, visitors &amp; healthcare providers and aiming to prevent potential outbreaks with mers-cov infection. in spite of our efforts on practicing failure mode effect analysis for mers-cov infection management we ended up having an outbreak with mers-cov. based on our experience, we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures for preventing future outbreaks at our healthcare facility. methods retrospectively we analyzed our failure in preventing the outbreak of mers-cov infection among our hospitalized patients by identifying the outbreak &amp; actively intervening as a team to control the outbreak with the support of hospital higher management, administrators, quality improvement team, infection prevention &amp; control team &amp; the active support of all healthcare workers of the facility. results following the early identification of mers-cov outbreak, we could successfully prevent large scale outbreak both in the hospital &amp; the community. conclusion continuous implementation of infection prevention &amp; control standards along with early clinical diagnosis of mers-cov infections based on the case definition as laid out by the ministry of health will prevent infectious outbreaks at healthcare facilities.</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>2e07c9fe06f4601ac9723ae3f8e52a2f52e7efb2</td>\n",
       "      <td>75 immunization</td>\n",
       "      <td>11.861440</td>\n",
       "      <td>75 immunization in the asia-pacific region</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>5d11cc6da84dd7b8930024ffc0fda1e561e5b1db</td>\n",
       "      <td>and investigations</td>\n",
       "      <td>4.837470</td>\n",
       "      <td>outbreaks and investigations</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>fad298f1cd61f082485146720b7ae95157aa5bd8</td>\n",
       "      <td>69 immunization</td>\n",
       "      <td>12.385361</td>\n",
       "      <td>69 immunization in the asia-pacific region</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>6f6616e258f5b782162e6c10253edd153b62b2fe</td>\n",
       "      <td>buffalo husbandry</td>\n",
       "      <td>1.560815</td>\n",
       "      <td>buffalo husbandry | asia</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>112 rows Ã— 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                      brt_sha  \\\n",
       "0    f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0   \n",
       "1    709e51c08788944db48106970f38cebe2b5bd596   \n",
       "2    dc845f9fdcd05760f704f4250fae42c9f29773b0   \n",
       "3    c3cb6dbc8f9856954962672e54253ab8fe627446   \n",
       "4    6f192000b0e87fe2c55632441655de31c61596c4   \n",
       "..                                        ...   \n",
       "107  d535e9201c038010f5cdad2faab7418d7fe520eb   \n",
       "108  2e07c9fe06f4601ac9723ae3f8e52a2f52e7efb2   \n",
       "109  5d11cc6da84dd7b8930024ffc0fda1e561e5b1db   \n",
       "110  fad298f1cd61f082485146720b7ae95157aa5bd8   \n",
       "111  6f6616e258f5b782162e6c10253edd153b62b2fe   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      brt_ans  \\\n",
       "0    the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1    through direct or indirect physical contact, droplets or aerosols                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "2    when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.   \n",
       "3    either contact or large respiratory droplet transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "4    via airborne aerosols and / or large droplets routes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "..                                                    ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "107  we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "108  75 immunization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "109  and investigations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "110  69 immunization                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "111  buffalo husbandry                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "\n",
       "      brt_conf  \\\n",
       "0    5.082181    \n",
       "1    7.419631    \n",
       "2    2.446246    \n",
       "3    2.585962    \n",
       "4    3.018323    \n",
       "..        ...    \n",
       "107  3.939699    \n",
       "108  11.861440   \n",
       "109  4.837470    \n",
       "110  12.385361   \n",
       "111  1.560815    \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 brt_abst  \\\n",
       "0    the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites although air borne transmission has not been ruled out. this clearly places dental personnel at risks as they work in close proximity to their patients employing droplet and aerosol generating procedures. although the principle of universal precautions is widely advocated and followed throughout the dental community, additional precautionary measures â€” termed standard precaution may be necessary to help control the spread of this highly contagious disease. patient assessment should include questions on recent travel to sars infected areas and, contacts of patients, fever and symptoms of respiratory infections. special management protocols and modified measures that regulate droplet and aerosol contamination in a dental setting have to be introduced and may include the reduction or avoidance of droplet / aerosol generation, the disinfection of the treatment field, application of rubber dam, pre-procedural antiseptic mouthrinse and the dilution and efficient removal of contaminated ambient air. the gag, cough or vomiting reflexes that lead to the generation of aerosols should also be prevented.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "1    abstract the presence of patients with diverse pathologies in hospitals results in an environment that can be rich in various microorganisms including respiratory and enteric viruses, leading to outbreaks in hospitals or spillover infections to the community. all hospital patients are at risk of nosocomial viral infections, but vulnerable groups such as older adults, children and immuno-compromised /-suppressed patients are at particular risk of severe outcomes including prolonged hospitalization or death. these pathogens could transmit through direct or indirect physical contact, droplets or aerosols, with increasing evidence suggesting the importance of aerosol transmission in nosocomial infections of respiratory and enteric viruses. factors affecting the propensity to transmit and the severity of disease transmitted via the aerosol route include the biological characteristics affecting infectivity of the viruses and susceptibility of the host, the physical properties of aerosol particles, and the environmental stresses that alter these properties such as temperature and humidity. non-specific systematic and individual-based interventions designed to mitigate the aerosol route are available although empirical evidence of their effectiveness in controlling transmission of respiratory and enteric viruses in healthcare settings are sparse. the relative importance of aerosol transmission in healthcare setting is still an on-going debate, with particular challenge being the recovery of infectious viral bioaerosols from real-life settings and the difficulty in delineating transmission events that may also be a result of other modes of transmission. for the prevention and control of nosocomial infections via the aerosol route, more research is needed on identifying settings, medical procedures or equipment that may be associated with an increased risk of aerosol transmission, including defining which procedures are aerosol-generating ; and on the effectiveness of systematic interventions on aerosol transmission of respiratory and enteric viruses in healthcare settings.   \n",
       "2    abstract viral infections can be transmitted by various routes. at one extreme, airborne or droplet viral infections (e. g., varicella zoster, ebola) are highly contagious. most viruses can be spread by touching surfaces contaminated by the virus and then touching the mouth or eyes. mass gatherings, clinical, and chronic care facilities may be hotspots for virus spread when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "3    infection of healthcare workers with the severe acute respiratory syndrome â€“ associated coronavirus (sars-cov) is thought to occur primarily by either contact or large respiratory droplet transmission. however, infrequent healthcare worker infections occurred despite the use of contact and droplet precautions, particularly during certain aerosol-generating medical procedures. we investigated a possible cluster of sars-cov infections in healthcare workers who used contact and droplet precautions during attempted cardiopulmonary resuscitation of a sars patient. unlike previously reported instances of transmission during aerosol-generating procedures, the index case-patient was unresponsive, and the intubation procedure was performed quickly and without difficulty. however, before intubation, the patient was ventilated with a bag-valve-mask that may have contributed to aerosolization of sars-cov. on the basis of the results of this investigation and previous reports of sars transmission during aerosol-generating procedures, a systematic approach to the problem is outlined, including the use of the following : 1) administrative controls, 2) environmental engineering controls, 3) personal protective equipment, and 4) quality control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "4    understanding of bacterial survival in aerosols is crucial for controlling infection transmission via airborne aerosols and / or large droplets routes. the cell viability changes of four bacteria species (escherichia coli k12 jm109 ; acinetobacter sp. 5a5 ; pseudomonas oleovorans x5 ; and staphylococcus aureus x8), three gram-negative and one gram-positive, in a large evaporating droplet of size 1,800 Î¼m in diameter on teflon-coated slides were measured using the live / dead baclight solution and a microscope. droplets of three levels of salinity (0,0. 9, and 36 % w / v) were tested. all four species survived well during the droplet evaporation process, but died mostly at the time when droplets were dried out at 40 â€“ 45 min. the final bacteria survival rate after droplets were completely dried was dependent on bacteria species and the salinity of the suspension solution. droplet evaporation over the first 35 â€“ 40 min had no adverse effect on bacterial survival for the droplets tested. the lethal effect of desiccation was found to be the most important death mechanism.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "..                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "107  abstract objective mers-cov infection is uncommonly identified among patients visiting healthcare facilities & we were vigilant in screening all patients entering our hospital to prevent cross infection among patients, visitors & healthcare providers and aiming to prevent potential outbreaks with mers-cov infection. in spite of our efforts on practicing failure mode effect analysis for mers-cov infection management we ended up having an outbreak with mers-cov. based on our experience, we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures for preventing future outbreaks at our healthcare facility. methods retrospectively we analyzed our failure in preventing the outbreak of mers-cov infection among our hospitalized patients by identifying the outbreak & actively intervening as a team to control the outbreak with the support of hospital higher management, administrators, quality improvement team, infection prevention & control team & the active support of all healthcare workers of the facility. results following the early identification of mers-cov outbreak, we could successfully prevent large scale outbreak both in the hospital & the community. conclusion continuous implementation of infection prevention & control standards along with early clinical diagnosis of mers-cov infections based on the case definition as laid out by the ministry of health will prevent infectious outbreaks at healthcare facilities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "108  75 immunization in the asia-pacific region                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "109  outbreaks and investigations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "110  69 immunization in the asia-pacific region                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "111  buffalo husbandry | asia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "\n",
       "                                                                                           brt_question  \n",
       "0    Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "1    Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "2    Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "3    Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "4    Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "..                                                                                                  ...  \n",
       "107  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "108  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "109  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "110  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "111  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "\n",
       "[112 rows x 5 columns]"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#df_ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites\n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 112,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#df_ans['brt_ans'].head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12    igate asymptomatic   \n",
       "13    those asymptomatic   \n",
       "14    do asymptomatic      \n",
       "15    the incubation period\n",
       "16    of asymptomatic      \n",
       "17    of asymptomatic      \n",
       "18    of asymptomatic      \n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#df_ans.loc[df_ans[\"brt_question\"]==\"Can the virus be transmitted asymptomatically or during the incubation period?\", \"brt_ans\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "19    ) will not necessarily lead to declines in covid-19 case counts                                                                                                                                                                                                                              \n",
       "20    the temperature variation and humidity may be important factors affecting the covid-19 mortality                                                                                                                                                                                             \n",
       "21    ) infection                                                                                                                                                                                                                                                                                  \n",
       "22    19 mortality                                                                                                                                                                                                                                                                                 \n",
       "23    ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld                                                                                                                                     \n",
       "24    there were appreciable associations between weather and covid-19 incidence during the epidemic in china. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19\n",
       "25    heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission                                                                                                                                                              \n",
       "26    patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                              \n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#df_ans.loc[df_ans[\"brt_question\"]==\"How does weather, heat, and humidity affect the transmission of COVID 19?\", \"brt_ans\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites through direct or indirect physical contact, droplets or aerosols when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person was 4.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>the former group had a longer incubation period and a larger variance than the latter between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter the incubation period is the delay from infection until onset of symptoms, and varies from person to person background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td>igate asymptomatic those asymptomatic do asymptomatic the incubation period of asymptomatic of asymptomatic of asymptomatic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>) will not necessarily lead to declines in covid-19 case counts the temperature variation and humidity may be important factors affecting the covid-19 mortality ) infection 19 mortality ld risk increases when weather is warm and humid. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19 heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long can the COVID 19 virus remain viable on common surfaces?</td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "      <td>long covid 19 viru remain viabl common surfac</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "      <td>person effect protect equip ppe reduc risk transmiss health care commun set</td>\n",
       "      <td>a crucial means of preventing influenza pandemics a primary strategy to protect health care personnel (hcp) from infectious diseases is crucial ) designed to arrest nosocomial transmission</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.</td>\n",
       "      <td>effect movement control strategi prevent secondari transmiss health care commun set</td>\n",
       "      <td>including reducing exposure to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. as the mers-cov epidemic continues to evolve, issues concerning best infection control measures will arise, and studies to better define their effectiveness</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "      <td>tool studi monitor phenotyp chang potenti adapt viru</td>\n",
       "      <td>interviews, site visitations, and an accommodation survey of health and health monitoring on oncology studies the ring dosimeters and eye lens dosimeters</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n</td>\n",
       "      <td>implement diagnost product improv clinic process</td>\n",
       "      <td>a coordinated implementation plan the improvement of clinical diagnostic techniques means not only the improvement of diagnostic accuracy but also the further study of diagnostic basis in real time advances in real-time pcr product focus a harmonized process abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "      <td>risk factor contribut sever covid 19</td>\n",
       "      <td>) infection 19 therapeutic and prevention patients with respiratory symptoms parenting the diagnosis, infection control, and treatment conclusions low platelet count is associated with increased risk of severe disease and mortality</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does hypertension affect patients?</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "      <td>hypertens affect patient</td>\n",
       "      <td>to clinically devastating complications failure of salt to mobilise renal dopamine a major risk factor for stroke, coronary events, heart and renal failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. no significant heterogeneity between studies. most of the studies in the funnel plot are on the upper part and few on the base part, and are roughly symmetrical left and right. methods, findings : patients with systolic hf (nyhaii-iv, enrolled for cardiac resynchronisation therapy, crt, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (ef &gt; 50 %) in a single center prospective clinical study. serum angiotensin converting enzyme (ace) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters. conclusions : soluble ace2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does heart disease affect patients?</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "      <td>heart diseas affect patient</td>\n",
       "      <td>heart transplantation to substantial cardiac damage and severe acute heart failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. methods : available data from pubmed, web of science, china national knowledge infrastructure database, wanfang database and vip database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (or) with 95 % cis. no significant heterogeneity between studies.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.</td>\n",
       "      <td>copd affect patient</td>\n",
       "      <td>a major incurable global health burden and is currently the 4th largest cause of death in the world preventing exacerbation by persistent airflow limitation and an abnormal inflammatory response of the lung have frequent exacerbations some patients with copd are prone to frequent exacerbations, which are an important determinant of health status.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "      <td>smoke affect patient</td>\n",
       "      <td>is not associated with severity of coronavirus disease why smokers are particularly likely to develop severe sars-cov-2 infections the negative progression and adverse outcomes of covid-19 a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference can reduce this risk</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.</td>\n",
       "      <td>pregnanc affect patient</td>\n",
       "      <td>influenza and pneumonia 60 pregnancy loss conditions associated with high-risk pregnancy sars</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "      <td>fatal rate covid 19</td>\n",
       "      <td>imating case fatality rates imating case fatality rates ) infection is lower than that of 2003-sars were 2.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.</td>\n",
       "      <td>public health polici prevent control spread covid 19</td>\n",
       "      <td>19 therapeutic and prevention policies on the use of respiratory protection for hospital health workers public health public health a new infection control system create targeted measures</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "      <td>anim transmit covid 19</td>\n",
       "      <td>) infection covid-19 was transmitted in a more diverse way parenting initiation of a new infection control system</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.</td>\n",
       "      <td>anim covid 19 come</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "      <td>\\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.</td>\n",
       "      <td>real-tim genom track tool exist</td>\n",
       "      <td>to clinical laboratory diagnostics using social media â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What geographic variations are there in the genome of COVID 19?</td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "      <td>geograph variat genom covid 19</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.</td>\n",
       "      <td>effort done asia prevent outbreak</td>\n",
       "      <td>to cases isolation and contact tracing measures efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials infectious diseases and regional security we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures 75 immunization and investigations 69 immunization buffalo husbandry</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                          Task  \\\n",
       "0   What is known about transmission, incubation, and environmental stability?   \n",
       "1   What is known about transmission, incubation, and environmental stability?   \n",
       "2   What is known about transmission, incubation, and environmental stability?   \n",
       "3   What is known about transmission, incubation, and environmental stability?   \n",
       "4   What is known about transmission, incubation, and environmental stability?   \n",
       "5   What is known about transmission, incubation, and environmental stability?   \n",
       "6   What is known about transmission, incubation, and environmental stability?   \n",
       "7   What is known about transmission, incubation, and environmental stability?   \n",
       "8   What is known about transmission, incubation, and environmental stability?   \n",
       "9   What is known about transmission, incubation, and environmental stability?   \n",
       "10  What do we know about COVID-19 risk factors?                                 \n",
       "11  What do we know about COVID-19 risk factors?                                 \n",
       "12  What do we know about COVID-19 risk factors?                                 \n",
       "13  What do we know about COVID-19 risk factors?                                 \n",
       "14  What do we know about COVID-19 risk factors?                                 \n",
       "15  What do we know about COVID-19 risk factors?                                 \n",
       "16  What do we know about COVID-19 risk factors?                                 \n",
       "17  What do we know about COVID-19 risk factors?                                 \n",
       "18  What do we know about virus genetics, origin, and evolution?                 \n",
       "19  What do we know about virus genetics, origin, and evolution?                 \n",
       "20  What do we know about virus genetics, origin, and evolution?                 \n",
       "21  What do we know about virus genetics, origin, and evolution?                 \n",
       "22  What do we know about virus genetics, origin, and evolution?                 \n",
       "\n",
       "                                                                                                                                Questions  \\\n",
       "0   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?                                      \n",
       "1   How long is the incubation period for the virus in humans?                                                                              \n",
       "2   How does the incubation period in humans vary across age and health conditions?                                                         \n",
       "3   Can the virus be transmitted asymptomatically or during the incubation period?                                                          \n",
       "4   How does weather, heat, and humidity affect the transmission of COVID 19?                                                               \n",
       "5   How long can the COVID 19 virus remain viable on common surfaces?                                                                       \n",
       "6   How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?   \n",
       "7   What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?       \n",
       "8   What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?                                      \n",
       "9   What is the Implementation of diagnostics and products to improve clinical processes?                                                   \n",
       "10  What risk factors contribute to the severity of COVID 19?                                                                               \n",
       "11  How does hypertension affect patients?                                                                                                  \n",
       "12  How does heart disease affect patients?                                                                                                 \n",
       "13  How does COPD affect patients?                                                                                                          \n",
       "14  How does smoking affect patients?                                                                                                       \n",
       "15  How does pregnancy affect patients?                                                                                                     \n",
       "16  What is the fatality rate of COVID 19?                                                                                                  \n",
       "17  What public health policies prevent or control the spread of COVID 19?                                                                  \n",
       "18  Can animals transmit COVID 19?                                                                                                          \n",
       "19  What animal did COVID 19 come from?                                                                                                     \n",
       "20  What real-time genomic tracking tools exist?                                                                                            \n",
       "21  What geographic variations are there in the genome of COVID 19?                                                                         \n",
       "22  What efforts are being done in Asia to prevent further outbreaks?                                                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Reference Answers  \\\n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "20  \\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                                                                                                       \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "                                                                                 prp_qa  \\\n",
       "0   covid viru transmit aerosol droplet food close contact faecal matter water            \n",
       "1   long incub period viru human                                                          \n",
       "2   incub period human vari across age health condit                                      \n",
       "3   viru transmit asymptomat incub period                                                 \n",
       "4   weather heat humid affect transmiss covid 19                                          \n",
       "5   long covid 19 viru remain viabl common surfac                                         \n",
       "6   person effect protect equip ppe reduc risk transmiss health care commun set           \n",
       "7   effect movement control strategi prevent secondari transmiss health care commun set   \n",
       "8   tool studi monitor phenotyp chang potenti adapt viru                                  \n",
       "9   implement diagnost product improv clinic process                                      \n",
       "10  risk factor contribut sever covid 19                                                  \n",
       "11  hypertens affect patient                                                              \n",
       "12  heart diseas affect patient                                                           \n",
       "13  copd affect patient                                                                   \n",
       "14  smoke affect patient                                                                  \n",
       "15  pregnanc affect patient                                                               \n",
       "16  fatal rate covid 19                                                                   \n",
       "17  public health polici prevent control spread covid 19                                  \n",
       "18  anim transmit covid 19                                                                \n",
       "19  anim covid 19 come                                                                    \n",
       "20  real-tim genom track tool exist                                                       \n",
       "21  geograph variat genom covid 19                                                        \n",
       "22  effort done asia prevent outbreak                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Model_Sum_Answer  \n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites through direct or indirect physical contact, droplets or aerosols when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "1   is the delay from infection until onset of symptoms, and varies from person to person was 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "2   the former group had a longer incubation period and a larger variance than the latter between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter the incubation period is the delay from infection until onset of symptoms, and varies from person to person background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases.                                                                                                                                                                                                                                                                                                                                                    \n",
       "3   igate asymptomatic those asymptomatic do asymptomatic the incubation period of asymptomatic of asymptomatic of asymptomatic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "4   ) will not necessarily lead to declines in covid-19 case counts the temperature variation and humidity may be important factors affecting the covid-19 mortality ) infection 19 mortality ld risk increases when weather is warm and humid. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19 heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   a crucial means of preventing influenza pandemics a primary strategy to protect health care personnel (hcp) from infectious diseases is crucial ) designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "7   including reducing exposure to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. as the mers-cov epidemic continues to evolve, issues concerning best infection control measures will arise, and studies to better define their effectiveness                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "8   interviews, site visitations, and an accommodation survey of health and health monitoring on oncology studies the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "9   a coordinated implementation plan the improvement of clinical diagnostic techniques means not only the improvement of diagnostic accuracy but also the further study of diagnostic basis in real time advances in real-time pcr product focus a harmonized process abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "10  ) infection 19 therapeutic and prevention patients with respiratory symptoms parenting the diagnosis, infection control, and treatment conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "11  to clinically devastating complications failure of salt to mobilise renal dopamine a major risk factor for stroke, coronary events, heart and renal failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. no significant heterogeneity between studies. most of the studies in the funnel plot are on the upper part and few on the base part, and are roughly symmetrical left and right. methods, findings : patients with systolic hf (nyhaii-iv, enrolled for cardiac resynchronisation therapy, crt, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (ef > 50 %) in a single center prospective clinical study. serum angiotensin converting enzyme (ace) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters. conclusions : soluble ace2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent  \n",
       "12  heart transplantation to substantial cardiac damage and severe acute heart failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. methods : available data from pubmed, web of science, china national knowledge infrastructure database, wanfang database and vip database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (or) with 95 % cis. no significant heterogeneity between studies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "13  a major incurable global health burden and is currently the 4th largest cause of death in the world preventing exacerbation by persistent airflow limitation and an abnormal inflammatory response of the lung have frequent exacerbations some patients with copd are prone to frequent exacerbations, which are an important determinant of health status.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "14  is not associated with severity of coronavirus disease why smokers are particularly likely to develop severe sars-cov-2 infections the negative progression and adverse outcomes of covid-19 a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference can reduce this risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "15  influenza and pneumonia 60 pregnancy loss conditions associated with high-risk pregnancy sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "16  imating case fatality rates imating case fatality rates ) infection is lower than that of 2003-sars were 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "17  19 therapeutic and prevention policies on the use of respiratory protection for hospital health workers public health public health a new infection control system create targeted measures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "18  ) infection covid-19 was transmitted in a more diverse way parenting initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "20  to clinical laboratory diagnostics using social media â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "22  to cases isolation and contact tracing measures efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials infectious diseases and regional security we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures 75 immunization and investigations 69 immunization buffalo husbandry                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           "
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#qa_dt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites through direct or indirect physical contact, droplets or aerosols when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "1     is the delay from infection until onset of symptoms, and varies from person to person was 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "2     the former group had a longer incubation period and a larger variance than the latter between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter the incubation period is the delay from infection until onset of symptoms, and varies from person to person background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases.                                                                                                                                                                                                                                                                                                                                                  \n",
       "3     igate asymptomatic those asymptomatic do asymptomatic the incubation period of asymptomatic of asymptomatic of asymptomatic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "4     ) will not necessarily lead to declines in covid-19 case counts the temperature variation and humidity may be important factors affecting the covid-19 mortality ) infection 19 mortality ld risk increases when weather is warm and humid. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19 heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6     a crucial means of preventing influenza pandemics a primary strategy to protect health care personnel (hcp) from infectious diseases is crucial ) designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "7     including reducing exposure to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. as the mers-cov epidemic continues to evolve, issues concerning best infection control measures will arise, and studies to better define their effectiveness                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "8     interviews, site visitations, and an accommodation survey of health and health monitoring on oncology studies the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "9     a coordinated implementation plan the improvement of clinical diagnostic techniques means not only the improvement of diagnostic accuracy but also the further study of diagnostic basis in real time advances in real-time pcr product focus a harmonized process abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "10    ) infection 19 therapeutic and prevention patients with respiratory symptoms parenting the diagnosis, infection control, and treatment conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "11    to clinically devastating complications failure of salt to mobilise renal dopamine a major risk factor for stroke, coronary events, heart and renal failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. no significant heterogeneity between studies. most of the studies in the funnel plot are on the upper part and few on the base part, and are roughly symmetrical left and right. methods, findings : patients with systolic hf (nyhaii-iv, enrolled for cardiac resynchronisation therapy, crt, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (ef > 50 %) in a single center prospective clinical study. serum angiotensin converting enzyme (ace) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters. conclusions : soluble ace2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent\n",
       "12    heart transplantation to substantial cardiac damage and severe acute heart failure is more likely to worsen, but with mixed results for covid-19 severity. this meta-analysis is to analyze the correlation between hypertension, diabetes, coronary heart disease and covid-19 disease severity. methods : available data from pubmed, web of science, china national knowledge infrastructure database, wanfang database and vip database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (or) with 95 % cis. no significant heterogeneity between studies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "13    a major incurable global health burden and is currently the 4th largest cause of death in the world preventing exacerbation by persistent airflow limitation and an abnormal inflammatory response of the lung have frequent exacerbations some patients with copd are prone to frequent exacerbations, which are an important determinant of health status.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "14    is not associated with severity of coronavirus disease why smokers are particularly likely to develop severe sars-cov-2 infections the negative progression and adverse outcomes of covid-19 a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference can reduce this risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "15    influenza and pneumonia 60 pregnancy loss conditions associated with high-risk pregnancy sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "16    imating case fatality rates imating case fatality rates ) infection is lower than that of 2003-sars were 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "17    19 therapeutic and prevention policies on the use of respiratory protection for hospital health workers public health public health a new infection control system create targeted measures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "18    ) infection covid-19 was transmitted in a more diverse way parenting initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "20    to clinical laboratory diagnostics using social media â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "22    to cases isolation and contact tracing measures efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials infectious diseases and regional security we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures 75 immunization and investigations 69 immunization buffalo husbandry                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "Name: Model_Sum_Answer, dtype: object"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#qa_dt[\"Model_Sum_Answer\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites through direct or indirect physical contact, droplets or aerosols when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person was 4.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>the former group had a longer incubation period and a larger variance than the latter between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter the incubation period is the delay from infection until onset of symptoms, and varies from person to person background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td>igate asymptomatic those asymptomatic do asymptomatic the incubation period of asymptomatic of asymptomatic of asymptomatic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>) will not necessarily lead to declines in covid-19 case counts the temperature variation and humidity may be important factors affecting the covid-19 mortality ) infection 19 mortality ld risk increases when weather is warm and humid. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19 heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "1  What is known about transmission, incubation, and environmental stability?   \n",
       "2  What is known about transmission, incubation, and environmental stability?   \n",
       "3  What is known about transmission, incubation, and environmental stability?   \n",
       "4  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "1  How long is the incubation period for the virus in humans?                                           \n",
       "2  How does the incubation period in humans vary across age and health conditions?                      \n",
       "3  Can the virus be transmitted asymptomatically or during the incubation period?                       \n",
       "4  How does weather, heat, and humidity affect the transmission of COVID 19?                            \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Reference Answers  \\\n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "\n",
       "                                                                       prp_qa  \\\n",
       "0  covid viru transmit aerosol droplet food close contact faecal matter water   \n",
       "1  long incub period viru human                                                 \n",
       "2  incub period human vari across age health condit                             \n",
       "3  viru transmit asymptomat incub period                                        \n",
       "4  weather heat humid affect transmiss covid 19                                 \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Model_Sum_Answer  \n",
       "0  the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites through direct or indirect physical contact, droplets or aerosols when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "1  is the delay from infection until onset of symptoms, and varies from person to person was 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "2  the former group had a longer incubation period and a larger variance than the latter between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter the incubation period is the delay from infection until onset of symptoms, and varies from person to person background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases.  \n",
       "3  igate asymptomatic those asymptomatic do asymptomatic the incubation period of asymptomatic of asymptomatic of asymptomatic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "4  ) will not necessarily lead to declines in covid-19 case counts the temperature variation and humidity may be important factors affecting the covid-19 mortality ) infection 19 mortality ld risk increases when weather is warm and humid. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19 heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                      "
      ]
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#qa_dt.head(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The proposed model architecture seemed to have generated relevant answers for most questions. However, there are few questions such as \"Can the virus be transmitted asymptomatically or during the incubation period?\" where the proposed BERT model was not able to generate meaningful spans from the shortlisted abstracts, while, there was no span generated for few queries such as \"What do we know about virus genetics, origin, and evolution?\". In the case of few queries the generated answers start with incomplete sentences or paranthesis, highlighting model not being able to understand the context for the given query and generate proper span. This can be fixed by updating filter condition within the 'BERTSQUADPred' function.\n",
    "The two output dataframes will now be exported as first experiment results. \n",
    "Will update the 'overlapFac' factor to '1.2' and include the filter conditions within the function 'BERTSQUADPred' and analyse the results to see if we can get better results.\n",
    "Will also summarise the joined generated answers based on length of the combined answer and also put condition for minimum sentence length for sentence to be considered to summarise."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 313,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df_ans.to_excel(\"df_ans_v1.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 314,
   "metadata": {},
   "outputs": [],
   "source": [
    "#qa_dt.to_excel(\"qa_dt_v1.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 311,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df_ans.to_csv(\"df_ans_v1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 312,
   "metadata": {},
   "outputs": [],
   "source": [
    "#qa_dt.to_csv(\"qa_dt_v1.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Result analysis with updates to the two functions, 'BERTSQUADPred' and 'answergen'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Second and selected iteration\n",
    "def BERTSQUADPred_v2(context, question):\n",
    "    ## the following code chuncks the \"abstract\" into multiple smaller word segments with\n",
    "    ## word overlaps on either end so that model can better understand and check longer abstracts\n",
    "    nWords = len(context.split())\n",
    "    input_ids_all = tokenizer.encode(question, context)\n",
    "    tokens_all = tokenizer.convert_ids_to_tokens(input_ids_all)\n",
    "    #print(nWords)\n",
    "    #print(len(input_ids_all))\n",
    "    overlapFac = 1.2 # factor that determines number of 'overlap' words considered\n",
    "    if len(input_ids_all)*overlapFac > 2048:\n",
    "        nSearchWords = int(np.ceil(nWords/5))\n",
    "        quarter = int(np.ceil(nWords/4))\n",
    "        contsplit = context.split()\n",
    "        contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "                     ' '.join(contsplit[quarter-int(nSearchWords*overlapFac/2):quarter+int(quarter*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[quarter*2-int(nSearchWords*overlapFac/2):quarter*2+int(quarter*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[quarter*3-int(nSearchWords*overlapFac/2):quarter*3+int(quarter*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "        input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "        len(input_ids)\n",
    "        \n",
    "    elif len(input_ids_all)*overlapFac > 1536:\n",
    "        nSearchWords = int(np.ceil(nWords/4))\n",
    "        third = int(np.ceil(nWords/3))\n",
    "        contsplit = context.split()\n",
    "        contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "                     ' '.join(contsplit[third-int(nSearchWords*overlapFac/2):third+int(nSearchWords*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[third*2-int(nSearchWords*overlapFac/2):third*2+int(nSearchWords*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "        input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "        #len(input_ids)\n",
    "        \n",
    "    elif len(input_ids_all)*overlapFac > 1024:\n",
    "        nSearchWords = int(np.ceil(nWords/3))\n",
    "        middle = int(np.ceil(nWords/2))\n",
    "        contsplit = context.split()\n",
    "        contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), \n",
    "                     ' '.join(contsplit[middle-int(nSearchWords*overlapFac/2):middle+int(nSearchWords*overlapFac/2)]),\n",
    "                     ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "        input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "        len(input_ids)\n",
    "    elif len(input_ids_all)*overlapFac > 512:\n",
    "        nSearchWords = int(np.ceil(nWords/2))\n",
    "        contsplit = context.split()\n",
    "        contpieces = [' '.join(contsplit[:int(nSearchWords*overlapFac)]), ' '.join(contsplit[-int(nSearchWords*overlapFac):])]\n",
    "        input_ids = [tokenizer.encode(question, dp) for dp in contpieces]\n",
    "        #print(len(input_ids))\n",
    "    else:\n",
    "        input_ids = [input_ids_all]\n",
    "        #print(len(input_ids))\n",
    "    absTooLong = False    \n",
    "    #print(input_ids)\n",
    "    answers = []\n",
    "    cons = []\n",
    "    for iptIds in input_ids:\n",
    "        tokens = tokenizer.convert_ids_to_tokens(iptIds)\n",
    "        sep_index = iptIds.index(tokenizer.sep_token_id)\n",
    "        num_seg_a = sep_index + 1\n",
    "        num_seg_b = len(iptIds) - num_seg_a\n",
    "        segment_ids = [0]*num_seg_a + [1]*num_seg_b\n",
    "        assert len(segment_ids) == len(iptIds)\n",
    "        n_ids = len(segment_ids)\n",
    "        \n",
    "        #print(n_ids)\n",
    "        if n_ids < 512:\n",
    "            start_scores, end_scores = model(torch.tensor([iptIds]).to(torch_device), \n",
    "                                     token_type_ids=torch.tensor([segment_ids]).to(torch_device))\n",
    "        else:\n",
    "            #this cuts off the text if its more than 512 words so it fits in model space\n",
    "            #need run multiple inferences for longer text. add to the todo\n",
    "            print('****** warning only considering first 512 tokens, document is '+str(nWords)+' words long.  There are '+str(n_ids)+ ' tokens')\n",
    "            absTooLong = True\n",
    "            start_scores, end_scores = model(torch.tensor([iptIds[:512]]).to(torch_device), \n",
    "                                     token_type_ids=torch.tensor([segment_ids[:512]]).to(torch_device))\n",
    "        start_scores = start_scores[:,1:-1]\n",
    "        end_scores = end_scores[:,1:-1]\n",
    "        answer_start = torch.argmax(start_scores)\n",
    "        answer_end = torch.argmax(end_scores)\n",
    "        #print(answer_start, answer_end)\n",
    "        answer = cleanText(tokens, answer_start, answer_end+2)\n",
    "    \n",
    "        if answer.startswith('. ') or answer.startswith(', ') or answer.startswith(') ') or answer.startswith(' )'):\n",
    "            answer = answer[2:]\n",
    "            \n",
    "        c = start_scores[0,answer_start].item()+end_scores[0,answer_end].item()\n",
    "        answers.append(answer)\n",
    "        cons.append(c)\n",
    "    #print(answers)\n",
    "    #print(cons)\n",
    "    # Considering the 'confidence' and respective answer for 'max confidence'\n",
    "    # value\n",
    "    maxC = max(cons)\n",
    "    iMaxC = [i for i, j in enumerate(cons) if j == maxC][0]\n",
    "    confidence = cons[iMaxC]\n",
    "    answer = answers[iMaxC]\n",
    "    #print(answer)\n",
    "    #print(confidence)\n",
    "    sep_index = tokens_all.index('[SEP]')\n",
    "    full_txt_tokens = tokens_all[sep_index+1:]\n",
    "    \n",
    "    abs_returned = cleanText(full_txt_tokens)\n",
    "\n",
    "    ans={}\n",
    "    ans['answer'] = answer.strip()\n",
    "    if answer.startswith('[CLS]') or answer_end.item() < sep_index or answer.endswith('[SEP]'):\n",
    "        ans['confidence'] = -1000000\n",
    "    else:\n",
    "        ans['confidence'] = confidence\n",
    "        ans['abstract_bert'] = abs_returned\n",
    "        ans['abs_too_long'] = absTooLong\n",
    "    return ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Second and selected iteration\n",
    "#brtmp_ans = []\n",
    "#brt_ans = []\n",
    "#brt_conf = []\n",
    "#brt_abst = []\n",
    "#brt_qt = []\n",
    "def answergen_v2(metdatfn, qa_dt, tfidf_model, vectorizer):\n",
    "    brtmp_ans = []\n",
    "    brt_ans = []\n",
    "    brt_conf = []\n",
    "    brt_abst = []\n",
    "    brt_qt = []\n",
    "    brt_sha = []\n",
    "    exlist = ['will', 'on', 'and', 'were', 'was', 'at', 'of', 'from'] # preposition/connecting words that should not start valid sentence\n",
    "    #t = 0\n",
    "    for j in range(len(qa_dt)):\n",
    "        #print('i')\n",
    "        metdatfntop = td_idf_cos(qa_dt.loc[j, \"prp_qa\"], tfidf_model, vectorizer, metdatfn)\n",
    "        #print(len(metdatfntop))\n",
    "        #answ = BERTSQUADPred(metdatfntop.loc[, \"abstract\"], qa_dt.loc[0, \"Questions\"])\n",
    "        #print(len(answ))\n",
    "        for i in range(len(metdatfntop)):\n",
    "            #print(i)\n",
    "            #print(len(metdatfntop))\n",
    "            #print(qa_dt.loc[j, \"Questions\"])\n",
    "            answ = BERTSQUADPred_v2(metdatfntop.loc[i, \"abstract\"], qa_dt.loc[j, \"Questions\"])\n",
    "            chword = re.match(r\"[a-zA-z]+\", answ['answer'])\n",
    "            #print(chword)\n",
    "            #print(answ['answer'])\n",
    "            if chword is not None:\n",
    "                chword = chword.group()\n",
    "            else:\n",
    "                chword = \"\"   \n",
    "            #print(qa_dt.loc[j, \"Questions\"])\n",
    "            if answ['answer'] != '' and answ['confidence'] > 0 and len(answ['answer']) >= 20 and chword not in exlist:\n",
    "                #print('i')\n",
    "                brtmp_ans.append(answ['answer'])\n",
    "                brt_conf.append(answ['confidence'])\n",
    "                brt_abst.append(answ['abstract_bert'])\n",
    "                brt_qt.append(qa_dt.loc[j,\"Questions\"])\n",
    "                brt_sha.append(metdatfntop.loc[i, \"sha\"])\n",
    "            #df_ans = pd.DataFrame(data = {'brt_ans':brt_ans, 'brt_conf':brt_conf, 'brt_abst':brt_abst, 'brt_question':brt_qt})\n",
    "        #print(len(brtmp_ans))\n",
    "        brt_ans = brt_ans + brtmp_ans\n",
    "        bart_answ = \". \".join(brtmp_ans)\n",
    "            #bart_answ = \" \".join(df_ans['brt_ans'])\n",
    "        bart_answ = bart_answ.replace('\\s+',' ')\n",
    "        if len(bart_answ) <= 400:\n",
    "            sum_answ = sum_model(bart_answ, ratio = 1.0, min_length = 30)\n",
    "        elif len(bart_answ) > 400 and len(bart_answ) <= 600:\n",
    "            sum_answ = sum_model(bart_answ, ratio = 0.8, min_length = 30)\n",
    "        else:\n",
    "            sum_answ = sum_model(bart_answ, ratio = 0.6, min_length = 30)\n",
    "        qa_dt.loc[j, \"Model_Sum_Answer\"] = sum_answ\n",
    "        #brt_ans.append(brtmp_ans)\n",
    "        brtmp_ans = []\n",
    "        sum_answ = ''\n",
    "        answ = {}\n",
    "        #t = t+ 1\n",
    "    #print(len(brt_ans))\n",
    "    #print(len(brt_conf))\n",
    "    #print(len(brt_abst))\n",
    "    #print(len(brt_qt))\n",
    "        # Summarising the reference answers as well\n",
    "        ref_answ = qa_dt.loc[j, \"Reference Answers\"]\n",
    "        if len(ref_answ) <= 400:\n",
    "            ref_answ = sum_model(ref_answ, ratio = 1.0)\n",
    "        elif len(ref_answ) > 400 and len(ref_answ) <= 600:\n",
    "            ref_answ = sum_model(ref_answ, ratio = 0.8)\n",
    "        elif len(ref_answ) > 600 and len(ref_answ) <= 800:\n",
    "            ref_answ = sum_model(ref_answ, ratio = 0.6)\n",
    "        else:\n",
    "            ref_answ = sum_model(ref_answ, ratio = 0.4)\n",
    "        qa_dt.loc[j, \"Sum_Reference_answers\"] = ref_answ\n",
    "    df_ans = pd.DataFrame(data = {'brt_sha':brt_sha,'brt_ans':brt_ans, 'brt_conf':brt_conf, 'brt_abst':brt_abst, 'brt_question':brt_qt})\n",
    "    #print(t)\n",
    "    return(df_ans, qa_dt)\n",
    "            \n",
    "\n",
    "            \n",
    "#df_ans"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Funstion to use similarity scores as annotation in the plot\n",
    "def annotlabel(df, bars):\n",
    "    for i, bar in enumerate(bars):\n",
    "        height = bar.get_height()\n",
    "        value = round(df.loc[i, \"similarity_score\"], 2) \n",
    "        ann = ax.annotate('{}'.format(value),\n",
    "                    xy=(bar.get_x() + bar.get_width() / 2, height),\n",
    "                    xytext=(0, 3),  # 3 points vertical offset\n",
    "                    textcoords=\"offset points\",\n",
    "                    ha='center', va='bottom')\n",
    "        ann.set_fontsize(18)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Practice code \n",
    "#exlist = ['will', 'is', 'are', 'on', 'and', 'were', 'was', 'at', 'of', 'from']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "x\n"
     ]
    }
   ],
   "source": [
    "# Practice code\n",
    "#chwdf = re.match(r\"[a-zA-z]+\", 'I ever be the same')\n",
    "#print(type(chwdf.group()))\n",
    "#if not chwdf.group() in exlist:\n",
    "    #print('x')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Token indices sequence length is longer than the specified maximum sequence length for this model (591 > 512). Running this sequence through the model will result in indexing errors\n"
     ]
    }
   ],
   "source": [
    "df_ans_v2, qa_dt_v2 = answergen_v2(metdatfn, qa_dt, tfidf_model, vectorizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 70 entries, 0 to 69\n",
      "Data columns (total 5 columns):\n",
      "brt_sha         70 non-null object\n",
      "brt_ans         70 non-null object\n",
      "brt_conf        70 non-null float64\n",
      "brt_abst        70 non-null object\n",
      "brt_question    70 non-null object\n",
      "dtypes: float64(1), object(4)\n",
      "memory usage: 2.9+ KB\n"
     ]
    }
   ],
   "source": [
    "df_ans_v2.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 23 entries, 0 to 22\n",
      "Data columns (total 6 columns):\n",
      "Task                     23 non-null object\n",
      "Questions                23 non-null object\n",
      "Reference Answers        23 non-null object\n",
      "prp_qa                   23 non-null object\n",
      "Model_Sum_Answer         23 non-null object\n",
      "Sum_Reference_answers    23 non-null object\n",
      "dtypes: object(6)\n",
      "memory usage: 1.2+ KB\n"
     ]
    }
   ],
   "source": [
    "qa_dt_v2.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The above function,'answergen', generates two dataframes- df_ans and qa_dt. The df_ans_v2 dataframe consists of queries, respective answers from abstracts as generated by 'BERTSQUADPred_v2' function, abstracts themselves, the respective confidence scores, the file ids.\n",
    "The qa_dt_v2 dataframe consists of the 'Task', respective questions, the 'Reference answers', the processed queries 'prp_qa' and the answers generated by model-'Model_Sum_Answer'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brt_sha</th>\n",
       "      <th>brt_ans</th>\n",
       "      <th>brt_conf</th>\n",
       "      <th>brt_abst</th>\n",
       "      <th>brt_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites</td>\n",
       "      <td>5.082181</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites although air borne transmission has not been ruled out. this clearly places dental personnel at risks as they work in close proximity to their patients employing droplet and aerosol generating procedures. although the principle of universal precautions is widely advocated and followed throughout the dental community, additional precautionary measures â€” termed standard precaution may be necessary to help control the spread of this highly contagious disease. patient assessment should include questions on recent travel to sars infected areas and, contacts of patients, fever and symptoms of respiratory infections. special management protocols and modified measures that regulate droplet and aerosol contamination in a dental setting have to be introduced and may include the reduction or avoidance of droplet / aerosol generation, the disinfection of the treatment field, application of rubber dam, pre-procedural antiseptic mouthrinse and the dilution and efficient removal of contaminated ambient air. the gag, cough or vomiting reflexes that lead to the generation of aerosols should also be prevented.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>709e51c08788944db48106970f38cebe2b5bd596</td>\n",
       "      <td>through direct or indirect physical contact, droplets or aerosols</td>\n",
       "      <td>7.419631</td>\n",
       "      <td>abstract the presence of patients with diverse pathologies in hospitals results in an environment that can be rich in various microorganisms including respiratory and enteric viruses, leading to outbreaks in hospitals or spillover infections to the community. all hospital patients are at risk of nosocomial viral infections, but vulnerable groups such as older adults, children and immuno-compromised /-suppressed patients are at particular risk of severe outcomes including prolonged hospitalization or death. these pathogens could transmit through direct or indirect physical contact, droplets or aerosols, with increasing evidence suggesting the importance of aerosol transmission in nosocomial infections of respiratory and enteric viruses. factors affecting the propensity to transmit and the severity of disease transmitted via the aerosol route include the biological characteristics affecting infectivity of the viruses and susceptibility of the host, the physical properties of aerosol particles, and the environmental stresses that alter these properties such as temperature and humidity. non-specific systematic and individual-based interventions designed to mitigate the aerosol route are available although empirical evidence of their effectiveness in controlling transmission of respiratory and enteric viruses in healthcare settings are sparse. the relative importance of aerosol transmission in healthcare setting is still an on-going debate, with particular challenge being the recovery of infectious viral bioaerosols from real-life settings and the difficulty in delineating transmission events that may also be a result of other modes of transmission. for the prevention and control of nosocomial infections via the aerosol route, more research is needed on identifying settings, medical procedures or equipment that may be associated with an increased risk of aerosol transmission, including defining which procedures are aerosol-generating ; and on the effectiveness of systematic interventions on aerosol transmission of respiratory and enteric viruses in healthcare settings.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>dc845f9fdcd05760f704f4250fae42c9f29773b0</td>\n",
       "      <td>when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.</td>\n",
       "      <td>2.446246</td>\n",
       "      <td>abstract viral infections can be transmitted by various routes. at one extreme, airborne or droplet viral infections (e. g., varicella zoster, ebola) are highly contagious. most viruses can be spread by touching surfaces contaminated by the virus and then touching the mouth or eyes. mass gatherings, clinical, and chronic care facilities may be hotspots for virus spread when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>c3cb6dbc8f9856954962672e54253ab8fe627446</td>\n",
       "      <td>either contact or large respiratory droplet transmission</td>\n",
       "      <td>2.585962</td>\n",
       "      <td>infection of healthcare workers with the severe acute respiratory syndrome â€“ associated coronavirus (sars-cov) is thought to occur primarily by either contact or large respiratory droplet transmission. however, infrequent healthcare worker infections occurred despite the use of contact and droplet precautions, particularly during certain aerosol-generating medical procedures. we investigated a possible cluster of sars-cov infections in healthcare workers who used contact and droplet precautions during attempted cardiopulmonary resuscitation of a sars patient. unlike previously reported instances of transmission during aerosol-generating procedures, the index case-patient was unresponsive, and the intubation procedure was performed quickly and without difficulty. however, before intubation, the patient was ventilated with a bag-valve-mask that may have contributed to aerosolization of sars-cov. on the basis of the results of this investigation and previous reports of sars transmission during aerosol-generating procedures, a systematic approach to the problem is outlined, including the use of the following : 1) administrative controls, 2) environmental engineering controls, 3) personal protective equipment, and 4) quality control.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>6f192000b0e87fe2c55632441655de31c61596c4</td>\n",
       "      <td>via airborne aerosols and / or large droplets routes</td>\n",
       "      <td>3.018323</td>\n",
       "      <td>understanding of bacterial survival in aerosols is crucial for controlling infection transmission via airborne aerosols and / or large droplets routes. the cell viability changes of four bacteria species (escherichia coli k12 jm109 ; acinetobacter sp. 5a5 ; pseudomonas oleovorans x5 ; and staphylococcus aureus x8), three gram-negative and one gram-positive, in a large evaporating droplet of size 1,800 Î¼m in diameter on teflon-coated slides were measured using the live / dead baclight solution and a microscope. droplets of three levels of salinity (0,0. 9, and 36 % w / v) were tested. all four species survived well during the droplet evaporation process, but died mostly at the time when droplets were dried out at 40 â€“ 45 min. the final bacteria survival rate after droplets were completely dried was dependent on bacteria species and the salinity of the suspension solution. droplet evaporation over the first 35 â€“ 40 min had no adverse effect on bacterial survival for the droplets tested. the lethal effect of desiccation was found to be the most important death mechanism.</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>6.145387</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>154c8e9d755975afaee2877623277747ddaa47d2</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter</td>\n",
       "      <td>1.778185</td>\n",
       "      <td>background : few previous studies have investigated the association between the severity of an infectious disease and the length of incubation period. methods : we estimated the association between the length of the incubation period and the severity of infection with the severe acute respiratory syndrome (sars) coronavirus, using data from the epidemic in 2003 in hong kong. results : we estimated the incubation period of sars based on a subset of patients with available data on exposure periods and a separate subset of patients in a putative common source outbreak, and we found significant associations between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter incubation period proceeded to have more severe disease. further studies are needed to investigate potential biological mechanisms for this association.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>the incubation period is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>7.114547</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>fd96fc1859201e13e35526c188e022fa6e335327</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days</td>\n",
       "      <td>2.443212</td>\n",
       "      <td>background : the ongoing outbreak of novel corona virus disease 2019 (covid-19) in wuhan, china, is arousing international concern. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. methods : we collected data on demographic characteristics, exposure history, and symptom onset day of the confirmed cases, which had been announced by the chinese local authorities. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. all the secondary cases had a history of contact with their first-generation cases prior to symptom onset. results : the estimated mean incubation period for covid-19 was 4. 9 days (95 % confidence interval [ ci ], 4. 4 to 5. 4) days, ranging from 0. 8 to 11. 1 days (2. 5th to 97. 5th percentile). the observed mean and standard deviation (sd) of serial interval was 4. 1Â±3. 3 days, with the 2. 5th and 97. 5th percentiles at-1 and 13 days. the infectious curve showed that in 73. 0 % of the secondary cases, their date of getting infected was before symptom onset of the first-generation cases, particularly in the last three days of the incubation period. conclusions : the results indicated the transmission of covid-9 occurs among close contacts during the incubation period, which may lead to a quarantine loophole. strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the incubation period in populations at high risk.</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>4589d4013cf69c396e0fdb67131022fc11119654</td>\n",
       "      <td>the incubation period</td>\n",
       "      <td>1.267918</td>\n",
       "      <td>background : in early 2013, a novel avian-origin influenza a (h7n9) virus emerged in china, and has caused sporadic human infections. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. methods and findings : we analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza a (h7n9) virus infection in china in a bayesian framework using a weibull distribution. we found a longer incubation period for the 173 fatal cases with a mean of 3. 7 days (95 % credibility interval, cri : 3. 4 â€“ 4. 1), compared to a mean of 3. 3 days (95 % cri : 2. 9 â€“ 3. 6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0. 47 days (95 % cri :-0. 04,0. 99). there was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1. 70 per day increase in incubation period ; 95 % credibility interval 1. 47 â€“ 1. 97). conclusions : we found a significant association between a longer incubation period and a greater risk of death among human h7n9 cases. the underlying biological mechanisms leading to this association deserve further exploration.</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>bbd9d63dc2c733c763770f62205ef9adeceb0127</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality</td>\n",
       "      <td>3.377445</td>\n",
       "      <td>object meteorological parameters are the important factors influencing the infectious diseases like severe acute respiratory syndrome (sars). this study aims to explore the association between coronavirus disease (covid-19) death and weather parameters. methods in this study, we collected the daily death number of covid-19, meteorological and air pollutant data from 20 january, 2020 to 29 february, 2020 in wuhan, china. then, the generalized additive model was applied to explore the impact of temperature, humidity and diurnal temperature range on daily mortality of covid-19. results there were in total 2299 covid-19 mortality counts in wuhan. a positive association with covid-19 mortality was observed for diurnal temperature range (r = 0. 44), but negative association for relative humidity (r = âˆ’0. 32). in addition, each 1 unit increase in diurnal temperature range was only associated with a 2. 92 % (95 % ci : 0. 61 %, 5. 28 %) increase in covid-19 mortality at lag 3. however, both per 1 unit increase of temperature and absolute humidity were related to the decreased covid-19 mortality at lag 3 and lag 5, respectively. conclusion in summary, this study suggests the temperature variation and humidity may be important factors affecting the covid-19 mortality.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>7d7255ec9a213b7fe04cb8c08b326e0aacd2fd9b</td>\n",
       "      <td>ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld</td>\n",
       "      <td>4.479241</td>\n",
       "      <td>using the nationwide inpatient sample and us weather data, we estimated the probability of community-acquired pneumonia (cap) being diagnosed as legionnaires â€™ disease (ld). ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. when the mean temperature was 60Â° â€“ 80Â°f with high humidity (&gt; 80. 0 %), the odds for cap being diagnosed with ld were 3. 1 times higher than with lower levels of humidity (&lt; 50. 0 %). thus, in some regions (e. g., the southwest), ld is rarely the cause of hospitalizations. in other regions and seasons (e. g., the mid-atlantic in summer), ld is much more common. thus, suspicion for ld should increase when weather is warm and humid. however, when weather is cold, dry, or extremely hot, empirically treating all cap patients for ld might contribute to excessive antimicrobial drug use at a population level.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>e9e27abe482c8949d0edbd0bbd9702c1ce355dd8</td>\n",
       "      <td>there were appreciable associations between weather and covid-19 incidence</td>\n",
       "      <td>3.271722</td>\n",
       "      <td>background : the outbreak of covid-19 in china in early 2020 provides a rich data source for exploring the ecological determinants of this new infection, which may be of relevance elsewhere. objectives : assessing the spread of the covid-19 across china, in relation to associations between cases and ecological factors including population density, temperature, solar radiation and precipitation. methods : open-access covid-19 case data include 18,069 geo-located cases in china during january and february 2020, which were mapped onto a 0. 25Â° latitude / longitude grid together with population and weather data (temperature, solar radiation and precipitation). of 15,539 grid cells, 559 (3. 6 %) contained at least one case, and these were used to construct a poisson regression model of cell-weeks. weather parameters were taken for the preceding week given the established 5-7 day incubation period for covid-19. the dependent variable in the poisson model was incident cases per cell-week and exposure was cell population, allowing for clustering of cells over weeks, to give incidence rate ratios. results : the overall covid-19 incidence rate in cells with confirmed cases was 0. 12 per 1,000. there was a single case in 113 / 559 (20. 2 %) of cells, while two grid cells recorded over 1,000 cases. weekly means of maximum daily temperature varied from-28. 0 to 30. 1 Â°c, minimum daily temperature from-42. 4 to 23. 0 Â°c, maximum solar radiation from 0. 04 to 2. 74 mjm-2 and total precipitation from 0 to 72. 6 mm. adjusted incidence rate ratios suggested brighter, warmer and drier conditions were associated with lower incidence. conclusion : though not demonstrating cause and effect, there were appreciable associations between weather and covid-19 incidence during the epidemic in china. this does not mean the pandemic will go away with summer weather but demonstrates the importance of using weather conditions in understanding and forecasting the spread of covid-19.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>2ae710bf5f60c23c489e4c61245a35a4f85178cb</td>\n",
       "      <td>heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission</td>\n",
       "      <td>2.218985</td>\n",
       "      <td>the detection of serum antibodies to the severe acute respiratory syndrome coronavirus 2 (sars-cov-2) is emerging as a new tool for the coronavirus disease-2019 (covid-19) diagnosis. since many coronaviruses are sensitive to heat, heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission, but the effect of heating on the measurement of sars-cov-2 antibodies is still unclear. by comparing the levels of sars-cov-2 antibodies before and after heat inactivation of serum at 56 [UNK] for 30 minutes using a quantitative fluorescence immunochromatographic assay, we shown that heat inactivation significantly interferes with the levels of antibodies to sars-cov-2. the igm levels of all the 34 serum samples (100 %) from covid-19 patients decreased by an average level of 53. 56 %. the igg levels were decreased in 22 of 34 samples (64. 71 %) by an average level of 49. 54 %. similar changes can also be observed in the non-covid-19 diseases group (n = 9). of note, 44. 12 % of the detected igm levels were dropped below the cut-off value after heating, suggesting heat inactivation can lead to false-negative results of these samples. our results indicate that heat inactivation of serum at 56 [UNK] for 30 minutes interferes with the immunoanalysis of antibodies to sars-cov-2. heat inactivation prior to immunoanalysis is not recommended and the possibility of false-negative results should be considered if the sample was pre-inactivated by heating.</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>d87523b89f762c34133a495ccd495489e7d061da</td>\n",
       "      <td>patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>4.097483</td>\n",
       "      <td>patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>8c7de742ccdab73cf04032fc703ad83aa65b685e</td>\n",
       "      <td>a crucial means of preventing influenza pandemics</td>\n",
       "      <td>6.709593</td>\n",
       "      <td>background personal protective equipment (ppe) is known to be a crucial means of preventing influenza pandemics ; however, the amount of ppe that should be stored in hospital settings has been unclear. objectives the purpose of this paper is to propose a ppe calculation system to help hospitals to decide their ppe stockpile. methods we searched influenza guidelines from a number of countries and research papers on protective devices and infectious diseases. the ppe calculation system included factors such as the influenza pandemic period, risk classification by health care workers (hcw) type, and the type and number of ppe for a hcw per day. results we concluded that 4 sets of ppe (n95 respirators, double gloves, gowns, and goggles) per day should be prepared for hcws in a high-risk group. similarly, 2 sets of appropriate ppe, depending on the risk level, are required for medium-and low-risk groups. in addition, 2 surgical masks are required for every worker and inpatient and 1 for each outpatient. the ppe stockpile should be prepared to cover at least an 8-week pandemic. conclusion purchasing a ppe stockpile requires a sizable budget. the ppe calculation system in this paper will hopefully support hospitals in deciding their ppe stockpile.</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>fd51530ed73c17ccd16690c0bfa046be2f360f7f</td>\n",
       "      <td>a primary strategy to protect health care personnel (hcp) from infectious diseases</td>\n",
       "      <td>2.922970</td>\n",
       "      <td>background personal protective equipment (ppe) is a primary strategy to protect health care personnel (hcp) from infectious diseases. when transmission-based ppe ensembles are not appropriate, hcp must recognize the transmission pathway of the disease and anticipate the exposures to select ppe. because guidance for this process is extremely limited, we proposed a systematic, risk-based approach to the selection and evaluation of ppe ensembles to protect hcp against infectious diseases. methods the approach used in this study included the following 4 steps : (1) job hazard analysis, (2) infectious disease hazard analysis, (3) selection of ppe, and (4) evaluation of selected ppe. selected ppe should protect hcp from exposure, be usable by hcp, and fit for purpose. results the approach was demonstrated for the activity of intubation of a patient with methicillin-resistant staphylococcus aureus or severe acute respiratory syndrome coronavirus. as expected, the approach led to the selection of different ensembles of ppe for these 2 pathogens. discussion a systematic risk-based approach to the selection of ppe will help health care facilities and hcp select ppe when transmission-based precautions are not appropriate. owing to the complexity of ppe ensemble selection and evaluation, a team with expertise in infectious diseases, occupational health, the health care activity, and related disciplines, such as human factors, should be engaged. conclusions participation, documentation, and transparency are necessary to ensure the decisions can be communicated, critiqued, and understood by hcp.</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>289deae0b2050aa259a05ba84565a4df82fa099a</td>\n",
       "      <td>designed to arrest nosocomial transmission</td>\n",
       "      <td>1.420590</td>\n",
       "      <td>abstract purpose the recent ebola epidemic that devastated west africa has infected and killed more health care providers than any other outbreak in the history of this virus. an improved understanding of pathogen transmission and the institution of strategies to protect health care providers against infection are needed in infectious disease outbreaks. this review connects what is known about ebola virus transmission with personal protective equipment (ppe) designed to arrest nosocomial transmission. methods articles pertaining to filovirus transmission and ppe in filovirus outbreaks were reviewed and findings are presented. in addition, studies that evaluated ppe and donning and doffing strategies are presented. findings ppe is one step in a comprehensive infection prevention and control strategy that is required to protect health care providers. given that the ebola virus is primarily transmitted through direct contact of mucous membranes and cuts in the skin with infected patients and / or their bodily fluids, it is necessary to cover these potential portals of infection with ppe as part of a structured and instructed donning and doffing procedure. implications current recommendations about ppe and the donning and doffing processes are based on anecdotal experience. however, the use of non-human viruses can help provide evidence-based guidelines on both ppe and donning and doffing processes.</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>4591faf113bf68a0283ab338b77483e9da52cdeb</td>\n",
       "      <td>including reducing exposure</td>\n",
       "      <td>1.160535</td>\n",
       "      <td>preventing transmission of emerging infectious diseases remains a challenge for infection prevention and occupational safety programs. the recent ebola and measles outbreaks highlight the need for pre-epidemic planning, early identification, and appropriate isolation of infected individuals and health care personnel protection. to optimally allocate limited infection control resources, careful consideration of major modes of transmission, the relative infectiousness of the agent, and severity of the pathogen-specific disease are considered. a framework to strategically approach pathogens proposed for health care settings includes generic principles (1) elimination of potential exposure, (2) implementation of administrative controls, (3) facilitation of engineering and environmental controls, and (4) protection of the health care worker and patient using hand hygiene and personal protective equipment. additional considerations are pre-epidemic vaccination and incremental costs and benefits of infection prevention interventions. here, major strategies for preventing health-care-associated transmissions are reviewed, including reducing exposure ; vaccination ; administrative, engineering, and environmental controls ; and personal protective equipment. examples from recent outbreaks are used to highlight key infection prevention aspects and controversies.</td>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>75c449ce799f8e2c627894620b85c4c349463036</td>\n",
       "      <td>to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited. as the mers-cov epidemic continues to evolve, issues concerning best infection control measures will arise, and studies to better define their effectiveness</td>\n",
       "      <td>2.809269</td>\n",
       "      <td>background middle east respiratory syndrome coronavirus (mers-cov) is a novel coronavirus that causes a severe respiratory disease with high case fatality rate. starting in march 2014, a dramatic increase of cases has occurred in the arabian peninsula, many of which were acquired in health care settings. as of may 9,2014,536 laboratory-confirmed cases and 145 deaths have been reported globally. methods review of publicly available data about mers-cov health care â€“ associated transmission. results we identified 11 events of possible or confirmed health care â€“ associated transmission with high morbidity and mortality, mainly among patients with comorbidities. health care workers are also frequently affected ; however, they tend to have milder symptoms and better prognosis. gaps in infection control were noted in all events. currently, health care â€“ associated outbreaks are playing a pivotal role in the evolution of the mers-cov epidemic in countries in the arabian peninsula. conclusion there is a need to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited. as the mers-cov epidemic continues to evolve, issues concerning best infection control measures will arise, and studies to better define their effectiveness in real life are needed.</td>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>486c78271899877a7d310b525330971ecec0db65</td>\n",
       "      <td>interviews, site visitations, and an accommodation survey</td>\n",
       "      <td>8.027894</td>\n",
       "      <td>abstract tourism in island states is vulnerable to climate change because it may result in detrimental changes in relation to extreme events, sea level rise, transport and communication interruption. this study analyses adaptation to climate change by tourist resorts in fiji, as well as their potential to reduce climate change through reductions in carbon dioxide emissions. interviews, site visitations, and an accommodation survey were undertaken. many operators already prepare for climate-related events and therefore adapt to potential impacts resulting from climate change. reducing emissions is not important to operators ; however, decreasing energy costs for economic reasons is practised. recommendations for further initiatives are made and synergies between the adaptation and mitigation approaches are explored.</td>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>ec9755d0db388d8a9066baffc9fd33bdf24f5bac</td>\n",
       "      <td>the ring dosimeters and eye lens dosimeters</td>\n",
       "      <td>6.052358</td>\n",
       "      <td>this review paper presents an overview of individual monitoring, as well as the national dose register and dose record management of radiation workers in china. progress has recently been made on the individual monitoring of radiation workers. a critical analysis of current status and problems in individual monitoring is also presented and necessary future research on individual monitoring, such as the monitoring technology in the form of the ring dosimeters and eye lens dosimeters, is suggested.</td>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>9e9667fc7fcb441ee60a45d5cc2a8550205c9ad3</td>\n",
       "      <td>a coordinated implementation plan</td>\n",
       "      <td>1.567443</td>\n",
       "      <td>diagnostics are fundamental for successful outbreak containment. in this supplement, â€˜ diagnostic preparedness for who blueprint pathogens â€™, we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics. some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of ebola, zika and yellow fever. in this article, we review these overarching challenges and explore potential solutions. challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. addressing these challenges in an efficient and effective way will require multiple stakeholders â€” public and private â€” coordinated in implementing a holistic approach to diagnostics preparedness. all require strengthening of healthcare system diagnostic capacity (including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach ; target product profiles for diagnostics should be refined accordingly. we recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. in addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as coalition for epidemic preparedness innovations and gavi, could be expanded to cover diagnostics.</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>d75af019ef5ffd2aeba20f07de567d9c827a7142</td>\n",
       "      <td>advances in real-time pcr</td>\n",
       "      <td>11.221045</td>\n",
       "      <td>advances in real-time pcr : application to clinical laboratory diagnostics</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>cf085d7780e024e54db7c45b4ca64900e5713a5e</td>\n",
       "      <td>a harmonized process</td>\n",
       "      <td>3.396326</td>\n",
       "      <td>eight manufacturing facilities participating in the national institutes of health â€“ sponsored clinical islet transplantation (cit) consortium jointly developed and implemented a harmonized process for the manufacture of allogeneic purified human pancreatic islet (phpi) product evaluated in a phase 3 trial in subjects with type 1 diabetes. manufacturing was controlled by a common master production batch record, standard operating procedures that included acceptance criteria for deceased donor organ pancreata and critical raw materials, phpi product specifications, certificate of analysis, and test methods. the process was compliant with current good manufacturing practices and current good tissue practices. this report describes the manufacturing process for 75 phpi clinical lots and summarizes the results, including lot release. the results demonstrate the feasibility of implementing a harmonized process at multiple facilities for the manufacture of a complex cellular product. the quality systems and regulatory and operational strategies developed by the cit consortium yielded product lots that met the prespecified characteristics of safety, purity, potency, and identity and were successfully transplanted into 48 subjects. no adverse events attributable to the product and no cases of primary nonfunction were observed.</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>cb0a6f6ded1a53b699f8a704fb5155b445e6987c</td>\n",
       "      <td>abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor. with the implementation of molecular biological and genetic techniques</td>\n",
       "      <td>4.536536</td>\n",
       "      <td>abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor. with the implementation of molecular biological and genetic techniques, the use of diagnostic em decreased. objectives : (1) to give a perspective on future indications and possible uses by discussing the past and the present of diagnostic em, (2) to describe the system of external quality assessment on em virus diagnosis (eqa-emv) established in 1994 by our laboratory and its achievements. study design : eqa-emv is run to evaluate, to confirm and to improve the quality of diagnostic em. two different types of specimen are sent out : (1) prepared grids to assess and train the diagnostic skills of the participants, (2) stabilized virus particle suspensions to assess preparation efficiency. results : diagnostic em differs from other diagnostic tests in its rapidity and its undirected â€˜ open view â€™. to emphasize these advantages, the indications for diagnostic em are discussed, fundamental for a continuing future adaptation. besides appropriate techniques, quality control measures are required to achieve and keep high diagnostic standards. the results from 6 years of eqa-emv are presented. conclusions : in the history of diagnostic em in virology, a change in use has been seen. starting in the 1990s and coincident with the broad introduction of â€˜ modern â€™ diagnostic techniques, the number of em diagnostic labs has decreased considerably â€” in spite of the obvious advantages of this technique. to guarantee the continuing performance of diagnostic em in the future, eqa runs have to be performed as with other techniques in the diagnostic armament. the growing number of participants and participating countries indicates an interest in as well as a need for this program.</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>17de15d04f7a7643550666d2f0da773f5b7dc95c</td>\n",
       "      <td>19 therapeutic and prevention</td>\n",
       "      <td>9.562543</td>\n",
       "      <td>covid-19 therapeutic and prevention</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>d87523b89f762c34133a495ccd495489e7d061da</td>\n",
       "      <td>patients with respiratory symptoms</td>\n",
       "      <td>10.026717</td>\n",
       "      <td>patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>ff54e074416d584681566019cdec2d3683ac2fc5</td>\n",
       "      <td>the diagnosis, infection control, and treatment</td>\n",
       "      <td>3.561525</td>\n",
       "      <td>coronavirus disease 2019 (covid-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (sars-cov-2). previous studies of the covid-19 pneumonia outbreak were based on information from the general population. limited data are available for hemodialysis patients with covid-19 pneumonia. this report describes the clinical characteristics of covid-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of covid-19 pneumonia among in-center hemodialysis patients. the diagnosis, infection control, and treatment of covid-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to covid-19 based on our experiences.</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>e53601fdcfda49cda637b01cc42da5b621abba13</td>\n",
       "      <td>conclusions low platelet count is associated with increased risk of severe disease and mortality</td>\n",
       "      <td>7.162691</td>\n",
       "      <td>abstract background coronavirus disease 2019 (covid-19) is a novel infectious disease with lack of established laboratory markers available to evaluate illness severity. in this study, we investigate whether platelet count could differentiate between covid-19 patients with or without severe disease. additionally, we evaluate if thrombocytopenia is associated with severe covid-19. methods an electronic search in medline, scopus and web of science was performed to identify studies reporting data on platelet count in covid-19 patients. a meta-analysis was performed, with calculation of weighted mean difference (wmd) of platelet number in covid-19 patients with or without severe disease and odds ratio (or) of thrombocytopenia for severe form of covid-19. results nine studies with 1779 covid-19 patients, 399 (22. 4 %) with severe disease, were included in the meta-analysis. the pooled analysis revealed that platelet count was significantly lower in patients with more severe covid-19 (wmd âˆ’31 Ã— 109 / l ; 95 % ci, from âˆ’35 to âˆ’29 Ã— 109 / l). a subgroup analysis comparing patients by survival, found an even lower platelet count was observed with mortality (wmd, âˆ’48 Ã— 109 / l ; 95 % ci, âˆ’57 to âˆ’39 Ã— 109 / l. in the four studies (n = 1427) which reported data on rate of thrombocytopenia, a low platelet count was associated with over fivefold enhanced risk of severe covid-19 (or, 5. 1 ; 95 % ci, 1. 8 â€“ 14. 6). conclusions low platelet count is associated with increased risk of severe disease and mortality in patients with covid-19, and thus should serve as clinical indicator of worsening illness during hospitalization.</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>a0c464060a220478a12604e6ee37141c9ca89d8f</td>\n",
       "      <td>a major incurable global health burden and is currently the 4th largest cause of death in the world</td>\n",
       "      <td>1.302854</td>\n",
       "      <td>abstract chronic obstructive pulmonary disease (copd) is a major incurable global health burden and is currently the 4th largest cause of death in the world. importantly, much of the disease burden and health care utilisation in copd is associated with the management of its comorbidities (e. g. skeletal muscle wasting, ischemic heart disease, cognitive dysfunction) and infective viral and bacterial acute exacerbations (aecopd). current pharmacological treatments for copd are relatively ineffective and the development of effective therapies has been severely hampered by the lack of understanding of the mechanisms and mediators underlying copd. since comorbidities have a tremendous impact on the prognosis and severity of copd, the 2015 american thoracic society / european respiratory society (ats / ers) research statement on copd urgently called for studies to elucidate the pathobiological mechanisms linking copd to its comorbidities. it is now emerging that up to 50 % of copd patients have metabolic syndrome (mets) as a comorbidity. it is currently not clear whether metabolic syndrome is an independent co-existing condition or a direct consequence of the progressive lung pathology in copd patients. as mets has important clinical implications on copd outcomes, identification of disease mechanisms linking copd to mets is the key to effective therapy. in this comprehensive review, we discuss the potential mechanisms linking mets to copd and hence plausible therapeutic strategies to treat this debilitating comorbidity of copd.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>359417eec03774de55b638845646f0f377f35de8</td>\n",
       "      <td>preventing exacerbation</td>\n",
       "      <td>4.459830</td>\n",
       "      <td>preventing exacerbation in chronic obstructive pulmonary disease (copd) patients is crucial, but requires identification of the exacerbating factors. to date, no integrated analysis of patient-derived and external factors has been reported. to identify factors associated with copd exacerbation, we collected data, including smoking status, lung function, and copd assessment test scores, from 594 copd patients in the korean copd subgroup study (kocoss), and merged these data with patients â€™ korean health insurance review and assessment service data for 2007 â€“ 2012. we also collected primary weather variables, including levels of particulate matter &lt; 10 microns in diameter, daily minimum ambient temperature, as well as respiratory virus activities, and the logs of web queries on copd-related issues. we then assessed the associations between these patient-derived and external factors and copd exacerbations. univariate analysis showed that patient factors, air pollution, various types of viruses, temperature, and the number of copd-related web queries were associated with copd exacerbation. multivariate analysis revealed that the number of exacerbations in the preceding year, female sex, copd grade, and influenza virus detection rate, and lowest temperature showed significant association with exacerbation. our findings may help copd patients predict when exacerbations are likely, and provide intervention as early as possible.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>c97243d65788222d1cf09203e27ae04deaf0ef1c</td>\n",
       "      <td>by persistent airflow limitation and an abnormal inflammatory response of the lung</td>\n",
       "      <td>6.418941</td>\n",
       "      <td>chronic obstructive pulmonary disease (copd) is characterized by persistent airflow limitation and an abnormal inflammatory response of the lung. bacteria and viruses are a major cause of copd exacerbations and may contribute to copd progression by perpetuating the inflammatory response in the airways. bacterial variety diminishes with increasing copd severity. respiratory viruses can colonize the lower respiratory tract in stable copd, altering the respiratory microbiome and facilitating secondary bacterial infections. in this review, we present the most updated information about the role of bacteria and viruses in stable and exacerbated copd. in our opinion, to optimize therapeutic strategies, the dynamic events involving bacterial â€“ viral infections and related immune response in copd phenotypes need to be better clarified. our paper would address these points that we consider of great importance for the clinical management of copd.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>c61dff4c277d87714af42ea265f73fcb1a74af84</td>\n",
       "      <td>have frequent exacerbations</td>\n",
       "      <td>10.181784</td>\n",
       "      <td>summary background patients with copd have frequent exacerbations. the role of respiratory viral infection is just emerging. we wished to determine prospectively the incidence of viral infection in exacerbated and stable copd patients as well as smokers who do not have airways obstruction. methods stable and exacerbated copd patients were recruited along with a group of patients who had smoked but who did not have any airways obstruction. spirometry was performed and sputum specimens were tested for a range of 12 different respiratory viruses using pcr. results one hundred and thirty-six patients with exacerbations of copd, 68 stable copd patients and 16 non-obstructed smokers were recruited. a respiratory virus was detected in 37 % of exacerbations, 12 % of stable copd patients and 12 % of non-obstructed smokers, p &lt; 0. 0005. rhinovirus was most frequently detected. the symptom of fever was associated with virus detection, p &lt; 0. 05. infection with more than one virus was only found in the exacerbated copd patients. conclusion respiratory viral infection is associated with exacerbations of copd. rhinovirus was the most common infecting agent identified and in two cases human metapneumovirus was also detected. dual infections were only seen amongst those patients admitted to hospital with acute exacerbations of copd. viruses were more commonly detected in those with more severe airways disease.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>96c39eb3cb96d0a6ecb0a0ba02e45ab21b425c3a</td>\n",
       "      <td>some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels</td>\n",
       "      <td>6.659016</td>\n",
       "      <td>some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels, suggesting the presence of increased inflammation that may increase their susceptibility to exacerbation. the inflammatory response during a copd exacerbation is variable, but increases in interleukin-6 levels during the exacerbation are related to the presence of a common cold. rhinovirus infection is the most important etiologic factor in copd exacerbations and is an important target for preventive therapy. the reduction of copd exacerbations will have an important impact on the considerable morbidity and mortality associated with copd.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>79c4b114ab9f9e8070911e38d090446dc700453f</td>\n",
       "      <td>improve patients ' self-management</td>\n",
       "      <td>6.681585</td>\n",
       "      <td>although, to our knowledge, there has been no exhaustive or credible review of the evidence of the disease burden of copd in china, copd has become an increasing public health concern to the chinese medical community. the purpose of this article is to review the evidence and evaluate and clarify the disease burden of copd in china with the aim of improving effective management. we reviewed previous studies of copd in china, which included data on prevalence, mortality, disease burden, risk factors, diagnosis, and management by searching related web sites, including pubmed, proquest, and thomson reuters ' web of knowledge, as well as major chinese databases and government web sites. reported copd prevalence varied between 5 % and 13 % in different provinces / cities across china. in 2008, copd ranked fourth as a leading cause of death in urban areas and third in rural areas. in addition, copd accounted for 1. 6 % of all hospital admissions in china in that year. the high prevalence of smoking and biomass fuel use acted as major contributors to the high occurrence of copd in china. management of copd in china should focus on adjusting the distribution of medical resources and on addressing public health policies to facilitate earlier diagnosis in rural areas, aim to reduce smoking prevalence, improve patients ' self-management, and keep physicians ' knowledge up to date and consistent with current guidelines. copd is one of the most challenging medical issues facing china because of its influence on both personal and public health and its impact on the economy. optimal management strategies should be adopted and strengthened immediately.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>163f5cb9d4d18dda324d70d6b3a100c208434941</td>\n",
       "      <td>to increased exacerbation frequency, an accelerated decline in lung function and impaired health-related quality of life</td>\n",
       "      <td>4.737972</td>\n",
       "      <td>summary microorganisms, particularly bacteria, are frequently found in the lower airways of copd patients, both in stable state and during exacerbations. the host â€“ pathogen relationship in copd is a complex, dynamic process characterised by frequent changes in pathogens, their strains and loads, and subsequent host immune responses. exacerbations are detrimental events in the course of copd and evidence suggests that 70 % may be caused by microorganisms. when considering bacterial exacerbations, recent findings based on molecular typing have demonstrated that the acquisition of new strains of bacteria or antigenic changes in pre-existing strains are the most important triggers for exacerbation onset. even in clinically stable copd patients the presence of microorganisms in their lower airways may cause harmful effects and induce chronic low-grade airway inflammation leading to increased exacerbation frequency, an accelerated decline in lung function and impaired health-related quality of life. besides intraluminal localisation in the distal airways, bacteria can be found in the bronchial walls and parenchymal lung tissue of copd patients. therefore, the isolation of pathogenic bacteria in stable copd should be considered as a form of chronic infection rather than colonisation. this new approach may have important implications for the management of patients with copd.</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>16bfa83d011a2f290843d20f6850d8ea08a853ae</td>\n",
       "      <td>is not associated with severity of coronavirus disease</td>\n",
       "      <td>3.353435</td>\n",
       "      <td>active smoking is not associated with severity of coronavirus disease 2019 (covid-19)</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>602bd8abdd8f0d464941d989322e843533cea15d</td>\n",
       "      <td>why smokers are particularly likely to develop severe sars-cov-2 infections</td>\n",
       "      <td>2.181077</td>\n",
       "      <td>the coronavirus sars-cov-2 has infected more than 600,000 people and has overwhelmed hospital systems around the world. however, the factors mediating fatal sars-cov-2 infections are poorly understood. here, we show that cigarette smoke causes a dose-dependent upregulation of angiotensin converting enzyme 2 (ace2), the sars-cov-2 receptor, in rodent and human lungs. using single-cell sequencing data, we demonstrate that ace2 is expressed in a subset of epithelial cells that line the respiratory tract, including goblet cells, club cells, and alveolar type 2 cells. chronic smoke exposure triggers a protective expansion of mucus-secreting goblet cells and a concomitant increase in ace2 expression. in contrast, quitting smoking causes a decrease in lung ace2 levels. taken together, these results may partially explain why smokers are particularly likely to develop severe sars-cov-2 infections, and they suggest that quitting smoking could lessen coronavirus susceptibility.</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>f4bde74efeb547d3d6d3f935482a80c9d456198f</td>\n",
       "      <td>smoking is also detrimental to the immune system and its responsiveness to infections, making smokers more vulnerable to infectious diseases</td>\n",
       "      <td>5.886074</td>\n",
       "      <td>covid-19 is a coronavirus outbreak that initially appeared in wuhan, hubei province, china, in december 2019, but it has already evolved into a pandemic spreading rapidly worldwide (1,2). as of 18 march 2020, a total number of 194909 cases of covid-19 have been reported, including 7876 deaths, the majority of which have been reported in china (3242) and italy (2505) (3). however, as the pandemic is still unfortunately under progression, there are limited data with regard to the clinical characteristics of the patients as well as to their prognostic factors (4). smoking, to date, has been assumed to be possibly associated with adverse disease prognosis, as extensive evidence has highlighted the negative impact of tobacco use on lung health and its causal association with a plethora of respiratory diseases (5). smoking is also detrimental to the immune system and its responsiveness to infections, making smokers more vulnerable to infectious diseases (6). previous studies have shown that smokers are twice more likely than non-smokers to contract influenza and have more severe symptoms, while smokers were also noted to have higher mortality in the previous mers-cov outbreak (7,8). given the gap in the evidence, we conducted a systematic review of studies on covid-19 that included information on patients â€™ smoking status to evaluate the association between smoking and covid-19 outcomes including the severity of the disease, the need for mechanical ventilation, the need for intensive care unit (icu) hospitalization and death. the literature search was conducted on 17 march 2020, using two databases (pubmed, sciencedirect), with the search terms : [ â€˜ smoking â€™ or â€˜ tobacco â€™ or â€˜ risk factors â€™ or â€˜ smoker * â€™ ] and [ â€˜ covid-19 â€™ or â€˜ covid 19 â€™ or â€˜ novel coronavirus â€™ or â€˜ sars cov-2 â€™ or â€˜ sars cov 2 â€™ ] and included studies published in 2019 and 2020. further inclusion criteria were that the studies were in english and referred to humans. we also searched the reference lists of the studies included. a total of 71 studies were retrieved through the search, of which 66 were excluded after full-text screening, leaving five studies that were included. all of the studies were conducted in china, four in wuhan and one across provinces in mainland china. the populations in all studies were patients with covid-19, and the sample size ranged from 41 to 1099 patients. with regard to the study design, retrospective and prospective methods were used, and the timeframe of all five studies covered the first two months of the covid-19 pandemic (december 2019, january 2020). specifically, zhou et al. (9) studied the epidemiological characteristics of 191 individuals infected with covid-19, without, however, reporting in more detail the mortality risk factors and the clinical outcomes of the disease. among the 191 patients, there were 54 deaths, while 137 survived. among those that died, 9 % were current smokers compared to 4 % among those that survived, with no statistically significant difference between the smoking rates of survivors and non-survivors (p = 0. 21) with regard to mortality from covid-19. similarly, zhang et al. (10) presented clinical characteristics of 140 patients with covid-19. the results showed that among severe patients (n = 58), 3. 4 % were current smokers and 6. 9 % were former smokers, in contrast to non-severe patients (n = 82) among which 0 % were current smokers and 3. 7 % were former smokers, leading to an or of 2. 23 ; (95 % ci : 0. 65 â€“ 7. 63 ; p = 0. 2). huang et al. (11) studied the epidemiological characteristics of covid-19 among 41 patients. in this study, none of those who needed to be admitted to an icu (n = 13) was a current smoker. in contrast, three patients from the non-icu group were current smokers, with no statistically significant difference between the two groups of patients (p = 0. 31), albeit the small sample size of the study. the largest study population of 1099 patients with covid-19 was provided by guan et al. (12) from multiple regions of mainland china. descriptive results on the smoking status of patients were provided for the 1099 patients, of which 173 had severe symptoms, and 926 had non-severe symptoms. among the patients with severe symptoms, 16. 9 % were current smokers and 5. 2 % were former smokers, in contrast to patients with non-severe symptoms where 11. 8 % were current smokers and 1. 3 % were former smokers. additionally, in the group of patients that either needed mechanical ventilation, admission to an icu or died, 25. 5 % were current smokers and 7. 6 % were former smokers. in contrast, in the group of patients that did not have these adverse outcomes, only 11. 8 % were current smokers and 1. 6 % were former smokers. no statistical analysis for evaluating the association between the severity of the disease outcome and smoking status was conducted in that study. finally, liu et al. (13) found among their population of 78 patients with covid-19 that the adverse outcome group had a significantly higher proportion of patients with a history of smoking (27. 3 %) than the group that showed improvement or stabilization (3. 0 %), with this difference statistically significant at the p = 0. 018 level. in their multivariate logistic regression analysis, the history of smoking was a risk factor of disease progression (or = 14. 28 ; 95 % ci : 1. 58 â€“ 25. 00 ; p = 0. 018). we identified five studies that reported data on the smoking status of patients infected with covid-19. notably, in the largest study that assessed severity, there were higher percentages of current and former smokers among patients that needed icu support, mechanical ventilation or who had died, and a higher percentage of smokers among the severe cases (12). however, from their published data we can calculate that the smokers were 1. 4 times more likely (rr = 1. 4,95 % ci : 0. 98 â€“ 2. 00) to have severe symptoms of covid-19 and approximately 2. 4 times more likely to be admitted to an icu, need mechanical ventilation or die compared to non-smokers (rr = 2. 4,95 % ci : 1. 43 â€“ 4. 04). in conclusion, although further research is warranted as the weight of the evidence increases, with the limited available data, and although the above results are unadjusted for other factors that may impact disease progression, smoking is most likely associated with the negative progression and adverse outcomes of covid-19.</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>f2603d2893999eedb199e31c102dc357da352eb2</td>\n",
       "      <td>a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference</td>\n",
       "      <td>2.553784</td>\n",
       "      <td>abstract eight groups of 30 male and 30 female rats were exposed 1 hr per day, 5 days per week for 13 weeks, to smoke from reference (tobacco burned) or test (tobacco only heated) cigarettes, at nicotine concentrations of 5,15, or 30 Î¼g / liter of air. similar smoke concentrations of wet total particulate matter and carbon monoxide were produced in each of the test / reference comparisons. there was a pronounced depression of minute ventilation of animals in the reference groups, but not in the test animals. blood carboxyhemoglobin concentrations were similar in animals exposed to smoke from test and reference cigarettes. plasma concentrations of nicotine and cotinine in the test groups were higher than in the reference groups. there were no differences between the smoke-exposed groups in terms of body weight or feed consumption. at necropsy, an increase in heart weight was noted in both high exposure groups. there were notable differences in histopathology, with fewer and less-pronounced changes in the test groups than in the reference groups. many of the histopathological responses induced in the reference groups were absent in the test groups. overall, the study demonstrated a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference.</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>ee106840a4b1667303e4b84d25795de3617bd7ef</td>\n",
       "      <td>a reduction in the hospitalization of asthmatic children</td>\n",
       "      <td>4.834503</td>\n",
       "      <td>identifying asthma triggers forms the basis of environmental secondary prevention. these triggers may be allergenic or nonallergenic. allergenic triggers include indoor allergens, such as house dust mites (hdms), molds, pets, cockroaches, and rodents, and outdoor allergens, such as pollens and molds. clinical observations provide support for the role of hdm exposure as a trigger, although avoidance studies provide conflicting results. molds and their metabolic products are now considered to be triggers of asthma attacks. pets, dogs, and especially cats can undoubtedly trigger asthmatic symptoms in sensitized subjects. avoidance is difficult and rarely adhered to by families. cockroach allergens contribute to asthma morbidity, and avoidance strategies can lead to clinical benefit. mouse allergens are mostly found in inner-city dwellings, but their implication in asthma morbidity is debated. in the outdoors, pollens can induce seasonal asthma in sensitized individuals. avoidance relies on preventing pollens from getting into the house and on minimizing seasonal outdoor exposure. outdoor molds may lead to severe asthma exacerbations. nonallergenic triggers include viral infections, active and passive smoking, meteorological changes, occupational exposures, and other triggers that are less commonly involved. viral infection is the main asthma trigger in children. active smoking is associated with higher asthma morbidity, and smoking cessation interventions should be personalized. passive smoking is also a risk factor for asthma exacerbation. the implementation of public smoking bans has led to a reduction in the hospitalization of asthmatic children. air pollution levels have been linked with asthmatic symptoms, a decrease in lung function, and increased emergency room visits and hospitalizations. since avoidance is not easy to achieve, clean air policies remain the most effective strategy. indoor air is also affected by air pollutants, such as cigarette smoke and volatile organic compounds generated by building and cleaning materials. occupational exposures include work-exacerbated asthma and work-related asthma.</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>8fcf6065b0f6a43539a7f4c7f4ba5217237b0782</td>\n",
       "      <td>can reduce this risk</td>\n",
       "      <td>7.598982</td>\n",
       "      <td>community-acquired pneumonia continues to be an important complication of hiv infection. rates of pneumonia decrease with the use of antiretroviral therapy but continue to be higher than in hiv uninfected individuals. risk factors for pneumonia include low blood cd4 + count, unsuppressed plasma hiv load, smoking, injection drug use and renal impairment. immunization against streptococcus pneumoniae and smoking cessation can reduce this risk. it is unclear whether newly reported viral respiratory pathogens (such as the middle east respiratory syndrome coronavirus, will be more of a problem in hiv-infected individuals than the general population.</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>8df8ef4da11139c2c1dd7db65237ff43cfdeb1af</td>\n",
       "      <td>influenza and pneumonia</td>\n",
       "      <td>3.738694</td>\n",
       "      <td>influenza and pneumonia in pregnancy</td>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>9f750562dd90551bc2e6ab3d190eb172fef863af</td>\n",
       "      <td>conditions associated with high-risk pregnancy</td>\n",
       "      <td>2.424435</td>\n",
       "      <td>conditions associated with high-risk pregnancy</td>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>d7194d66d5891aed89ea7e21949b0de91f42d049</td>\n",
       "      <td>imating case fatality rates</td>\n",
       "      <td>0.393852</td>\n",
       "      <td>estimating case fatality rates of covid-19</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>190812e971ca261958c83df9a5ab74eba93a22dc</td>\n",
       "      <td>imating case fatality rates</td>\n",
       "      <td>0.393852</td>\n",
       "      <td>estimating case fatality rates of covid-19</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>f17c6ac4986aecba2dc22f67b32f2d16b369117b</td>\n",
       "      <td>is lower than that of 2003-sars</td>\n",
       "      <td>8.632621</td>\n",
       "      <td>objectives : latest epidemic data of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infected pneumonia (covid-19) was collected and a detailed statistical analysis was carried out to make comparison with 2003-sars in order to provide scientific reference for the prevention and control of covid-19. methods : the information of covid-19 and 2003-sars from websites of nhcprc and the world health organization was collected, and then the transmission dynamics of the two kinds of infectious diseases were analyzed. the information of 853 confirmed covid-19 patients obtained from the website of health committees of 18 provinces. a descriptive epidemiological analysis method was employed to carefully analyze the epidemic characteristics. subsequently, the covid-19 epidemic data in wuhan and other inland regions of china was analyzed separately and compared. a multivariate function model was constructed based on the confirmed covid-19 case data. results : the growth rate of new cases and deaths of covid-19 were significantly faster than those of 2003-sars. the number of confirmed cases in wuhan and other inland areas both showed increasing trends. 853 confirmed covid-19 cases aged 1 months to 94 years and the average age was (45. 05 Â± 17. 22) years. the gender ratio (m : f) was 1. 12 : 1. conclusions : the fatality rate of covid-19 is lower than that of 2003-sars and the cure rate is higher. the age of covid-19 patients is mainly concentrated in the 30-50 years old (60. 61 %). the harm of the first-generation covid-19 patients is higher than that of secondary cases.</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>17de15d04f7a7643550666d2f0da773f5b7dc95c</td>\n",
       "      <td>19 therapeutic and prevention</td>\n",
       "      <td>10.176889</td>\n",
       "      <td>covid-19 therapeutic and prevention</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>ed4831fb9499b8c666ebcf39b3775c534d251c84</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers</td>\n",
       "      <td>8.746075</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (covid-19)</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>6f07f5dc2599b774baffd5a80e0b0a59662b7f35</td>\n",
       "      <td>a new infection control system</td>\n",
       "      <td>5.490075</td>\n",
       "      <td>initiation of a new infection control system for the covid-19 outbreak</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>59ebacae3048d5db81d51968371b6350658e8b94</td>\n",
       "      <td>create targeted measures</td>\n",
       "      <td>3.718908</td>\n",
       "      <td>background : since the new coronavirus epidemic in china in december 2019, information and discussions about covid-19 have spread rapidly on the internet and have quickly become the focus of worldwide attention, especially on social media. objective : this study aims to investigate and analyze the public ' s attention to covid-19-related events in china at the beginning of the covid-19 epidemic in china (december 31,2019, to february 20,2020) through the sina microblog hot search list. methods : we collected topics related to the covid-19 epidemic on the sina microblog hot search list from december 31,2019, to february 20,2020 and described the trend of public attention on covid-19 epidemic-related topics. rost cm6. 0 (rost content mining system version 6. 0) was used to analyze the collected text for word segmentation, word frequency, and sentiment analysis. we further described the hot topic keywords and sentiment trends of public attention. we used vosviewer to implement a visual cluster analysis of hot keywords and build a social network of public opinion content. results : the study has four main findings. first, we analyzed the changing trend of the public ' s attention to the covid-19 epidemic, which can be divided into three stages. second, the hot topic keywords of public attention at each stage are slightly different. in addition, the emotional tendency of the public toward the covid-19 epidemic-related hot topics has changed from negative to neutral, with negative emotions weakening and positive emotions increasing as a whole. finally, we divided the covid-19 topics with the most public concern into five categories : (1) new covid-19 epidemics and their impact ; (2) frontline reporting of the epidemic and prevention and control measures ; (3) expert interpretation and discussion on the source of infection ; (4) medical services on the frontline of the epidemic ; and (5) focus on the global epidemic and the search for suspected cases. conclusions : this is the first study of public attention on the covid-19 epidemic using a chinese social media platform (i. e., sina microblog). our study found that social media (e. g., sina microblog) can be used to measure public attention to public health emergencies. during the epidemic of the novel coronavirus, a large amount of information about the covid-19 epidemic was disseminated on sina microblog and received widespread public attention. we have learned about the hotspots of public concern regarding the covid-19 epidemic. these findings can help the government and health departments better communicate with the public on health and translate public health needs into practice to create targeted measures to prevent and control the spread of covid-19. keywords : covid-19 ; sina microblog ; public attention ; social media ; china ; public health emergency</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>6fcf4019b0be24071210f97eda4baba53a6a79de</td>\n",
       "      <td>covid-19 was transmitted in a more diverse way</td>\n",
       "      <td>6.311663</td>\n",
       "      <td>importance : in 2002-2003, a severe pulmonary infectious disease occurred in guangdong, china. the disease was caused by sars-cov, 17 years apart, also happen in china, and sars-cov-2, this epidemic has posed a significant hazard to people health both china and the whole world. objective : summarized the latest epidemiological changes, clinical manifestations, auxiliary examination and pathological characteristics of covid-19. evidence review : pubmed database were searched from 2019 to 2020 using the index terms novel coronavirus or covid-19 or 2019-ncov or sars-cov-2 and synonyms. articles that reported clinical characteristics, laboratory results, imageological diagnosis and pathologic condition were included and were retrospectively reviewed for these cases. this paper adopts the method of descriptive statistics. results : 34 covid-19-related articles were eligible for this systematic review ; four of the articles were related to pathology. we found that fever (86. 0 %), cough (63. 9 %) and malaise / fatigue (34. 7 %) were the most common symptoms in covid-19. but in general, the clinical symptoms and signs of covid-19 were not obvious. compared with sars, covid-19 was transmitted in a more diverse way. the mortality rates of covid-19 were 2. 5 %, and the overall infection rate of healthcare worker of covid-19 was 3. 9 %. we also found that the pathological features of covid-19 have greatly similar with sars, which manifested as ards. but the latest pathological examination of covid-19 revealed the obvious mucinous secretions in the lungs. interpretation : the clinical and pathological characteristics of sars and covid-19 in china are very similar, but also difference. the latest finds of pathological examination on covid-19 may upend existing treatment schemes, so the early recognition of disease by healthcare worker is very important.</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>6f07f5dc2599b774baffd5a80e0b0a59662b7f35</td>\n",
       "      <td>initiation of a new infection control system</td>\n",
       "      <td>0.942579</td>\n",
       "      <td>initiation of a new infection control system for the covid-19 outbreak</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>d75af019ef5ffd2aeba20f07de567d9c827a7142</td>\n",
       "      <td>to clinical laboratory diagnostics</td>\n",
       "      <td>1.169152</td>\n",
       "      <td>advances in real-time pcr : application to clinical laboratory diagnostics</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>623fb8ad6037966919e2feccfaf25068892779bb</td>\n",
       "      <td>â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "      <td>2.934915</td>\n",
       "      <td>our research is motivated by the rapidly-evolving outbreaks of rare and fatal infectious diseases, for example, the severe acute respiratory syndrome (sars) and the middle east respiratory syndrome. in many of these outbreaks, main transmission routes were healthcare facility-associated and through person-to-person contact. while a majority of existing work on modelling of the spread of infectious diseases focuses on transmission processes at a community level, we propose a new methodology to model the outbreaks of healthcare-associated infections (hais), which must be considered at an individual level. our work also contributes to a novel aspect of integrating real-time positioning technologies into the tracking and modelling framework for effective hai outbreak control and prompt responses. our proposed solution methodology is developed based on three key components â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation â€“ and aims to identify the hidden health state of each patient and worker within the healthcare facility. we conduct experiments with a four-month human tracking data set collected in a hospital, which bore a big nosocomial outbreak of the 2003 sars in hong kong. the evaluation results demonstrate that our framework outperforms existing epidemic models for characterizing macro-level phenomena such as the number of infected people and epidemic threshold.</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>a1f9e6d1c2717f4555275f25d6169063b7f8bb23</td>\n",
       "      <td>to cases isolation and contact tracing measures</td>\n",
       "      <td>5.070963</td>\n",
       "      <td>what further should be done to control covid-19 outbreaks in addition to cases isolation and contact tracing measures ?</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>4634bbdcdabf5d53fb7b2f81f1625a815540aae5</td>\n",
       "      <td>efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials</td>\n",
       "      <td>5.882801</td>\n",
       "      <td>summary the causative agent of severe acute respiratory syndrome (sars), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002 â€“ 2003 outbreak, is a coronavirus that was unknown before the outbreak. although many different treatments were used during the outbreak, none were implemented in a controlled fashion. thus, the optimal treatment for sars is unknown. since the outbreak, much work has been done testing new agents against sars using in-vitro methods and animal models. in addition, global research efforts have focused on the development of vaccines against sars. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials, should another sars outbreak occur.</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>b39171b7e9363a54727c33c8d7d197d2acfbc1ce</td>\n",
       "      <td>infectious diseases and regional security</td>\n",
       "      <td>1.128130</td>\n",
       "      <td>infectious diseases and regional security in east asia</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>d535e9201c038010f5cdad2faab7418d7fe520eb</td>\n",
       "      <td>we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures</td>\n",
       "      <td>3.939699</td>\n",
       "      <td>abstract objective mers-cov infection is uncommonly identified among patients visiting healthcare facilities &amp; we were vigilant in screening all patients entering our hospital to prevent cross infection among patients, visitors &amp; healthcare providers and aiming to prevent potential outbreaks with mers-cov infection. in spite of our efforts on practicing failure mode effect analysis for mers-cov infection management we ended up having an outbreak with mers-cov. based on our experience, we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures for preventing future outbreaks at our healthcare facility. methods retrospectively we analyzed our failure in preventing the outbreak of mers-cov infection among our hospitalized patients by identifying the outbreak &amp; actively intervening as a team to control the outbreak with the support of hospital higher management, administrators, quality improvement team, infection prevention &amp; control team &amp; the active support of all healthcare workers of the facility. results following the early identification of mers-cov outbreak, we could successfully prevent large scale outbreak both in the hospital &amp; the community. conclusion continuous implementation of infection prevention &amp; control standards along with early clinical diagnosis of mers-cov infections based on the case definition as laid out by the ministry of health will prevent infectious outbreaks at healthcare facilities.</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70 rows Ã— 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     brt_sha  \\\n",
       "0   f26952fcfc1863fcb5ae1d05f0e072ffa597f9b0   \n",
       "1   709e51c08788944db48106970f38cebe2b5bd596   \n",
       "2   dc845f9fdcd05760f704f4250fae42c9f29773b0   \n",
       "3   c3cb6dbc8f9856954962672e54253ab8fe627446   \n",
       "4   6f192000b0e87fe2c55632441655de31c61596c4   \n",
       "..                                       ...   \n",
       "65  623fb8ad6037966919e2feccfaf25068892779bb   \n",
       "66  a1f9e6d1c2717f4555275f25d6169063b7f8bb23   \n",
       "67  4634bbdcdabf5d53fb7b2f81f1625a815540aae5   \n",
       "68  b39171b7e9363a54727c33c8d7d197d2acfbc1ce   \n",
       "69  d535e9201c038010f5cdad2faab7418d7fe520eb   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     brt_ans  \\\n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1   through direct or indirect physical contact, droplets or aerosols                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "2   when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.   \n",
       "3   either contact or large respiratory droplet transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "4   via airborne aerosols and / or large droplets routes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "..                                                   ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "65  â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "66  to cases isolation and contact tracing measures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "67  efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "68  infectious diseases and regional security                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "69  we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "\n",
       "    brt_conf  \\\n",
       "0   5.082181   \n",
       "1   7.419631   \n",
       "2   2.446246   \n",
       "3   2.585962   \n",
       "4   3.018323   \n",
       "..       ...   \n",
       "65  2.934915   \n",
       "66  5.070963   \n",
       "67  5.882801   \n",
       "68  1.128130   \n",
       "69  3.939699   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                brt_abst  \\\n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites although air borne transmission has not been ruled out. this clearly places dental personnel at risks as they work in close proximity to their patients employing droplet and aerosol generating procedures. although the principle of universal precautions is widely advocated and followed throughout the dental community, additional precautionary measures â€” termed standard precaution may be necessary to help control the spread of this highly contagious disease. patient assessment should include questions on recent travel to sars infected areas and, contacts of patients, fever and symptoms of respiratory infections. special management protocols and modified measures that regulate droplet and aerosol contamination in a dental setting have to be introduced and may include the reduction or avoidance of droplet / aerosol generation, the disinfection of the treatment field, application of rubber dam, pre-procedural antiseptic mouthrinse and the dilution and efficient removal of contaminated ambient air. the gag, cough or vomiting reflexes that lead to the generation of aerosols should also be prevented.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "1   abstract the presence of patients with diverse pathologies in hospitals results in an environment that can be rich in various microorganisms including respiratory and enteric viruses, leading to outbreaks in hospitals or spillover infections to the community. all hospital patients are at risk of nosocomial viral infections, but vulnerable groups such as older adults, children and immuno-compromised /-suppressed patients are at particular risk of severe outcomes including prolonged hospitalization or death. these pathogens could transmit through direct or indirect physical contact, droplets or aerosols, with increasing evidence suggesting the importance of aerosol transmission in nosocomial infections of respiratory and enteric viruses. factors affecting the propensity to transmit and the severity of disease transmitted via the aerosol route include the biological characteristics affecting infectivity of the viruses and susceptibility of the host, the physical properties of aerosol particles, and the environmental stresses that alter these properties such as temperature and humidity. non-specific systematic and individual-based interventions designed to mitigate the aerosol route are available although empirical evidence of their effectiveness in controlling transmission of respiratory and enteric viruses in healthcare settings are sparse. the relative importance of aerosol transmission in healthcare setting is still an on-going debate, with particular challenge being the recovery of infectious viral bioaerosols from real-life settings and the difficulty in delineating transmission events that may also be a result of other modes of transmission. for the prevention and control of nosocomial infections via the aerosol route, more research is needed on identifying settings, medical procedures or equipment that may be associated with an increased risk of aerosol transmission, including defining which procedures are aerosol-generating ; and on the effectiveness of systematic interventions on aerosol transmission of respiratory and enteric viruses in healthcare settings.   \n",
       "2   abstract viral infections can be transmitted by various routes. at one extreme, airborne or droplet viral infections (e. g., varicella zoster, ebola) are highly contagious. most viruses can be spread by touching surfaces contaminated by the virus and then touching the mouth or eyes. mass gatherings, clinical, and chronic care facilities may be hotspots for virus spread when transmission is via aerosols, droplets, or fomites (contaminated surfaces). environmental factors which are often important for virus survival may include the ambient humidity, temperature, and ph of the environment they are in, so many viruses survive only a few hours in the environment and are often readily inactivated by common hygiene techniques, such as using soap and water, and some detergents, disinfectants, and antiseptics. sexually transmitted viral infections, such as herpes simplex, are often transmitted by close mucosal contacts.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "3   infection of healthcare workers with the severe acute respiratory syndrome â€“ associated coronavirus (sars-cov) is thought to occur primarily by either contact or large respiratory droplet transmission. however, infrequent healthcare worker infections occurred despite the use of contact and droplet precautions, particularly during certain aerosol-generating medical procedures. we investigated a possible cluster of sars-cov infections in healthcare workers who used contact and droplet precautions during attempted cardiopulmonary resuscitation of a sars patient. unlike previously reported instances of transmission during aerosol-generating procedures, the index case-patient was unresponsive, and the intubation procedure was performed quickly and without difficulty. however, before intubation, the patient was ventilated with a bag-valve-mask that may have contributed to aerosolization of sars-cov. on the basis of the results of this investigation and previous reports of sars transmission during aerosol-generating procedures, a systematic approach to the problem is outlined, including the use of the following : 1) administrative controls, 2) environmental engineering controls, 3) personal protective equipment, and 4) quality control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "4   understanding of bacterial survival in aerosols is crucial for controlling infection transmission via airborne aerosols and / or large droplets routes. the cell viability changes of four bacteria species (escherichia coli k12 jm109 ; acinetobacter sp. 5a5 ; pseudomonas oleovorans x5 ; and staphylococcus aureus x8), three gram-negative and one gram-positive, in a large evaporating droplet of size 1,800 Î¼m in diameter on teflon-coated slides were measured using the live / dead baclight solution and a microscope. droplets of three levels of salinity (0,0. 9, and 36 % w / v) were tested. all four species survived well during the droplet evaporation process, but died mostly at the time when droplets were dried out at 40 â€“ 45 min. the final bacteria survival rate after droplets were completely dried was dependent on bacteria species and the salinity of the suspension solution. droplet evaporation over the first 35 â€“ 40 min had no adverse effect on bacterial survival for the droplets tested. the lethal effect of desiccation was found to be the most important death mechanism.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "..                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ...                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "65  our research is motivated by the rapidly-evolving outbreaks of rare and fatal infectious diseases, for example, the severe acute respiratory syndrome (sars) and the middle east respiratory syndrome. in many of these outbreaks, main transmission routes were healthcare facility-associated and through person-to-person contact. while a majority of existing work on modelling of the spread of infectious diseases focuses on transmission processes at a community level, we propose a new methodology to model the outbreaks of healthcare-associated infections (hais), which must be considered at an individual level. our work also contributes to a novel aspect of integrating real-time positioning technologies into the tracking and modelling framework for effective hai outbreak control and prompt responses. our proposed solution methodology is developed based on three key components â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation â€“ and aims to identify the hidden health state of each patient and worker within the healthcare facility. we conduct experiments with a four-month human tracking data set collected in a hospital, which bore a big nosocomial outbreak of the 2003 sars in hong kong. the evaluation results demonstrate that our framework outperforms existing epidemic models for characterizing macro-level phenomena such as the number of infected people and epidemic threshold.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "66  what further should be done to control covid-19 outbreaks in addition to cases isolation and contact tracing measures ?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "67  summary the causative agent of severe acute respiratory syndrome (sars), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002 â€“ 2003 outbreak, is a coronavirus that was unknown before the outbreak. although many different treatments were used during the outbreak, none were implemented in a controlled fashion. thus, the optimal treatment for sars is unknown. since the outbreak, much work has been done testing new agents against sars using in-vitro methods and animal models. in addition, global research efforts have focused on the development of vaccines against sars. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials, should another sars outbreak occur.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "68  infectious diseases and regional security in east asia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "69  abstract objective mers-cov infection is uncommonly identified among patients visiting healthcare facilities & we were vigilant in screening all patients entering our hospital to prevent cross infection among patients, visitors & healthcare providers and aiming to prevent potential outbreaks with mers-cov infection. in spite of our efforts on practicing failure mode effect analysis for mers-cov infection management we ended up having an outbreak with mers-cov. based on our experience, we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures for preventing future outbreaks at our healthcare facility. methods retrospectively we analyzed our failure in preventing the outbreak of mers-cov infection among our hospitalized patients by identifying the outbreak & actively intervening as a team to control the outbreak with the support of hospital higher management, administrators, quality improvement team, infection prevention & control team & the active support of all healthcare workers of the facility. results following the early identification of mers-cov outbreak, we could successfully prevent large scale outbreak both in the hospital & the community. conclusion continuous implementation of infection prevention & control standards along with early clinical diagnosis of mers-cov infections based on the case definition as laid out by the ministry of health will prevent infectious outbreaks at healthcare facilities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "\n",
       "                                                                                          brt_question  \n",
       "0   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "1   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "2   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "3   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "4   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?  \n",
       "..                                                                                                 ...  \n",
       "65  What real-time genomic tracking tools exist?                                                        \n",
       "66  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "67  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "68  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "69  What efforts are being done in Asia to prevent further outbreaks?                                   \n",
       "\n",
       "[70 rows x 5 columns]"
      ]
     },
     "execution_count": 164,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ans_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 256,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'the most common cause of death and disability'"
      ]
     },
     "execution_count": 256,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ans_v2.loc[39, \"brt_ans\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites\n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 165,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ans_v2['brt_ans'].head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "9    the incubation period\n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 166,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ans_v2.loc[df_ans_v2[\"brt_question\"]==\"Can the virus be transmitted asymptomatically or during the incubation period?\", \"brt_ans\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10    the temperature variation and humidity may be important factors affecting the covid-19 mortality                                                        \n",
       "11    ld risk increases when weather is warm and humid. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld\n",
       "12    there were appreciable associations between weather and covid-19 incidence                                                                              \n",
       "13    heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission                         \n",
       "14    patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                         \n",
       "Name: brt_ans, dtype: object"
      ]
     },
     "execution_count": 167,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_ans_v2.loc[df_ans_v2[\"brt_question\"]==\"How does weather, heat, and humidity affect the transmission of COVID 19?\", \"brt_ans\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "      <th>Sum_Reference_answers</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td></td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long can the COVID 19 virus remain viable on common surfaces?</td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "      <td>long covid 19 viru remain viabl common surfac</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "      <td>person effect protect equip ppe reduc risk transmiss health care commun set</td>\n",
       "      <td>a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.</td>\n",
       "      <td>effect movement control strategi prevent secondari transmiss health care commun set</td>\n",
       "      <td>to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "      <td>tool studi monitor phenotyp chang potenti adapt viru</td>\n",
       "      <td>interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n</td>\n",
       "      <td>implement diagnost product improv clinic process</td>\n",
       "      <td>a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "      <td>risk factor contribut sever covid 19</td>\n",
       "      <td>patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does hypertension affect patients?</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "      <td>hypertens affect patient</td>\n",
       "      <td>to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does heart disease affect patients?</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "      <td>heart diseas affect patient</td>\n",
       "      <td>to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.</td>\n",
       "      <td>copd affect patient</td>\n",
       "      <td>a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "      <td>smoke affect patient</td>\n",
       "      <td>is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.</td>\n",
       "      <td>pregnanc affect patient</td>\n",
       "      <td>conditions associated with high-risk pregnancy</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "      <td>fatal rate covid 19</td>\n",
       "      <td>is lower than that of 2003-sars</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.</td>\n",
       "      <td>public health polici prevent control spread covid 19</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers. a new infection control system.</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "      <td>anim transmit covid 19</td>\n",
       "      <td>covid-19 was transmitted in a more diverse way. initiation of a new infection control system</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.</td>\n",
       "      <td>anim covid 19 come</td>\n",
       "      <td></td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "      <td>\\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.</td>\n",
       "      <td>real-tim genom track tool exist</td>\n",
       "      <td>to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "      <td>Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What geographic variations are there in the genome of COVID 19?</td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "      <td>geograph variat genom covid 19</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.</td>\n",
       "      <td>effort done asia prevent outbreak</td>\n",
       "      <td>to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                          Task  \\\n",
       "0   What is known about transmission, incubation, and environmental stability?   \n",
       "1   What is known about transmission, incubation, and environmental stability?   \n",
       "2   What is known about transmission, incubation, and environmental stability?   \n",
       "3   What is known about transmission, incubation, and environmental stability?   \n",
       "4   What is known about transmission, incubation, and environmental stability?   \n",
       "5   What is known about transmission, incubation, and environmental stability?   \n",
       "6   What is known about transmission, incubation, and environmental stability?   \n",
       "7   What is known about transmission, incubation, and environmental stability?   \n",
       "8   What is known about transmission, incubation, and environmental stability?   \n",
       "9   What is known about transmission, incubation, and environmental stability?   \n",
       "10  What do we know about COVID-19 risk factors?                                 \n",
       "11  What do we know about COVID-19 risk factors?                                 \n",
       "12  What do we know about COVID-19 risk factors?                                 \n",
       "13  What do we know about COVID-19 risk factors?                                 \n",
       "14  What do we know about COVID-19 risk factors?                                 \n",
       "15  What do we know about COVID-19 risk factors?                                 \n",
       "16  What do we know about COVID-19 risk factors?                                 \n",
       "17  What do we know about COVID-19 risk factors?                                 \n",
       "18  What do we know about virus genetics, origin, and evolution?                 \n",
       "19  What do we know about virus genetics, origin, and evolution?                 \n",
       "20  What do we know about virus genetics, origin, and evolution?                 \n",
       "21  What do we know about virus genetics, origin, and evolution?                 \n",
       "22  What do we know about virus genetics, origin, and evolution?                 \n",
       "\n",
       "                                                                                                                                Questions  \\\n",
       "0   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?                                      \n",
       "1   How long is the incubation period for the virus in humans?                                                                              \n",
       "2   How does the incubation period in humans vary across age and health conditions?                                                         \n",
       "3   Can the virus be transmitted asymptomatically or during the incubation period?                                                          \n",
       "4   How does weather, heat, and humidity affect the transmission of COVID 19?                                                               \n",
       "5   How long can the COVID 19 virus remain viable on common surfaces?                                                                       \n",
       "6   How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?   \n",
       "7   What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?       \n",
       "8   What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?                                      \n",
       "9   What is the Implementation of diagnostics and products to improve clinical processes?                                                   \n",
       "10  What risk factors contribute to the severity of COVID 19?                                                                               \n",
       "11  How does hypertension affect patients?                                                                                                  \n",
       "12  How does heart disease affect patients?                                                                                                 \n",
       "13  How does COPD affect patients?                                                                                                          \n",
       "14  How does smoking affect patients?                                                                                                       \n",
       "15  How does pregnancy affect patients?                                                                                                     \n",
       "16  What is the fatality rate of COVID 19?                                                                                                  \n",
       "17  What public health policies prevent or control the spread of COVID 19?                                                                  \n",
       "18  Can animals transmit COVID 19?                                                                                                          \n",
       "19  What animal did COVID 19 come from?                                                                                                     \n",
       "20  What real-time genomic tracking tools exist?                                                                                            \n",
       "21  What geographic variations are there in the genome of COVID 19?                                                                         \n",
       "22  What efforts are being done in Asia to prevent further outbreaks?                                                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Reference Answers  \\\n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "20  \\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                                                                                                       \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "                                                                                 prp_qa  \\\n",
       "0   covid viru transmit aerosol droplet food close contact faecal matter water            \n",
       "1   long incub period viru human                                                          \n",
       "2   incub period human vari across age health condit                                      \n",
       "3   viru transmit asymptomat incub period                                                 \n",
       "4   weather heat humid affect transmiss covid 19                                          \n",
       "5   long covid 19 viru remain viabl common surfac                                         \n",
       "6   person effect protect equip ppe reduc risk transmiss health care commun set           \n",
       "7   effect movement control strategi prevent secondari transmiss health care commun set   \n",
       "8   tool studi monitor phenotyp chang potenti adapt viru                                  \n",
       "9   implement diagnost product improv clinic process                                      \n",
       "10  risk factor contribut sever covid 19                                                  \n",
       "11  hypertens affect patient                                                              \n",
       "12  heart diseas affect patient                                                           \n",
       "13  copd affect patient                                                                   \n",
       "14  smoke affect patient                                                                  \n",
       "15  pregnanc affect patient                                                               \n",
       "16  fatal rate covid 19                                                                   \n",
       "17  public health polici prevent control spread covid 19                                  \n",
       "18  anim transmit covid 19                                                                \n",
       "19  anim covid 19 come                                                                    \n",
       "20  real-tim genom track tool exist                                                       \n",
       "21  geograph variat genom covid 19                                                        \n",
       "22  effort done asia prevent outbreak                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Model_Sum_Answer  \\\n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1   is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "2   between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.                                            \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "4   the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                      \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "6   a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "7   to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.                                                                                                                                                                                                                                                                                                                     \n",
       "8   interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "9   a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.                                                                                                                                                                               \n",
       "10  patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "11  to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.   \n",
       "12  to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "13  a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.                                                                                                                                                                                                                                                              \n",
       "14  is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.                                                                                                                                                                                                                                                                                                                                            \n",
       "15  conditions associated with high-risk pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "16  is lower than that of 2003-sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "17  policies on the use of respiratory protection for hospital health workers. a new infection control system.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "18  covid-19 was transmitted in a more diverse way. initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "20  to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "22  to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sum_Reference_answers  \n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.                                                                                                                                                                                                                                                       \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                     \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                     \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                       \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.  \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.                                                                                                                                                                                                                                                                                                                                                              \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "20  Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 "
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1     is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "2     between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "4     the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "6     a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "7     to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.                                                                                                                                                                                                                                                                                                                  \n",
       "8     interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "9     a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.                                                                                                                                                                            \n",
       "10    patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "11    to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.\n",
       "12    to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "13    a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.                                                                                                                                                                                                                                                           \n",
       "14    is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.                                                                                                                                                                                                                                                                                                                                         \n",
       "15    conditions associated with high-risk pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "16    is lower than that of 2003-sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "17    policies on the use of respiratory protection for hospital health workers. a new infection control system.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "18    covid-19 was transmitted in a more diverse way. initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "20    to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "22    to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                  \n",
       "Name: Model_Sum_Answer, dtype: object"
      ]
     },
     "execution_count": 169,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2[\"Model_Sum_Answer\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "      <th>Sum_Reference_answers</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td></td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "1  What is known about transmission, incubation, and environmental stability?   \n",
       "2  What is known about transmission, incubation, and environmental stability?   \n",
       "3  What is known about transmission, incubation, and environmental stability?   \n",
       "4  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "1  How long is the incubation period for the virus in humans?                                           \n",
       "2  How does the incubation period in humans vary across age and health conditions?                      \n",
       "3  Can the virus be transmitted asymptomatically or during the incubation period?                       \n",
       "4  How does weather, heat, and humidity affect the transmission of COVID 19?                            \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Reference Answers  \\\n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "\n",
       "                                                                       prp_qa  \\\n",
       "0  covid viru transmit aerosol droplet food close contact faecal matter water   \n",
       "1  long incub period viru human                                                 \n",
       "2  incub period human vari across age health condit                             \n",
       "3  viru transmit asymptomat incub period                                        \n",
       "4  weather heat humid affect transmiss covid 19                                 \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Model_Sum_Answer  \\\n",
       "0  the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                         \n",
       "1  is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "2  between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "4  the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                             \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sum_Reference_answers  \n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.  \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.                                                                                                                                                                                                                                                                                                              \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                        \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                        "
      ]
     },
     "execution_count": 170,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2.head(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The proposed model architecture seemed to have generated relevant answers for most questions again and with updates, removed paranthesis such as ')' from start of the answer. However, for the same questions such as \"Can the virus be transmitted asymptomatically or during the incubation period?\" the proposed BERT model with updates to functions was still not able to generate meaningful spans from the shortlisted abstracts, while, there was no span generated for the same queries such as \"What do we know about virus genetics, origin, and evolution?\". \n",
    "The results from second iteration highlighted that updating the 'overlapFac' factor did not give meaningful improvements as model was still not able to understand the context for the given query and generate proper span for the same queries as in the first iteration. \n",
    "This means that to improve the performance, proposed BERT model will need to be fine tuned with help of larger queries/reference answers data base along with the existing large context documents database. This is however, not in scope of this research due to paucity of time required to collect data and fine tune the model\n",
    "The filtering condition of removing answer spans starting with prepositions or connecting words such as \"on\", \"at\", \"from\", \"will\", etc helped getting better answer spans from the model\n",
    "The changes to the way summarization of joined answers was carried by the model helped in improving the quality of summarized answers. The setting of minimum length for sentence to be considered helped in only valid sentences to be considered, while, the dynamic 'sentence ratio' settings based on the length of the joined answer made sure relevant information was retained.\n",
    "The summarization of \"reference answers\", using similar conditions as considered for the joined answers, helped in resizing them to reasonable lengths when compared to respective summarized answers without loosing relevant information.  \n",
    "Will now calculate the sentence similarity between the answers generated from proposed model architecture and the reference answers collected from cited sources."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ans_v2.to_excel(\"df_ans_v2.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {},
   "outputs": [],
   "source": [
    "qa_dt_v2.to_excel(\"qa_dt_v2.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_ans_v2.to_csv(\"df_ans_v2.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "metadata": {},
   "outputs": [],
   "source": [
    "qa_dt_v2.to_csv(\"qa_dt_v2.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The Word2Vec embeddings model from gensim library and then train the same with the words within all the abstracts in the dataset.\n",
    "The model will then be used to create embeddings or vectors for the summarized joined answer and respective summarized reference answer.\n",
    "The cosine product of the two will then be calculated to measure the similarity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?                                   \n",
       "1     How long is the incubation period for the virus in humans?                                                                           \n",
       "2     How does the incubation period in humans vary across age and health conditions?                                                      \n",
       "3     Can the virus be transmitted asymptomatically or during the incubation period?                                                       \n",
       "4     How does weather, heat, and humidity affect the transmission of COVID 19?                                                            \n",
       "5     How long can the COVID 19 virus remain viable on common surfaces?                                                                    \n",
       "6     How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?\n",
       "7     What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?    \n",
       "8     What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?                                   \n",
       "9     What is the Implementation of diagnostics and products to improve clinical processes?                                                \n",
       "10    What risk factors contribute to the severity of COVID 19?                                                                            \n",
       "11    How does hypertension affect patients?                                                                                               \n",
       "12    How does heart disease affect patients?                                                                                              \n",
       "13    How does COPD affect patients?                                                                                                       \n",
       "14    How does smoking affect patients?                                                                                                    \n",
       "15    How does pregnancy affect patients?                                                                                                  \n",
       "16    What is the fatality rate of COVID 19?                                                                                               \n",
       "17    What public health policies prevent or control the spread of COVID 19?                                                               \n",
       "18    Can animals transmit COVID 19?                                                                                                       \n",
       "19    What animal did COVID 19 come from?                                                                                                  \n",
       "20    What real-time genomic tracking tools exist?                                                                                         \n",
       "21    What geographic variations are there in the genome of COVID 19?                                                                      \n",
       "22    What efforts are being done in Asia to prevent further outbreaks?                                                                    \n",
       "Name: Questions, dtype: object"
      ]
     },
     "execution_count": 128,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2[\"Questions\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:41.311948 140212937652032 word2vec.py:1588] collecting all words and their counts\n",
      "W1125 12:20:41.313469 140212937652032 word2vec.py:1567] Each 'sentences' item should be a list of words (usually unicode strings). First item here is instead plain <class 'str'>.\n",
      "I1125 12:20:41.314479 140212937652032 word2vec.py:1573] PROGRESS: at sentence #0, processed 0 words, keeping 0 word types\n",
      "I1125 12:20:41.326358 140212937652032 word2vec.py:1573] PROGRESS: at sentence #10000, processed 74931 words, keeping 45 word types\n",
      "I1125 12:20:41.338841 140212937652032 word2vec.py:1573] PROGRESS: at sentence #20000, processed 146111 words, keeping 47 word types\n",
      "I1125 12:20:41.350579 140212937652032 word2vec.py:1573] PROGRESS: at sentence #30000, processed 217143 words, keeping 49 word types\n",
      "I1125 12:20:41.361868 140212937652032 word2vec.py:1573] PROGRESS: at sentence #40000, processed 289895 words, keeping 54 word types\n",
      "I1125 12:20:41.373350 140212937652032 word2vec.py:1573] PROGRESS: at sentence #50000, processed 362026 words, keeping 55 word types\n",
      "I1125 12:20:41.385042 140212937652032 word2vec.py:1573] PROGRESS: at sentence #60000, processed 434185 words, keeping 56 word types\n",
      "I1125 12:20:41.394859 140212937652032 word2vec.py:1573] PROGRESS: at sentence #70000, processed 505281 words, keeping 59 word types\n",
      "I1125 12:20:41.404892 140212937652032 word2vec.py:1573] PROGRESS: at sentence #80000, processed 577083 words, keeping 60 word types\n",
      "I1125 12:20:41.415645 140212937652032 word2vec.py:1573] PROGRESS: at sentence #90000, processed 648797 words, keeping 61 word types\n",
      "I1125 12:20:41.425728 140212937652032 word2vec.py:1573] PROGRESS: at sentence #100000, processed 719997 words, keeping 62 word types\n",
      "I1125 12:20:41.437424 140212937652032 word2vec.py:1573] PROGRESS: at sentence #110000, processed 797937 words, keeping 63 word types\n",
      "I1125 12:20:41.449250 140212937652032 word2vec.py:1573] PROGRESS: at sentence #120000, processed 875650 words, keeping 64 word types\n",
      "I1125 12:20:41.460707 140212937652032 word2vec.py:1573] PROGRESS: at sentence #130000, processed 953046 words, keeping 65 word types\n",
      "I1125 12:20:41.472108 140212937652032 word2vec.py:1573] PROGRESS: at sentence #140000, processed 1031074 words, keeping 65 word types\n",
      "I1125 12:20:41.483277 140212937652032 word2vec.py:1573] PROGRESS: at sentence #150000, processed 1108023 words, keeping 65 word types\n",
      "I1125 12:20:41.495177 140212937652032 word2vec.py:1573] PROGRESS: at sentence #160000, processed 1185513 words, keeping 65 word types\n",
      "I1125 12:20:41.506650 140212937652032 word2vec.py:1573] PROGRESS: at sentence #170000, processed 1263412 words, keeping 65 word types\n",
      "I1125 12:20:41.518001 140212937652032 word2vec.py:1573] PROGRESS: at sentence #180000, processed 1341013 words, keeping 67 word types\n",
      "I1125 12:20:41.529408 140212937652032 word2vec.py:1573] PROGRESS: at sentence #190000, processed 1419368 words, keeping 67 word types\n",
      "I1125 12:20:41.541182 140212937652032 word2vec.py:1573] PROGRESS: at sentence #200000, processed 1499118 words, keeping 69 word types\n",
      "I1125 12:20:41.553084 140212937652032 word2vec.py:1573] PROGRESS: at sentence #210000, processed 1577836 words, keeping 69 word types\n",
      "I1125 12:20:41.564342 140212937652032 word2vec.py:1573] PROGRESS: at sentence #220000, processed 1654120 words, keeping 75 word types\n",
      "I1125 12:20:41.575802 140212937652032 word2vec.py:1573] PROGRESS: at sentence #230000, processed 1729031 words, keeping 76 word types\n",
      "I1125 12:20:41.586591 140212937652032 word2vec.py:1573] PROGRESS: at sentence #240000, processed 1801697 words, keeping 80 word types\n",
      "I1125 12:20:41.597942 140212937652032 word2vec.py:1573] PROGRESS: at sentence #250000, processed 1876572 words, keeping 81 word types\n",
      "I1125 12:20:41.608226 140212937652032 word2vec.py:1573] PROGRESS: at sentence #260000, processed 1945461 words, keeping 84 word types\n",
      "I1125 12:20:41.618718 140212937652032 word2vec.py:1573] PROGRESS: at sentence #270000, processed 2018344 words, keeping 85 word types\n",
      "I1125 12:20:41.630264 140212937652032 word2vec.py:1573] PROGRESS: at sentence #280000, processed 2092082 words, keeping 86 word types\n",
      "I1125 12:20:41.641653 140212937652032 word2vec.py:1573] PROGRESS: at sentence #290000, processed 2164200 words, keeping 87 word types\n",
      "I1125 12:20:41.654041 140212937652032 word2vec.py:1573] PROGRESS: at sentence #300000, processed 2237183 words, keeping 87 word types\n",
      "I1125 12:20:41.666621 140212937652032 word2vec.py:1573] PROGRESS: at sentence #310000, processed 2310813 words, keeping 91 word types\n",
      "I1125 12:20:41.678922 140212937652032 word2vec.py:1573] PROGRESS: at sentence #320000, processed 2384226 words, keeping 91 word types\n",
      "I1125 12:20:41.691027 140212937652032 word2vec.py:1573] PROGRESS: at sentence #330000, processed 2457694 words, keeping 91 word types\n",
      "I1125 12:20:41.703412 140212937652032 word2vec.py:1573] PROGRESS: at sentence #340000, processed 2532949 words, keeping 91 word types\n",
      "I1125 12:20:41.715999 140212937652032 word2vec.py:1573] PROGRESS: at sentence #350000, processed 2605459 words, keeping 91 word types\n",
      "I1125 12:20:41.728485 140212937652032 word2vec.py:1573] PROGRESS: at sentence #360000, processed 2677615 words, keeping 92 word types\n",
      "I1125 12:20:41.741574 140212937652032 word2vec.py:1573] PROGRESS: at sentence #370000, processed 2754988 words, keeping 92 word types\n",
      "I1125 12:20:41.754286 140212937652032 word2vec.py:1573] PROGRESS: at sentence #380000, processed 2831026 words, keeping 92 word types\n",
      "I1125 12:20:41.766157 140212937652032 word2vec.py:1573] PROGRESS: at sentence #390000, processed 2903253 words, keeping 92 word types\n",
      "I1125 12:20:41.777561 140212937652032 word2vec.py:1573] PROGRESS: at sentence #400000, processed 2977641 words, keeping 93 word types\n",
      "I1125 12:20:41.790140 140212937652032 word2vec.py:1573] PROGRESS: at sentence #410000, processed 3051529 words, keeping 95 word types\n",
      "I1125 12:20:41.803185 140212937652032 word2vec.py:1573] PROGRESS: at sentence #420000, processed 3126118 words, keeping 95 word types\n",
      "I1125 12:20:41.815517 140212937652032 word2vec.py:1573] PROGRESS: at sentence #430000, processed 3200271 words, keeping 96 word types\n",
      "I1125 12:20:41.827535 140212937652032 word2vec.py:1573] PROGRESS: at sentence #440000, processed 3273941 words, keeping 96 word types\n",
      "I1125 12:20:41.838224 140212937652032 word2vec.py:1573] PROGRESS: at sentence #450000, processed 3346603 words, keeping 96 word types\n",
      "I1125 12:20:41.850274 140212937652032 word2vec.py:1573] PROGRESS: at sentence #460000, processed 3418367 words, keeping 97 word types\n",
      "I1125 12:20:41.861202 140212937652032 word2vec.py:1573] PROGRESS: at sentence #470000, processed 3490661 words, keeping 97 word types\n",
      "I1125 12:20:41.872751 140212937652032 word2vec.py:1573] PROGRESS: at sentence #480000, processed 3564340 words, keeping 97 word types\n",
      "I1125 12:20:41.884180 140212937652032 word2vec.py:1573] PROGRESS: at sentence #490000, processed 3635015 words, keeping 97 word types\n",
      "I1125 12:20:41.896350 140212937652032 word2vec.py:1573] PROGRESS: at sentence #500000, processed 3706033 words, keeping 97 word types\n",
      "I1125 12:20:41.907298 140212937652032 word2vec.py:1573] PROGRESS: at sentence #510000, processed 3777555 words, keeping 97 word types\n",
      "I1125 12:20:41.918350 140212937652032 word2vec.py:1573] PROGRESS: at sentence #520000, processed 3850983 words, keeping 98 word types\n",
      "I1125 12:20:41.931081 140212937652032 word2vec.py:1573] PROGRESS: at sentence #530000, processed 3925823 words, keeping 99 word types\n",
      "I1125 12:20:41.943713 140212937652032 word2vec.py:1573] PROGRESS: at sentence #540000, processed 3999479 words, keeping 99 word types\n",
      "I1125 12:20:41.955775 140212937652032 word2vec.py:1573] PROGRESS: at sentence #550000, processed 4070974 words, keeping 99 word types\n",
      "I1125 12:20:41.968966 140212937652032 word2vec.py:1573] PROGRESS: at sentence #560000, processed 4142575 words, keeping 99 word types\n",
      "I1125 12:20:41.980631 140212937652032 word2vec.py:1573] PROGRESS: at sentence #570000, processed 4216604 words, keeping 99 word types\n",
      "I1125 12:20:41.991785 140212937652032 word2vec.py:1573] PROGRESS: at sentence #580000, processed 4288228 words, keeping 99 word types\n",
      "I1125 12:20:42.004076 140212937652032 word2vec.py:1573] PROGRESS: at sentence #590000, processed 4361957 words, keeping 100 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:42.015249 140212937652032 word2vec.py:1573] PROGRESS: at sentence #600000, processed 4434356 words, keeping 100 word types\n",
      "I1125 12:20:42.026650 140212937652032 word2vec.py:1573] PROGRESS: at sentence #610000, processed 4509365 words, keeping 100 word types\n",
      "I1125 12:20:42.037832 140212937652032 word2vec.py:1573] PROGRESS: at sentence #620000, processed 4584296 words, keeping 101 word types\n",
      "I1125 12:20:42.049416 140212937652032 word2vec.py:1573] PROGRESS: at sentence #630000, processed 4659619 words, keeping 101 word types\n",
      "I1125 12:20:42.060024 140212937652032 word2vec.py:1573] PROGRESS: at sentence #640000, processed 4732943 words, keeping 101 word types\n",
      "I1125 12:20:42.071738 140212937652032 word2vec.py:1573] PROGRESS: at sentence #650000, processed 4808058 words, keeping 101 word types\n",
      "I1125 12:20:42.083080 140212937652032 word2vec.py:1573] PROGRESS: at sentence #660000, processed 4880195 words, keeping 101 word types\n",
      "I1125 12:20:42.094568 140212937652032 word2vec.py:1573] PROGRESS: at sentence #670000, processed 4953823 words, keeping 101 word types\n",
      "I1125 12:20:42.105392 140212937652032 word2vec.py:1573] PROGRESS: at sentence #680000, processed 5023127 words, keeping 101 word types\n",
      "I1125 12:20:42.116284 140212937652032 word2vec.py:1573] PROGRESS: at sentence #690000, processed 5094105 words, keeping 101 word types\n",
      "I1125 12:20:42.128153 140212937652032 word2vec.py:1573] PROGRESS: at sentence #700000, processed 5166873 words, keeping 102 word types\n",
      "I1125 12:20:42.138874 140212937652032 word2vec.py:1573] PROGRESS: at sentence #710000, processed 5240543 words, keeping 102 word types\n",
      "I1125 12:20:42.150591 140212937652032 word2vec.py:1573] PROGRESS: at sentence #720000, processed 5314334 words, keeping 102 word types\n",
      "I1125 12:20:42.162224 140212937652032 word2vec.py:1573] PROGRESS: at sentence #730000, processed 5386831 words, keeping 102 word types\n",
      "I1125 12:20:42.173699 140212937652032 word2vec.py:1573] PROGRESS: at sentence #740000, processed 5459615 words, keeping 103 word types\n",
      "I1125 12:20:42.185620 140212937652032 word2vec.py:1573] PROGRESS: at sentence #750000, processed 5534670 words, keeping 103 word types\n",
      "I1125 12:20:42.196271 140212937652032 word2vec.py:1573] PROGRESS: at sentence #760000, processed 5604715 words, keeping 103 word types\n",
      "I1125 12:20:42.208042 140212937652032 word2vec.py:1573] PROGRESS: at sentence #770000, processed 5677572 words, keeping 104 word types\n",
      "I1125 12:20:42.218397 140212937652032 word2vec.py:1573] PROGRESS: at sentence #780000, processed 5747081 words, keeping 104 word types\n",
      "I1125 12:20:42.230143 140212937652032 word2vec.py:1573] PROGRESS: at sentence #790000, processed 5820505 words, keeping 104 word types\n",
      "I1125 12:20:42.240977 140212937652032 word2vec.py:1573] PROGRESS: at sentence #800000, processed 5893032 words, keeping 104 word types\n",
      "I1125 12:20:42.252002 140212937652032 word2vec.py:1573] PROGRESS: at sentence #810000, processed 5962672 words, keeping 104 word types\n",
      "I1125 12:20:42.262730 140212937652032 word2vec.py:1573] PROGRESS: at sentence #820000, processed 6033689 words, keeping 104 word types\n",
      "I1125 12:20:42.273535 140212937652032 word2vec.py:1573] PROGRESS: at sentence #830000, processed 6103545 words, keeping 104 word types\n",
      "I1125 12:20:42.285290 140212937652032 word2vec.py:1573] PROGRESS: at sentence #840000, processed 6173367 words, keeping 104 word types\n",
      "I1125 12:20:42.296347 140212937652032 word2vec.py:1573] PROGRESS: at sentence #850000, processed 6243529 words, keeping 104 word types\n",
      "I1125 12:20:42.307551 140212937652032 word2vec.py:1573] PROGRESS: at sentence #860000, processed 6315432 words, keeping 104 word types\n",
      "I1125 12:20:42.319225 140212937652032 word2vec.py:1573] PROGRESS: at sentence #870000, processed 6389752 words, keeping 107 word types\n",
      "I1125 12:20:42.329908 140212937652032 word2vec.py:1573] PROGRESS: at sentence #880000, processed 6457433 words, keeping 108 word types\n",
      "I1125 12:20:42.340567 140212937652032 word2vec.py:1573] PROGRESS: at sentence #890000, processed 6528194 words, keeping 108 word types\n",
      "I1125 12:20:42.352778 140212937652032 word2vec.py:1573] PROGRESS: at sentence #900000, processed 6604010 words, keeping 108 word types\n",
      "I1125 12:20:42.364587 140212937652032 word2vec.py:1573] PROGRESS: at sentence #910000, processed 6676839 words, keeping 108 word types\n",
      "I1125 12:20:42.375417 140212937652032 word2vec.py:1573] PROGRESS: at sentence #920000, processed 6742750 words, keeping 108 word types\n",
      "I1125 12:20:42.387418 140212937652032 word2vec.py:1573] PROGRESS: at sentence #930000, processed 6816566 words, keeping 108 word types\n",
      "I1125 12:20:42.398965 140212937652032 word2vec.py:1573] PROGRESS: at sentence #940000, processed 6891596 words, keeping 109 word types\n",
      "I1125 12:20:42.410169 140212937652032 word2vec.py:1573] PROGRESS: at sentence #950000, processed 6962521 words, keeping 109 word types\n",
      "I1125 12:20:42.421712 140212937652032 word2vec.py:1573] PROGRESS: at sentence #960000, processed 7039077 words, keeping 110 word types\n",
      "I1125 12:20:42.432488 140212937652032 word2vec.py:1573] PROGRESS: at sentence #970000, processed 7107722 words, keeping 110 word types\n",
      "I1125 12:20:42.443486 140212937652032 word2vec.py:1573] PROGRESS: at sentence #980000, processed 7178161 words, keeping 110 word types\n",
      "I1125 12:20:42.455137 140212937652032 word2vec.py:1573] PROGRESS: at sentence #990000, processed 7252018 words, keeping 110 word types\n",
      "I1125 12:20:42.466617 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1000000, processed 7330160 words, keeping 111 word types\n",
      "I1125 12:20:42.478584 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1010000, processed 7406427 words, keeping 111 word types\n",
      "I1125 12:20:42.490061 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1020000, processed 7480045 words, keeping 112 word types\n",
      "I1125 12:20:42.501469 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1030000, processed 7555257 words, keeping 113 word types\n",
      "I1125 12:20:42.512989 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1040000, processed 7629830 words, keeping 113 word types\n",
      "I1125 12:20:42.524207 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1050000, processed 7700042 words, keeping 113 word types\n",
      "I1125 12:20:42.534843 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1060000, processed 7771162 words, keeping 113 word types\n",
      "I1125 12:20:42.546565 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1070000, processed 7844593 words, keeping 113 word types\n",
      "I1125 12:20:42.557693 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1080000, processed 7915872 words, keeping 113 word types\n",
      "I1125 12:20:42.569050 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1090000, processed 7988647 words, keeping 113 word types\n",
      "I1125 12:20:42.580467 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1100000, processed 8060165 words, keeping 113 word types\n",
      "I1125 12:20:42.591299 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1110000, processed 8131566 words, keeping 113 word types\n",
      "I1125 12:20:42.601799 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1120000, processed 8199387 words, keeping 115 word types\n",
      "I1125 12:20:42.612468 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1130000, processed 8269095 words, keeping 115 word types\n",
      "I1125 12:20:42.624562 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1140000, processed 8344121 words, keeping 115 word types\n",
      "I1125 12:20:42.635899 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1150000, processed 8417251 words, keeping 115 word types\n",
      "I1125 12:20:42.646342 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1160000, processed 8488152 words, keeping 115 word types\n",
      "I1125 12:20:42.659599 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1170000, processed 8561635 words, keeping 119 word types\n",
      "I1125 12:20:42.671800 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1180000, processed 8635528 words, keeping 119 word types\n",
      "I1125 12:20:42.683398 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1190000, processed 8705820 words, keeping 119 word types\n",
      "I1125 12:20:42.695236 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1200000, processed 8772000 words, keeping 119 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:42.707464 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1210000, processed 8841608 words, keeping 119 word types\n",
      "I1125 12:20:42.718121 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1220000, processed 8913340 words, keeping 121 word types\n",
      "I1125 12:20:42.729584 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1230000, processed 8986522 words, keeping 121 word types\n",
      "I1125 12:20:42.740934 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1240000, processed 9061437 words, keeping 122 word types\n",
      "I1125 12:20:42.752455 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1250000, processed 9135764 words, keeping 122 word types\n",
      "I1125 12:20:42.763831 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1260000, processed 9207451 words, keeping 123 word types\n",
      "I1125 12:20:42.774494 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1270000, processed 9276823 words, keeping 144 word types\n",
      "I1125 12:20:42.786771 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1280000, processed 9351997 words, keeping 144 word types\n",
      "I1125 12:20:42.798289 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1290000, processed 9425769 words, keeping 144 word types\n",
      "I1125 12:20:42.809372 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1300000, processed 9499617 words, keeping 144 word types\n",
      "I1125 12:20:42.820646 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1310000, processed 9574164 words, keeping 144 word types\n",
      "I1125 12:20:42.832014 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1320000, processed 9648886 words, keeping 144 word types\n",
      "I1125 12:20:42.843397 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1330000, processed 9723248 words, keeping 144 word types\n",
      "I1125 12:20:42.854759 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1340000, processed 9797501 words, keeping 144 word types\n",
      "I1125 12:20:42.866266 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1350000, processed 9871863 words, keeping 144 word types\n",
      "I1125 12:20:42.877488 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1360000, processed 9945197 words, keeping 144 word types\n",
      "I1125 12:20:42.888981 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1370000, processed 10018556 words, keeping 144 word types\n",
      "I1125 12:20:42.900250 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1380000, processed 10091691 words, keeping 144 word types\n",
      "I1125 12:20:42.911581 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1390000, processed 10164647 words, keeping 144 word types\n",
      "I1125 12:20:42.924093 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1400000, processed 10238164 words, keeping 144 word types\n",
      "I1125 12:20:42.936689 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1410000, processed 10311300 words, keeping 144 word types\n",
      "I1125 12:20:42.947830 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1420000, processed 10384420 words, keeping 144 word types\n",
      "I1125 12:20:42.960542 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1430000, processed 10457420 words, keeping 144 word types\n",
      "I1125 12:20:42.971202 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1440000, processed 10531621 words, keeping 144 word types\n",
      "I1125 12:20:42.983417 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1450000, processed 10605689 words, keeping 144 word types\n",
      "I1125 12:20:42.995632 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1460000, processed 10679728 words, keeping 144 word types\n",
      "I1125 12:20:43.007304 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1470000, processed 10753273 words, keeping 144 word types\n",
      "I1125 12:20:43.018056 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1480000, processed 10826964 words, keeping 144 word types\n",
      "I1125 12:20:43.029170 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1490000, processed 10898602 words, keeping 144 word types\n",
      "I1125 12:20:43.040803 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1500000, processed 10971308 words, keeping 144 word types\n",
      "I1125 12:20:43.051945 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1510000, processed 11045481 words, keeping 144 word types\n",
      "I1125 12:20:43.062593 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1520000, processed 11118583 words, keeping 144 word types\n",
      "I1125 12:20:43.073571 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1530000, processed 11192032 words, keeping 144 word types\n",
      "I1125 12:20:43.085145 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1540000, processed 11265663 words, keeping 144 word types\n",
      "I1125 12:20:43.096181 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1550000, processed 11339556 words, keeping 144 word types\n",
      "I1125 12:20:43.106996 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1560000, processed 11413238 words, keeping 144 word types\n",
      "I1125 12:20:43.118240 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1570000, processed 11486173 words, keeping 144 word types\n",
      "I1125 12:20:43.129561 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1580000, processed 11560017 words, keeping 144 word types\n",
      "I1125 12:20:43.140837 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1590000, processed 11633428 words, keeping 144 word types\n",
      "I1125 12:20:43.151561 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1600000, processed 11706766 words, keeping 144 word types\n",
      "I1125 12:20:43.162928 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1610000, processed 11780368 words, keeping 145 word types\n",
      "I1125 12:20:43.174461 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1620000, processed 11853666 words, keeping 145 word types\n",
      "I1125 12:20:43.187044 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1630000, processed 11926593 words, keeping 146 word types\n",
      "I1125 12:20:43.197918 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1640000, processed 11999787 words, keeping 146 word types\n",
      "I1125 12:20:43.210774 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1650000, processed 12073249 words, keeping 146 word types\n",
      "I1125 12:20:43.222988 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1660000, processed 12145056 words, keeping 146 word types\n",
      "I1125 12:20:43.234081 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1670000, processed 12218196 words, keeping 146 word types\n",
      "I1125 12:20:43.246760 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1680000, processed 12291032 words, keeping 146 word types\n",
      "I1125 12:20:43.257515 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1690000, processed 12364350 words, keeping 146 word types\n",
      "I1125 12:20:43.269657 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1700000, processed 12438175 words, keeping 146 word types\n",
      "I1125 12:20:43.280996 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1710000, processed 12512452 words, keeping 146 word types\n",
      "I1125 12:20:43.294242 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1720000, processed 12585868 words, keeping 146 word types\n",
      "I1125 12:20:43.305480 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1730000, processed 12658960 words, keeping 147 word types\n",
      "I1125 12:20:43.317837 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1740000, processed 12733477 words, keeping 147 word types\n",
      "I1125 12:20:43.330200 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1750000, processed 12806369 words, keeping 148 word types\n",
      "I1125 12:20:43.342355 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1760000, processed 12879389 words, keeping 148 word types\n",
      "I1125 12:20:43.354492 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1770000, processed 12951255 words, keeping 148 word types\n",
      "I1125 12:20:43.365649 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1780000, processed 13024272 words, keeping 148 word types\n",
      "I1125 12:20:43.378196 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1790000, processed 13096747 words, keeping 148 word types\n",
      "I1125 12:20:43.389280 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1800000, processed 13169710 words, keeping 148 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:43.400214 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1810000, processed 13242724 words, keeping 148 word types\n",
      "I1125 12:20:43.411646 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1820000, processed 13315702 words, keeping 148 word types\n",
      "I1125 12:20:43.422722 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1830000, processed 13389235 words, keeping 148 word types\n",
      "I1125 12:20:43.433369 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1840000, processed 13461243 words, keeping 148 word types\n",
      "I1125 12:20:43.444816 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1850000, processed 13535779 words, keeping 148 word types\n",
      "I1125 12:20:43.456116 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1860000, processed 13608295 words, keeping 148 word types\n",
      "I1125 12:20:43.466612 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1870000, processed 13681260 words, keeping 148 word types\n",
      "I1125 12:20:43.478461 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1880000, processed 13755672 words, keeping 148 word types\n",
      "I1125 12:20:43.489568 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1890000, processed 13829079 words, keeping 148 word types\n",
      "I1125 12:20:43.500735 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1900000, processed 13903165 words, keeping 148 word types\n",
      "I1125 12:20:43.511005 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1910000, processed 13975004 words, keeping 149 word types\n",
      "I1125 12:20:43.522384 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1920000, processed 14048937 words, keeping 150 word types\n",
      "I1125 12:20:43.534278 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1930000, processed 14122982 words, keeping 150 word types\n",
      "I1125 12:20:43.545407 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1940000, processed 14196840 words, keeping 150 word types\n",
      "I1125 12:20:43.556932 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1950000, processed 14270826 words, keeping 150 word types\n",
      "I1125 12:20:43.568210 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1960000, processed 14344251 words, keeping 150 word types\n",
      "I1125 12:20:43.579394 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1970000, processed 14417732 words, keeping 150 word types\n",
      "I1125 12:20:43.590188 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1980000, processed 14490114 words, keeping 150 word types\n",
      "I1125 12:20:43.602354 140212937652032 word2vec.py:1573] PROGRESS: at sentence #1990000, processed 14562627 words, keeping 150 word types\n",
      "I1125 12:20:43.613084 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2000000, processed 14634336 words, keeping 150 word types\n",
      "I1125 12:20:43.624404 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2010000, processed 14708199 words, keeping 150 word types\n",
      "I1125 12:20:43.635856 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2020000, processed 14781811 words, keeping 150 word types\n",
      "I1125 12:20:43.646763 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2030000, processed 14855703 words, keeping 150 word types\n",
      "I1125 12:20:43.659301 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2040000, processed 14928421 words, keeping 150 word types\n",
      "I1125 12:20:43.671209 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2050000, processed 15001452 words, keeping 150 word types\n",
      "I1125 12:20:43.683557 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2060000, processed 15073541 words, keeping 150 word types\n",
      "I1125 12:20:43.695911 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2070000, processed 15146776 words, keeping 150 word types\n",
      "I1125 12:20:43.707841 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2080000, processed 15219810 words, keeping 150 word types\n",
      "I1125 12:20:43.718688 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2090000, processed 15293432 words, keeping 150 word types\n",
      "I1125 12:20:43.729654 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2100000, processed 15360536 words, keeping 150 word types\n",
      "I1125 12:20:43.740636 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2110000, processed 15422558 words, keeping 150 word types\n",
      "I1125 12:20:43.752209 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2120000, processed 15494778 words, keeping 151 word types\n",
      "I1125 12:20:43.765069 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2130000, processed 15565785 words, keeping 151 word types\n",
      "I1125 12:20:43.776298 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2140000, processed 15640242 words, keeping 151 word types\n",
      "I1125 12:20:43.787169 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2150000, processed 15713271 words, keeping 151 word types\n",
      "I1125 12:20:43.798964 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2160000, processed 15787232 words, keeping 151 word types\n",
      "I1125 12:20:43.810540 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2170000, processed 15860231 words, keeping 151 word types\n",
      "I1125 12:20:43.821382 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2180000, processed 15932243 words, keeping 155 word types\n",
      "I1125 12:20:43.832858 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2190000, processed 16004113 words, keeping 156 word types\n",
      "I1125 12:20:43.843697 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2200000, processed 16076745 words, keeping 156 word types\n",
      "I1125 12:20:43.857045 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2210000, processed 16150410 words, keeping 156 word types\n",
      "I1125 12:20:43.868964 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2220000, processed 16223136 words, keeping 156 word types\n",
      "I1125 12:20:43.880805 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2230000, processed 16296806 words, keeping 156 word types\n",
      "I1125 12:20:43.892953 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2240000, processed 16370275 words, keeping 156 word types\n",
      "I1125 12:20:43.905078 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2250000, processed 16443634 words, keeping 156 word types\n",
      "I1125 12:20:43.916804 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2260000, processed 16515910 words, keeping 156 word types\n",
      "I1125 12:20:43.929078 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2270000, processed 16589201 words, keeping 156 word types\n",
      "I1125 12:20:43.941721 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2280000, processed 16662392 words, keeping 156 word types\n",
      "I1125 12:20:43.953752 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2290000, processed 16735763 words, keeping 156 word types\n",
      "I1125 12:20:43.964156 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2300000, processed 16796237 words, keeping 156 word types\n",
      "I1125 12:20:43.976092 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2310000, processed 16864159 words, keeping 156 word types\n",
      "I1125 12:20:43.988827 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2320000, processed 16938781 words, keeping 156 word types\n",
      "I1125 12:20:44.001074 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2330000, processed 17012440 words, keeping 156 word types\n",
      "I1125 12:20:44.013246 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2340000, processed 17085871 words, keeping 156 word types\n",
      "I1125 12:20:44.024502 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2350000, processed 17159769 words, keeping 156 word types\n",
      "I1125 12:20:44.036636 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2360000, processed 17232780 words, keeping 157 word types\n",
      "I1125 12:20:44.049000 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2370000, processed 17307589 words, keeping 157 word types\n",
      "I1125 12:20:44.060250 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2380000, processed 17380473 words, keeping 157 word types\n",
      "I1125 12:20:44.071340 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2390000, processed 17453059 words, keeping 157 word types\n",
      "I1125 12:20:44.082285 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2400000, processed 17525573 words, keeping 157 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:44.093861 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2410000, processed 17597117 words, keeping 157 word types\n",
      "I1125 12:20:44.104904 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2420000, processed 17669684 words, keeping 157 word types\n",
      "I1125 12:20:44.116063 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2430000, processed 17744351 words, keeping 157 word types\n",
      "I1125 12:20:44.127340 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2440000, processed 17817866 words, keeping 157 word types\n",
      "I1125 12:20:44.138120 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2450000, processed 17891897 words, keeping 157 word types\n",
      "I1125 12:20:44.149572 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2460000, processed 17966457 words, keeping 157 word types\n",
      "I1125 12:20:44.160852 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2470000, processed 18039770 words, keeping 157 word types\n",
      "I1125 12:20:44.171925 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2480000, processed 18113749 words, keeping 159 word types\n",
      "I1125 12:20:44.183193 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2490000, processed 18187607 words, keeping 163 word types\n",
      "I1125 12:20:44.194270 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2500000, processed 18260827 words, keeping 163 word types\n",
      "I1125 12:20:44.204910 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2510000, processed 18331982 words, keeping 163 word types\n",
      "I1125 12:20:44.217822 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2520000, processed 18404841 words, keeping 163 word types\n",
      "I1125 12:20:44.230117 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2530000, processed 18479245 words, keeping 163 word types\n",
      "I1125 12:20:44.242176 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2540000, processed 18552916 words, keeping 163 word types\n",
      "I1125 12:20:44.254266 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2550000, processed 18625934 words, keeping 163 word types\n",
      "I1125 12:20:44.264989 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2560000, processed 18699486 words, keeping 163 word types\n",
      "I1125 12:20:44.276676 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2570000, processed 18772726 words, keeping 163 word types\n",
      "I1125 12:20:44.288596 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2580000, processed 18846165 words, keeping 163 word types\n",
      "I1125 12:20:44.299479 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2590000, processed 18918402 words, keeping 163 word types\n",
      "I1125 12:20:44.311805 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2600000, processed 18992565 words, keeping 163 word types\n",
      "I1125 12:20:44.322536 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2610000, processed 19065971 words, keeping 163 word types\n",
      "I1125 12:20:44.334148 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2620000, processed 19139598 words, keeping 164 word types\n",
      "I1125 12:20:44.345653 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2630000, processed 19212921 words, keeping 164 word types\n",
      "I1125 12:20:44.356377 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2640000, processed 19285251 words, keeping 164 word types\n",
      "I1125 12:20:44.367861 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2650000, processed 19359588 words, keeping 165 word types\n",
      "I1125 12:20:44.379347 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2660000, processed 19433141 words, keeping 165 word types\n",
      "I1125 12:20:44.390704 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2670000, processed 19505552 words, keeping 165 word types\n",
      "I1125 12:20:44.402117 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2680000, processed 19579429 words, keeping 165 word types\n",
      "I1125 12:20:44.413414 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2690000, processed 19652432 words, keeping 165 word types\n",
      "I1125 12:20:44.424847 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2700000, processed 19726327 words, keeping 165 word types\n",
      "I1125 12:20:44.435573 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2710000, processed 19798551 words, keeping 165 word types\n",
      "I1125 12:20:44.447105 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2720000, processed 19872028 words, keeping 165 word types\n",
      "I1125 12:20:44.458166 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2730000, processed 19944854 words, keeping 165 word types\n",
      "I1125 12:20:44.469195 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2740000, processed 20017442 words, keeping 165 word types\n",
      "I1125 12:20:44.480105 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2750000, processed 20089484 words, keeping 165 word types\n",
      "I1125 12:20:44.490718 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2760000, processed 20162306 words, keeping 165 word types\n",
      "I1125 12:20:44.501929 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2770000, processed 20234987 words, keeping 165 word types\n",
      "I1125 12:20:44.512779 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2780000, processed 20308446 words, keeping 165 word types\n",
      "I1125 12:20:44.523672 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2790000, processed 20380474 words, keeping 165 word types\n",
      "I1125 12:20:44.535073 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2800000, processed 20453498 words, keeping 165 word types\n",
      "I1125 12:20:44.546285 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2810000, processed 20526125 words, keeping 165 word types\n",
      "I1125 12:20:44.557526 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2820000, processed 20600151 words, keeping 165 word types\n",
      "I1125 12:20:44.568446 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2830000, processed 20673734 words, keeping 165 word types\n",
      "I1125 12:20:44.579595 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2840000, processed 20745751 words, keeping 165 word types\n",
      "I1125 12:20:44.590931 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2850000, processed 20819069 words, keeping 165 word types\n",
      "I1125 12:20:44.601580 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2860000, processed 20893154 words, keeping 165 word types\n",
      "I1125 12:20:44.613264 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2870000, processed 20967894 words, keeping 165 word types\n",
      "I1125 12:20:44.626584 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2880000, processed 21043231 words, keeping 166 word types\n",
      "I1125 12:20:44.638825 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2890000, processed 21117834 words, keeping 166 word types\n",
      "I1125 12:20:44.650708 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2900000, processed 21188259 words, keeping 166 word types\n",
      "I1125 12:20:44.662907 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2910000, processed 21260058 words, keeping 166 word types\n",
      "I1125 12:20:44.673297 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2920000, processed 21330481 words, keeping 166 word types\n",
      "I1125 12:20:44.685814 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2930000, processed 21400395 words, keeping 166 word types\n",
      "I1125 12:20:44.697605 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2940000, processed 21472970 words, keeping 166 word types\n",
      "I1125 12:20:44.708349 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2950000, processed 21543827 words, keeping 166 word types\n",
      "I1125 12:20:44.719816 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2960000, processed 21617121 words, keeping 166 word types\n",
      "I1125 12:20:44.730792 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2970000, processed 21690837 words, keeping 166 word types\n",
      "I1125 12:20:44.741767 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2980000, processed 21763290 words, keeping 166 word types\n",
      "I1125 12:20:44.753033 140212937652032 word2vec.py:1573] PROGRESS: at sentence #2990000, processed 21836710 words, keeping 166 word types\n",
      "I1125 12:20:44.764145 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3000000, processed 21910557 words, keeping 166 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:44.775125 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3010000, processed 21982516 words, keeping 166 word types\n",
      "I1125 12:20:44.786056 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3020000, processed 22054686 words, keeping 166 word types\n",
      "I1125 12:20:44.798033 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3030000, processed 22128062 words, keeping 166 word types\n",
      "I1125 12:20:44.808505 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3040000, processed 22200235 words, keeping 166 word types\n",
      "I1125 12:20:44.820226 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3050000, processed 22271359 words, keeping 166 word types\n",
      "I1125 12:20:44.831480 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3060000, processed 22344011 words, keeping 166 word types\n",
      "I1125 12:20:44.844700 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3070000, processed 22417791 words, keeping 166 word types\n",
      "I1125 12:20:44.855623 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3080000, processed 22491456 words, keeping 166 word types\n",
      "I1125 12:20:44.867049 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3090000, processed 22564245 words, keeping 166 word types\n",
      "I1125 12:20:44.880262 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3100000, processed 22637280 words, keeping 166 word types\n",
      "I1125 12:20:44.892363 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3110000, processed 22713433 words, keeping 166 word types\n",
      "I1125 12:20:44.904748 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3120000, processed 22790820 words, keeping 166 word types\n",
      "I1125 12:20:44.916846 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3130000, processed 22865221 words, keeping 166 word types\n",
      "I1125 12:20:44.927932 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3140000, processed 22941459 words, keeping 166 word types\n",
      "I1125 12:20:44.941887 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3150000, processed 23017603 words, keeping 166 word types\n",
      "I1125 12:20:44.952642 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3160000, processed 23091816 words, keeping 166 word types\n",
      "I1125 12:20:44.964648 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3170000, processed 23166378 words, keeping 166 word types\n",
      "I1125 12:20:44.976581 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3180000, processed 23241205 words, keeping 166 word types\n",
      "I1125 12:20:44.988175 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3190000, processed 23316067 words, keeping 166 word types\n",
      "I1125 12:20:44.999485 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3200000, processed 23389451 words, keeping 166 word types\n",
      "I1125 12:20:45.010767 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3210000, processed 23463679 words, keeping 168 word types\n",
      "I1125 12:20:45.022596 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3220000, processed 23537187 words, keeping 168 word types\n",
      "I1125 12:20:45.034117 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3230000, processed 23611883 words, keeping 168 word types\n",
      "I1125 12:20:45.045449 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3240000, processed 23685008 words, keeping 168 word types\n",
      "I1125 12:20:45.056953 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3250000, processed 23758238 words, keeping 168 word types\n",
      "I1125 12:20:45.068179 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3260000, processed 23831525 words, keeping 168 word types\n",
      "I1125 12:20:45.079846 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3270000, processed 23906687 words, keeping 168 word types\n",
      "I1125 12:20:45.091346 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3280000, processed 23982448 words, keeping 168 word types\n",
      "I1125 12:20:45.102902 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3290000, processed 24057226 words, keeping 168 word types\n",
      "I1125 12:20:45.114353 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3300000, processed 24131636 words, keeping 168 word types\n",
      "I1125 12:20:45.125512 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3310000, processed 24205441 words, keeping 168 word types\n",
      "I1125 12:20:45.136865 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3320000, processed 24279474 words, keeping 168 word types\n",
      "I1125 12:20:45.147945 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3330000, processed 24354865 words, keeping 168 word types\n",
      "I1125 12:20:45.159491 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3340000, processed 24429180 words, keeping 168 word types\n",
      "I1125 12:20:45.171369 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3350000, processed 24505645 words, keeping 168 word types\n",
      "I1125 12:20:45.182733 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3360000, processed 24580969 words, keeping 168 word types\n",
      "I1125 12:20:45.194362 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3370000, processed 24653861 words, keeping 168 word types\n",
      "I1125 12:20:45.206305 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3380000, processed 24724104 words, keeping 168 word types\n",
      "I1125 12:20:45.218410 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3390000, processed 24794382 words, keeping 168 word types\n",
      "I1125 12:20:45.230533 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3400000, processed 24865751 words, keeping 169 word types\n",
      "I1125 12:20:45.242823 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3410000, processed 24937728 words, keeping 169 word types\n",
      "I1125 12:20:45.255107 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3420000, processed 25009204 words, keeping 169 word types\n",
      "I1125 12:20:45.267175 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3430000, processed 25081603 words, keeping 169 word types\n",
      "I1125 12:20:45.277761 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3440000, processed 25152023 words, keeping 169 word types\n",
      "I1125 12:20:45.289435 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3450000, processed 25223519 words, keeping 169 word types\n",
      "I1125 12:20:45.300701 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3460000, processed 25294776 words, keeping 169 word types\n",
      "I1125 12:20:45.311500 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3470000, processed 25365950 words, keeping 169 word types\n",
      "I1125 12:20:45.323076 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3480000, processed 25438679 words, keeping 169 word types\n",
      "I1125 12:20:45.334835 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3490000, processed 25513370 words, keeping 169 word types\n",
      "I1125 12:20:45.346345 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3500000, processed 25589466 words, keeping 170 word types\n",
      "I1125 12:20:45.357627 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3510000, processed 25663679 words, keeping 170 word types\n",
      "I1125 12:20:45.369537 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3520000, processed 25739746 words, keeping 170 word types\n",
      "I1125 12:20:45.381270 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3530000, processed 25817229 words, keeping 170 word types\n",
      "I1125 12:20:45.392943 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3540000, processed 25891872 words, keeping 170 word types\n",
      "I1125 12:20:45.404294 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3550000, processed 25963373 words, keeping 170 word types\n",
      "I1125 12:20:45.415066 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3560000, processed 26036851 words, keeping 170 word types\n",
      "I1125 12:20:45.426810 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3570000, processed 26109463 words, keeping 170 word types\n",
      "I1125 12:20:45.437886 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3580000, processed 26182388 words, keeping 170 word types\n",
      "I1125 12:20:45.449290 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3590000, processed 26256630 words, keeping 170 word types\n",
      "I1125 12:20:45.460507 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3600000, processed 26329595 words, keeping 171 word types\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:20:45.471991 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3610000, processed 26402073 words, keeping 171 word types\n",
      "I1125 12:20:45.482738 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3620000, processed 26473946 words, keeping 171 word types\n",
      "I1125 12:20:45.494526 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3630000, processed 26547744 words, keeping 171 word types\n",
      "I1125 12:20:45.505574 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3640000, processed 26621972 words, keeping 171 word types\n",
      "I1125 12:20:45.517083 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3650000, processed 26694383 words, keeping 197 word types\n",
      "I1125 12:20:45.528493 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3660000, processed 26767861 words, keeping 197 word types\n",
      "I1125 12:20:45.539967 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3670000, processed 26840882 words, keeping 197 word types\n",
      "I1125 12:20:45.551565 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3680000, processed 26916067 words, keeping 197 word types\n",
      "I1125 12:20:45.562272 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3690000, processed 26988144 words, keeping 197 word types\n",
      "I1125 12:20:45.573948 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3700000, processed 27061233 words, keeping 197 word types\n",
      "I1125 12:20:45.585377 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3710000, processed 27134831 words, keeping 197 word types\n",
      "I1125 12:20:45.596808 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3720000, processed 27209301 words, keeping 197 word types\n",
      "I1125 12:20:45.608346 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3730000, processed 27282892 words, keeping 197 word types\n",
      "I1125 12:20:45.619674 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3740000, processed 27355036 words, keeping 220 word types\n",
      "I1125 12:20:45.631172 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3750000, processed 27428332 words, keeping 220 word types\n",
      "I1125 12:20:45.642654 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3760000, processed 27502599 words, keeping 220 word types\n",
      "I1125 12:20:45.653576 140212937652032 word2vec.py:1573] PROGRESS: at sentence #3770000, processed 27575749 words, keeping 220 word types\n",
      "I1125 12:20:45.655465 140212937652032 word2vec.py:1596] collected 220 word types from a corpus of 27583125 raw words and 3770998 sentences\n",
      "I1125 12:20:45.656236 140212937652032 word2vec.py:1647] Loading a fresh vocabulary\n",
      "I1125 12:20:45.657412 140212937652032 word2vec.py:1671] effective_min_count=2 retains 143 unique words (65% of original 220, drops 77)\n",
      "I1125 12:20:45.659670 140212937652032 word2vec.py:1677] effective_min_count=2 leaves 27583048 word corpus (99% of original 27583125, drops 77)\n",
      "I1125 12:20:45.660976 140212937652032 word2vec.py:1736] deleting the raw counts dictionary of 220 items\n",
      "I1125 12:20:45.661749 140212937652032 word2vec.py:1739] sample=0.001 downsamples 28 most-common words\n",
      "I1125 12:20:45.662745 140212937652032 word2vec.py:1742] downsampling leaves estimated 5290172 word corpus (19.2% of prior 27583048)\n",
      "I1125 12:20:45.663817 140212937652032 base_any2vec.py:1022] estimated required memory for 143 words and 300 dimensions: 414700 bytes\n",
      "I1125 12:20:45.664678 140212937652032 word2vec.py:1888] resetting layer weights\n",
      "I1125 12:20:45.669688 140212937652032 base_any2vec.py:1210] training model with 3 workers on 143 vocabulary and 300 features, using sg=0 hs=0 sample=0.001 negative=5 window=5\n",
      "I1125 12:20:46.684995 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 9.48% examples, 498278 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:47.688714 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 19.11% examples, 501343 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:48.695674 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 28.90% examples, 503375 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:20:49.699858 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 38.60% examples, 504487 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:50.700658 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 48.19% examples, 504973 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:51.701159 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 57.78% examples, 505872 words/s, in_qsize 6, out_qsize 2\n",
      "I1125 12:20:52.718049 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 67.39% examples, 505264 words/s, in_qsize 6, out_qsize 4\n",
      "I1125 12:20:53.721605 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 77.10% examples, 506457 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:54.725975 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 86.73% examples, 506644 words/s, in_qsize 6, out_qsize 1\n",
      "I1125 12:20:55.727686 140212937652032 base_any2vec.py:1305] EPOCH 1 - PROGRESS: at 96.27% examples, 507437 words/s, in_qsize 5, out_qsize 1\n",
      "I1125 12:20:56.100297 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 2 more threads\n",
      "I1125 12:20:56.101588 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 1 more threads\n",
      "I1125 12:20:56.102999 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 0 more threads\n",
      "I1125 12:20:56.103708 140212937652032 base_any2vec.py:1346] EPOCH - 1 : training on 27583125 raw words (5293574 effective words) took 10.4s, 508062 effective words/s\n",
      "I1125 12:20:57.120986 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 9.48% examples, 493827 words/s, in_qsize 5, out_qsize 4\n",
      "I1125 12:20:58.123125 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 19.14% examples, 500750 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:20:59.124814 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 28.75% examples, 500405 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:00.128056 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 38.45% examples, 502052 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:01.129045 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 47.93% examples, 501880 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:02.132493 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 57.67% examples, 504346 words/s, in_qsize 4, out_qsize 1\n",
      "I1125 12:21:03.134583 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 67.65% examples, 507791 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:04.139108 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 77.40% examples, 508881 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:05.139877 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 87.11% examples, 509311 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:06.142470 140212937652032 base_any2vec.py:1305] EPOCH 2 - PROGRESS: at 96.88% examples, 510992 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:06.457935 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 2 more threads\n",
      "I1125 12:21:06.460024 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 1 more threads\n",
      "I1125 12:21:06.460958 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 0 more threads\n",
      "I1125 12:21:06.461751 140212937652032 base_any2vec.py:1346] EPOCH - 2 : training on 27583125 raw words (5289764 effective words) took 10.3s, 511159 effective words/s\n",
      "I1125 12:21:07.473149 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 9.62% examples, 504684 words/s, in_qsize 4, out_qsize 1\n",
      "I1125 12:21:08.475534 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 19.18% examples, 503496 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:09.475552 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 28.72% examples, 501392 words/s, in_qsize 4, out_qsize 1\n",
      "I1125 12:21:10.479632 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 38.13% examples, 498906 words/s, in_qsize 4, out_qsize 1\n",
      "I1125 12:21:11.481105 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 47.93% examples, 502897 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:12.485121 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 57.56% examples, 503958 words/s, in_qsize 5, out_qsize 0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "I1125 12:21:13.486258 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 67.17% examples, 504944 words/s, in_qsize 6, out_qsize 1\n",
      "I1125 12:21:14.487562 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 76.76% examples, 505778 words/s, in_qsize 4, out_qsize 1\n",
      "I1125 12:21:15.489860 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 86.48% examples, 506546 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:16.490332 140212937652032 base_any2vec.py:1305] EPOCH 3 - PROGRESS: at 96.05% examples, 507456 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:16.888845 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 2 more threads\n",
      "I1125 12:21:16.890238 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 1 more threads\n",
      "I1125 12:21:16.891412 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 0 more threads\n",
      "I1125 12:21:16.892128 140212937652032 base_any2vec.py:1346] EPOCH - 3 : training on 27583125 raw words (5293258 effective words) took 10.4s, 507962 effective words/s\n",
      "I1125 12:21:17.904167 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 9.40% examples, 492618 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:18.909726 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 18.89% examples, 494274 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:19.912301 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 28.68% examples, 499117 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:20.912518 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 38.27% examples, 500048 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:21.918819 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 47.86% examples, 501058 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:22.921990 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 57.34% examples, 501213 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:23.927048 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 66.93% examples, 501963 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:24.933075 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 76.47% examples, 502404 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:25.934112 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 86.09% examples, 503110 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:26.937292 140212937652032 base_any2vec.py:1305] EPOCH 4 - PROGRESS: at 95.50% examples, 503482 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:27.393221 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 2 more threads\n",
      "I1125 12:21:27.395107 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 1 more threads\n",
      "I1125 12:21:27.396678 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 0 more threads\n",
      "I1125 12:21:27.397421 140212937652032 base_any2vec.py:1346] EPOCH - 4 : training on 27583125 raw words (5290540 effective words) took 10.5s, 504082 effective words/s\n",
      "I1125 12:21:28.409975 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 9.51% examples, 499678 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:29.412084 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 19.07% examples, 499963 words/s, in_qsize 6, out_qsize 1\n",
      "I1125 12:21:30.415696 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 28.90% examples, 503770 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:31.416003 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 38.56% examples, 504310 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:32.417714 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 48.11% examples, 504397 words/s, in_qsize 6, out_qsize 0\n",
      "I1125 12:21:33.420354 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 57.78% examples, 505721 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:34.427399 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 67.39% examples, 505868 words/s, in_qsize 5, out_qsize 1\n",
      "I1125 12:21:35.431286 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 76.95% examples, 505950 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:36.435132 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 86.30% examples, 504556 words/s, in_qsize 5, out_qsize 1\n",
      "I1125 12:21:37.438418 140212937652032 base_any2vec.py:1305] EPOCH 5 - PROGRESS: at 95.90% examples, 505718 words/s, in_qsize 5, out_qsize 0\n",
      "I1125 12:21:37.851847 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 2 more threads\n",
      "I1125 12:21:37.853389 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 1 more threads\n",
      "I1125 12:21:37.854207 140212937652032 base_any2vec.py:349] worker thread finished; awaiting finish of 0 more threads\n",
      "I1125 12:21:37.854849 140212937652032 base_any2vec.py:1346] EPOCH - 5 : training on 27583125 raw words (5288695 effective words) took 10.4s, 506215 effective words/s\n",
      "I1125 12:21:37.855562 140212937652032 base_any2vec.py:1382] training on a 137915625 raw words (26455831 effective words) took 52.2s, 506962 effective words/s\n"
     ]
    }
   ],
   "source": [
    "# Word2Vec model training code\n",
    "#def word2vec_cos()\n",
    "#comb_abs = (\".\").join(metdatfn[\"abstract\"])\n",
    "#len(comb_abs)\n",
    "#abs_words = conv_word(comb_abs)\n",
    "word2vec_md = Word2Vec(abs_words, size = 300, min_count=2)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "39576807"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(comb_abs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3770998"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(abs_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [],
   "source": [
    "qa_dt_v2 = wrd2vec_cos(word2vec_md, qa_dt_v2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 70 entries, 0 to 69\n",
      "Data columns (total 5 columns):\n",
      "brt_sha         70 non-null object\n",
      "brt_ans         70 non-null object\n",
      "brt_conf        70 non-null float64\n",
      "brt_abst        70 non-null object\n",
      "brt_question    70 non-null object\n",
      "dtypes: float64(1), object(4)\n",
      "memory usage: 2.9+ KB\n"
     ]
    }
   ],
   "source": [
    "df_ans_v2.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 23 entries, 0 to 22\n",
      "Data columns (total 7 columns):\n",
      "Task                     23 non-null object\n",
      "Questions                23 non-null object\n",
      "Reference Answers        23 non-null object\n",
      "prp_qa                   23 non-null object\n",
      "Model_Sum_Answer         23 non-null object\n",
      "Sum_Reference_answers    23 non-null object\n",
      "similarity_score         23 non-null float64\n",
      "dtypes: float64(1), object(6)\n",
      "memory usage: 1.4+ KB\n"
     ]
    }
   ],
   "source": [
    "qa_dt_v2.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 22:11:52.155535 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,8))\n",
    "ticks = ['Total number of model spans based summaries', 'Total Questions']\n",
    "plt.bar(np.arange(2), [len(qa_dt_v2[qa_dt_v2['Model_Sum_Answer'] != ''].index), len(qa_dt_v2['Questions'].index)], color = ['blue', 'green'])\n",
    "plt.xticks(np.arange(2), ticks)\n",
    "plt.xlabel('Comparison of number of model spans based summaries and Questions')\n",
    "plt.ylabel('Count')\n",
    "plt.legend(loc = 'Best')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It can be seen from above graph that the proposed model was able to generate summaries for 19 out of 23 questions."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 22:54:37.663835 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,8))\n",
    "ticks = ['Similarity score > 0.95', 'Similarity score <= 0.95']\n",
    "plt.bar(np.arange(2), [len(qa_dt_v2[qa_dt_v2['similarity_score'] > 0.95].index), len(qa_dt_v2[qa_dt_v2['similarity_score'] <= 0.95].index)], color = ['blue', 'green'])\n",
    "plt.xticks(np.arange(2), ticks)\n",
    "plt.xlabel('Similarity score distribution')\n",
    "plt.ylabel('Count')\n",
    "plt.legend(loc = 'Best')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It can be seem from the above plot that for 18 of the 23 questions, the similarity score between the model answer span based summaries and reference answer summaries of above 0.95 was achieved.  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "metadata": {},
   "outputs": [],
   "source": [
    "comb_ms = (\".\").join(qa_dt_v2[\"Model_Sum_Answer\"])\n",
    "#len(comb_abs)\n",
    "ms_words = conv_word(comb_ms)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 182,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 23:31:58.122776 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fe5b6fae6d8>"
      ]
     },
     "execution_count": 182,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plotting 15 most commonly used words in the model answer span based summaries along with their frequency\n",
    "plot_word_frequency(ms_words, 'Frequency', 'Model summary Words', 15)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The above plot shows that some of the most commonly mentioned words in the model answer span based summaries include 'infection', 'transmission', 'patients', 'health', 'incubation', 'period', 'risk', 'heart', 'covid-19'. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 180,
   "metadata": {},
   "outputs": [],
   "source": [
    "comb_rs = (\".\").join(qa_dt_v2[\"Sum_Reference_answers\"])\n",
    "#len(comb_abs)\n",
    "rs_words = conv_word(comb_rs)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 183,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "W1122 23:33:57.266725 140627866560320 legend.py:1289] No handles with labels found to put in legend.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fe5b6fba978>"
      ]
     },
     "execution_count": 183,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAwQAAAJQCAYAAAAwk6O3AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDMuMC4zLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvnQurowAAIABJREFUeJzs3WmYZVV97/HvTxpthKabSaKiNgKCgNBIizIpUWKclUGIwQG40I9TcLhmMHiJSTSgcB2IY8tVEDEqIIpgGOQKKEikG7obMCQYwStiIs0gIDP874uzyxzK6qrT3XXOqar9/TzPeWqftdde+7/rVf1q7bV3qgpJkiRJ7fS4YRcgSZIkaXgMBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcVmDbuAttl0001r/vz5wy5DkiRJM9zSpUtXVtVmE/UzEAzY/PnzWbJkybDLkCRJ0gyX5Oe99POWIUmSJKnFDASSJElSi3nL0IA9fOvt3PrZrwy7DEmSJPXZZm9747BL6ImBQJIkSZriHnroIW6++Wbuv//+39s3e/ZstthiC9Zdd901GttAIEmSJE1xN998M3PmzGH+/Pkk+V17VXHbbbdx8803s+WWW67R2K4hkCRJkqa4+++/n0022eQxYQAgCZtsssmYMwe9MhBIkiRJ08DoMDBRe68MBJIkSVKLGQgkSZKkFjMQSJIkSdNAVa1We68MBJIkSdIUN3v2bG677bbf++N/5ClDs2fPXuOxfeyoJEmSNMVtscUW3Hzzzdx6662/t2/kPQRrykAgSZIkTXHrrrvuGr9nYCKtu2Uoyd8l2XeM9n2SnLOKY96Z5KdJKsmmXe0bJTkryYokP06yYz9rlyRJkiZb6wJBVR1TVd9bzcMuA/YFfj6q/a+BZVW1E/Bm4JOTUKIkSZI0MNMuECR5c/Mf+eVJTk3yjCQXNW0XJXl6krlJbkryuOaYJyb5RZJ1k5yc5MCm/WVJrk/yQ2D/VZ2zqq6uqpvG2LU9cFHT53pgfpLNJ/2iJUmSpD6ZVoEgyQ7A0cCLq2pn4F3Ap4AvN/+lPw04sap+AywHXtQc+mrg/Kp6qGus2cAXmn17A3+wBiUtpwkSSXYDngH83oqOJIuSLEmy5LZ77lqD00iSJEn9Ma0CAfBi4IyqWglQVbcDuwNfbfafCuzVbH8dOLjZ/pPme7ftgBur6obqPL/pK2tQz3HARkmWAX8GXA08PLpTVS2uqoVVtXCTDTZcg9NIkiRJ/THdnjIUYKI3L4zsPxs4NsnGwK7A/x2n72NPkpwPbA4sqaojVnmiqruAw5pjAtzYfCRJkqRpYbrNEFwEHJRkE4Dmj/3L6cwAABwC/BCgqu4Bfkxnoe85VfXIqLGuB7ZMslXz/Q0jO6rqj6tqwXhhoDn/vCSPb74eAVzahARJkiRpWphWgaCqrgM+DFySZDnwMeAo4LAkK4A30VlXMOLrwBv5/duFqKr7gUXAuc2i4tFPEPqdJEcluZnO+oAVSU5qdj0buC7J9cDLR51bkiRJmvIy+vXH6q8Fz3hmXfhXfzfsMiRJktRnm73tjUM9f5KlVbVwon7TaoZAkiRJ0uQyEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBabNewC2mbWZhsP/a11kiRJ0ghnCCRJkqQWMxBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiPnZ0wB769S+45dPvHXYZkjTtPOUdHxt2CZI0IzlDIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQPBBJJ8N8m8cfbflGTTQdYkSZIkTZZZwy5gKksS4FVV9eiwa5EkSZL6wRmCUZLMT/KvST4DXAU8kmTTJOsnOTfJ8iTXJjl41HHrJTkvyZHDqVySJElafc4QjG1b4LCqenuSm5q2lwG3VNUrAZLM7eq/AfA14MtV9eWBVipJkiStBWcIxvbzqrpiVNs1wL5JPpJk76r6Tde+bwNfWlUYSLIoyZIkS267575+1SxJkiStNgPB2H47uqGq/h3YlU4wODbJMV27LwNe3qw5+D1VtbiqFlbVwk02WK8vBUuSJElrwkDQoyRPAe6tqq8AJwDP7dp9DHAb8Jlh1CZJkiStKQNB754D/DjJMuBo4EOj9r8bmJ3kowOvTJIkSVpDLioepapuAnbs+j6/2Ty/+YzuP7/r62F9LE2SJEmadM4QSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS3mm4oHbN0nPY2nvONjwy5DkiRJApwhkCRJklrNQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUov52NEB++2tP+VHi1817DIkqWe7Lzpn2CVIkvrIGQJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCBpJnpLkjGHXIUmSJA2SgaBRVbdU1YGj25PMGkY9kiRJ0iC0MhAk+UiSt3d9/2CS/5nk2ub7oUlOT/Id4IIk+yQ5p6v/p5Ic2mwfl+QnSVYkOWHQ1yJJkiStjVYGAuBrwMFd3w8CrhzVZ3fgLVX14lUNkmRjYD9gh6raCfjQZBcqSZIk9VMrA0FVXQ08qVk3sDNwB/D/RnW7sKpun2Cou4D7gZOS7A/cO1anJIuSLEmy5I57Hlzb8iVJkqRJ08pA0DgDOJDOTMHXxtj/267th3ns72o2QFU9DOwGnAm8DjhvrBNV1eKqWlhVCzfa4PGTULokSZI0Odq8YPZrwBeATYEXAU8Yp+/Pge2TPIFOGHgJ8MMkGwBPrKrvJrkC+Gmfa5YkSZImVWsDQVVdl2QO8Muq+lWS+eP0/UWSbwArgBuAq5tdc4BvJ5kNBHhPf6uWJEmSJldrAwFAVT2na/smYMdm+2Tg5FF9/wL4izGG2a1vBUqSJEl91uY1BJIkSVLrGQgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLtfpNxcOw/mZbs/uic4ZdhiRJkgQ4QyBJkiS1moFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLeZ7CAbsjpU3cMaXXjbsMiSpZwcedt6wS5Ak9ZEzBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQAEnmJ/nTtTj+0CRPmcyaJEmSpEEwEHTMB9Y4EACHAgYCSZIkTTszIhAkeXOSFUmWJzk1yTOSXNS0XZTk6U2/k5OcmOTyJD9LcmAzxHHA3kmWJXlPM2PwgyRXNZ89us71F0muac51XDPGQuC05vj1Bv8bkCRJktbMrGEXsLaS7AAcDexZVSuTbAycAny5qk5JcjhwIvC65pAnA3sB2wFnA2cAfwW8r6pe1Yz5ROCPqur+JNsA/wQsTPLyZpznV9W9STauqtuTvLM5fskqalwELALYdJPZ/fg1SJIkSWtkJswQvBg4o6pWAlTV7cDuwFeb/afSCQAjvlVVj1bVT4DNVzHmusAXklwDnA5s37TvC3ypqu7tOteEqmpxVS2sqoUbbvD41bg0SZIkqb+m/QwBEKAm6NO9/4FRx47lPcB/ATvTCU33r8a5JEmSpGljJswQXAQclGQTgOaWocuBP2n2HwL8cIIx7gbmdH2fC/yqqh4F3gSs07RfABze3FI0cq6xjpckSZKmhWk/Q1BV1yX5MHBJkkeAq4GjgC8m+XPgVuCwCYZZATycZDlwMvAZ4Mwkrwe+D/y2Odd5SRYAS5I8CHwX+OvmmM8luQ/Yvarum+TLlCRJkvoiVd4BM0hbzZ9bH/mb3YddhiT17MDDzht2CZKkNZBkaVUtnKjfTLhlSJIkSdIaMhBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWmzXsAtpmo0238a2fkiRJmjKcIZAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKL+djRAfv17Tdw4ml/POwyJKlnRx1y/rBLkCT1kTMEkiRJUosZCCRJkqQWMxBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWMxCspiSHJvnUsOuQJEmSJoOBQJIkSWqxGRcIksxPcn2SU5KsSHJGkicm2TXJJUmWJjk/yZOb/guSXNH0PSvJRk37xUk+keTyJNcm2W2Mc22W5MwkVzafPQd9vZIkSdLamHGBoLEtsLiqdgLuAt4B/CNwYFXtCnwR+HDT98vAXzZ9rwH+pmuc9atqD+DtzTGjfRL4eFU9DzgAOGmsYpIsSrIkyZJ77npw7a9OkiRJmiSzhl1An/yiqi5rtr8C/DWwI3BhEoB1gF8lmQvMq6pLmr6nAKd3jfNPAFV1aZINk8wbdZ59ge2bMQE2TDKnqu7u7lRVi4HFAE9/5tyajAuUJEmSJsNMDQSj/+i+G7iuqnbvbmwCweqMM/r744Ddq+q+1S9RkiRJGr6ZesvQ05OM/PH/BuAKYLORtiTrJtmhqn4D3JFk76bvm4BLusY5uOm/F/Cbpn+3C4B3jnxJsmDyL0WSJEnqn5k6Q/CvwFuSfB64gc76gfOBE5tZgVnAJ4DrgLcAn0vyROBnwGFd49yR5HJgQ+DwMc5zFPDpJCuaMS8F3tqfS5IkSZIm30wNBI9W1eg/zJcBLxzdsaqWAS9YxThnVtX7R/U/GTi52V5JM4sgSZIkTUcz9ZYhSZIkST2YcTMEVXUTnScKre04+6x1MZIkSdIU5wyBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLXYjHsPwVT3pI234ahDzh92GZIkSRLgDIEkSZLUagYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazMeODthNd97AYWe9bNhlSJomvrTfecMuQZI0wzlDIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFWh8IksxPcn2Sk5Jcm+S0JPsmuSzJDUl2az6XJ7m6+bltc+wPkizoGuuyJDsN72okSZKk1dP6QNDYGvgksBOwHfCnwF7A+4C/Bq4HXlhVuwDHAP/QHHcScChAkmcBT6iqFQOtXJIkSVoLBoKOG6vqmqp6FLgOuKiqCrgGmA/MBU5Pci3wcWCH5rjTgVclWRc4HDh5rMGTLEqyJMmS++96sL9XIkmSJK0GA0HHA13bj3Z9fxSYBfw98P2q2hF4NTAboKruBS4EXgscBHx1rMGranFVLayqhbM3fHx/rkCSJElaA7OGXcA0MRf4ZbN96Kh9JwHfAX5QVbcPsihJkiRpbTlD0JuPAscmuQxYp3tHVS0F7gK+NIzCJEmSpLXR+hmCqroJ2LHr+6Gr2PesrsP+18hGkqfQCVYX9LFMSZIkqS8mnCFIsn6SxzXbz0rymmYRbesleTPwL8DRzYJkSZIkaVrp5ZahS4HZSZ4KXAQcxiqeptM2VfXlqnpaVZ0+7FokSZKkNdFLIEjzNJ39gX+sqv2A7ftbliRJkqRB6CkQJNkdOAQ4t2lr/doDSZIkaSboJRC8G3g/cFZVXZfkmcD3+1uWJEmSpEGY8D/9VXUJcEnX958BR/WzKEmSJEmDscpAkOQ7QK1qf1W9pi8VSZIkSRqY8WYITmh+7g/8AfCV5vsbgJv6WJMkSZKkAVllIGhuFSLJ31fVC7t2fSfJpX2vTJIkSVLf9fK0oM2SPLNZO0CSLYHN+lvWzDV/3jZ8ab/zhl2GJEmSBPQWCN4DXJzkZ833+cCivlUkSZIkaWDGDQRJHgfcBWwDbNc0X19VD/S7MEmSJEn9N24gqKpHk/zvqtodWD6gmiRJkiQNSC8vJrsgyQFJ0vdqJEmSJA1UL2sI3gusDzyS5D4gQFXVhn2tTJIkSVLf9fKm4jmDKESSJEnS4PUyQ0CS1wAj7yK4uKrO6V9JM9sNd/6KV5z1oWGXIWma+O5+Hxh2CZKkGW7CNQRJjgPeBfyk+byraZMkSZI0zfUyQ/AKYEFVPQqQ5BTgauCv+lmYJEmSpP7r5SlDAPO6tuf2oxBJkiRJg9fLDMGxwNVJvk/nCUMvBN7f16okSZIkDUQvTxn6pyQXA8+jEwj+sqr+s9+FSZIkSeq/VQaCJN8GfghcDlxZVWcPrCpJkiRJAzHeGoIvABsBHwb+M8nlSY5Psl+SzQdTniRJkqR+WuUMQfOugXMAkqwD7ALsAxwPbAmsM4D6JEmSJPXRuGsIkmwK7NF8XgDMBr4H/Kj/pUmSJEnqt/HWENwA/AY4Ezgf+FBV3TOowiRJkiT133hrCL4I/BI4ADgSOCzJwub2oWklyaFJntL1/aQk26/hWPsk2WPyqpMkSZKGZ7w1BMeObCd5Fp3bho4E9k5ya1W9aAD1TZZDgWuBWwCq6oi1GGsf4B46T1+SJEmSprUJ31Sc5JnAbsDz6awj2Ay4u891TVTT/CTXJzklyYokZyR5YpJjklyZ5Noki9NxILAQOC3JsiTrJbk4ycJmrJcm+VGSq5KcnmSDpv2mJH/btF+TZLsk84G3Au9pxto7yeub8y1PcumwfieSJEnSmlhlIEhyVpJfAd8FXgIsBd5QVZtV1asGVeA4tgUWV9VOwF3A24FPVdXzqmpHYD3gVVV1BrAEOKSqFlTVfSMDNIumPwDsW1XPbfq9t+scK5v2zwLvq6qbgM8BH2/G+gFwDPDHVbUz8Jo+X7MkSZI0qcZ7ytCXgCOrauWgillNv6iqy5rtrwBHATcm+QvgicDGwHXAd8YZ4wXA9sBlSQAez2OfoPTN5udSYP9VjHEZcHKSb3T1f4wki4BFALM3mzv+VUmSJEkDNN4agqn+ZuIa4/tngIVV9YskH6TzmNTxBLiwqt6wiv0PND8fYRW/q6p6a5LnA68EliVZUFW3jeqzGFgMMHfrp46uW5IkSRqaCdcQTGFPT7J7s/0G4IfN9spmHcCBXX3vBuaMMcYVwJ5JtgZo1iE8a4LzPmasJFtV1b9U1THASuBpq38pkiRJ0nBM50Dwr8Bbkqygc3vQZ4EvANcA3wKu7Op7MvC5kUXFI41VdSudJxD9UzPOFcB2E5z3O8B+I4uKgeObRcfXApcCyyfj4iRJkqRBSNX4d7AkOZPOOwn+uaoeHUhVE2ie9nNOs3h4Wpm79VNrz+PfNuwyJE0T393vA8MuQZI0TSVZWlULJ+rXywzBZ4E/BW5IclySif6DLkmSJGmamDAQVNX3quoQ4LnATcCFSS5PcliSdftd4Cpqumk6zg5IkiRJU01PawiSbELnXvsjgKuBT9IJCBf2rTJJkiRJfTfeewgASPJNOgttTwVeXVW/anZ9PcmSfhYnSZIkqb/GDQRJHgcsq6oxX8rVyyIFSZIkSVPXuLcMNU8VevmAapEkSZI0YL2sIbggyQFJ0vdqJEmSJA3UhGsIgPcC6wMPJ7kfCFBVtWFfK5MkSZLUdxMGgqqaM4hCJEmSJA1eLzMEJNkI2AaYPdJWVZf2q6iZbJt5T/bNo5IkSZoyenns6BHAu4AtgGXAC4AfAS/ub2mSJEmS+q2XRcXvAp4H/Lyq/hDYBbi1r1VJkiRJGoheAsH9VXU/QJInVNX1wLb9LUuSJEnSIPSyhuDmJPOAbwEXJrkDuKW/ZUmSJEkahF6eMrRfs/nBJN8H5gLn9bUqSZIkSQPRyy1DJNkoyU7A3cDNwI59rUqSJEnSQPTylKG/Bw4FfgY82jQXPmVIkiRJmvZ6WUNwELBVVT3Y72La4IY7VvLKM08adhmSJnDuAUcMuwRJkgail1uGrgXm9bsQSZIkSYPXywzBscDVSa4FHhhprKrX9K0qSZIkSQPRSyA4BfgIcA3/vYZAkiRJ0gzQSyBYWVUn9r0SSZIkSQPXSyBYmuRY4Gwee8vQVX2rSpIkSdJA9BIIdml+vqCrzceOSpIkSTNAL28q/sNBFCJJkiRp8Hp5Mdk84M3A/O7+VXVU/8qSJEmSNAi93DL0XeAKfMqQJEmSNOP0EghmV9V7+17JakhyeVXtMUGfvYHPAQ8Bu1fVfasx/uuAf6+qn6xmXfdU1Qarc4wkSZI0TL28qfjUJEcmeXKSjUc+fa9sHBOFgcYhwAlVtWB1wkDjdcD2q1+ZJEmSNL30EggeBI4HfgQsbT5L+lnURJLc0/zcJ8nFSc5Icn2S09JxBHAQcEyS05q+f57kyiQrkvxt11hvbtqWJzk1yR7Aa4DjkyxLslXzOS/J0iQ/SLJdc+yWSX7UjPv3g/9NSJIkSWunl1uG3gtsXVUr+13MGtoF2AG4BbgM2LOqTkqyF3BOVZ2R5KXANsBuQICzk7wQuA04ujlmZZKNq+r2JGePHAuQ5CLgrVV1Q5LnA5+h89jVTwKfraovJ3nHYC9bkiRJWnu9BILrgHv7Xcha+HFV3QyQZBmdpyH9cFSflzafq5vvG9AJCDsDZ4yEnaq6ffTgSTYA9gBOTzLS/ITm557AAc32qcBHxiowySJgEcDsTYd6t5UkSZL0GL0EgkeAZUm+z2PfVDxVHjv6QNf2I4x9TQGOrarPP6YxOYrOS9bG8zjgzqpasIr9Ex1PVS0GFgPM3Wr+hP0lSZKkQellDcG3gA8Dl/PfawiW9rOoPjgfOLz5bz9JnprkScBFwEFJNmnaR/59fzcwB6Cq7gJuTPL6pk+S7Nz0uwz4k2b7kIFciSRJkjSJenlT8SmDKKSfquqCJM8GftTc9nMP8Maqui7Jh4FLkjxC55aiQ4GvAV9oZhAOpPPH/meTfABYt9m/HHgX8NUk7wLOHPBlSZIkSWstVePfwZLkRsa4LaaqntmvomayuVvNr70++oFhlyFpAucecMSwS5Akaa0kWVpVCyfq18sagu5BZgOvB1wZK0mSJM0AE64hqKrbuj6/rKpP0HnkpiRJkqRpbsIZgiTP7fr6ODozBnP6VpEkSZKkgenllqH/3bX9MHATnbcAS5IkSZrmennK0B8OohBJkiRJgzfhGoIk70qyYfP8/ZOSXJXkpYMoTpIkSVJ/9fJissObl3O9FHgScBhwXF+rkiRJkjQQvQSCND9fAXypqpZ3tUmSJEmaxnoJBEuTXEAnEJyfZA7waH/LkiRJkjQIvbyp+HHAAuBnVXVnkk2Ap1bVikEUONMsXLiwlixZMuwyJEmSNMNN2puKq+pR4Kqu77cBt61deZIkSZKmgl5uGZIkSZI0QxkIJEmSpBbrKRAk2SvJYc32Zkm27G9ZkiRJkgahlxeT/Q3wl8D7m6Z1ga/0syhJkiRJg9HLDMF+wGuA3wJU1S3AnH4WJUmSJGkwegkED1bn2aQFkGT9/pYkSZIkaVAmfOwo8I0knwfmJTkSOBz4Qn/Lmrl+esedvPqMbw67DEkT+M6B+w+7BEmSBqKX9xCckOSPgLuAbYFjqurCvlcmSZIkqe8mDATNE4V+MBICkqyXZH5V3dTv4iRJkiT1Vy9rCE4HHu36/kjTJkmSJGma6yUQzKqqB0e+NNuP719JkiRJkgall0Bwa5LXjHxJ8lpgZf9KkiRJkjQovTxl6K3AaUk+BQT4BfDmvlYlSZIkaSB6ecrQfwAvSLIBkKq6u/9lSZIkSRqEXp4y9ATgAGA+MCsJAFX1d32tTJIkSVLf9XLL0LeB3wBLgQf6W44kSZKkQeolEGxRVS/reyWSJEmSBq6XQHB5kudU1TV9r2YSJPkgcA+wIXBpVX1vuBVJkiRJU1cvgWAv4NAkN9K5ZShAVdVOfa1sLVXVMcOuQZIkSZrqenkPwcuBbYCXAq8GXtX8nDKSHJ3k35J8D9i2aTs5yYHN9nFJfpJkRZITmrbNkpyZ5Mrms2fTvluSy5Nc3fwcGW+HJD9OsqwZZ5um/Y1d7Z9Pss5QfgmSJEnSGpgwEFTVz4GnAS9utu/t5bhBSbIr8CfALsD+wPNG7d8Y2A/YoZnV+FCz65PAx6vqeXSeonRS03498MKq2gU4BviHpv2twCeragGwELg5ybOBg4E9m/ZHgEPGqHFRkiVJljx4128m6colSZKktdfLY0f/hs4fwNsCXwLWBb4C7Nnf0nq2N3BWVd0LkOTsUfvvAu4HTkpyLnBO074vsP3IY1SBDZPMAeYCpzQzAEXnegF+BBydZAvgm1V1Q5KXALsCVzbjrAf8enSBVbUYWAwwb6uta+0vWZIkSZocvawh2I/Of9+vAqiqW5o/nKeSVf6RXVUPJ9kNeAmdmYR3Ai+mM8uxe1Xd190/yT8C36+q/ZLMBy5uxvlqkn8BXgmcn+QIOuspTqmq90/6FUmSJEkD0MutPw9WVdH80Z1k/f6WtNouBfZLsl4TVB6zvqF5w/Lcqvou8G5gQbPrAjrhYKTfSPtc4JfN9qFd+58J/KyqTgTOBnYCLgIOTPKkps/GSZ4xuZcnSZIk9U8vgeAbST4PzEtyJPA94Av9Lat3VXUV8HVgGXAm8INRXeYA5yRZAVwCvKdpPwpY2CwQ/gmdNQIAHwWOTXIZ0L1A+GDg2iTLgO2AL1fVT4APABc0418IPHmyr1GSJEnql3T++T9Bp+SP6DxlKMD5VXVhvwubqeZttXXt/ZGPDrsMSRP4zoH7D7sESZLWSpKlVbVwon7jriFoHqF5flXtS+e/35IkSZJmkHFvGaqqR4B7k8wdUD2SJEmSBqiXpwzdD1yT5ELgtyONVXVU36qSJEmSNBC9BILyp4DiAAAbQ0lEQVRzm48kSZKkGWbCQFBVpyRZD3h6Vf3bAGqSJEmSNCATPnY0yavpPNLzvOb7gjHeBixJkiRpGurlPQQfBHYD7gSoqmXAln2sSZIkSdKA9BIIHq6q34xqm/jlBZIkSZKmvF4WFV+b5E+BdZJsQ+cNv5f3tyxJkiRJg9BLIPgz4GjgAeCrwPnAh/pZ1Ey29UbzfAOqJEmSpoxVBoIkp1bVm4Ajq+poOqFAkiRJ0gwy3hqCXZM8Azg8yUZJNu7+DKpASZIkSf0z3i1Dn6PzqNFnAleN2ldNuyRJkqRpbJUzBFV1YlU9G/hiVW056mMYkCRJkmaACR87WlVvS7JXksMAkmyaxPcQSJIkSTNAL28q/hvgL4H3N02PB77Sz6IkSZIkDUYvjx3dD9iFZh1BVd2SZE5fq5rB/uOOe9jvzB8OuwxJEzjrgL2GXYIkSQPRy5uKH6yqonk7cZL1+1uSJEmSpEHpJRB8I8nngXlJjgS+B5zU37IkSZIkDcKEtwxV1QlJ/gi4C9gWOKaqLux7ZZIkSZL6rpc1BDQB4EKAJOskOaSqTutrZZIkSZL6bpW3DCXZMMn7k3wqyUvT8U7gZ8BBgytRkiRJUr+MN0NwKnAH8CPgCODP6Txy9LVVtWwAtUmSJEnqs/ECwTOr6jkASU4CVgJPr6q7B1KZJEmSpL4b7ylDD41sVNUjwI2GAUmSJGlmGW+GYOckdzXbAdZrvgeoqtqw79VJkiRJ6qtVBoKqWmeQhUiSJEkavF5eTDZjJJmf5No+jLsgySsme1xJkiSp31oVCPohySxgAWAgkCRJ0rTT04vJZph1knwB2AP4JfBa4CnAp4HNgHuBI6vq+iSvBj5A53GrtwGHVNV/Jflgc8x8Ok9f2ovOGou9gGOr6uuDvSRJkiRpzbQxEGwDvKGqjkzyDeAA4DDgrVV1Q5LnA58BXgz8EHhBVVWSI4C/AP5nM86uwF5VdV+SQ4GFVfXOsU6YZBGwCGC9TTfv46VJkiRJq6eNgeDGrherLaXzX/49gNOTjPR5QvNzC+DrSZ5MZ5bgxq5xzq6q+3o5YVUtBhYDbLTVdrVW1UuSJEmTqI2B4IGu7UeAzYE7q2rBGH3/EfhYVZ2dZB/gg137ftu3CiVJkqQBcVEx3AXcmOT1AOnYudk3l846A4C3jDPG3cCc/pUoSZIk9YeBoOMQ4H8kWQ5cR2ehMXRmBE5P8gM6i4dX5fvA9kmWJTm4r5VKkiRJk6hVtwxV1U3Ajl3fT+ja/bIx+n8b+PYY7R8c9f124HmTVackSZI0KM4QSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS3WqjcVTwVbbbQBZx2w17DLkCRJkgBnCCRJkqRWMxBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiPnZ0wH5x54McddYvhl2GNKWduN/Thl2CJEmt4QyBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnF+hIIksxL8vZ+jL26kvxdkn1X85iFSU7sV02SJEnSVDGrT+POA94OfKa7Mck6VfVIn845pqo6Zg2OWQIs6UM5kiRJ0pTSr1uGjgO2SrIsyZVJvp/kq8A1AEm+lWRpkuuSLBo5KMk9ST6cZHmSK5Js3rS/Psm1TfulTduhzTjfSXJjkncmeW+Sq5tjN276nZzkwGb7uCQ/SbIiyQnjjL1PknOa7Y2b86xoxt2paf9gki8muTjJz5Ic1affpSRJktQ3/Zoh+Ctgx6pakGQf4Nzm+43N/sOr6vYk6wFXJjmzqm4D1geuqKqjk3wUOBL4EHAM8MdV9csk87rOsyOwCzAb+Cnwl1W1S5KPA28GPjHSsQkI+wHbVVV1jbOqsUf8LXB1Vb0uyYuBLwMLmn3bAX8IzAH+Lclnq+qhNf6tSZIkSQM2qEXFP+4KAwBHJVkOXAE8DdimaX8QOKfZXgrMb7YvA05OciSwTtc436+qu6vqVuA3wHea9mu6jh1xF3A/cFKS/YF7Jxh7xF7AqQBV9X+BTZLMbfadW1UPVNVK4NfA5mNdfJJFSZYkWXLfXbeP1UWSJEkaikEFgt+ObDQzBvsCu1fVzsDVdP7DD/BQVVWz/QjNDEZVvRX4AJ3wsCzJJk2fB7rO8WjX90cZNftRVQ8DuwFnAq8Dzptg7N+VPMb1jNTYff7f1ft7nasWV9XCqlq43oYbj9VFkiRJGop+BYK76dxGM5a5wB1VdW+S7YAXTDRYkq2q6l+aBcIr6fzxvlqSbADMrarvAu+mue2nh7EvBQ5p+u4DrKyqu1b3/JIkSdJU1Jc1BFV1W5LLklwL3Af8V9fu84C3JlkB/Bud24YmcnySbej8t/4iYDn/fR9/r+YA304yuxnnPeOM/aKu4z4IfKmp917gLat5XkmSJGnKyn/foaNB2Hzrnerg488ddhnSlHbifqs9CShJkkZJsrSqFk7UzzcVS5IkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS02a9gFtM3T5j3et7BKkiRpynCGQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS3mY0cH7M47HuabZ6wcdhnSlLb/gZsOuwRJklrDGQJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLWYgkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLWYgGCXJe5Nc23zenWR+kn9N8oUk1yW5IMl6Td+tkpyXZGmSHyTZbtj1S5IkSavDQNAlya7AYcDzgRcARwIbAdsAn66qHYA7gQOaQxYDf1ZVuwLvAz4z8KIlSZKktTBr2AVMMXsBZ1XVbwGSfBPYG7ixqpY1fZYC85NsAOwBnJ5k5PgnjDVokkXAIoBNN92if9VLkiRJq8lA8FhZRfsDXduPAOvRmV25s6oWTDRoVS2mM5vA1lstqLUtUpIkSZos3jL0WJcCr0vyxCTrA/sBPxirY1XdBdyY5PUA6dh5cKVKkiRJa89A0KWqrgJOBn4M/AtwEnDHOIccAvyPJMuB64DX9rtGSZIkaTJ5y9AoVfUx4GOjmnfs2n9C1/aNwMsGVJokSZI06ZwhkCRJklrMQCBJkiS1mIFAkiRJajEDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLWYgkCRJklrMNxUP2LyNZrH/gZsOuwxJkiQJcIZAkiRJajUDgSRJktRiBgJJkiSpxQwEkiRJUosZCCRJkqQWMxBIkiRJLWYgkCRJklrM9xAM2L0rH+bqk3497DKkKW2XI5407BIkSWoNZwgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazECwhpLMGnYNkiRJ0tqacYEgyfpJzk2yPMm1SQ5OsmuSS5IsTXJ+kicneXaSH3cdNz/Jimb79/o37Rcn+YcklwDvSrJZkjOTXNl89hzSZUuSJElrZCb+l/tlwC1V9UqAJHOBfwZeW1W3JjkY+HBVHZ7k8UmeWVU/Aw4GvpFkXeAfR/cHDm/Gn1dVL2rG/irw8ar6YZKnA+cDzx5dUJJFwCKAP9h4iz5euiRJkrR6ZmIguAY4IclHgHOAO4AdgQuTAKwD/Krp+w3gIOA4OoHgYGDbcfoDfL1re19g+6YfwIZJ5lTV3d0FVdViYDHA9vMX1KRcpSRJkjQJZlwgqKp/T7Ir8ArgWOBC4Lqq2n2M7l8HTk/yzc6hdUOS54zTH+C3XduPA3avqvsm8RIkSZKkgZmJawieAtxbVV8BTgCeD2yWZPdm/7pJdgCoqv8AHgH+F//9n/9/W1X/MVwAvLPr3Av6cEmSJElS38y4GQLgOcDxSR4FHgLeBjwMnNisJ5gFfAK4run/deB4YEuAqnowyYHj9O92FPDpZjHyLOBS4K39ujBJkiRpsqXKW9oHafv5C+q0D1ww7DKkKW2XI5407BIkSZr2kiytqoUT9ZtxtwxJkiRJ6p2BQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktdisYRfQNk/cdJZvYZUkSdKU4QyBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWszHjg7YQ//1AP95wk+HXYY0pj9439bDLkGSJA2YMwSSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFDASSJElSixkIJEmSpBabkoEgyeU99Nk7yXVJliVZbzXHf12S7bu+/12SfdekVkmSJGk6m5KBoKr26KHbIcAJVbWgqu5bzVO8DvhdIKiqY6rqe6s5hiRJkjTtTclAkOSe5uc+SS5OckaS65Oclo4jgIOAY5Kc1vT98yRXJlmR5G+7xnpz07Y8yalJ9gBeAxzfzC5sleTkJAc2/V+S5Ook1yT5YpInNO03JfnbJFc1+7Zr2l/UjLOsOW7OYH9bkiRJ0pqbNewCerALsANwC3AZsGdVnZRkL+CcqjojyUuBbYDdgABnJ3khcBtwdHPMyiQbV9XtSc4eORYgCc3P2cDJwEuq6t+TfBl4G/CJppaVVfXcJG8H3gcc0fx8R1VdlmQD4P7RF5BkEbAI4KnznjLZvx9JkiRpjU3JGYJRflxVN1fVo8AyYP4YfV7afK4GrgK2oxMQXgycUVUrAarq9gnOtS1wY1X9e/P9FOCFXfu/2fxc2lXHZcDHkhwFzKuqh0cPWlWLq2phVS3cZIONJyhBkiRJGpzpEAge6Np+hLFnNQIc26wnWFBVW1fV/2naazXOlR5r+V0dVXUcnZmC9YArRm4lkiRJkqaD6RAIenE+cHhzyw5JnprkScBFwEFJNmnaR/49fzcw1r3+1wPzk2zdfH8TcMl4J06yVVVdU1UfAZbQmZ2QJEmSpoUZEQiq6gLgq8CPklwDnAHMqarrgA8DlyRZDnysOeRrwJ83i4C36hrnfuAw4PRmnEeBz01w+ncnubYZ/z7gnyfz2iRJkqR+StXq3FGjtbXz055T57/rrGGXIY3pD9639cSdJEnStJBkaVUtnKjfjJghkCRJkrRmDASSJElSixkIJEmSpBYzEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFZg27gLZZd/Mn+DZYSZIkTRnOEEiSJEktZiCQJEmSWsxAIEmSJLWYgUCSJElqMQOBJEmS1GIGAkmSJKnFfOzogD3067v5rxMvHnYZ0pg2P2qfYZcgSZIGzBkCSZIkqcUMBJIkSVKLGQgkSZKkFjMQSJIkSS1mIJAkSZJazEAgSZIktZiBQJIkSWoxA4EkSZLUYgYCSZIkqcUMBJIkSVKLGQgmUZKLkywcdh2SJElSrwwEkiRJUovNGnYBw5L8//buP1iu8q7j+PszBEMkkR9FsFCQTqfVWoxQAthhZDLTGinSAoolnf6gUqelWpQ/qEUZFekfVkv9AeNUKwVrSzGlSpt2Wkk6lKGDQn6ZhrYJgvZWUzJBjSZNwxRDv/6xJ7C97N7cJPvjbs77NXPn7p7nObvP+c6zZ893z/Ock9OBz1XVGc3z64CFwA7gamAv8PWqWp7kaOBW4CfpxOzGqvpMkgXAHcBPAJuBBaPeDkmSJOlQtDYhmMH1wIur6rtJjm2W3QDcV1VXNcvWJPki8E5gT1UtTrIY2DCmNkuSJEkHxSFDz7cJuDPJm+mcJQBYBlyfZCNwP3AUcBpwAfBxgKra1Kz7PEnekWRdknU7du8ccvMlSZKk2WtzQrCX79/+o5r/Pw/8OXA2sD7JPCDAL1bVmc3faVW1ualf+3ujqvpwVS2pqiXHLzxmgJsgSZIkHZo2JwTbgROTvCDJfOBiOvE4taq+BPwmcCydeQX3AtckCUCSs5rXeAB4U7PsDGDxaDdBkiRJOjStnUNQVf+X5CbgYeAbwBbgCODjSY6hc1bgT6rqf5O8D/hTYFOTFEzRSSA+BNyRZBOwEVgz+i2RJEmSDl5rEwKAqroFuGUW9Z6iM4G41/LlQ2iaJEmSNBJtHjIkSZIktZ4JgSRJktRiJgSSJElSi5kQSJIkSS1mQiBJkiS1mAmBJEmS1GImBJIkSVKLmRBIkiRJLWZCIEmSJLVYq+9UPA5HnriIk3596bibIUmSJAGeIZAkSZJazYRAkiRJajETAkmSJKnFUlXjbkOrJPk28Oi423EYOQH4r3E34jBiPAfLeA6W8Rws4zlYxnOwjOdg/GhV/fD+KjmpePQeraol427E4SLJOuM5OMZzsIznYBnPwTKeg2U8B8t4jpZDhiRJkqQWMyGQJEmSWsyEYPQ+PO4GHGaM52AZz8EynoNlPAfLeA6W8Rws4zlCTiqWJEmSWswzBJIkSVKLmRAMSZILkzya5PEk1/con59kRVP+cJLTR9/KyZDk1CRfSrI5ydeS/EaPOkuT7Eyysfn73XG0dVIkmUrySBOrdT3Kk+SWpn9uSvLKcbRzEiT5sa5+tzHJriTXTqtj/5xBktuTPJnkq13Ljk+yOsljzf/j+qx7ZVPnsSRXjq7Vc1efeH4gyZbm83xPkmP7rDvjvqGN+sTzxiTf6vpMX9Rn3RmPBdqoTzxXdMVyKsnGPuvaP4fEIUNDkOQI4F+AnwW2AmuBN1bV17vq/CqwuKquTrIcuKyqrhhLg+e4JC8EXlhVG5IsAtYDl06L51Lguqq6eEzNnChJpoAlVdXzGs/Nl9s1wEXAecCfVdV5o2vhZGo++98Czquqb3YtX4r9s68kFwC7gb+pqjOaZX8E7Kiq9zcHUsdV1XunrXc8sA5YAhSdfcPZVfU/I92AOaZPPJcB91XV3iR/CDA9nk29KWbYN7RRn3jeCOyuqptnWG+/xwJt1Cue08o/COysqpt6lE1h/xwKzxAMx7nA41X1b1X1NPC3wCXT6lwCfLR5/Cng1UkywjZOjKraVlUbmsffBjYDp4y3VYe9S+jsrKuqHgKObRIzzezVwL92JwPav6p6ANgxbXH3PvKjwKU9Vv05YHVV7WiSgNXAhUNr6IToFc+qWlVVe5unDwEvGnnDJlSf/jkbszkWaJ2Z4tkcB70BuGukjZIJwZCcAvxH1/OtPP8A9tk6zU56J/CCkbRugjVDq84CHu5R/KokX0nyhSSvGGnDJk8Bq5KsT/KOHuWz6cN6vuX0/yKzfx6Yk6pqG3R+FABO7FHHfnpwrgK+0Kdsf/sGPefdzRCs2/sMabN/HrifAbZX1WN9yu2fQ2JCMBy9fumfPjZrNnXUJclC4O+Aa6tq17TiDXRuz/1TwK3Ap0fdvglzflW9Engt8GvNKdxu9s8DlOQHgNcDd/cotn8Oh/30ACW5AdgL3Nmnyv72Der4EPAS4ExgG/DBHnXsnwfujcx8dsD+OSQmBMOxFTi16/mLgCf61UkyDziGgzsl2QpJjqSTDNxZVX8/vbyqdlXV7ubx54Ejk5ww4mZOjKp6ovn/JHAPnVPb3WbTh/X9XgtsqKrt0wvsnwdl+75has3/J3vUsZ8egGbS9cXAm6rPBMJZ7BsEVNX2qnqmqr4H/BW942T/PADNsdAvACv61bF/Do8JwXCsBV6a5MXNr4bLgZXT6qwE9l0R43I6k7385aCHZkzhR4DNVfXHfer8yL45GEnOpdO3/3t0rZwcSY5uJmeT5GhgGfDVadVWAm9Nx0/TmeC1bcRNnTR9f9myfx6U7n3klcBnetS5F1iW5LhmyMayZpmmSXIh8F7g9VW1p0+d2ewbxLNJ6j6X0TtOszkW0HNeA2ypqq29Cu2fwzVv3A04HDVXcXg3nS+mI4Dbq+prSW4C1lXVSjoHuB9L8jidMwPLx9fiOe984C3AI12XIvtt4DSAqvoLOknVu5LsBZ4Clptg9XUScE9zfDoP+ERV/UOSq+HZeH6ezhWGHgf2AL88prZOhCQ/SOdKIu/sWtYdT/vnDJLcBSwFTkiyFfg94P3AJ5O8Hfh34JeaukuAq6vqV6pqR5L30TnwAripqlp/prVPPH8LmA+sbj77DzVXuTsZuK2qLqLPvmEMmzCn9Inn0iRn0hkCNEXz2e+OZ79jgTFswpzSK55V9RF6zMGyf46Olx2VJEmSWswhQ5IkSVKLmRBIkiRJLWZCIEmSJLWYCYEkSZLUYiYEkiRJUot52VFJ0iFJ8gzwSNeiS6tqakzNkSQdIC87Kkk6JEl2V9XCGcrnVdXeUbZJkjR7DhmSJA1ckrcluTvJZ4FVzbL3JFmbZFOS3++qe0OSR5N8McldSa5rlt/f3IiMJCckmWoeH5HkA12vte+mUEubdT6VZEuSO7vuEH1Okn9M8pUka5IsSvLl5uZS+9rxYJLFo4qRJM0VDhmSJB2qBV13Ef9GVV3WPH4VsLi5o/Ay4KXAuUCAlUkuAL5D5w6lZ9H5TtoArN/P+70d2FlV5ySZDzyYZFVTdhbwCuAJ4EHg/CRrgBXAFVW1NskP0blj9G3A24Brk7wMmF9Vmw4pEpI0gUwIJEmH6qmqOrPH8tVVtaN5vKz5++fm+UI6CcIi4J6q2gOQZOUs3m8ZsDjJ5c3zY5rXehpYU1Vbm9faCJwO7AS2VdVagKra1ZTfDfxOkvcAVwF/PdsNlqTDiQmBJGlYvtP1OMAfVNVfdldIci3QbzLbXp4b2nrUtNe6pqrunfZaS4Hvdi16hs73XHq9R1XtSbIauAR4A7BkP9sjSYcl5xBIkkbhXuCqJAsBkpyS5ETgAeCyJAuSLAJe17XOFHB28/jyaa/1riRHNq/1siRHz/DeW4CTk5zT1F+UZN8PYrcBtwBru85mSFKreIZAkjR0VbUqycuBf2rm+e4G3lxVG5KsADYC3wS+3LXazcAnk7wFuK9r+W10hgJtaCYN/ydw6Qzv/XSSK4BbkyygM3/gNcDuqlqfZBdwx4A2VZImjpcdlSTNGUlupHOgfvOI3u9k4H7gx6vqe6N4T0maaxwyJElqpSRvBR4GbjAZkNRmniGQJEmSWswzBJIkSVKLmRBIkiRJLWZCIEmSJLWYCYEkSZLUYiYEkiRJUouZEEiSJEkt9v8kpGPxIqyDkQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 864x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plotting 15 most commonly used words in the reference answer based summaries along with their frequency\n",
    "plot_word_frequency(rs_words, 'Frequency', 'Reference summary Words', 15)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The above plot shows that some of the most commonly mentioned words in the reference answer based summaries include 'covid-19', 'risk', 'virus','infected', 'transmission', 'patients', 'heart', 'contact', 'people'."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "qa_df = qa_dt_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(qa_df)):\n",
    "    qa_df.loc[i, \"Model_ans_length\"] = int(len(abs_proc(qa_df.loc[i, \"Model_Sum_Answer\"])))\n",
    "    qa_df.loc[i, \"Sum_ref_ans_length\"] = int(len(abs_proc(qa_df.loc[i, \"Sum_Reference_answers\"])))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "      <th>Sum_Reference_answers</th>\n",
       "      <th>similarity_score</th>\n",
       "      <th>Model_ans_length</th>\n",
       "      <th>Sum_ref_ans_length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.</td>\n",
       "      <td>0.977188</td>\n",
       "      <td>177.0</td>\n",
       "      <td>433.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.</td>\n",
       "      <td>0.979442</td>\n",
       "      <td>45.0</td>\n",
       "      <td>204.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>0.970880</td>\n",
       "      <td>387.0</td>\n",
       "      <td>435.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td></td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>250.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>0.990345</td>\n",
       "      <td>286.0</td>\n",
       "      <td>291.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                         Task  \\\n",
       "0  What is known about transmission, incubation, and environmental stability?   \n",
       "1  What is known about transmission, incubation, and environmental stability?   \n",
       "2  What is known about transmission, incubation, and environmental stability?   \n",
       "3  What is known about transmission, incubation, and environmental stability?   \n",
       "4  What is known about transmission, incubation, and environmental stability?   \n",
       "\n",
       "                                                                                            Questions  \\\n",
       "0  Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?   \n",
       "1  How long is the incubation period for the virus in humans?                                           \n",
       "2  How does the incubation period in humans vary across age and health conditions?                      \n",
       "3  Can the virus be transmitted asymptomatically or during the incubation period?                       \n",
       "4  How does weather, heat, and humidity affect the transmission of COVID 19?                            \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Reference Answers  \\\n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "\n",
       "                                                                       prp_qa  \\\n",
       "0  covid viru transmit aerosol droplet food close contact faecal matter water   \n",
       "1  long incub period viru human                                                 \n",
       "2  incub period human vari across age health condit                             \n",
       "3  viru transmit asymptomat incub period                                        \n",
       "4  weather heat humid affect transmiss covid 19                                 \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Model_Sum_Answer  \\\n",
       "0  the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                         \n",
       "1  is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "2  between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "4  the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                             \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sum_Reference_answers  \\\n",
       "0  Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.   \n",
       "1  An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.                                                                                                                                                                                                                                                                                                               \n",
       "2  The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                 \n",
       "3  The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                         \n",
       "4  The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                         \n",
       "\n",
       "   similarity_score  Model_ans_length  Sum_ref_ans_length  \n",
       "0  0.977188          177.0             433.0               \n",
       "1  0.979442          45.0              204.0               \n",
       "2  0.970880          387.0             435.0               \n",
       "3  0.000000          0.0               250.0               \n",
       "4  0.990345          286.0             291.0               "
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 2880x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "#plt.figure(figsize=(40,15))\n",
    "index = np.arange(23)\n",
    "bar_width = 0.35\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(40,15))\n",
    "#plt.figure(figsize=(40,15)\n",
    "Model_ans_len = ax.bar(index, qa_df['Model_ans_length'], bar_width, label = 'Model_ans_len')\n",
    "Sum_ans_len = ax.bar(index + bar_width, qa_df['Sum_ref_ans_length'], bar_width, label = 'Sum_ans_len')\n",
    "ax.set_xlabel('Model and Reference summarised Answers', fontsize = 25)\n",
    "ax.set_ylabel('Answer lengths', fontsize = 20)\n",
    "ax.set_title('Answer length comparison with Similarity scores', fontsize = 25)\n",
    "ax.set_xticks(index + bar_width / 2)\n",
    "ax.set_xticklabels([\"Ans1\", \"Ans2\", \"Ans3\", \"Ans4\", \"Ans5\", \"Ans6\", \"Ans7\", \"Ans8\", \"Ans9\", \"Ans10\", \"Ans11\", \"Ans12\", \"Ans13\", \"Ans14\", \"Ans15\", \"Ans16\", \"Ans17\", \"Ans18\", \"Ans19\", \"Ans20\", \"Ans21\", \"Ans22\", \"Ans23\"])\n",
    "ax.tick_params(labelsize=20)\n",
    "\n",
    "ax.legend(fontsize = 25)\n",
    "annotlabel(qa_df, Model_ans_len)\n",
    "annotlabel(qa_df, Sum_ans_len)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The plot shows the sizes of the answer span based summaries, reference answer summaries and respective similarity scores.\n",
    "The plot shows that size difference between the two answers does not necessarily impact the similarity scores till both answers are big enough to capture important information, making them similar symantically.\n",
    "The similarity scores are '0' for all the cases where answer span based summaries are not generated and the score is low for an instance (Ans17) when the answer span based summary is too small and does not have enough information to match the reference answer summary.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Few experiments that were conducted to test the word2vec, trained on \"combined Abstract dataset\", performance by running the algorithm on few instances. Code below and results were all part of experiments and analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Model summarised answer and reference answer for same question\n",
    "vs_set = []\n",
    "sent1 = abs_proc(qa_dt_v2.loc[0, \"Model_Sum_Answer\"])\n",
    "#sent1 = abs_proc(\"Its time to play and enjoy victory\")\n",
    "sent2 = abs_proc(qa_dt_v2.loc[0, \"Sum_Reference_answers\"])\n",
    "for answer in [sent1, sent2]:\n",
    "        vs = np.zeros(300)\n",
    "        for word in answer:\n",
    "            vs = np.add(vs, word2vec_md.wv[word]) \n",
    "        vs_set.append(vs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [],
   "source": [
    "cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9778376975727566"
      ]
     },
     "execution_count": 127,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cost[0][0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The 'cost' score is the cosine similarity score and it can be seen that high similaruty score is achieved between the two answers for first question \"Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Random sentence and reference answer for some question\n",
    "vs_set = []\n",
    "#sent1 = abs_proc(qa_dt_v2.loc[0, \"Model_Sum_Answer\"])\n",
    "sent1 = abs_proc(\"Its time to play and enjoy victory\")\n",
    "sent2 = abs_proc(qa_dt_v2.loc[0, \"Sum_Reference_answers\"])\n",
    "for answer in [sent1, sent2]:\n",
    "        vs = np.zeros(300)\n",
    "        for word in answer:\n",
    "            vs = np.add(vs, word2vec_md.wv[word]) \n",
    "        vs_set.append(vs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [],
   "source": [
    "cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.9344918228162001"
      ]
     },
     "execution_count": 131,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cost[0][0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The 'cost' score is the cosine similarity score and it can be seen that high similarity score is still achieved between a random sentence and reference answers for first question \"Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?\" This shows that the proposed sentence similarity algorithm could be improved further "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Using Smooth inverse frequency technique to improve performance of word2vec model. It involves taking weighted average of word embeddings, instead of simple mean average. Every word embedding is weighted by a/(a + p(w)), where a is a parameter that is typically set to 0.001 and p(w) is the estimated frequency of the word in a corpus. This algorithm helps in giving importance to semantical similarity  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {},
   "outputs": [],
   "source": [
    "a = 0.001\n",
    "def mp_wrd_freq(document):\n",
    "    return Counter(itertools.chain(*document))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Test with Smooth inverse frequency (SIF) technique  \n",
    "# Model summarised answer and reference answer for same question\n",
    "vs_set = []\n",
    "sent1 = abs_proc(qa_dt_v2.loc[0, \"Model_Sum_Answer\"])\n",
    "#sent1 = abs_proc(\"Its time to play and enjoy victory\")\n",
    "sent2 = abs_proc(qa_dt_v2.loc[0, \"Sum_Reference_answers\"])\n",
    "wrd_cnt = mp_wrd_freq((sent1 + sent2))\n",
    "for answer in [sent1, sent2]:\n",
    "        vs = np.zeros(300)\n",
    "        cont_lt = len(answer)\n",
    "        for word in answer:\n",
    "            a_value = a / (a + wrd_cnt[word]) #SIF factor\n",
    "            vs = np.add(vs, np.multiply(a_value, word2vec_md.wv[word])) \n",
    "        vs = np.divide(vs, cont_lt)\n",
    "        vs_set.append(vs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "metadata": {},
   "outputs": [],
   "source": [
    "cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.09679692529760227"
      ]
     },
     "execution_count": 146,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cost[0][0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "It can be seen that using SIF has made Word2vec model lot more aggessive in checking semantic similarity between the two answers. The difference in content length, quality in terms of gramatical correctness of sentences have considered to an extreme, resulting in a score that not necessarily depicts true variance between the two sentences."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Test with Smooth inverse frequency (SIF) technique  \n",
    "# Model random answer and reference answer for same question\n",
    "vs_set = []\n",
    "sent1 = abs_proc(\"Its time to play and enjoy victory\")\n",
    "#sent1 = abs_proc(\"Its time to play and enjoy victory\")\n",
    "sent2 = abs_proc(qa_dt_v2.loc[0, \"Sum_Reference_answers\"])\n",
    "wrd_cnt = mp_wrd_freq((sent1 + sent2))\n",
    "for answer in [sent1, sent2]:\n",
    "        vs = np.zeros(300)\n",
    "        cont_lt = len(answer)\n",
    "        for word in answer:\n",
    "            a_value = a / (a + wrd_cnt[word]) #SIF factor\n",
    "            vs = np.add(vs, np.multiply(a_value, word2vec_md.wv[word])) \n",
    "        vs = np.divide(vs, cont_lt)\n",
    "        vs_set.append(vs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {},
   "outputs": [],
   "source": [
    "cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.23267663430758986"
      ]
     },
     "execution_count": 143,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cost[0][0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The similarity score for the case wherein one content is a random sentence and the other is one of the reference answers is higher than when the model generated summary answer was compared to the reference answer to the same question, even though the content in both of them was quite similar. This showed that SIF is not ideal for the dataset being considered for this project.\n",
    "Therefore, will consider the original implementation of Word2Vec only"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Function for Word2Vec model output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {},
   "outputs": [],
   "source": [
    "def wrd2vec_cos(word2vec_md, qa_dt_v2):\n",
    "    vs_set = []\n",
    "    for i in range(len(qa_dt_v2)):\n",
    "        sent1 = abs_proc(qa_dt_v2.loc[i, \"Model_Sum_Answer\"])\n",
    "        sent2 = abs_proc(qa_dt_v2.loc[i, \"Sum_Reference_answers\"])\n",
    "        for answer in [sent1, sent2]:\n",
    "            vs = np.zeros(300)\n",
    "            for word in answer:\n",
    "                vs = np.add(vs, word2vec_md.wv[word]) \n",
    "            vs_set.append(vs)\n",
    "            #print(len(vs_set))\n",
    "        cost = cosine_similarity(vs_set[0].reshape(1,-1), vs_set[1].reshape(1,-1))[0][0]\n",
    "        #print(cost)\n",
    "        qa_dt_v2.loc[i, \"similarity_score\"] = cost\n",
    "        vs_set = []\n",
    "    return qa_dt_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "metadata": {},
   "outputs": [],
   "source": [
    "qa_dt_v2 = wrd2vec_cos(word2vec_md, qa_dt_v2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Task</th>\n",
       "      <th>Questions</th>\n",
       "      <th>Reference Answers</th>\n",
       "      <th>prp_qa</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "      <th>Sum_Reference_answers</th>\n",
       "      <th>similarity_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ?m in diameter they are referred to as respiratory droplets, and when then are &lt;5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles &lt;5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.</td>\n",
       "      <td>covid viru transmit aerosol droplet food close contact faecal matter water</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.</td>\n",
       "      <td>0.977838</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.</td>\n",
       "      <td>long incub period viru human</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.</td>\n",
       "      <td>0.980423</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>incub period human vari across age health condit</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>0.970849</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>viru transmit asymptomat incub period</td>\n",
       "      <td></td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>weather heat humid affect transmiss covid 19</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>0.990806</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How long can the COVID 19 virus remain viable on common surfaces?</td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "      <td>long covid 19 viru remain viabl common surfac</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "      <td>person effect protect equip ppe reduc risk transmiss health care commun set</td>\n",
       "      <td>a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "      <td>0.995006</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.</td>\n",
       "      <td>effect movement control strategi prevent secondari transmiss health care commun set</td>\n",
       "      <td>to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.</td>\n",
       "      <td>0.991068</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "      <td>tool studi monitor phenotyp chang potenti adapt viru</td>\n",
       "      <td>interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "      <td>0.988067</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>What is known about transmission, incubation, and environmental stability?</td>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n</td>\n",
       "      <td>implement diagnost product improv clinic process</td>\n",
       "      <td>a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.</td>\n",
       "      <td>0.995304</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "      <td>risk factor contribut sever covid 19</td>\n",
       "      <td>patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "      <td>0.992492</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does hypertension affect patients?</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "      <td>hypertens affect patient</td>\n",
       "      <td>to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "      <td>0.992428</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does heart disease affect patients?</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "      <td>heart diseas affect patient</td>\n",
       "      <td>to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "      <td>0.981140</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.</td>\n",
       "      <td>copd affect patient</td>\n",
       "      <td>a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.</td>\n",
       "      <td>0.982809</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "      <td>smoke affect patient</td>\n",
       "      <td>is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "      <td>0.990938</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.</td>\n",
       "      <td>pregnanc affect patient</td>\n",
       "      <td>conditions associated with high-risk pregnancy</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.</td>\n",
       "      <td>0.988653</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "      <td>fatal rate covid 19</td>\n",
       "      <td>is lower than that of 2003-sars</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "      <td>0.172076</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>What do we know about COVID-19 risk factors?</td>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.</td>\n",
       "      <td>public health polici prevent control spread covid 19</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers. a new infection control system.</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.</td>\n",
       "      <td>0.985679</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "      <td>anim transmit covid 19</td>\n",
       "      <td>covid-19 was transmitted in a more diverse way. initiation of a new infection control system</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "      <td>0.971591</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.</td>\n",
       "      <td>anim covid 19 come</td>\n",
       "      <td></td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "      <td>\\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.</td>\n",
       "      <td>real-tim genom track tool exist</td>\n",
       "      <td>to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "      <td>Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.</td>\n",
       "      <td>0.985532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What geographic variations are there in the genome of COVID 19?</td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "      <td>geograph variat genom covid 19</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>What do we know about virus genetics, origin, and evolution?</td>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.</td>\n",
       "      <td>effort done asia prevent outbreak</td>\n",
       "      <td>to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.</td>\n",
       "      <td>0.987362</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                          Task  \\\n",
       "0   What is known about transmission, incubation, and environmental stability?   \n",
       "1   What is known about transmission, incubation, and environmental stability?   \n",
       "2   What is known about transmission, incubation, and environmental stability?   \n",
       "3   What is known about transmission, incubation, and environmental stability?   \n",
       "4   What is known about transmission, incubation, and environmental stability?   \n",
       "5   What is known about transmission, incubation, and environmental stability?   \n",
       "6   What is known about transmission, incubation, and environmental stability?   \n",
       "7   What is known about transmission, incubation, and environmental stability?   \n",
       "8   What is known about transmission, incubation, and environmental stability?   \n",
       "9   What is known about transmission, incubation, and environmental stability?   \n",
       "10  What do we know about COVID-19 risk factors?                                 \n",
       "11  What do we know about COVID-19 risk factors?                                 \n",
       "12  What do we know about COVID-19 risk factors?                                 \n",
       "13  What do we know about COVID-19 risk factors?                                 \n",
       "14  What do we know about COVID-19 risk factors?                                 \n",
       "15  What do we know about COVID-19 risk factors?                                 \n",
       "16  What do we know about COVID-19 risk factors?                                 \n",
       "17  What do we know about COVID-19 risk factors?                                 \n",
       "18  What do we know about virus genetics, origin, and evolution?                 \n",
       "19  What do we know about virus genetics, origin, and evolution?                 \n",
       "20  What do we know about virus genetics, origin, and evolution?                 \n",
       "21  What do we know about virus genetics, origin, and evolution?                 \n",
       "22  What do we know about virus genetics, origin, and evolution?                 \n",
       "\n",
       "                                                                                                                                Questions  \\\n",
       "0   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?                                      \n",
       "1   How long is the incubation period for the virus in humans?                                                                              \n",
       "2   How does the incubation period in humans vary across age and health conditions?                                                         \n",
       "3   Can the virus be transmitted asymptomatically or during the incubation period?                                                          \n",
       "4   How does weather, heat, and humidity affect the transmission of COVID 19?                                                               \n",
       "5   How long can the COVID 19 virus remain viable on common surfaces?                                                                       \n",
       "6   How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?   \n",
       "7   What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?       \n",
       "8   What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?                                      \n",
       "9   What is the Implementation of diagnostics and products to improve clinical processes?                                                   \n",
       "10  What risk factors contribute to the severity of COVID 19?                                                                               \n",
       "11  How does hypertension affect patients?                                                                                                  \n",
       "12  How does heart disease affect patients?                                                                                                 \n",
       "13  How does COPD affect patients?                                                                                                          \n",
       "14  How does smoking affect patients?                                                                                                       \n",
       "15  How does pregnancy affect patients?                                                                                                     \n",
       "16  What is the fatality rate of COVID 19?                                                                                                  \n",
       "17  What public health policies prevent or control the spread of COVID 19?                                                                  \n",
       "18  Can animals transmit COVID 19?                                                                                                          \n",
       "19  What animal did COVID 19 come from?                                                                                                     \n",
       "20  What real-time genomic tracking tools exist?                                                                                            \n",
       "21  What geographic variations are there in the genome of COVID 19?                                                                         \n",
       "22  What efforts are being done in Asia to prevent further outbreaks?                                                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Reference Answers  \\\n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ?m in diameter they are referred to as respiratory droplets, and when then are <5?m in diameter, they are referred to as droplet nuclei. According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.\\nDroplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). \\nAirborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5?m in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. \\nIn the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. \\nThere is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen. There have been no reports of faecal?oral transmission of the COVID-19 virus to date.   \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start.\\nCurrently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure.\\nAccording to a recent reportTrusted Source, more than 97 percent of people who contract SARS-CoV-2 show symptoms within 11.5 days of exposure. The average incubation period seems to be around 5 days. However, this estimate may change as we learn more about the virus.\\nFor many people, COVID-19 symptoms start as mild symptoms and gradually get worse over a few days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Accordingly, it was found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. The age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structuresâ€”such as many low-income countriesâ€”the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. \\nCool and humid weather can effectively suppress the formation of aerosol particles, but it also facilitates the spreading of large droplets. \\nThe current social distancing standard is insufficient in eliminating all droplet contacts. In some extremely cool and humid weathers, the required physical distance may reach as far as 6 m.\\nAlternatively,  a  relaxed  standard  of  1.4 m is able to block 95% of viruses carried by respiratory droplets  (excluding  that  carried  by  aerosol  particles)  and  shows  negligible weather dependence. \\nThere  is  a  slight  increase  of  PM2.5  floating  in  air  in  hot  and  dry  weather,  owing  to  the increased suspension time. \\nImproper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Airborne transmission may occur ifpatient respiratory activity or medical proceduresgenerate respiratory aerosols. These aerosols contain particles that may travel much longer distancesand remain airborne longer,but their infective potential is uncertain. Contact, droplet and airborne transmission are each relevantduring airway manoeuvres in infected patients, particularly during tracheal intubation. Personal protective equipment is an important component, but only one part, of a system protectingstaff and other patients from COVID-19 cross-infection. Appropriate use significantly reduces risk of viral transmission. Personal protective equipment should logically be matched to the potential mode of viral transmission occurring during patient care â€“contact, droplet, or airborne. Recommendations from international organisations are broadly consistent, but equipmentuse is not.Only airborne precautionsinclude a fitted high-filtrationmask,and this should bereserved for aerosol-generating procedures.Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine. With increased testing capacity, detecting more positive patients in the community will also enable the reduction of secondary cases with stricter quarantine rules.  \\nAs per WHO, in countries and/or subnational regions in which community transmission has become established, or that are at risk of entering this phase of an epidemic, authorities must immediately adopt and adapt population-level distancing measures and movement restrictions in addition to other public health and health system measures to reduce exposure and suppress transmission, including the following:\\nPersonal measures that reduce the risk of person-to-person transmission, such as hand washing, physicaldistancing, and respiratory etiquette;\\nCommunity-level measures to reduce contact between individuals, such as the suspension of mass gatherings,theclosure of non-essential places of work and educational establishments, and reduced public transport;\\nMeasures to reduce the risk of importation or reintroduction of the virus from high-transmission areas, such as limits on national and international travel, enhanced screeningand quarantine;\\nMeasures to ensure the protection of health workers andvulnerable groups, such as through the provision of correctpersonal protective equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the geo-climate distribution of the mutations deciphered higher unique mutations as well as disease severity in the European temperate countries. Further investigations should focus on structural validations and subsequent phenotypic consequences of the deletions and/or mismatches in transmission dynamics of the current epidemics and the immediate implications of these genomic markers to develop potential prophylaxis and mitigation for tackling the crisis of pandemic COVID-19. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. SARS-CoV took 5 months to be identified. The same techniques were used to identify SARS-CoV-2 in only 3 weeks. The rapid identification and sequencing of SARS-CoV-2 has enabled the rapid development of nucleic acid tests. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. There is now a call for development of point-of-care tests and multiplex assays. Technologies that are straddling phases 2 and 3 such as isothermal amplification, barcoding, and microfluidic technologies should be further developed so that they can become plug-and-play systems and can be rapidly implemented in an outbreak situation. The combination of diagnostics and smartphones should provide greater communication and surveillance. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19. This process can curb the spread of infectious pathogens and reduce mortality.\\n                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Coagulation dysfunctions could play a critical role in the organ damaging. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. However, this result may be related to the higher age in this group than in nonhypertension group. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. But it could also affect the heart, especially a diseased heart, that has already been struggling to get the oxygenated blood throughout the body. So, heart patients need to take additional, reasonable precautions in order to cut down their risk.\\nHeart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways.\\nThe  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light. Similar to SARS-CoV (which was responsible for the 2002â€“2003 SARS pandemic), SARS-CoV-2 bears an envelope spike protein that is primed by the cellular serine protease TMPRSS2 to facilitate fusion of the virus with the cell's angiotensin-converting enzyme 2 (ACE-2) receptor and subsequent cell entry. Current smoking was also associated with higher ACE-2 expression compared with former and never smokers, an observation which has subsequently been validated by other groups in separate cohorts of lung tissue and airway epithelial samples and supported by additional evidence linking ACE-2 expression with nicotine exposure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Tobacco is also a major risk factor for noncommunicable diseases like cardiovascular disease, cancer, respiratory disease and diabetes which put people with these conditions at higher risk for developing severe illness when affected by COVID-19. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Current reports suggest that pregnant women may have a higher risk for more severe illness from COVID-19 than nonpregnant women. Reports note that:\\nPregnant women with COVID-19 may be more likely than nonpregnant women with COVID-19 to need care in an intensive care unit (ICU) or need a ventilator (for breathing support).\\nPregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.\\nPregnant women who are Black or Hispanic have a higher rate of illness from COVID-19 than other pregnant women. But itâ€™s not about biology. Black and Hispanic women face social, health, and economic inequities that put them at greater risk of illness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. That statistic is called the infection fatality rate (IFR) â€“ or colloquially, the death rate â€“ and means that for every hundred people infected with COVID-19, on average, between three and four would die.\\nAs time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65% for the IFR. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick.\\nAvoid touching eyes, nose, and mouth.\\nStay home when sick.\\nCover the cough or sneeze with a tissue, then throw the tissue in the trash.\\nClean and disinfect frequently touched objects and surfaces every day. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. This list has been pre-approved by the US Environmental Protection Agency (EPA) for use during the COVID-19 outbreak.\\nWash hands often with soap and water.\\nContact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.\\nSocial distancing refers to actions taken to stop or slow down the spread of a contagious disease. For an individual, it refers to maintaining enough distance (6 feet or more) between yourself and another person to avoid getting infected or infecting someone else. School closures, directives to work from home, library closings, and cancelling meetings and larger events help enforce social distancing at a community level.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage. There is substantial diversity among SARS-like coronaviruses circulating in bats and other animals and the identification of precisely where the virus originated will need further sampling and surveillance of animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "20  \\n\\nSeveral methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction. Fluorescent markers in the reaction mixture help reveal the identity of the sequences being generated. Once scientists know the sequences of the fragments, they can computationally stitch the whole genome back together with the help of a reference sequence from a closely related virus.\\nSome of this work is conducted at large, specialized facilities, but because of advances in technology, genome sequencing can also be carried out in smaller labs. Hospitals and universities around the world are collecting samples from people with COVID-19. Some in-house sequencing devices are the size of a smartphone or suitcase, and many can report a genome sequence within 7â€“8 h.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. The number of mutations is relatively low, with mode per sample equaling 6, an average of 7.23, and very few samples having more than 15 events. Overall, no continent differs significantly from the average mutation rate, but there is a significant difference (one-way ANOVA p = 9.55 Ã— 10?205) in the average number of mutations per sample between countries. Specifically, amongst the top 40 nations with the highest number of sequenced full viral genomes, these countries have a slightly but significant higher number of observed mutations per sample, when compared to the world's average: India: (8.40), Congo (8.30), Bangladesh (9.83), and Kazakhstan (9.47). On the other hand, the sequences from the following countries show a significantly lower mutational burden: Germany (6.09), Japan (4.55), Italy (5.92), Greece (5.91), Hong Kong (5.00), and Kenya (5.38). One must bear in mind that some sampling biases may affect this comparison: for example, some countries have generated the highest number of sequences in the early phases of the pandemic, and may have therefore observed fewer mutations (for example, Italy has not shared any sequence in the months of May and June 2020, the last two considered in our analysis). On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                                                                                                       \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread.\\nIn East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient. Citizens supported these initiatives and downloaded the apps which helped in flattening the curve and avoid outbreaks. South Korea has been appreciated for its aggressive and efficient response in preventing the COVID 19 spread. \\nA vibrant democracy that has also won praise for its Covid-19 containment, Taiwan is believed to be the first to have used mobile phone tracking to enforce quarantines, which the government reportedly reinforces by calling those in quarantine twice a day to ensure they do not evade tracking by leaving their phones at home.\\nChina too re-purposed its vast existing system of digital surveillance for Covid-19 tracking to prevent further outbreaks.\\nIn India, complete nationwide lockdown was announced intially for two months and then gradual opening up of economy based on the known COVID 19 spread, increased testing capacity, contact tracing and containment zones are the techniques deployed to prevent the COVID 19 spread.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "                                                                                 prp_qa  \\\n",
       "0   covid viru transmit aerosol droplet food close contact faecal matter water            \n",
       "1   long incub period viru human                                                          \n",
       "2   incub period human vari across age health condit                                      \n",
       "3   viru transmit asymptomat incub period                                                 \n",
       "4   weather heat humid affect transmiss covid 19                                          \n",
       "5   long covid 19 viru remain viabl common surfac                                         \n",
       "6   person effect protect equip ppe reduc risk transmiss health care commun set           \n",
       "7   effect movement control strategi prevent secondari transmiss health care commun set   \n",
       "8   tool studi monitor phenotyp chang potenti adapt viru                                  \n",
       "9   implement diagnost product improv clinic process                                      \n",
       "10  risk factor contribut sever covid 19                                                  \n",
       "11  hypertens affect patient                                                              \n",
       "12  heart diseas affect patient                                                           \n",
       "13  copd affect patient                                                                   \n",
       "14  smoke affect patient                                                                  \n",
       "15  pregnanc affect patient                                                               \n",
       "16  fatal rate covid 19                                                                   \n",
       "17  public health polici prevent control spread covid 19                                  \n",
       "18  anim transmit covid 19                                                                \n",
       "19  anim covid 19 come                                                                    \n",
       "20  real-tim genom track tool exist                                                       \n",
       "21  geograph variat genom covid 19                                                        \n",
       "22  effort done asia prevent outbreak                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Model_Sum_Answer  \\\n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1   is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "2   between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.                                            \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "4   the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                      \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "6   a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "7   to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.                                                                                                                                                                                                                                                                                                                     \n",
       "8   interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "9   a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.                                                                                                                                                                               \n",
       "10  patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "11  to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.   \n",
       "12  to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "13  a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.                                                                                                                                                                                                                                                              \n",
       "14  is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.                                                                                                                                                                                                                                                                                                                                            \n",
       "15  conditions associated with high-risk pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "16  is lower than that of 2003-sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "17  policies on the use of respiratory protection for hospital health workers. a new infection control system.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "18  covid-19 was transmitted in a more diverse way. initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "20  to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "22  to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sum_Reference_answers  \\\n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.                                                                                                                                                                                                                                                        \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                      \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                      \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                        \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.   \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.                                                                                                                                                                                                                                                                                                                                                               \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "20  Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                 \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "    similarity_score  \n",
       "0   0.977838          \n",
       "1   0.980423          \n",
       "2   0.970849          \n",
       "3   0.000000          \n",
       "4   0.990806          \n",
       "5   0.000000          \n",
       "6   0.995006          \n",
       "7   0.991068          \n",
       "8   0.988067          \n",
       "9   0.995304          \n",
       "10  0.992492          \n",
       "11  0.992428          \n",
       "12  0.981140          \n",
       "13  0.982809          \n",
       "14  0.990938          \n",
       "15  0.988653          \n",
       "16  0.172076          \n",
       "17  0.985679          \n",
       "18  0.971591          \n",
       "19  0.000000          \n",
       "20  0.985532          \n",
       "21  0.000000          \n",
       "22  0.987362          "
      ]
     },
     "execution_count": 160,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Questions</th>\n",
       "      <th>Model_Sum_Answer</th>\n",
       "      <th>Sum_Reference_answers</th>\n",
       "      <th>similarity_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?</td>\n",
       "      <td>the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).</td>\n",
       "      <td>Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are &gt;5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.</td>\n",
       "      <td>0.977838</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>How long is the incubation period for the virus in humans?</td>\n",
       "      <td>is the delay from infection until onset of symptoms, and varies from person to person</td>\n",
       "      <td>An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.</td>\n",
       "      <td>0.980423</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>How does the incubation period in humans vary across age and health conditions?</td>\n",
       "      <td>between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.</td>\n",
       "      <td>The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.</td>\n",
       "      <td>0.970849</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Can the virus be transmitted asymptomatically or during the incubation period?</td>\n",
       "      <td></td>\n",
       "      <td>The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>How does weather, heat, and humidity affect the transmission of COVID 19?</td>\n",
       "      <td>the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission</td>\n",
       "      <td>The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.</td>\n",
       "      <td>0.990806</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>How long can the COVID 19 virus remain viable on common surfaces?</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?</td>\n",
       "      <td>a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission</td>\n",
       "      <td>Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.</td>\n",
       "      <td>0.995006</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?</td>\n",
       "      <td>to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.</td>\n",
       "      <td>In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.</td>\n",
       "      <td>0.991068</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?</td>\n",
       "      <td>interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters</td>\n",
       "      <td>One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.</td>\n",
       "      <td>0.988067</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>What is the Implementation of diagnostics and products to improve clinical processes?</td>\n",
       "      <td>a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.</td>\n",
       "      <td>The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.</td>\n",
       "      <td>0.995304</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>What risk factors contribute to the severity of COVID 19?</td>\n",
       "      <td>patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality</td>\n",
       "      <td>Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.</td>\n",
       "      <td>0.992492</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>How does hypertension affect patients?</td>\n",
       "      <td>to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.</td>\n",
       "      <td>One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.</td>\n",
       "      <td>0.992428</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>How does heart disease affect patients?</td>\n",
       "      <td>to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability</td>\n",
       "      <td>Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up</td>\n",
       "      <td>0.981140</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>How does COPD affect patients?</td>\n",
       "      <td>a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.</td>\n",
       "      <td>COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.</td>\n",
       "      <td>0.982809</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>How does smoking affect patients?</td>\n",
       "      <td>is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.</td>\n",
       "      <td>COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.</td>\n",
       "      <td>0.990938</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>How does pregnancy affect patients?</td>\n",
       "      <td>conditions associated with high-risk pregnancy</td>\n",
       "      <td>Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.</td>\n",
       "      <td>0.988653</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>What is the fatality rate of COVID 19?</td>\n",
       "      <td>is lower than that of 2003-sars</td>\n",
       "      <td>Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.</td>\n",
       "      <td>0.172076</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>What public health policies prevent or control the spread of COVID 19?</td>\n",
       "      <td>policies on the use of respiratory protection for hospital health workers. a new infection control system.</td>\n",
       "      <td>The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.</td>\n",
       "      <td>0.985679</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Can animals transmit COVID 19?</td>\n",
       "      <td>covid-19 was transmitted in a more diverse way. initiation of a new infection control system</td>\n",
       "      <td>Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.</td>\n",
       "      <td>0.971591</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>What animal did COVID 19 come from?</td>\n",
       "      <td></td>\n",
       "      <td>Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>What real-time genomic tracking tools exist?</td>\n",
       "      <td>to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation</td>\n",
       "      <td>Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.</td>\n",
       "      <td>0.985532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>What geographic variations are there in the genome of COVID 19?</td>\n",
       "      <td></td>\n",
       "      <td>As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (&gt;50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>What efforts are being done in Asia to prevent further outbreaks?</td>\n",
       "      <td>to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures &amp; practices on early identification &amp; appropriate isolation practices along with supplemental infection prevention &amp; control measures</td>\n",
       "      <td>The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.</td>\n",
       "      <td>0.987362</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                Questions  \\\n",
       "0   Is the COVID virus transmitted by aerosol, droplets, food, close contact, faecal matter, or water?                                      \n",
       "1   How long is the incubation period for the virus in humans?                                                                              \n",
       "2   How does the incubation period in humans vary across age and health conditions?                                                         \n",
       "3   Can the virus be transmitted asymptomatically or during the incubation period?                                                          \n",
       "4   How does weather, heat, and humidity affect the transmission of COVID 19?                                                               \n",
       "5   How long can the COVID 19 virus remain viable on common surfaces?                                                                       \n",
       "6   How personal effective are the protective equipment (PPE) in reducing the risk of transmission in health care and community settings?   \n",
       "7   What is the effectiveness of movement control strategies to prevent secondary transmission in health care and community settings?       \n",
       "8   What are the tools and studies to monitor phenotypic change and potential adaptation of the virus?                                      \n",
       "9   What is the Implementation of diagnostics and products to improve clinical processes?                                                   \n",
       "10  What risk factors contribute to the severity of COVID 19?                                                                               \n",
       "11  How does hypertension affect patients?                                                                                                  \n",
       "12  How does heart disease affect patients?                                                                                                 \n",
       "13  How does COPD affect patients?                                                                                                          \n",
       "14  How does smoking affect patients?                                                                                                       \n",
       "15  How does pregnancy affect patients?                                                                                                     \n",
       "16  What is the fatality rate of COVID 19?                                                                                                  \n",
       "17  What public health policies prevent or control the spread of COVID 19?                                                                  \n",
       "18  Can animals transmit COVID 19?                                                                                                          \n",
       "19  What animal did COVID 19 come from?                                                                                                     \n",
       "20  What real-time genomic tracking tools exist?                                                                                            \n",
       "21  What geographic variations are there in the genome of COVID 19?                                                                         \n",
       "22  What efforts are being done in Asia to prevent further outbreaks?                                                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Model_Sum_Answer  \\\n",
       "0   the transmission modes of sars-coronavirus appear to be through droplet spread, close contact and fomites. through direct or indirect physical contact, droplets or aerosols. when transmission is via aerosols, droplets, or fomites (contaminated surfaces).                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1   is the delay from infection until onset of symptoms, and varies from person to person                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "2   between shorter incubation period and greater severity in both groups after adjusting for potential confounders. conclusions : our findings suggest that patients with a shorter. the incubation period is the delay from infection until onset of symptoms, and varies from person to person. this study evaluated whether and when the infected but asymptomatic cases during the incubation period could infect others. we evaluated the potential of transmission during the incubation period in 50 infection clusters, including 124 cases. results : the estimated mean incubation period for covid-19 was 4.                                            \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "4   the temperature variation and humidity may be important factors affecting the covid-19 mortality. with warm weather, we found a dose-response relationship between relative humidity and the odds for ld. heating inactivation of samples at 56 [UNK] prior to testing is considered a possible method to reduce the risk of transmission. patients with respiratory symptoms are at greater risk of covid-19 transmission                                                                                                                                                                                                                                      \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "6   a crucial means of preventing influenza pandemics. a primary strategy to protect health care personnel (hcp) from infectious diseases. designed to arrest nosocomial transmission                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "7   to increase infection control capacity in affected areas and areas at increased risk of being affected to prevent transmission in health care settings. vaccines and antiviral agents are urgently needed. overall, our knowledge about the epidemiologic characteristics of mers-cov that impact health care transmission is very limited.                                                                                                                                                                                                                                                                                                                     \n",
       "8   interviews, site visitations, and an accommodation survey. the ring dosimeters and eye lens dosimeters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n",
       "9   a coordinated implementation plan. abstract background : parallel to its technical development starting in the 1930s, electron microscopy (em) became an important tool in basic and clinical virology. first utilized in the rapid diagnosis of smallpox, it developed to a diagnostic routine in the early 1960s using the negative staining technique. em was applied to infected cell-cultures and also to â€˜ dirty â€™ specimens including urine, feces, vesicle fluid, liquor.                                                                                                                                                                               \n",
       "10  patients with respiratory symptoms. the diagnosis, infection control, and treatment. conclusions low platelet count is associated with increased risk of severe disease and mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "11  to clinically devastating complications. failure of salt to mobilise renal dopamine. a major risk factor for stroke, coronary events, heart and renal failure. with imminent heart failure and in reverse remodeling. the status of the heart failure patients were checked before and after crt. biochemical (ace and sace2 activity, ace concentration) and echocardiographic parameters (ef, left ventricular end-diastolic (edd) and end-systolic diameter (esd) and dp / dt) were measured. sace2 activity negatively correlated with ef and positively with esd and edd in all patient ' s populations, while it was independent in the healthy cohort.   \n",
       "12  to substantial cardiac damage and severe acute heart failure. the most common cause of death and disability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n",
       "13  a major incurable global health burden and is currently the 4th largest cause of death in the world. by persistent airflow limitation and an abnormal inflammatory response of the lung. some patients with copd are prone to frequent exacerbations, which are an important determinant of health status. such patients have elevated airway cytokine levels. improve patients ' self-management.                                                                                                                                                                                                                                                              \n",
       "14  is not associated with severity of coronavirus disease. why smokers are particularly likely to develop severe sars-cov-2 infections. a substantial reduction in the biological activity of smoke from the test cigarette when compared with the reference. a reduction in the hospitalization of asthmatic children.                                                                                                                                                                                                                                                                                                                                            \n",
       "15  conditions associated with high-risk pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "16  is lower than that of 2003-sars                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "17  policies on the use of respiratory protection for hospital health workers. a new infection control system.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "18  covid-19 was transmitted in a more diverse way. initiation of a new infection control system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "20  to clinical laboratory diagnostics. â€“ time-varying contact network construction, individual-level transmission tracking and hai parameter estimation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "22  to cases isolation and contact tracing measures. efforts should be made to evaluate the most promising treatments and vaccines in controlled clinical trials. infectious diseases and regional security. we actively implemented policies, procedures & practices on early identification & appropriate isolation practices along with supplemental infection prevention & control measures                                                                                                                                                                                                                                                                     \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sum_Reference_answers  \\\n",
       "0   Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 ? In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces.                                                                                                                                                                                                                                                        \n",
       "1   An incubation period is the time between when you contract a virus and when your symptoms start. Currently, according to the Centers for Disease Control and Prevention (CDC)Trusted Source, the incubation period for the novel coronavirus is somewhere between 2 to 14 days after exposure. However, this estimate may change as we learn more about the virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "2   The COVID-19 pandemic has shown a markedly low proportion of cases among children. As per  estimate based on analysis from  'Nature Medicine' , the susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12â€“31%) of infections in 10- to 19-year-olds, rising to 69% (57â€“82%) of infections in people aged over 70 years. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.                                                                                                                                                                                                                                                                      \n",
       "3   The new coronavirus can be transmitted by people who are infected but before their symptoms appear â€“ pre-symptomatic carriers. There is evidence that infected people who never develop symptoms â€“ asymptomatic carriers â€“ can also transmit coronavirus. While pre-symptomatic carriers appear to be an important source of infection, the role of asymptomatic carriers is less clear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "4   The main findings as per one of the studies related to effects of environemnt on COVID 19 are: Hot  and  dry  weather  can  reduce  infections  caused  by  droplet  contact,  but  the  risk  of transmission via aerosol particles is increased. Improper design of ventilation systems can dramatically increase the traveling distance of both droplets and aerosol particles,and consequently increases the likelihood of infections in both modes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \n",
       "5   As per one of the studies, people may acquire the coronavirus through the air and after touching contaminated objects. Scientists discovered the virus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "6   Personal protective equipmenthas become an important and emotive subject during the current coronavirus (COVID-19)epidemic. COVID-19 is predominantly causedby contact or droplet transmissionattributed to relatively large respiratory particles which are subject to gravitational forces and travel only approximately onemetrefrom the patient. Appropriate use significantly reduces risk of viral transmission. Recommendations from international organisations are broadly consistent, but equipmentuse is not. Uncertainty remains around certain details of personal protective equipmentincluding use of hoods, mask type and the potential for re-use of equipment.                                                                                                                                                                                                                                                      \n",
       "7   In COVID-19, which has no approved treatment, it is very important to prevent the spread in the society. The main points in preventing the spread in society are hand hygiene, social distancing and quarantine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n",
       "8   One of the studies, revealed a number of unreported mutations, which cover both mismatches and deletions in translated and untranslated regions of the SARS-CoV-2 genomes. Moreover, the identification of the conformational changes in mutated protein structures and untranslated cis-acting elements is of significance for studying the virulence, pathogenicity and transmissibility of SARS-CoV-2. This mutational diversity should be investigated by further studies, including their metabolic functional pathway, intra-viral and virus-host interactions analyses.                                                                                                                                                                                                                                                                                                                                                        \n",
       "9   The availability of established diagnostic technologies have enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Lessons learned from the 2002 SARS outbreak have guided the development of COVID-19 identification and detection. Transmission electron microscopy was used to identify the morphology of the virus, genome sequencing was used to confirm the identity of the virus, and sequence data were used to help design PCR primers and probes. These approaches provide a first line of defense against an outbreak. The next step being worked on is to establish serological tests because they are easier to administer and may complement nucleic acid tests for diagnosing COVID-19 infection. In conclusion, diagnostics are an important part of the toolbox for dealing with outbreaks because they enable healthcare workers to direct resources and efforts to patients with COVID-19.   \n",
       "10  Studies have indicated that conditions and comorbidities connected to a poor state of health such as high age, obesity, diabetes and hypertension are risk factors for severe and fatal disease courses. Furthermore, severe and fatal courses are associated with organ damages mainly affecting the heart, liver and kidneys. Time to hospital admission, tuberculosis, inflammation disorders and coagulation dysfunctions are identified as risk factors found in the review but not mentioned by the public authorities.                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "11  One of the comparative analysis of COVID-19 patients with and without hypertension showed that hypertensive patients had greater disease severity and adverse progression than nonhypertensive patients. In addition, there were more severe symptoms; greater likelihood of other complications, such as diabetes; more likelihood of transfer to the ICU; and worse laboratory indicators. COVID-19 patients with hypertension need additional attention to prevent adverse outcomes.                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "12  Coronavirus affects the respiratory system, mainly the lungs. So, heart patients need to take additional, reasonable precautions in order to cut down their risk. Heart patients who are considered to be at increased risk of developing COVID-19 are those who have:\\nHistory of heart attack or stroke\\nChronic heart failure\\nHeart valve disease\\nConditions that affect heart rhythms, including atrial fibrillation\\nPeripheral artery disease\\nNarrowed blood vessels due to plaque build-up                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "13  COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. The  recent evidence that COPD patients and smokers may display the machinery required for SARS-CoV-2 cellular entry differently has come to light.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "14  COVID-19 is an infectious disease that primarily attacks the lungs. Smoking impairs lung function making it harder for the body to fight off coronaviruses and other diseases. Available research suggests that smokers are at higher risk of developing severe disease and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n",
       "15  Researchers are still learning how COVID-19 affects pregnant women. Pregnant women with some health conditions, such as obesity and gestational diabetes, may have an even higher risk of severe illness, similar to nonpregnant women with these conditions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "16  Initially, the World Health Organisation (WHO) estimated that the percentage of infected individuals who die from COVID-19 was 3.4%. As time has gone on, it has become clear that the true risk of death is much lower. But current estimates fall anywhere between 0.2% and 1%, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n",
       "17  The following actions help prevent the spread of COVID-19, as well as other coronaviruses and influenza:\\nAvoid close contact with people who are sick. High touch surfaces include counters, tabletops, doorknobs, bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables. A list of products suitable for use against COVID-19 is available here. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.                                                                                                                                                                                                                                                                                                                                                               \n",
       "18  Based on the limited available information, the risk of animals spreading the COVID-19 virus to people is considered low. Animals don't appear to play a significant role in spreading the virus that causes COVID-19. There is no evidence that viruses can spread to people or other animals from a pet's skin, fur or hair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n",
       "19  Current data indicate that SARS-CoV-2 originated directly or indirectly from a bat coronavirus, but these findings remain suggestive rather than conclusive because genetic and other investigations are still at a preliminary stage.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "20  Several methods exist for scientists to sequence an RNA virus like SARS-CoV-2. One common technique begins with collecting viral RNA and breaking it into small fragments. Scientists then transcribe the sequences into DNA and amplify them with polymerase chain reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "21  As per one of the analysis of of 48,635 SARS-CoV-2, a total of 353,341 mutation events were highlighted compared to the NC_045512.2 Wuhan reference genome. While 256 samples, mostly originating from Asia, did not have any difference from the reference, 48,379 samples possessed at least one mutation. On the other hand, one would expect China to have a lower number of mutations, being the likely point of origin of SARS-CoV-2 (Ceraolo and Giorgi, 2020), and indeed the distribution of mutations per sample seems to suggest that; however, a small number of sequences carrying a very high number (>50) of mutations are associated to China, shifting the distribution for this country. Upon manual inspection, these sequences do not appear to share similarities between each other, and are likely the product of technical sequencing errors.                                                                 \n",
       "22  The wearing of masks and social distancing have been common practices that have been followed in Asia to prevent COVID 19 spread. In East Asian countries, technology for contact for contact tracing has been extensively used for prevention of COVID 19 outbreaks and flattening the curve. In South Korea, private developers took it upon themselves to develop apps that supplement official government contact tracing efforts, which many find insufficient.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "    similarity_score  \n",
       "0   0.977838          \n",
       "1   0.980423          \n",
       "2   0.970849          \n",
       "3   0.000000          \n",
       "4   0.990806          \n",
       "5   0.000000          \n",
       "6   0.995006          \n",
       "7   0.991068          \n",
       "8   0.988067          \n",
       "9   0.995304          \n",
       "10  0.992492          \n",
       "11  0.992428          \n",
       "12  0.981140          \n",
       "13  0.982809          \n",
       "14  0.990938          \n",
       "15  0.988653          \n",
       "16  0.172076          \n",
       "17  0.985679          \n",
       "18  0.971591          \n",
       "19  0.000000          \n",
       "20  0.985532          \n",
       "21  0.000000          \n",
       "22  0.987362          "
      ]
     },
     "execution_count": 163,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_dt_v2[[\"Questions\",\"Model_Sum_Answer\", \"Sum_Reference_answers\", \"similarity_score\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Code after this is test and failed code due to technical issues"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "torch.Size([1, 168])\n"
     ]
    },
    {
     "ename": "RuntimeError",
     "evalue": "bool value of Tensor with more than one value is ambiguous",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-125-1191c71a74f0>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      7\u001b[0m                                                \u001b[0mlength_penalty\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m1.2\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      8\u001b[0m                                                \u001b[0mmax_length\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m5\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 9\u001b[0;31m                                                early_stopping=True)\n\u001b[0m\u001b[1;32m     10\u001b[0m                                                \u001b[0;31m#no_repeat_ngram_size=4)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     11\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0msum_ids\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m/mnt/disks/user/anaconda3/lib/python3.7/site-packages/torch/autograd/grad_mode.py\u001b[0m in \u001b[0;36mdecorate_no_grad\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     41\u001b[0m         \u001b[0;32mdef\u001b[0m \u001b[0mdecorate_no_grad\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     42\u001b[0m             \u001b[0;32mwith\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 43\u001b[0;31m                 \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     44\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mdecorate_no_grad\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     45\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m/mnt/disks/user/anaconda3/lib/python3.7/site-packages/transformers/generation_utils.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self, input_ids, decoder_input_ids, max_length, min_length, do_sample, early_stopping, num_beams, temperature, top_k, top_p, repetition_penalty, bad_words_ids, bos_token_id, pad_token_id, eos_token_id, length_penalty, no_repeat_ngram_size, num_return_sequences, attention_mask, decoder_start_token_id, use_cache, **model_kwargs)\u001b[0m\n\u001b[1;32m    350\u001b[0m         \u001b[0;31m# create attention mask if necessary\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    351\u001b[0m         \u001b[0;31m# TODO (PVP): this should later be handled by the forward fn() in each model in the future see PR 3140\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 352\u001b[0;31m         \u001b[0;32mif\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mattention_mask\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m \u001b[0;32min\u001b[0m \u001b[0minput_ids\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    353\u001b[0m             \u001b[0mattention_mask\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0minput_ids\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mne\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlong\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    354\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mattention_mask\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mRuntimeError\u001b[0m: bool value of Tensor with more than one value is ambiguous"
     ]
    }
   ],
   "source": [
    "#Creating summary using BART summarizer\n",
    "# As can be seen by below error, this BART library did not work on the Nimblebox environment\n",
    "# and so had to study and consider other summarization model or BART library\n",
    "#bart_sum_input_ids = sum_tokenizer.batch_encode_plus([bart_answ], return_tensors='pt', max_length=1024, truncation = True)['input_ids'].to(torch_device)\n",
    "#print(bart_sum_input_ids.shape)\n",
    "#bart_sum_input_ids_lt = bart_sum_input_ids[0].tolist()\n",
    "#sum_ids = sum_model.generate(bart_sum_input_ids,\n",
    "                                               #num_beams=4,\n",
    "                                               #length_penalty=1.2,\n",
    "                                               #max_length=5,\n",
    "                                               #early_stopping=True)\n",
    "                                               #no_repeat_ngram_size=4)\n",
    "#print(sum_ids)\n",
    "#bart_sum = sum_tokenizer.decode(sum_ids.squeeze(), skip_special_tokens=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Truncation was not explicitely activated but `max_length` is provided a specific value, please use `truncation=True` to explicitely truncate examples to max length. Defaulting to 'longest_first' truncation strategy. If you encode pairs of sequences (GLUE-style) with the tokenizer you can select this strategy more precisely by providing a specific strategy to `truncation`.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tensor([[    0,  2387,   964,    32,  3035,    53,    51,  3529,   350,   171,\n",
      "         33237,     4,     2]])\n"
     ]
    },
    {
     "ename": "RuntimeError",
     "evalue": "bool value of Tensor with more than one value is ambiguous",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-12-d8381b0b566a>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mbart_sum_input_ids\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;31m# Generate Summary\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 5\u001b[0;31m \u001b[0msummary_ids\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0msum_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mbart_sum_input_ids\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mnum_beams\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m4\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mmax_length\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m5\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mearly_stopping\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      6\u001b[0m \u001b[0;31m#bart_sum = sum_tokenizer.decode(summary_ids.squeeze(), skip_special_tokens=True)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m/mnt/disks/user/anaconda3/lib/python3.7/site-packages/torch/autograd/grad_mode.py\u001b[0m in \u001b[0;36mdecorate_no_grad\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m     41\u001b[0m         \u001b[0;32mdef\u001b[0m \u001b[0mdecorate_no_grad\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     42\u001b[0m             \u001b[0;32mwith\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 43\u001b[0;31m                 \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     44\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mdecorate_no_grad\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     45\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m/mnt/disks/user/anaconda3/lib/python3.7/site-packages/transformers/generation_utils.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self, input_ids, decoder_input_ids, max_length, min_length, do_sample, early_stopping, num_beams, temperature, top_k, top_p, repetition_penalty, bad_words_ids, bos_token_id, pad_token_id, eos_token_id, length_penalty, no_repeat_ngram_size, num_return_sequences, attention_mask, decoder_start_token_id, use_cache, **model_kwargs)\u001b[0m\n\u001b[1;32m    350\u001b[0m         \u001b[0;31m# create attention mask if necessary\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    351\u001b[0m         \u001b[0;31m# TODO (PVP): this should later be handled by the forward fn() in each model in the future see PR 3140\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 352\u001b[0;31m         \u001b[0;32mif\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mattention_mask\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m \u001b[0;32min\u001b[0m \u001b[0minput_ids\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    353\u001b[0m             \u001b[0mattention_mask\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0minput_ids\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mne\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpad_token_id\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlong\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    354\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mattention_mask\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mRuntimeError\u001b[0m: bool value of Tensor with more than one value is ambiguous"
     ]
    }
   ],
   "source": [
    "# Error generating test code for BART model not working\n",
    "#ARTICLE_TO_SUMMARIZE = \"My friends are cool but they eat too many carbs.\"\n",
    "#bart_sum_input_ids = sum_tokenizer([ARTICLE_TO_SUMMARIZE], max_length=1024, return_tensors='pt')['input_ids']\n",
    "#print(bart_sum_input_ids)\n",
    "# Generate Summary\n",
    "#summary_ids = sum_model.generate(bart_sum_input_ids, num_beams=4, max_length=5, early_stopping=True)\n",
    "#bart_sum = sum_tokenizer.decode(summary_ids.squeeze(), skip_special_tokens=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3.7.3\n"
     ]
    }
   ],
   "source": [
    "from platform import python_version\n",
    "print(python_version())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [],
   "source": [
    "import tensorflow as tf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2.2.0'"
      ]
     },
     "execution_count": 129,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tf.__version__ "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "accelerator": "GPU",
  "colab": {
   "name": "word_rnn.ipynb",
   "provenance": [],
   "version": "0.3.2"
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
